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Stimulated by the outbreak of type B hepatitis in the renal
dialysis and transplant unit in which both patients and staff died,
a frozen blood bank has been established in the Edinburgh Blood
Transfusion Service. The method adopted in freezing utilizes a low
concentration of glycerol, a penetrating additive, to protect the red
blood cells against the damaging effects of freezing. The glycerolized
erythrocytes, placed in aluminium cans, are frozen rapidly in liquid
nitrogen and stored in the vapour phase for as long as required.
Only group "0" Rh-positive and group "0" Rh-negative blood is used
for freezing and typing for other blood group antigens is performed as
far as the availability of antisera permits.
Deglycerolization is accomplished by serial centrifugal "batch
washing" either manually in five-tailed Tuta bag or automatically in
the IBM 2991 Cell Processor. A comparative study between both methods
showed that automatic washing in the IBM offers the following
advantages.
1. Being an automatic process it saves both time and effort of the
operator.
2. It gives higher red cell recoveries.
3. It washes better as evidenced by the residual glycerol and
sorbitol content of the supernatant fluid.
4. As the number of open manipulations are limited, blood processed
by the IBM 2991 is lass liable to bacterial contamination and thus
can be stored at 4°C for longer periods than that processed
manually.
Immediately after processing and resuspension in isotomic saline
the red blood cell have an acceptable level of intracellular potassium,
2,3 DPG and ATP content. However, on further storage at 4°C the
cells were unstable and showed a high rate of autohaemolysis evidenced
by the rapidly increasing levels of extracellular potassium and free
haemoglobin.
After exhaustive studies we found that the reconstitution of the
processed erythrocytes in an equal volume of a medium made up from
isotomic saline and "(0 ml acid-citrate-dextrose solution remarkably
improved the post-thaw stability. Thus, there was a four fold
reduction in the supernatant free haemoglobin whereas the extracellular
potassium was reduced to half of its concentration n isotonic saline
alone. This effect is due to the low pH and citrate content oT the
ACD solution.
Bacteriological studies on blood processed in the IBM 2991 and
reconstituted in saline-ACT) medium showed that this blood was sterile
for at least ten days of post-thaw storage at 4°C. During this period
the blood had acceptable levels of extracellular free haemoglobin
and potassium whilst the intracellular potassium and organic phosphate
content was still satisfactory after five days.
In vivo survival studies were performed in healthy volunteers
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using radioactive chromium ( Cr) as a red cell label and radioactive
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I iodinated human serum albumin to measure the plasma volume.
Complete units of frozen-washed red cells were transfused to the
original donors and the survival of the lagged cells was measured at
24 hours and at weekly intervals after that for four successive weeks.
The results obtained for five-day old (post-thaw) blood were compared
to those of previously frozen-washed erythrocytes . nfused immediately
after processing. Both the 24-hour survivals and the half-life times
were comparable in either case.
We have also investigated the leucocyte and platelet content of
blood frozen and processed according to our protocol, by several
different methods. Using the conventional haematological techniques
of counting we found that the final red cell suspension contained 5-6%
of the original leucocytes in the form of intact lymphocytes, whilst
the polyraorphnuclear cells and platelets disappeared completely.
The viability of these cells was assessed by two different methods.
The dye exclusion technique showed the absence of any viable cells
whilst a low response to PHA stimulation was detected in lymphocyte
culture.
However, using the radioactive assay technique in which the cell
membrane of either lymphocytes, granulocytes or platelets was labelled
12S
with I - Na - I and added to the blood before freezing, we found
that approximately one third of the labelled leucocyte material and
2$ of the platelet material remained in the final product after
processing. However, most of the remaining leucocyte-derived material
could be removed either by passing the blood through a Swank Blood
Transfusion Filter or by removing the buffy coat after each centrifugal
wash step. Although the latter technique was more efficient, it
results in higher loss of red blood cells. When the remaining
leucocytes were cultured in vitro with incompatible lymphocytes in a
one-way mixed lymphocyte reaction no evidence of transformation could
be detected indicating that these cells were not antigenic; to foreign
cells. However, when the antigen status of the frozen blood as a
whole was studied in vivo by injection into laboratory an:mals and
the results were compared to those of fresh blood, we found that
frozen-washed blood was able to stimulate antibody production against
human lymphocytes. However, the levels of antibody produced from the
injection of fresh blood were much higher than those induced by the
infusion of frozen-washed red cells, whilst the latter could be
diminished further by passing the blood through a Swank Blood Trans¬
fusion Filter prior to injection.
Following these experimental studies a frozen blood bank was
established for therapeutic use. Since the establishment of the bank,
frozen blood is given to the following categories of patientsi
1. Patients suffering from thalassaemia major.
2. Patients in the medical renal dialysis and transplant unit.
3. Chronic anaemic patients who require regular blood transfusions.
Experiences with more than one thousand unit transfused to these types
of patients showed the efficacy of frozen blood in restoring their
haemaglobin levels to normal and in preventing Jebrile transfusion
reactions in multiple transfused patients, which would otherwise
occur with fresh blood transfusions.
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INTRODUCTION
HISTORY
The evolution of blood transfusion has been reviewed by Zimmerman
in 1942 and by Hurn in 1968. Blood has always been linked with life
and health. One of the earliest beliefs was that blood carried the
secret of life which flowed out of the body with the streaming of
blood. For this reason blood has always been used as a drug for
restoring life and improving health. Ancient Egyptians have used
baths of blood for resuscitation and treatment (Zimmerman 1942).
Roman spectators used to rush into the arenas to suck the flowing
blood from the necks of the tidying gladiators.
The consideration of blood for transfusion only started after the
discovery of the circulation by Harvey in 1616. This discovery
stimulated interest in infusion and transfusion. Thus the first
intravenous infusion was performed forty years after Harvey's discovery
by an English astronomer and architect Christopher Wren. Using a
bladder tied to a quill, Wren was able to infuse some drugs into the
veins of dogs (Zimmerman and Howell 1932).
The first blood transfusion from one dog to another was also
performed in England by the British anatomist and physician Richard
Lower in I665. One dog was bled to the point of death, then, its
vein was connected to the artery of another healthy dog. The operation
was highly successful and both animals survived.
Jean Baptists Denis of France in 1667 carried out the first human
transfusion using sheep's blood. Denis's first trial seemed successful,
but repitition of the process into the same patient ended with the
first mortality from blood transfusion. A complaint from the widow
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against Deni3 brought about a parliamentary act to ban the whole
operation- Following this disaster the first chapter in the history
of blood transfusion was closed.
A hundred and fifty years passed before James Blundell, an Egnlish
obstetrician, revived the interest in blood transfusion once more.
Inspired by the high mortality rate among women suffering from post¬
partum haemorrhage, Blundell raised the question of restoring the lost
blood to these patients. Using a more scientific approach than his
predecessors, he began experiments on animals and came to the conclusion
that only blood from the same species was effective in saving animals
suffering from fatal haemorrhage.
Based on this theory Blundell performed the first human transfusion
with human blood. All the first four trials failed, but because he
was convinced and determined to succeed, Blundell carried out several
other experiments which were all successful. Blundell also introduced
a three-way syringe for transferring the blood from the donor to
recipient without undergoing vascular anastomosis. This success
brought back blood transfusion practice into notice and led to its
spread to many countries. Also the indications for blood transfusion
were extended from cases of anaemia and acute haemorrhage to include
chronic infections and debilitating diseases, burns, uremia, syphilitic
and mad patients. However the operation remained dangerous and
surrounded with some mystery; success in one case followed failure in
another.
In the year 1900 the problem was eventually solved by the discovery
of the human blood groups and iso-agglutinins by Landsteiner. Soon
after this discovery immunological tests for grouping and selecting
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donors were introduced and thus the hazards of blood transfusion were
eliminated and widespread application was possible.
In spite of the adoption of blood transfusion in many countries,
the actual technique of the operation remained difficult, tedious and
complicated. Further more, emergency operations were practically
impossible. At first blood had to be transfused by direct anastomosis
of the donor's artery with the recipient's vein, an operation which
was full of potential complications. Later, many devices were
introduced for direct transfusion of fresh blood; however, clotting
within the apparatus constituted the major difficulty in application.
It was, therefore, evident that in order to make maximum use of blood
transfusion in practice, methods of preserving the blood unclotted must
be found.
In 1914 Hustin in Belgium discovered the effect of sodium citrate
in preventing coagulation of blood before transfusion. This was
considered a major achievement in the practice of blood transfusion
because for the first time it became possible to separate the recipient
away from the donor during transfusion. Hustin made no attempt to
preserve the blood which was used immediately after collection.
Nevertheless, later experience with citrated blood showed that it had
a tendency for rapid haemalysis if stored for more than one weak.
In 1916 Rous and Turner discovered that the addition of glucose to
the blood-citrate mixture greatly prolonged the shelf life of the blood
without loss of its viability. The preservative mixture suggested by
them was as follows
2 parts of isotonic citrate (3.8$ Sodium citrate in water)
5 parts of isotonic dextrose (5-4'$ dextrose in water)
3 parts of blood
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Rous-Turner mixture was efficiently used during World War I and remained
unchallenged after that for almost two decades. However the
beneficial effect of glucose in delaying haemolysis has not been
explained until twenty-five years later, when Aylward et al (1940) and
Maizels (1941) suggested that it is metabolized by the red cell. In
this way the breakdown of organic phosphates, which otherwise took
place, was delayed. Glucose also helps the red-cell membrane to
maintain its relative impermeability to cations and thus prevents
swelling of the red-cell on storage (Maizels 1941). Furthermore, the
progressive increase in red-cell fragility which normally occurs on
storage in the absence of glucose is greatly reduced in its presence
(Maizels 1941 - Rapoport 1947)*
"Just as one cannot draw money from a bank unless one has deposited
some, so the blood preservation department cannot supply blood unless
as much comes in as goes out". On this simple principle Pantus (1937)
started the first "blood bank" at the Cook County Hospital in the
United States. The establishment of this "blood bank" has made the
use of stored blood an easy techniaue in .America and Europe. Storage
of blood had greatly economized both time and effort and made available
more blood for transfusion.
By the year 1940 the anti-coagulant-preservative mixture used in
the United Kingdom was the M.R.C. solution and was composed of:-
100 ml y$t trisodium citrate
20 ml 15/6 glucose
to be mixed with 420 ml of blood
However because the citrate solution has an alkaline reaction,
caramalization of glucose was inevitable when the two compounds were
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autoclaved together. Each solution was autoclaved separately and
then both are mixed under aseptic conditions (Loutit et al. 1943).
Acidification of the preservative mixture was originally suggested
by Maizels and Whittaker in 1940 when they found that it had a
beneficial effect in preventing in vitro haemolysis during storage.
Loutit et al. 1943 investigated the effect of acidification of
the glucose-citrate mixture on prevention of caramalization of glucose
during autoclaving. They reported that acidification not only
inhibited caramalization but also improved the preservative power of
the mixture as evidenced by in vivo survival of the red cells after
infusion. Loutit and Mollison 1943 recommended the following solution
to replace the standard M.R.C. mixture:-
Disod. citrate (monohydric) 2g
Dextrose (anhydrous) 3g
Water 120ml
to be mixed with 420 ml of blood.
Further investigations showed that a decrease in the pH of the
preservative solution, adds io the effect of glucose in slowing the
progressive increase in fragility during storage and in retarding the
permeation of cations.
By the year 1947 it was obvious that whole blood could be collected
into ACD anticoagulant, stored at +4°C for 21 days and still remain
clinically acceptable for transfusion. However at the end of this
period the 24 hour post-transfusion survival is only 10i (Valeri 1968a),
the oxygen transport function has deteriorated (Valtis and Kennedy 1954),
and the 2,3 DPG content has reached zero (Blagdon 1972). Because of
the progressive deterioration of the blood in ACD much effort has been
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devoted to prolonging the storage period of blood as well as to improve
its physiological function after storage.
Gibson et al. (1957) suggested that the viability of stored blood
collected on ACD anticoagulant was mainly determined by the amount of
damage imposed during collection, "lesion of collection". In order
to minimize the severity of this lesion they developed a "Citrate-
phosphate-dextrose" (CPD) preservative mixture. The use of such
preservative has extended the shelf-life of stored blood from 21 days
to 28 days. Compared with ACD, CPD showed slightly less haemolysis,
decrease in the amount of potassium leak from the cells and higher in
vivo survival. Furthermore the citrate content was 20$ less than
ACD, and this means decreased risk of citrate intoxication and serum
calcium depression. Finally, CPD was found to be a better medium for
the maintainance of the red-cell 2,3 DPG (Mollison 1972),
Supplementation of either ACD or CPD with puiine nucleoside,
adenine, maintained the red-cell viability for a longer period than CPD
alone (Mollison 1972)•Akerblom et al (1967) reported their experience
with over 5,000 transfusions of blood collected on ACD - adenine. No
untowards clinical reactions were observed with the use of this blood
even after multiple transfusions. They recommended its use without
reservation for transfusing adult recipients, however, care should be
taken with exchange transfusion in newborn infants.
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FREEZING
Adequate supplies for all contingencies has long been the ambition
of blood banks throughout the world. It is important to insure
availability of blood in time of major disaster and to compensate for
the fluctuation of supply and demand. Stored blood progressively
loses its viability. This loss of viability is believed to be due to
continuation of glycolysis outside the body (Sloviter and Ravdin 1965)-
Slowing of the rate of glycolysis and thus improvement of viability
could be achieved through reduction of the storage temperature. Thus
storing of blood at +4°C prolonged its shelf-life to three weeks.
It is regretable that additional prolongation of the storage period
through further decrease of temperature is impossible, for the extent
of the reduction of temperature is limited by the fact that red blood
cells tend to haemolyse rapidly if frozen below -3°C (Meryman 1964).
A solution for this problem was found by Polge, Smith and Parkes (1949)
when they discovered that glycerol could protect fowl spermatozoa
against freezing injury. Luyet in 1949 also reported his success in
recovering intact red blood cells after very rapid freezing and
thawing, 200°C per second, without any protective. Thin layers of
blood supported on glass slides were rapidly frozen, by direct
immersion in liquid nitrogen, then rapidly thawed in warm saline.
Most of the cells were recovered morphologically intact.
Smith, in 195° extended and adapted the work, of Polge et al. to
the red blood cells. She showed that, in the presence of glycerol,
human red blood cells could be frozen and thawed without major
haemolysis.
e
Following these findings preservation of blood by freezing has
followed two different lines. One method utilized rapid rates of
cooling with extracellular additives and the other slow cooling rates
in the presence of glycerol or similar compounds that penetrate the
red cell membrane.
In order to produce its action, glycerol has to permeate the red
cell (Lovelock 1953b). Ironically it is this permeation that has
produced many of the practical problems, because glycerol has to be
washed out of the cell before transfusion (Sloviter 1951a). Further¬
more, high concentrations of glycerol, (4.0 M) are required, to produce
full protection, and the removal of such a concentration of this viscous
material has presented major difficulties.
Rapid freezing in the absence of additives, as proposed by Luyet
(1949)> necessitates the use of very high cooling rates, 200°C per
second, and difficulties in obtaining such high rates with large
volumes of blood prevented its application in practice. Addition of
sugars and polymers, as extracellular cryoprotective agents, has made
it possible to freeze large quantities at less rapid cooling rates
and at the same time maintained high recovery of red cells (Meryman and
Kafig 1955, Doebbler and Rinfret 1962). Obviously the use of extracellular
compounds does not call for post-thaw washing, the so called "one step
approach". However, none of the extracellular cryoprotectants have
been shown to give clinically acceptable products without post-thaw
manipulation (Meryman 1968b).
It was such difficulties that led to the development of a method
which utilized a mixture of low concentrations of sugars and glycerol
(relatively easy to remove) coupled with intermediate rate of freezing
(Pert et al 1963, Krijnen et al, 1964) •
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GENERAL AND PHYSICAL ASPECTS OF FREEZING
Ice crystal formation does not normally begin as soon as the
freezing point of a solution is reached. A nucleus must be present
in the solution for ice to condense around it. This nucleus is not
formed of ice, except at very low temperatures, but of some other
particle simulating ice in configuration and happening to be present
by chance in the liquid phase. The size of the nucleus necessary to
initiate ice crystal growth depends upon the temperature of the solution
cooled (Meryman 1963). The higher the temperature the larger the
size needed. Around, the true freezing point the size of the crystal
nucleus is quite large and the chance of finding such a large sized
nucleus is very low. Thus as the temperature drops below the true
freezing point no freezing takes place and the solution is said to be
supercooled. With further drop of temperature the required size of
the nucleus necessary to start crystallization becomes less stringent
and eventually an existing nucleus becomes of critical size and thus
water begins to condense around it.
The change of phase from liquid to solid greatly limits the
movement of the water molecules and thus reduces the consumption of
energy. The excess energy is released as heat "latent heat of fusion"
and unless this heat is rapidly removed from the growing crystals, the
temperature of the solution will rise to the true freezing point and
remain there until the transition phase is complete.
In almost every living cell or tissue, slow freezing results in
extracellular nucleation and ice crystallization. An exception to
that are tissues which have been killed by previous freezing and
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thawing, further freezing of these tissues results in ice crystal
formation throughout the media (Meryman 1956 - Hurn 1968). Again
when the rate of heat removal from the medium is slow, the few growing
ice crystals will be sufficient to balance all the heat removed by
the coolant and the temperature of the solution will remain at the
freezing point where further nuclei will be of the critical size.
As the ice crystals formed grow they extract water from the
surrounding fluid and thus the electrolyte concentration of the extra¬
cellular fluid rises. The resulting high osmotic pressure removes
more water from the cells which thus become shrunken. This process
proceeds until all the available free water is consumed and the cells
are left suspended in a highly concentrated solution.
On the other hand, if the heat resulting from ice crystal growth
is removed rapidly, the few crystals formed will not be sufficient to
balance the heat lost to the coolant. Under these conditions the
temperature of the solution will continue to drop and thus more nuclei
become of critical size throughout the field and water crystallizes
around them until eventually the number of ice crystals become
sufficient to balance the heat removed. For this reason it is said
that rapid freezing results in the formation of numerous small ice
crystals which are uniformly distributed throughout the specimen but
predominantly intracellular (Meryman 1956, and Meryman 1963).
There is a considerable confusion in the literature as regards the
meaning of cooling rates. Cooling rates are often classified into
slow, rapid and ultrarapid. However, all these mean different things
to different investigators. Thus Luyet et al (1963) described a
cooling rate ranging from 25°C to 250°C per second as rapid for blood
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frozen in capillary tubes. Rinfret (i960) sprayed water on the
surface of liquid nitrogen and reported a rapid rate about 50°C per
second. Doebbler and Rinfret (1962) using aluminium tubes of
elliptical section for freezing 5 ml quantities of blood reported an
average cooling rate about 10°C per second and the rate was described
as rapid. Strumia et al (1958a, 1960a) reported a cooling rate from
3 to 7°C per second when a very thin flat metal container or Teflon
bag was cooled in dry ice-ethanol bath.
Pert et al (1964, 1965) and Krij nen et al (1965) used a rapid
rate of cooling to freeze blood suspended in low concentration of
glycerol. The average cooling rates described by Pert et al. (1963)
ranged from 0.36 up to 6.7°C per second when they immersed Teflon bags
containing 100 ml of glycerolized blood in liquid nitrogen and changed
the thickness of the surrounding layer.
This shows that the term "rapid" as used by the five groups of
investigators was very imprecise as it reflected a wide range of
velocities without consideration of the volume of sample under
investigation or the presence of protective agent. Luyet and Rapatz
(1970) classified the rate of cooling into three categories:-
(1) Rapid cooling rate: from 100 to 25°C per second
(2) Medium rate: from 5 "to 1°C per second
(3) Slow rate: from 5 to 1°C per minute
They considered a rate higher than 100°C per second or slower than 1.0°C
per minute as very high and very slow respectively.
Hums (1968) described cooling rates in various approximations,
thus 1°C per minute was described as slow cooling, a 100 C to 1000 C
per minute as rapid cooling and a rate higher than 10,000 C per minute
12
as ultrarapid.
Meryman (1956) suggested basing the concept of slow or rapid
freezing on the location of ice crystals. Thus the term "slow
freezing" designates conditions under which only extracellular
crystallization develops. "Rapid freezing" would indicate the
conditions in which the cooling rates are sufficiently high to produce
intracellular crystal formation.
SLOW FREEZING
This type of freezing could be achieved by placing the material
in a conventional deep freeze. Ice crystals are formed by the so
called "heterogeneous nucleation" (Meryman 1956 - Hum 1968). As has
been mentioned the crystals of ice are few in number and grow around a
nucleus simulating ice that is present by chance in the liquid phase.
The slow rate of freezing leads to the formation of ice crystals only
outside the cell. As the crystals of ice grow the osmolarity of the
extracellular fluid increases and water is removed from within the
cell and added to the growing crystals the cell itself becomes crenated.
This process of water withdrawal and ice crystal growth continues until
all the "available freezable" water is consumed and the cells are left
in a concentrated solution (Meryman 1956, 1963). Many types of cell3,
epidermal and muscle cells, can withstand freezing in this way without
suffering appreciable damage, for on rewarming the cellular water is
reimbibed and the cell resumes its histological features and physio¬
logical functions (Meryman 1956). Red cells however are notable
exception, they are immediately hernolyzed after slow freezing once
the temperature drops below -4°C (Lovelock 1953a).
Damage from this type of freezing is primarily attributed to the
increased concentration of electrolytes, particularly sodium chloride,
which results from freezing of water out of the solution (Lovelock
1953a, Meryman 1956). High concentrations of glycerol may be used
to protect against this type of injury. Glycerol, as well as other
similar compounds, produces its action by reducing the amount of ice
formed. These compounds tie up a great proportion of water making it
unavailable for crystallization while it is still available as solvent
for the electrolytes. In doing so the concentration of electrolytes
and cell solutes are thus reduced and haemolysis may be minimized
(Lovelock 1953a). Meryman (1956) maintained that one molecule of
glycerol can bind up three moles of water and prevent it from freezing.
Glycerol, in order to be effective as a protective agent, has to
penetrate the red cell (Lovelock 1953b) and it has been shown that those
cells which are rendered impermeable to glycerol, e.g. in the presence
of copper ions, are not protected by it. However, it is the permeation
of glycerol into the red cell which constitutes all the difficulties
surrounding its use. Because of its viscosity, removal of high
concentration of glycerol presents a major drawback for this method
(Meryman 1964). The principal obstacle was that of the washing
procedure. Continuous-flow centrifugal washing was completely
ineffective in the early days and as a consequence wash solutions of
varying composition and hypertonicity -were required to minimize osmotic
haemolysis. Excessive hypertonicity of these solutions, particularly
when they were non-electrolytes, led to electrolyte loss from the
cells (Meryrnan 1968b).
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MECHANISM OF FREEZING INJURY
1. Salt concentration theory:
The ability of investigators to preserve red blood cells for
prolonged periods at subzero temperatures has turned their attention
away from investigating into the mechanism of freeze-thaw injury and
the mode of additive protection. Thus most of the efforts have been
devoted to the empirical development of methods of freezing. Fortun¬
ately, however, the subject of freeze-thaw injury and the mechanism of
its prevention has attracted the interest of a few investigators.
One of the pioneers in this field was J.E. Lovelock who, in 1953,
suggested the salt concentration as a cause of freezing damage.
At first the observation that slow freezing leads to the formation
of large plaques of ice crystals that might compress the red cells
between them has led to the assumption that mechanical pressure of ice
was the principal cause of freezing damage (Luyet 1949, Smith et al.
1951, Glauser and Talbot 1950- However, the demonstration that red
cells could be frozen solid to temperature lower than -3°C without
appreciable haemolysis (Strumia 1949) and that intact animal extremeties
can survive freezing for short period (Meryman 19&3) has proved that
the physical presence of extracellular ice crystals alone is not
necessarily lethal. As an alternative to the straight forward
mechanical injury, it has been proposed that the injury is a biochemical
one resulting from the increased concentration of electrolytes that
develop from the separation of water into ice (Lovelock 1953a),
Working with human erythrocytes Lovelock found that slow freezing to
-4°C and very rapid freezing to -79°C both gave equally good recoveries
of red cells. This led to the conclusion that lysis occurred not
because of the presence of solid ice, but because of some other factor
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that becomes active on slow freezing to temperature lower than -3°C.
Lovelock also demonstrated that the temperature range in which maximum
haemolysis takes place lies between -3°C and -40°C for cells
unprotected by cryoprotective agents. He estimated that this range
must be passed through in less than three seconds if damage is to be
avoided. Further experiments showed that the upper limit of this
critical region is identical with the freezing point of 0.8U sodium
chloride solution while the lower limit corresponds to the eutectic
point of the intracellular salt content. This was taken by Lovelock
as an indication that the critical region of temperature was that
range during which the red cells are exposed to salt concentration
higher than 0.8M. Accordingly he suggested that the freezing damage
was caused by increased concentrations of electrolytes within and
without the cell due to the removal of water in the form of ice. Thus
haemolysis starts at -3°C when the amount of water removed is sufficient
to raise the salt concentration in the fluid phase to 0.8M. A further
drop in temperature results in solidification of more and more water
and increase in salt concentration until at -40°C when all the water
within and outside the cell has frozen solid and the salts are no
longer available to exert their damaging effect. If the electrolyte
concentration theory is to be accepted, then it must be expected that
suspension of red cells in fluid medium containing increasing salt
concentration must give the same haemolysis caused by freezing;
Lovelock was able to demonstrate this. Furthermore, he has been able
to show that even in the presence of glycerol, haemolysis of red cells
always starts once the concentration of sodium chloride reaches a
mole fraction of 0.014 (0.8m) regardless of the concentration of
glycerol or the temperature reached (Lovelock 1953b).
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Lovelock's assumption was confirmed later by the work of Farrant
(1965) who showed that living organised tissue frozen in a system
specially designed to prevent rising electrolyte concentration during
cooling survived and regained its normal function after rewarming in
spite of the development of ice crystals.
As a mechanism of injury Lovelock (1953a) suggested that:-
1. Exposure of the red cells to salt concentration higher than 0.8M
renders them permeable to sodium ions. Haemolysis then takes place
either slowly in the suspending medium or rapidly when the erythrocytes
are restored to isotonic media. Freezing and thawing probably carries
the cells through a similar change.
2. High salt concentration increases the sensitivity of the red cells
to thermal shock and mechanical stress resulting from the formation
of ice crystals.
3. Exposure of the red cells to sodium chloride concentration higher
than 3.0M brings about the lyotropic action of sodium chloride and the
cells are completely destroyed and loses its integrity.
It was therefore concluded that one aspect of the protective action of
glycerol at low temperature is that it acts as a salt buffer.
Meryman (1956) discussed general principles of freezing and
freezing injury in living cells. In his discussion, he supported the
salt concentration theory of Lovelock and stated that there was no
evidence that extracellular ice formation produced mechanical damage.
When freezing is slow and ice crystals are extracellular, flexible
cells can collapse passively during dehydration without suffering
mechanical injurj'. If mechanical injury is not a factor, then cell
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death results from the denaturing effect of high salt and solute
concentration associated with the dehydration process. Since the
resultant denaturation is a biochemical reaction it would proceed at
both time and temperature - dependant rates. This would explain the
cessation of injury at low temperature as well as the survival of the
red cells after very rapid freezing and thawings.
The fact that damage suffered by the red cells is arrested once
the temperature is below a certain point is of great practical
implication. This phenomenon has been attributed to the eutectic of
the cell contents (Lovelock 1953a). Thus, when all the intracellular
solvent have frozen solid the salts are no longer available to produce
its injurious effect. However subsequent experiments with red cells
suspended in glycerol containing media showed* that while glycerol can
lower the temperature at which haemolysis starts, it does not shift the
lower limits of the critical region. This implies that, in the
presence of glycerol, haemolysis still continues to decrease at -40°C
while the phase transition is still incomplete. This also means
that while glycerol can delay the rise in salt concentration at the
early stages of the critical region, high concentrations might still
be expected in the lower temperature ranges. This suggests that the
external sodium chloride concentration is not the sole factor in
determining cellular damage. Attention has thus been directed to
the intracellular salt concentration particularly potassium chloride,
and Lovelock (1953b) proposed that unlike sodium chloride, the
solubility of potassium chloride progressively decrease with the fall
of temperature and below -40°C potassium chloride becomes insuffic¬
iently soluble to maintain the lethal concentration of 0.8M.
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2. Mechanical Injury:-
Luyet in 1949 originally attributed the damage from which the
red cells suffer during slow freezing to the mechanical deformation
of ice crystals within the cells and explained the benificial effect
of ultrarapid freezing on the basis of prevention of crystal formation.
However what was described by Luyet in 1949 as slow freezing (few
degrees per second) is no longer valid in the context of blood
preservation by the present methods. Furthermore it has been realized
that slow freezing leads only to formation of extracellular ice
crystals. Nevertheless Glauser and Talbot (1956) considered that
even the presence of extracellular ice may be sufficient to cause part
of the haemolysis observed on freezing and thawing. Their hypothesis
was based on the observation that additives which prevent haemolysis
are strong hydrogen bonders and thus cause distortion of the ice
lattice. Also, high molecular weight hydrogen bonding additives
protect against haemolysis although they do not enter the red-blood
cells. They thus, attributed the damaging effect of extracellular
ice to the migratory recrystallization which takes place in the frozen
state but becomes progressively less and less at temperature below
-60°C. Lusena and Rose (1956), using hog's blood, studied the effect
of rate of ice crystal growth on haemolysis during freezing and
thawing. They observed that the amount of haemolysis increased
sharply when the rate of ice-crystal growth reached 0.7 cm per second
in the absence of glycerol and 0.3 cm per second in its presence.
They discussed the possible mechanism that made a slow rate of ice
crystal growth desirable and attributed, in part, the protection
afforded by glycerol to its retarding effect on crystal growth.
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Nei (1967, 1968a-1968b) has also investigated the mechanism of
haemolysis during freezing and thawing at temperatures between zero and
-10°C and studied the relationship between formation of ice and
packing of the cells in liquid channels at decreasing temperature.
They observed that within certain limits, increases in the concen¬
tration of cells in saline suspension resulted in increase of haemolysis
after freezing and thawing. Sedimentation of erythrocytes before
freezing or addition of other cells also increased the amount of
haemolysis following freezing. An increase of salt concentration
brought about a reduction of haemolysis. Packing of cells suspended
in concentrated sodium chloride caused severe haemolysis even without
freezing. Therefore, it was concluded by the author that the
increased salt concentration is not the principal cause of haemolysis
and that mechanical stress resulting from cell concentration is one
of the most important factors of injury in freezing at near zero
temperature.
3. Membrane damage:-
Although the salt concentration theory of freeze-thaw injury is
the most widely accepted theory, the mechanism by which increased salt
concentration might damage the cell is less clear. The fact that the
cell membrane acts as a limiting barrier between the cell and its
surrounding, exposes it to the brunt of the first assault brought
about by the physical and chemical changes in the surrounding medium,
as a result of freezing and thawing. Realization of this has led
many investigators to concentrate on the physical, chemical and
biological properties of the cell membrane to explore the mechanism
and nature of freezing injury.
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It is generally agreed that freezing damage is due to abnormal
permeability of the cell membrane to nondiffusable solutes or cations,
but the way this abnormality develops is a matter of controversy.
Thus Lovelock (1957) explained the red cell injury on basis of
denaturation of lipid protein complex of the cell membrane. According
to him lipid-protein complexes are important constituents of the cell
membrane of all living cells including the red cell. These complexes
are held together and to the rest of the membrane by labile bonds
which cannot stand vigorous changes in the surrounding environment.
Lovelock suggested that the increase in the ionic strength of the
suspension medium incurred by freezing is sufficiently great to bring
about the destruction of the lipid-protein complexes. He showed that
the level of phospholipids in the suspension medium steadily increased
as a function of the concentration of sodium chloride in the solution
and presumed that the loss of these phospholipids renders the cell
membrane permeable to the cation sodium. As a result of this the
red cells gradually swell and haemolyse when transferred back to
isotonic medium as occurs in thawing.
Dehydration of the surface of the red cell was also suggested as
a mechanism of freezing injury (Doebbler and Rinfret 1962). Those
authors proposed that, as freezing proceeds, the red cells are subjected
to an environment of continuously decreasing amount of "free" water
and increasing concentration of salts. In their hypothesis a portion
of the water of the red cell differ from "free" water and may be
positioned at the cell surface. Disruption of the hydration structure
of the red cell membrane could be a possible mechanism of freezing
injury together with the chemical action of salt or the mechanical
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stress of ice crystals. A confirmatory support of this view came from
the work of Valeri et al (1966) who studied the relationship between
the in vivo survival of previously frozen red cells and their physical
structure and metabolic state. They concluded that freeze-thaw
injury might be a membrane lesion and that cryoprotective additives
protect the red cells through preservation of its surface hydration.
However, iileryman (1968a) found no relation between freezing injury and
any specific action of electrolytes. On the other hand he observed
that this injury usually resulted from excessive concentrations of any
non-penetrating extracellular solute which created an osmetic pressure
gradient across the cell membrane. This pressure gradient led to
leakage of solute into the cell rendering it osmotically hypertonic,
sudden transfer of these cells back to a physiological medium results
in their haemolysis. In the absence of such a gradient, very high
solute concentration, including electrolyte solutes, were unable to
produce haemolysis and Meryman was able to demonstrate that ammonium
acetate, a penetrating electrolyte, in high concentration is
equivalent to glycerol in protecting against freezing injury.
Further confirmation of Meryman's minimum cell volume hypothesis
came from the work of Farrant (1972) and Farrant and Woolgar (1972a
and 1972b) who showed that exposure of the red-cells to the effect
of hypertonic solution of sodium chloride or sucrose led to crenation
of the red-cell volume until it reached a minimum at 2000 m. Osm./Kg
water. Beyond this limit the cell resisted any further shrinkage,
and leakage of cations to and from the cell took place. However,
although there was evidence to indicate that a net uptake of solute
occurred in cells exposed to hypertonic solutions of sodium chloride,
as observed by Meryman (1968a), Farrant and Woolgar 1972a and 1972b
found no evidence for a net uptake of solutes in those cells exposed
to hypertonic solutions of sucrose. They, therefore, suggested that
post hypertonic haemolysis was probably of colloid osomotic nature.
This means that when the cell is permeable to cations, the osmotic
pressure due to intracellular haemoglobin, (if unopposed by extra¬
cellular impermeant solute) would cause the cell to swell and eventually
rupture, when transferred back to isotonic media. If the cells were
suspended in a hypertonic penetrating additive like dimethylsulfoxide
(DMSO), the latter will rapidly permeate the cell and hence prevents
it from shrinking. Under these conditions the osmolality of 2000 m.
Osm.would be passed without leakage taking place. This was taken by
Farrant (1972) as an indication that cation leakage is mainly
determined by cell shrinkage and that penetrating additives protect
against freezing injury by delaying the sodium leak to a higher
osmolality, in other words it lowers the freezing temperature.
Sumida and Toshihiko (1968) also studied the membrane permeability
of fresh, frozen and liquid stored ACD blcod. They measured the
intracellular potassium and sodium and using an arbitary formula
worked out the resting membrane potentials before freezing and after
thawing. They observed that the potentials were significantly lower
in frozen and ACD blood in comparison with the fresh blood. They,
thus, concluded that the membrane permeability of the ACD and frozen
cells was dependant on the passive rather than on the active transport
of the membrane and would be easily affected by the fluid change
outside the cell with endosmosis taking place in these cells with
abnormally lowered potentials. However, the change in permeability
above 1800 m. Osm/kg water found by Farrant and Woolgar (1972a)
23
occurred at membrane potentials of 22.4 mV (inside positive) or at
19.0 mV (inside negative) depending on the composition of the extra¬
cellular solution. This was taken by Farrant and tfoolgar (1972a)
and Woolgar (1974) as evidence that the change in permeability was
not dependent on a specific membrane potential.
Grieff and Seifert (1968) postulated that the mucopolysaccharides
on the external surface of the cell membrane are cryosensitive sites.
Eecause they are closely connected with other biochemical units of the
cell membrane, physical changes in these sites, may affect the amount
of injury to transport mechanisms for the movement of ions and proteins
across these highly selective, serai permeable barriers. They developed
a membrane adsorption test for determining the effect, on those
cryosensitive sites, of:-
1. different rates of cooling (slow, intermediate and rapid)
2. Cyclic freezing and thawing
3. storage in the frozen state at low temperature
4. the addition of various types of additives.
They observed that the amount of damage to the cryosensitive sites was
inversly proportional to the rate of cooling. However once frozen,
storage did not add to the initial damage, but the latter was
progressively increased by cyclic freezing and thawing. Minimal
damage occurred in the presence of DMSO or glycerol. They thus
concluded that protective agents act by external binding with the
sensitive sites of the cell membrane.
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MODS OF ACTION OF GLYCEROL
The cryoprotective property of glycerol was discovered in 1949
by Polge et al., when they found that fowl spermatozoa could be frozen
and thawed, without losing motility if suspended in a medium containing
glycerol. Smith (195^) w&s able to adapt the protective action of
glycerol to the red cells. Glycerol has since been the favourite
cryoprotective additive and in fact all the methods of cryopreservation
of blood in current use today depend on its ability to prevent red
cell haemolysis which would otherwise occur on freezing. However,
despite this wide acceptance, the mechanism by which glycerol produces
its action has remained unclear, though several theories have been
advanced.
One of the earliest investigations into the mechanisms of
protection afforded by glycerol was carried out by Smith et al. (1951)
who observed directly under the microscope the consequences of addition
of glycerol to red-cell suspensions. They reported that glycerol
modified the pattern of ice from coarse broad-plaques, which were
compressing the red-cells, into delicate feathery-like crystals. In
addition, a substantial amount of fluid was left unfrozen forming narrow
channels in which the erythrocyte were seen lying unaffected. Although
the authors did not attribute the mode of action of glycerol,
particularly, to these alterations, they suggested that the mechanical
stress of freezing must have been greatly reduced by its presence.
No doubt, glycerol substantially minimizes the mechanical effect
of ice crystals in the erythrocytes, but to ascribe its action
completely to this effect is hard to believe. A more sensible theory
was advanced by Lovelock (1953b), who suggested that glycerol acts as
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a salt buffer. He demonstrated that the concentration of electrolytes,
which increases when a solution of sodium chloride is frozen, decreases
with increasing the glycerol concentration until in the presence of
2.5 M glycerol the lethal salt concentration, 0.8 M,is not reached in
the temperature range 0 to -40°C.
For the protective action to be fully expressed, glycerol has to
be present both intra - and extra-cellularly. If it is prevented
from entering the red cells, by the addition of copper ions, they are
no longer protected against freezing injury (Lovelock 1953b). This
observation has led to the assumption that intracellular salt concen¬
tration is, at least, as important as the extra cellular sodium
chloride in producing freezing damage (Lovelock 1953b).
The effect of glycerol in buffering the increased salt concentration
was totally explained on the basis of its colligative property (Lovelock
1954). This means that the more the mole fraction of the soluts i3
increased, the less the amount of water is frozen, the greater the
reduction in the electrolyte concentration. Thus it is possible to
maintain the salt concentration below the lethal level at any given
temperature simply by adding a sufficient amount of the additive.
The protective action of glycerol and all cryoprotective additives
has been related not to the molarity of the solute, but to the number
of potential hydrogen-bonding groups provided by the additive (Doebbler
and Rinfret 1962). Those authors suggested that H-bonding
protectives, including glycerol, serve to stabilize the surface
hydration of the cell. This would mean that the protection afforded
by glycerol, and other solutes is the result of specific rather than
simple colligative property.
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In 1968a Meryman examined the effect of increased salt concen¬
tration on the volume of red cells. He found that as the salt
concentration of the surrounding increases, cell volume gradually
decreases by losing more water to the external environment. This
goes on until a certain volume is reached below which the cell cannot
shrink any more. Haemolysis of the red cells is thus the result of
membrane damage produced by the development of an "osmotic pressure
gradient" across the cell membrane greater than the cell can compensate
for by reducing its volume. The argument that freezing damage is
the result of denaturation of the cell membrane by the strong sodium
chloride concentration is off-set by the demonstration that identical
results have been produced in the presence of concentrated solution of
sorbitol or sucrose (Meryman 1971b). According to this model the role
of the cryoprotective additive is to minimize the increase in the
extracellular salt concentration, absolutely by a colligative action
(Meryman X968a-1971a and 1971b, and Meryman and Hornblower 1972b).
Meryman further assumed that any solute which equilibrate rapidly
across the cell membrane, whether it is an electrolyte or non-
electrolyte, would reduce the salt concentration and if present in
sufficient amount would prevent completely the shrinkage of the cells
beyond their tolerable limits (Meryman 1971b). However for any solute
to exert this effect, it is essential to be freely penetrating to the
cell membrane otherwise it will add to the osmotic pressure of the
extracellular environment by itself (Meryman 1968a, 1971a, 1971b, and
Meryman and Hornblower 1972b). Again the solute has to be non toxic
in the highest concentration used and must be used at multimolor concen¬
tration as required according to the rate of freezing.
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OLYCERAL CONCENTRATION AND STORAGE TEMPERATURE
Smith in 1950 discovered that small aliquots of human red blood
cells could be frozen rapidly to -79°C and recovered intact if 10 to
20^ glycerol was added to the blood. In 1951a Sloviter reported that
equal volumes of whole blood and 30^ (w/v) glycerol were frozen
rapidly to -79°0 in a test tube, held at this temperature for two
minutes and then thawed, 79 to 94^ of the cells were recovered intact.
Experiments with rabbit blood (Sloviter 1951b) showed that, these
frozen cells also had normal in Vivo survival. However, when
Sloviter's technique for freezing was attempted with large volumes of
blood, e.g. with 500 ml volumes, the rapid rate of cooling could not
be maintained and poor red cell recovery was obtained (Mollison et al.
1952).
Chaplin and Mollison in 1953 discovered that when the concentration
of glycerol was increased to 30^ W/V (final concentration) the in vitro
red cell recovery became independent of the rate of cooling and thus
freezing of pint volumes of blood was attained. However, storage of
the blood in the frozen state at -79°C (Co£ and alcohol mixture) proved
to be fairly expensive and maintainance of that temperature at a
constant level required frequent replenishment of the coolant. Thi3
led to the search for other methods of cooling and storage. Chaplin
and Mollison (1953) attempted to store the blood at -20°C, and in
order to prevent the excessive increase of the salt concentration
intracellularly they substituted Trisodium citrate for the isotonic
saline in the glycerol solution.




Tri Sodium citrate 30 g.
Water to 1000 ml.
When equal volumes of this solution and packed red cells were mixed
together they calculated that the final glycerol concentration of the
fluid phase was approximately 30$ w/v. After storage at -20°C for
three months about 98$ of the red cells were recovered intact.
Brown and Hardin (1953) have used a final concentration of glycerol
about 40$ w/v., but mixing such high concentrations of glycerol directly
with the red cells brought about excessive haemolysis. For this
reason the authors suggested adding the glycerol in two steps. First
equal volumes of 30$ W/V glycerol, in 0.16M sodium lactate, and
erythrocytes are mixed and left to equilibrate at room temperature for
some time. In the second stage, a solution of 50$ glycerol (W/V) in
0.16M sodium lactate was added to give a final concentration of 40$.
After storage of such blood at -15°C for 50 days, only 79$ of tbe cells
were recovered intact and on transfusion only 47$ of them survived.
By contrast storage at -70°C for 6^ months resulted in 90$ in vitro
recovery and 64$ post transfusion survival at 24 hours.
Chaplin et al. (1954) demonstrated that -20°C was an unsatisfactory
temperature for long-term storage of human red blood protected by
glycerol. They maintained that while red cells stored at -20°C have
very little in vitro haemolysis, the decrease in post-transfusion
survival was rather rapid. This rapid loss was acribed to the
continuation of the chemical and metabolic process at this relatively
high temperature and was demonstrated by the progressive diminition of
the cellular glucose. Chaplin et al. (1957) compared the post
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transfusion survival of chromium labelled red blood cells that have
been stored at -20°C for 13 months with that which were preserved at
-45°C for one and a half years. Both types of cells were frozen in
the presence of buffered-citrate glycerol solution. They reported
that while the cells that had been stored at -20°C showed a 24 hour
post-transfusion survival of 58$ those preserved at ~45°C had a post¬
transfusion survival of 96$ at 24 hours.
llie idea of selecting -45°C as storage temperature was based on
the assumption that the range of temperature in which maximum haemolysis
occurs, lies between -3^C and -40°C (Lovelock 1953a). It was thus
thought that -45°0 was significantly below the critical temperature
but still within the limits of refrigeration available at that time.
Although -45°C was a satisfactory temperature for storage of
glycerolized red cells for up to 18 months, the results after six years
storage were disappointing (Schmidt and Stohlman 1964). These authors
reported a mean in vitro loss of 25.4$ and a 24 hour post-transfusion
survival ranged from 20% to 60£. These results suggested that -45°C
was not cold enough to maintain the viability of the preserved red
cells for very long duration, however -45°0 was satisfactory for blood
banks with a rapid turnover of frozen blood (» 6 weeks). Nevertheless
this had put an end to further investigations at this temperature.
Previously Chaplin et al- (1956) demonstrated that red blood cells
suspended in glycerol to a final concentration of 30$ w/v and stored
for 21 months at -79°0 had in vitro recovery of 90$ and in vivo survival
of 80$. There was no evidence that the viability of the cells was
influenced by the period of storage as these red cells which have been
stored for 21 months behaved in the same way as those stored for only
30
one month. They also found that if the glycerol concentration of red
cells stored at -79°C exceed 2.7M the electrolyte composition of the
medium became relatively unimportant. Thus results obtained with
glycerol-saline solution were as good as those obtained with glycerol-
citrate solution.
A glycerol concentration as high as 7.0 M has also been tried for
cryoprotection of the red cells but the results were discouraging
(Jones et al 1957). Exposure of the cells to this very high concen¬
tration of glycerol, even for a very short period, resulted in
inhibition of the glycolytic processes and diminished the post¬
transfusion survival. This confirmed the observation reported by
Tullis et al in 1956 that the highest concentration of glycerol that
can be tolerated by the red cells is 50$» At this concentration the
haemolysis of the red cells resulting from freezing injury was minimal,
but glycerol concentration higher than that were highly toxic. Tullis
et al have also demonstrated that with 50$ glycerol there was no need
to use a rapid cooling rate and rigid control of the storage temperature
was unnecessary.
In 1956 two important events in the history of the frozen blood
occurred. The first was the adaptation (by Tullis et al , 1956) of
the Cohn Blood Practionator, a closed sterile semiautomatic continuous
wash centrifuge, for both addition and removal of the glycerol from the
red blood cells. The second was the construction by Harris
Refrigeration Company of an electrical refrigerator with two stage
and three stage compressor system to maintain storage temperature
constant at -80°C and —120°C respectively. Following the introduction
of these refrigerators a new programme forthe preservation of red cells
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in the frozen state was immediately developed by a group of investi¬
gators at the United States Naval Hospital in Chelsea, Massachusetts,
This has, for the first time transferred the frozen blood from the
research laboratories to the hospital wards for clinical use (Tullis
et al 1958, Ketchel et al. 1958, Haynes et al. I960, Haynes et al.
1962). Glycerolization was achieved in two steps 300 ml of 20$, then
1000 ml of 50$ so that a final concentration of 50$ w/v was obtained.
The glycerolizing solution was made in isotonic-neutral sodium lactate
(0.16 M) which also contained the following:-
0.2$ dextrose
0.004 M potassium-chloride
0.004 M magnesium chloride
Freezing was carried out slowly by placing the blood-glycerol mixture
in the electrical refrigerator at either -80°C or -120°C where the
blood was completely frozen and reached refrigerator temperature in
eight hours. After storage for up to 44 months at the above temper¬
ature approximately 82$ of the donor cells were recovered intact and
on transfusion 90$ of them survived at 24 hours. There were no
apparent effects of the storage period on the in vivo survival of the
preserved red cells.
Huggins in 1965 used glycerolizing solution made up of:




The sugars were included to maintain the right osmotic pressure without
adding to the ionic strength of the solution. The EDTA was added to
32
prevent the binding of complement to the red cells which would otherwise
occur and results in a false positive Coomb's reaction. One volume
of that solution was added to one volume of packed red cells, the
mixture frozen slowly and stored at -85°C in a mechanical refrigerator
for a maximum of one year and a half in the presence of EDTA (Valeri
1970) or two years without EDTA (Huggins and Grove-Rasmussen 1973).
After deglycerolization by the so-called reversible agglomeration
in a cytoglomerator the in vitro recovery ranged from 70 - 82$ with
EDTA and from 80 - 85$ without EDTA and the 24-hour post-transfusion
survival, by the ^Cr method, was approximately 70$ in the presence
of EDTA and about 80$ in its absence (Valeri 1970).
Pert et al. 1963 introduced the low-glycerol intermediate-freezing
rates in liquid nitrogen. They studied the relationship between
cooling rates and the concentrations of the protective agent. They
used five different cooling rates together with a concentration of
glycerol which varied from 2$ to 50$ w/v. In terms of glycerol
concentration the recovery curves obtained with the five cooling rates
indicated that
1) At a glycerol concentration of 40$ or more the recovery of the red
cell was independent of the rate of cooling.
2) At glycerol concentrations of less than 14$ rigid control of the
cooling rate was essential for adequate recovery.
3) Glycerol concentrations between 20$ and 40$ required some control
of freezing rate to avoid too fast a cooling rate.
4) A concentration of glycerol between 14$ and 20$ was the most ideal
(Pert et al. 1965).
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The glycerolizing solution suggested by these authors consisted of
14 - 16$ W/V glycerol
2.76 g$ sucrose
O.85 g$ Na CI.
The Teflon-bag containing the glycerolized blood was frozen by direct
immersion in liquid nitrogen. After thawing and washing, 96 to 99• 5$
of the red cells were recovered intact and on transfusion 86 to 95$
of them survived at 24 hours post-transfusion.
Krijnen et al. (1964) utilized the low glycerol-intermediate rate
of freezing technique. They demonstrated that the best results were
obtained with 17«5$ (w/v) glycerol concentration and 4$ sorbital.
Equal volumes of packed red cells and 0.9$ sodium-chloride solution
contains 35$ w/v glycerol and 4$ sorbitol, were added in a flat
stainless steel container which was frozen in liquid nitrogen. They
reported in vitro recoveries of 97-98$ and 24 hour post-transfusion
survival of autologous blood ranged from 94-99$« In 1970 Krijnen
et al. improved their original method slightly by freezing the
giycerolised blood in a seamless, cylindrical, aluminium aerosol can
and obtained excellent results.
Howe et al. (1908) also utilized the low glycerol liquid nitrogen
freezing method for preservation of human red cells for transfusion.
They froze a mixture of packed red cells and glycerolizing solution in
the ratio 1:1 in a flat stainless steel container by direct immersion






The frozen blood was stored in liquid nitrogen temperature (-196°c).
After thawing and processing more than ^0$ of the cells were recovered
intact and the post transfusion survival was SG'%. An attempt to store
the blood, that was frozen in liquid nitrogen in a mechanical
refrigerator at -80°C gave disappointing results. Rowe in 1971
substituted a plastic polyethylene bag (Haemoflex) for the stainless
steel container. The process of freezing, thawing and washing were
all performed in the same bag, hence the time necessary for preparation
of the unit was markedly reduced.
Jenkins and Blagdon (1971) have adapted Krijnen's technique of
blood preservation utilizing the low-glycerol-liquid nitrogen-aluminium
canister method. They introduced some modification on the freezing
container by using a one piece aluminium bottle but with a push-in
rubber stopper "Suba Seal" instead of a crimped on vial cap and screw
cap dust seal cover of Krijnen et al. Experiments were performed to
determine the optimal final concentration of glycerol that suits the
new canister. They found that 20% w/V glycerol and sorbitol gave
the best protection. Freezing was performed by immersing the
aluminium bottle in liquid nitrogen where the rate of cooling wa3
approximately 0.7°C per second. Blood was then stored in the vapour
phase of liquid nitrogen at -150°C.
REMOVAL 0? GLYCEROL AND PREPARATION OF THE FROZEN CELLS FOR TRANSFUSION
The use of glycerol as a cryoprotective additive made possible the
preservation of human red cells in the frozen state for very long
periods, and in fact there are no practical difficulties concerning
freezing and storing the erythrocytes in this way. However, the
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preparation of these preserved cells for routine transfusion presented
difficulties for 3orne time. Although glycerol appeared to be nontoxic
when transfused to recipients, as it is an intermediate product of
carbohydrate metabolism, the impregnation of the erythrocytes with
glycerol makes it osmotically hypertonic so that its administration
into the circulation results in rapid swelling and lysis of the cells.
For the same reason the cells can not be washed with isotonic solutions
(Sloviter 1951a).
While glycerol penetrates the human red blood cells easily, its
removal has represented a major obstacle. The rate of water diffusion
into the cell is approximately four times greater than the rate of
diffusion of glycerol out of the cell. For this reason replacement
of red cells equilibrated with high concentrations of glycerol into
isotonic solution results in absorption of water much faster than
losing glycerol (Tullis et al. 1956).
It seemed that the best way of removing the glycerol out of the
red cells was by reversing the process by which it entered while
keeping in balance the osmotic pressure between the cells and its
surrounding medium. This would be achieved by suspending the cells
in solutions with sufficient osmotic pressure to hold the water whilst
the glycerol diffuses out of the cells.
In the early days of investigations, glycerol was completely
removed from the red cells prior to transfusion by dialysis against
saline solutions containing gradually decreasing concentrations of
glycerol (Sloviter 1951a)• However this method was cumbersome, slow
(48 hours) and carried a high risk of bacterial contamination.
Lovelock (1952) described a method for rapid removal of 15$ glycerol
out of previously frozen-thawed red cells by increasing the osmotic
pressure of the suspending medium to a very high level. He found that
the addition of 0.33 sodium citrate to the suspending medium will
increase its osmotic pressure seven-fold, glycerol and water would
thus diffuse out of the cells until an osmotic equilibrium is reached.
«*
The cells would then contain only small amounts of glycerol that
permitted its centrifugation and resuspension in plasma or any isotonic
medium.
Brown and Hardin (1953) have used a stepwise washing technique, as
a method of removing glycerol from previously frozen-thawed erythrocytes.
?/ashing was accomplished by serial processes of resuspension, centri-
fugation and decantation. The washing solution consisted of O.48 M
sodium lactate containing a small amount of glycerol. The Authors
also described a continuous washing centrifuge and method for removal
of intracellular glycerol using a salt solution of progressively
decreasing hypertonicity. Although no in vivo survival data was given,
the authors pointed out that this method of washing was superior to
the stepwise technique.
The methods of deglycerolization of red cells by washing with
sodium citrate or sodium lactate, though successful, were found to be
unsatisfactory. These hypertonic solutions result in severe sludging
of the red cells on centrifugation, and the subsequent disaggregation
gives substantial haemolysis (Sloviter and Ravdin 1965).
Chaplin et al (1956)described a method of glycerol removal by
stepwise dilution washing method. The method consisted of four
sequential wash cycles in citrate-glycerol solution containing
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respectively l6i, 8A'% and 2% glycerol in 3i dodium citrate. The
cells were then washed three times in unbuffered saline. The whole
process required a period of five hours to be completed.
Sloviter (1956) developed a method, for processing thawed
erythrocyte-glycerol mixtures, which did not require the complete
removal of the glycerol prior to transfusion. Based on the fact that
human erythrocytes are much less permeable to glucose than to glycerol,
a hypertonic glucose solution was added to the thawed blood-glycerol
mixture where it provided an osmotic counter balance to the glycerol
within the cells. After standing for 10 minutes at room temperature
the mixture was diluted by the addition of twice its volume cold 0.9
percent sodium chloride solution. At the end of this process the
resulting suspension contained approximately 4.5 percent glycerol and
5.5 percent glucose in addition to the isotonic electrolyte. It had
a haematocrit of 10^, and osmotic pressure approximately four times
that of the blood. This dilute suspension may be either transfused
directly or centrifuged to separate the red cells which may then be
resuspended in saline or plasma before transfusion.
SPECIAL TECHNIQUES OF WASHING
Continuous centrifugation:
The first investigators to make use of the idea of continuous
centrifugal washing for the removal of glycerol from the red cells
were Chaplin and Veall (1953). The apparatus used was based on the
principle of "long traverse centrifuge". The principle of this method
was that an upright conical flask was rotated on a turntable at speed
sufficient to maintain the red cells at the periphery. The wash
solution was administered, through inlet tubes, into the periphery of
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the vessel to create a turbulance in the red cell mass. The wash
fluid of lower density than the cells, was collected from an ejection
outlet near the neck of the flask. Hypertonic sodium citrate and
0.9% sodium chloride were the washing solutions used and the whole
process took about hours.
At the same time Brown and Hardin (1983) in U.S.A. were developing
a system based also on the "long traverse centrifuge" in which a
standard laboratory centrifuge was utilized. Pour units of blood in
standard blood bottles were simultaneously washed to get rid of their
glycerol content. The washing fluids, consisted of glycerol free salt
solutions of gradual decreasing tonicity, were fed from a common
reservoir in the centrifuge head into the red cell-glycerol mixture
during centrifugation. The red cell mass was kept in the outer position
of the container by the centrifugal force and thus prevented from over¬
flowing with wash fluids. Unequal flow to the four containers resulted
in uneven washing of the different units.
In 1958 Mollison et al. designed a centrifuge head to process two
units of blood kept in standard M.R.C. glass bottles. In their design
they avoided the defect met within the system of Brown and Hardin by
providing a separate supply of washing fluid for each bottle, thus
insuring even washing of the two units. The whole process took about
one hour and a half. That the M.R.C. bottle could be used in that
design was important, because it showed that the blood could be
collected, glycerolized, stored and processed in the same container
and therefore the risk of bacterial contamination was minimized.
Tullis et al 195^ adapted the Cohn Blood Practionator, a sterile
closed system, to add and remove ^0% w/V glycerol to units of packed
39
cells before freezing and after thawing. This apparatus was
originally developed for the separation of plasma on a continuous flow
basis. The use of a Cohn fractionator for glycerolization and
deglycerolization has eliminated the need for excessive manipulation
seen in manually processed red cells. Basically, the apparatus
consists of an inverted bowl of complex design rotating on a fixed
base. The wash solutions are continuously introduced and removed from
underneath the bowl. The fluids enter the bowl at its periphery,
percolate through the packed cells and are removed proximate to the
axis, so that a continuous separation is possible, with the red cells
collected in the peripheral portion of the bowl. Deglycerolization
was accomplished seraiautomatically by continuous flow washing of the
red cells with a gradient of hypertonic electrolyte solution made up
from:
Solution (l) first wash:




Solution (2) second wash:
Sodium lactate O.156 M
Potassium chloride 0.004 M
Distilled water Q.S.
The time required to process one unit was 120 minutes utilizing 4 litres
of wash fluid, and after completion of the process about 70 to 90$ of
the red cells were recovered intact, (Tullis et al- 1956). Despite the
cost and the complexity of the system and the relative slowness of
the washing time, the production of sterile unit of blood has made
possible post-thaw storage for distribution to other hospitals and
massive clinical experimentation (Tullis et al 1958, Ketchel et al
1958, Hynes et al i960). During the period from 1956 to 1961, 2,250
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units of blood that had been frozen with glycerol, and stored for
varying periods of time, were processed by the Cohn Practionator and
transfused to 653 patients of all ages (Haynes et al 1962). Also
during this period some improvements were introduced to the original
method. A third saline wash was suggested by Tullis et al (1958)?
0.1/£ dextrose and 0.008 11 MgClj was introduced by Haynes et al (i960)
and the processing time was reduced to 60 minutes. Although the
Cohn Fractionator had successfully operated for about ten years from
the stand-point of producing a clinically acceptable product, it was
criticized on the basis of expense, slowness and the high in vitro loss
of erythrocytes during washing (20$)(Valeri 1970). In addition, the
process presented significant difficulties as the different parts of
the apparatus have to be demounted, reassembled, sterilized and left
to cool for long periods before being remounted again.
A joint project of Tullis and the Arthur D. Little Co. yielded a
new pattern of bowl, the A.P.L. reusable bowl, a less expensive version
of the Cohn fractionator (Tullis et al 1967). Two types of bowl have
been developed, a stainless steel and a rigid clear plastic, both of
which could be mounted onto the spindle of a standard refrigerated
laboratory centrifuge by a special chuck: attachment. As with the
Cohn Fractionator, the new system was used for both the addition and
removal of the glycerol, to and from the red blood cells. Unlike the
old system, the A.D.L. bowl was fed and drained through a sterile
rotary seal at the top. The wash solution and details of the procedure
were similar to those described by Tullis et al (1958)* Utilizing
the new system the authors obtained 9° per cent in vitro recovery, and
the processing time was reduced to 30 minutes, but the total volume of
the wash solution remained as it was with the Cohn fractionator, four
litres (Valeri et §1. 1969). Nevertheless, the A.D.L. reusable bowl
represented only a transitional step in the evolution of the continuous
flow centrifugation procedure, for, it was obvious from the start
that the ideal system is that which employs a disposable liner. The
time spent in disassembly, cleaning, reassembly and sterilization of
the different parts, after each run still represented a major obstacle.
In 1968 Schlutz and Bellamy from the Travenol laboratories
developed a disposable cell washing system that utilizes the principle
of counter-flow washing. It consisted of a collapsible plastic
chambre and rotary seal, both of which were disposable. The system
was designed to serve with the RC-3 centrifuge and by slight modificat¬
ion could be fitted into a standard laboratory centrifuge cup. The
processing chambre, when fully inflated, was in the form of a cylinder
topped at either end with a conical section. The wash fluids enter
and leave the bag through an inlet and outlet tubing, the former
extends all the way down to the bottom of the bag. The processing
bag was constructed in a manner, so that the incoming wash solution
creates an extreme turbulance within the red cell mass but without
disturbing the cell-supernatant interface which is formed by the
centrifugal force. Both the rate of flow and the density of the wash
solution were important factors that determined the speed and efficacy
of washing. If the flow of the wash solution exceeded a certain rate,
the red cells would be forced out of the processing caambre.
Similarly, if the incoming solution was greater in density than the
red cells, all the cells would be washed out of the vessel. A wash
solution lighter than the supernate channelled through the red cell
mass, without mixing with it, and travelled to the waste part without
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efficient washing. This system was incorporated into a fully
automated continuous flow-double unit cell washing machine, Elutramatic
TM System, which included a distribution manifold, a roller pump, a
control centre, timers and flow rate potentiometers. The system is
connected to the external central circuit of an RC-3 centrifuge
allowing the automatic operation of the latter. Two units of frozen
blood could be simultaneously washed in 70 minutes utilizing approxi¬
mately four litres of wash solution per unit (Orlina et al 1972).
Meryman and Hornblower (1969, 1972a) introduced an important
modification in the process of washing red cells frozen with the high-
glycerol-slow freezing technique. They substituted a hypertonic
solution of sodium chloride for the glycerol-lactate-saline solution
in common use up to that date. After thawing, the glycerolized red
cells were first diluted with 150 ml of 12$ sodium chloride buffered to
PH 7«0jl©Ti; for few minutes to equilibrate at room temperature then
1000 ml of a solution containing 1.6$ NaCl PH 7-0 was added (the pre-
wash dilution). The cells were then washed with an additional two
litres of saline in a centrifugal-cell washing device; the first litre
consisted of 1.6$ sodium chloride solution and the second was a
solution made up of 0.8$ sodium chloride, 0.2 per cent glucose buffered
to keep a pH not less than 7.0^ Utilizing the above described methods
in the ADL centrifugal cell washing apparatus, the authors reported a
mean in vitro recovery of 98 per cent, supernatant haemoglobin 24 mg/lOO
ml and post-transfusion survival ranged between 76 and 90$-
Runck and Valeri (1969)» following extensive studies into the
variables affecting the washing procedure of frozen blood, came to the
conclusion that the initial dilution of the glycerolized blood, prior
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to washing, with hypertonic salt solution so as to reduce the glycerol
concentration to about 5 percent would permit rapid collection and
washing of the cells. The method was applied for both high and low
glycerol preserved blood (Valeri et al. 1969). In 1974aValeri
reported a modification of the method of washing previously frozen red
cells in the Naval Blood Research Laboratory at Chelsea Massachusetts.
Red blood cells that contained 40$ w/V glycerol were diluted with 150 ml
of 12$ sodium chloride solution and left to equilibrate for two minutes
at room temperature. The mixture is then diluted with 500 ml 1.6$
NaCl solution. This process resulted in a reduction of the concentration
of glycerol to about 18$. The cells are then washed in the Elutramatic
system with 2.2 litres of isotonic sodium chloride within 30 minutes.
In 1971 Tullis et al. developed a disposable plastic centrifuge
bowl and harnesses to replace the ADL bowl. It is made of clear
plastic and has the same geometry and basic principle as the reusable
ADL bowl. Removal of glycerol is achieved by washing the red cell in
a continuous-flow centrifugation system utilizing about four litres of
wash fluid (glycerol-lactate-saline). The time required to process
one unit is 25 minutes. Experiments with the new system has given a
satisfactory result as regards the in vitro recovery (89$) and the
immediate post transfusion survival (91$). The new set was later
incorporated into a continuous-flow single unit cell washing machine
(Haemonetics 10) which is composed of a disposable rigid polycarbonate
bowl driven by a compact centrifuge "Blood Processor No.10". The bowl
is made up of two compartments one that rotates and another which is
stationary. The thawed glycerolized blood enters the continuously
spinning bowl from the top via an inlet port, which goes down to the
bottom, where it is distributed to the periphery. As the bowl fills
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the supernatant fluid separates from the red cells. The flow of the
washing solutions is similar to that of the blood and the geometry of
the bowl is constructed so that it keeps the cells suspended against
the flow of the wash solution. After completion of the washing
process the red cells are syphoned into a transfer plastic pack for
transfusion. The Haemonetios-10 is relatively inexpensive to purchase
but the cost of the disposable bowl and harnesses is high. However
it is claimed that two units of blood for the same patient could be
processed in the same liner (Valeri 1974a).
REVERSIBLE AGGLOMERATION AND THE HUGGINS CYTOGLOMERATOR
In a search for a simple and an inexpensive alternative method,
to the Cohn blood fractionator, for the removal of glycerol from the
thawed erythrocytes Huggins (1963a) investigated the phenomenon of
red cell agglomeration that usually occurs in aqueous-nonelectrolyte
solutions. This phenomenon appears to be due to an interaction
between the gamma-globulin of the plasma and the lipo-protein of the
red cell membrane at an acid pH between 6.1 and ^.2. As a result of
this reaction a reversible complex is produced and when the salt
concentration of the medium is lower than 0.02 M these complexes
coalese to form a large clump of red cells which sediment rapidly
without the need for centrifugation. The phenomenon could be reversed
by either the addition of electrolyte to break the gamma-globulin-gamma-
globulin bonds or by increasing the pH thus breaking the gamma-globulin-
lipo-protein complex. A novel method, circumventing the need for a
centrifugation has been developed by Huggi ns(1963b) who made use of the
rapid sedimentation of the red cells in large aggregates to wash them
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by discarding the supernatant fluid and resuspending in a clear
solution. Successive dilution, and sedimentation, provided adequate
washing of erythrocytes that had been frozen with high concentrations
of cryoprotectant. When first described the method was applied for
processing red cell3 that have been frozen and thawed in the presence
of 8.6 M dimethyl-sulfoxide (DMSO). After three consecutive processes,
using four litres of wash fluid of dilution and sedimentation, the
DMSO concentration was reduced to C.2 g percent (Huggins 1963c and 1964).
"Doubts about the safety of DMSO led Huggins to substitute the nontoxic
additive, glycerol in the freezing step (Huggins 196b). Glycerol was
used in the same concentration as the DMSO i.e. 8.6 M or in a final
concentration of 4.5 M (40$ w/v). Initially the process of deglycero-
lization was performed manually by first diluting the thawed blood
with 5C0 ml of 50$ dextrose in water, followed by 3 litres of 8$
glucose and 1% fructose. After sedimentation, the red cells were
separated by decanting the supernatant and the dilutional wash was
repeated once more. The agglomerated red blood cell mass was then
resuspended by the addition of 250 ml of isotonic saline. The whole
process utilized 6.75 litres of fluids and required nearly one hour
to prepare one unit of blood for transfusion. However with the
introduction of the cytoglomerator, a specially designed automatic
processor and its disposable blood freezing unit in 1964, five units
of blood could be processed simultaneously in 20 minutes. This was
considered a revolutionary event in the history of preservation of
blood by freezing particularly if compared with the slow complicated
Cohn fractionator. By 1965,108l units of blood had been frozen and
stored at -85°C for up to IP months, then thawed, processed by the
Iluggins method and transfused to 124 patients with an average of about
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9 units per patient. With the exception of 136 units all the blood
has been frozen with 8.6 M glycerol (Huggins 1965). Iluggins reported
an in vitro recovery of about 90$ and post transfusion ^Cr survival
from 87 to 95$ after 24 hours. Furthermore he pointed out that this
method of washing had eliminated the isoagglutinins from the processed
blood and removed the white blood cells, extracellular potassium,
citrate anticoagulant and plasma.
Because of its simplicity, Huggins' method, has been extensively
used for clinical application at the Naval Blood Research Laboratory
in Chelsea, Mass.(Valeri 1966). A positive Coomb's test was observed
with the erythrocytes that have been washed by this method. This
appeared to be due to firm coating of the cells with some component of
the complement system and was inhibited by the addition of 0,3$ sodium
EDTA; to the glycerolizing solution (Huggins 1965). However, the
addition of EI)TA was found to have an adverse effect on both the in
vitro recovery and in vivo survival of the red cells. Thus red blood
cells frozen with high glycerol EDTA solution showed a mean in vitro
loss of 25$ and 24-hour post-transfusion survival about "70$ (Valeri
1970).
Whether EDTA was added to the glycerolizing solution or not,
processing of the thawed glycerolized erythrocytes by Huggins technique,
with non-electrolyte solution, resulted in a substantial decrease in
the intracellular potassium content and high residual free haemoglobin
(Valeri et al. 1969). The decrease in the intracellular potassium
was believed to be responsible for the low 24-hour post-transfusion
survival (Valeri and Runck (1969a). Further deterioration of the
in vivo survival was observed when the red cells that have been frozen
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without EDTA were stored at -80°C for longer than 2 years or with
EDTA for longer than ll- years and then processed by Huggins' technique.
By contrast to the Huggins' methods, washing of these prolonged
stored cells with electrolyte solution in a continuous flow centri-
fugation system gave a higher, in vitro recovery, intracellular
potassium and in vivo survival and lower free haemoglobin in the
supernatant (Valeri and Runck (1969a). The implication of this is
that Huggins' preserved red cells should not be washed by the reversible
agglomeration technique if it had been stored for more than two years
in the absence of EDTA or more than l| years with EDTA. A better
technique of washing is by an electrolyte solution in a continuous-
flow centrifugation system. This has decreased the interest in the
reversible agglomeration technique and the cytoglomerator as a means
of washing thawed glycerolized red cells. However an outstanding
character of the method is the rapid output of units, a matter of




Since the protective action of glycerol was found to be due to a
colligative property rather than to a specific character of the
compound itself, it was to be expected that a similar effect would be
provided by many other compounds.
Lovelock in (1954) had tested 15 neutral compounds, mostly with
multiple hydroxyl groups, including mono-, di-, and poly-hydric
alcohols, amides and sugars. The compounds were classified into
three categories penetrating, partially penetrating and non penetrating.
He found that only non-toxic neutral solutes which have a low molecular
weight and which can easily permeate the red cells would afford full
protection. However, Glauser and Talbot 1956 found that permeation
of the red cell is not a prerequisite for producing complete protection
as polymers with high molecular weight were also found to be effective
in this respect. Instead they ascribed the protective action of
any additive to a specific character in its structure where a polar
carbon to oxygen, bond is present with the oxygen available for bonding
with the hydrogen of the water molecule of the solvent.
Sloviter (1958) investigated the action of polyethylene glycols,
high molecular weight polymers, in protecting the red cells against
freezing injury. The molecular weight of the compounds tested varied
from 500 to 1500. However, all of them were found to be effective
with an optimum concentration of 25'^ by weight, a finding which
conflicted with the colligative action found by Lovelock.
Doebbler and Rinfret (1962) investigated 27 compounds of various
chemical structure and molecular weight for their protective effect
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against the injury of rapid freezing. Included in this list were
alcohols, glycols, glycol derivatives, sugars, amino acids, peptides
and carboxylic acid salts. They found that, in contrast to Lovelock's
results with slow freezing, disaccharides which are nonpenetrating
compounds afforded greater protection than most of the monosaccharides
to which the red cells were permeable. In addition they examined
the protective action of 14 high-molecular weight polymers, all of
which were found very effective. They concluded that the degree of
protection afforded by any compound is related to the concentration
of potential hydrogen bonding groups in its structure.
However, most of the compounds rested were abandoned either
because they are toxic to the red cells in the doses required for
protection or produce untowards side effect in the recipient. The
only compound that gave results comparable to those of glycerol was
the dimethylsulfoxide (DM30). The protective action of this compound
was first discovered by Lovelock and Bishop in (1959) when they found
that on a molar basis, DMSO afforded the same protection from freezing
to both bovine and human red blood cells. However DKSO offered an
outstanding advantage over glycerol. Being of lower molecular size
DMSO crosses the cell membrane more readily, and thus the difficulties
met with in removing the glycerol from within the cell were greatly
reduced. Furthermore, cells which are impermeable to glycerol,
bovine red cells, were found to be permeable to DMSO. Most of the
experience with DMSO come.; from the work of Huggins who in (1963a)
developed a method of blood preservation in the frozen state by
freezing equal volumes of packed red cells and solution containing
8.6 M DMSO, 8% glucose and 1L% functose. A total of 133 units of
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blood have been frozen, with DMSO stored at -85 C, for different periods
processed by Huggins technique and given to patients without untowards
effects. However doubts about the safety of P1130 led Huggins (1964)
to shift to the non-toxic, penetrating additive, glycerol.
So far glycerol remains unchallenged as the most nearly ideal
cryoprotective agent and all methods in current use today employ
glycerol in different concentrations.
RAPID FREEZING
Meryman in 1956 indicated that, successful preservation of blood
by rapid freezing requires:-
1. A very rapid rats of cooling
2. Storage at low temperature to prevent recrystallization
3. A very rapid rate of thawing
4. Suitable geometry of the specimen to allow uniform heat exchange
throughout its surface. Luyet in 1949 fulfilled this requirement
by freezing a very thin smear of ox-blood on a glass cover by direct
immersion in liquid nitrogen.
In 1955 Meryman and Hafig proposed that the most suitable shape
for heat exchange is the sphere or droplet form. In order to attain
maximum heat transfer rates they produced a very small sized droplet
by passing the blood through rapidly oscillating capillary jet. The
droplet size ranged from 0.45 to 0.9 mm in diameter and were sprayed
directly onto the surface of liquid nitrogen where they floated for a
while and then sank to the bottom. Thawing was performed by trans¬
ferring the frozen particles to a container of plasma or isotonic
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saline at 42 C. Initially 5intact cells were recovered by this
method. However, when whole blood was modified by the addition of
glucose the recovery rose to 9T^« 'Two autologous transfusions in
humans were performed, and the transfused cells were labelled with
51radioactive Cr. It was shown that the twenty-four hour post¬
transfusion survivals were 8?S and 86,f. It was hoped, after this
experiment that whole blood could be frozen in large volumes, thawed
and transfused without the need for po3t-thaw processing which is a
major drawback of the methods utilizing glycerol. However, it was
found later that glucose does penetrate the red cell membrane in
amounts sufficient to cause osmotic imbalance in the same way as
glycerol (Meryman 1968b). Moreover, the procedure was rather tedious,
time consuming and difficult to operate under sterile conditions.
In spite of these difficulties the Linde Company (in 1956) adopted the
method and designed an apparatus for freezing and thawing blood in
pint quantities by the spraying technique under aseptic conditions.
Although the device was technically satisfactory it has been abandoned
because it was found to be very expensive, bulky and complicated
(Meryman 1964 - Blagdon 1972).
The droplet-spray technique was largely abandoned when Strumia
et al. (1958a) developed a method for freezing a whole unit of blood,
treated with a mixture of glucose and lactose, in a closed metal
container. Equal volumes of citrated blood (ACD) and sugar solution
were mixed together to give a final concentration of 0.2M lactose and
0.7M dextrose. Freezing was accomplished, in a flat sealed metal
container, 3-4 mm in diameter, by immersion in dry-ice-ethanol mixture
at -78°C blood was thawed in a water bath at 37°C. With this
method 95^' of the frozen cells were recovered intact. In five human
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transfusions of blood labelled with Cr frozen and thawed without
being stored the ?4-hour post-transfusion survival was 2% less than
autologous fresh blood. Further experiments (Strumia 196C&)showed that
in vitro recovery of the cells remained unchanged for two years at
-93°C while the 24-hour post-transfusion survival of this blood was
similar to that frozen and thawed immediately without storage. It
was also clear that storage at -58°C and -70°C were unsatisfactory for
long periods, although the latter temperature was adequate for 3-4
weeks (Strumia et al. 196Cb). Freezing in a closed container was
quite promising because it offered major practical advantages, although
in unit-volumes the heat exchange was less efficient than with the
droplet-spray method and necessitated the use of a substantially
higher concentration of sugars. In spite of this, the technique was
soon adopted by Linde Co. group (Rinfret 1963) who developed a
corrugated aluminium container for freezing a whole unit cf sugar-
modified blood. The container was filled only up to half capacity
with blood so that on freezing, shaking the container would spread
the blood over the entire inner surface as a thin layer. Further
improvement in heat transfer was achieved by covering the outer surface
of the container with an insulating layer of PVP (Rinfret 1963).
Blood frozen by this technique was stored in liquid nitrogen while
thawing was carried out by continuous shaking of the container in a
water bath at 45°C. Linde Co. designed a sophisticated apparatus to
perform all these steps (Hum 1968). In this way, the advantages
offered by rapid-freezing were obvious, for a unit of blood could be
collected directly into the freezing container, frozen, stored in
liquid nitrogen and prepared for transfusion without post-thaw washing,
in less than five minutes. Although the system seemed very promising,
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practical application brought about the discovery of its disadvantages
(Blagdon 1972). First it was shown that freezing red-cells in the
presence of glucose, render them osmotically unstable, so that on
transfusion they rapidly haemolyse (Bloom et al. 1962). Moreover,
the amount of free haemoglobin present in the supernatant was high
(Blagdon 1972).
When glucose was abandoned as a cryoprotective addi+ive, lactose
was introduced (Strumia et al. 1958a - Rinfret 1963). Certainly
lactose does not penetrate the red cell membrane (Rinfret I960), but
because of its low molecular weight it is osmotically active and may
cause substantial increases of the recipient's plasma osmotic pressure.
Experimental work with dogs and rats showed that lactose, in doses
required for protection, produced pathological lesions in the kidneys,
lungs and livers of the animals. This suggested that if lactose, or
any other low molecular weight additive, were to be used as cryopro¬
tective agents, they must be removed prior to transfusion (Pert et al.
1964).
After the rejection of all sugars as cryoprotective additives,
attention was directed towards substances with high molecular weight
in the assumption that these compounds would have little effect on the
osmolarity of the recipient's plasma. Previously many investigators
have reported on the cryoprotective activity of many solutes. Of
special interest was the finding of Bricka and Bessis (1955) that
polyvinylpyrolidone (PVP) and dextran protected human red-blood cells
against freezing injury. Both substances are high molecular weight,
pharmacologically inert, polymers which are incapable of penetrating
the cells. In their experiments the authors added one volume of
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packed cells to four volumes of additive in a 15 mm diameter aluminium
tube. Freezing was achieved by immersion in dry ice-alcohol mixture.
A recovery of 95$ was obtained in the presence of 40$ PVP in saline
and at cooling rate of 1°C per second.
Sloviter in 1958 has also reported on the cryoprotective activity
of polyethylene glycol, a polymer with a M.W. in the range of 500 to
1500, when it was added to red-blood cells in a final concentration
of 25$ by weight. Looking into the mechanism of the additive's
protection, a group of investigators, at Linde Research Laboratories
tested a variety of compounds for their cryoprotective activity.
Among the list was, the plasma volume expander, PVP whose activity in
this field was previously demonstrated in 1955 (Bricka & Bessis).
Of all the compounds tested PVP showed an outstanding ability to
protect red-blood cells against rapid-freeze-thaw injury. At about
equal weight concentration PVP and glycerol offered similar protection
at a cooling rate of 3°C per second (Doebbler & Rinfret 1959 ~ Doebbler
et al. i960 - Doebbler and Rinfret 1962). Using rabbit blood Doebbler
et al. (1961) reported a recovery of 87 to 96$ after freezing a
mixture of ACD-blood and 7^ ?VP "final concentration" in small aluminium
tubes. On transfusion 85 - 98$ of the transfused cells survived in
the circulation after the first 24 hours.
By this time it has been realized that PVP was the most efficient
extracellular additive that could protect the red-cells against the
injury of rapid freezing (Rinfret et al. 1962). Accordingly most of
the subsequent work, which was devoted to the development of a
clinically acceptable technique for blood preservation by rapid-
freezing relied on the cryoprotective activity of PVP.
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Following this experimental work the technique was adopted by
the Linde group. Using the Linde Automatic Blood Processing Unit
Richards et al. (1964) reported a recovery of about 36% and 24-hour
post-transfusion survival of 80^ for blood frozen and thawed in the
presence of 1.5% PVP. In a series of 30 transfusions of whole units,
no instance of serious transfusion reaction was observed. Again no
incidence of renal function disturbance was recorded, although in
their initial trials several patients had dark-coloured urine for 12-
24 hours and some showed a fairly high in vivo haemolysis.
Transfusion of up to full-unit volumes of this blood resulted in
in vivo survival of approximately 85$ of the cells 24 hours after
infusion (Sakaida et al. 1965). Because of its large sized molecules
(M.W. range from 25,000-40,000) PVP, does not permeate the cell or
affect the osmolarity of the plasma after transfusion. But,
unfortunately, it is this high molecular weight that evoked a problem
concerning its use. Since this substance is not metabolized or
disintegrated into smaller sized molecules to permit its excretion,
the compound is stored in the reticuloendothelial system (R.E.S.) for
very long periods (Altemeier et al. 1954). That the large molecular
weight grades of PVP are retained in the body for very long periods was
also suspected by Bloom et al. 1962, 1965 Richards et al. (1964), and
Knorpp et al. 1967, and confirmed by Pert et al. 1965. The prolonged
retention of PVP by the R.E.S. is probably a disadvantage which must
be considered seriously. Another disadvantage of PVP-frozen blood
was the high level of free haemoglobin in the supernatant after
thawing (Valeri 1970 - Blagdon 1972). A post-thaw washing was
suggested, (Meryman 1968b, Valeri 1970), as a possible solution for
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removing the PVP, and the excess free haemoglobin. However, the
proposal did not receive great acceptance and it has been continuously
argued that this step would deprive the method its only advantage.
Moreover, washing erythrocytes processed by this technique usually
resulted in extensive haemolysis (Bloom et al. 1965) • Finally if
PVP frozen blood is to be washed, one might find it much easier to
use glycerolized-frozen blood as the latter is definitely nontoxic,
does not need special equipment for processing and controlled rates of
freezing and thawing are not required. Above all it yields a
clinically acceptable product (Pert et al. 1965 - Meryman 1968b). The
possibility that PVP is potentially toxic, has led investigators to
seek other polymers which might be more clinically acceptable. Dextran,
(M.W. 40,000), in a concentration, of 15-21 g/lOO ml and albumin in a
concentration 17-22 g/lOO ml were found to possess cryoprotective
activity. However, red cells frozen in their presence survived
poorly when transfused into human volunteers (Strumia and Strumia 1964).
The assumption that PVP retention might be circumvented by using
a low molecular weight fraction of PVP was first suggested by Pert et
al.(l964). Low molecular weight PVP was obtained by chromatographic
fractionation of "K-22" PVP (average M.W. 29,000) on G-75 Sephadex
columns. No apparent difference in activity was noticed between
different fractions, the average red cell recoveries varied between
95 and 97X. Although the idea seemed good and has been tried at the
Linde Laboratories, no successful reports have been published (Hurn
1968).
As a further substitute for PVP, Hydroxyethyl starch (HFS) has
been suggested (Knorpp et al. 1967)• Similar to PVP and dextran,
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HES, is a plasma volume expander used as 6f. solution, but unlike PVP
it is slowly hydrolized in the circulation into its precursor, glucose,
by the plasma amylases. Thus its transfusion does not present the
problem of long term retention experienced with PVP. For freezing,
fCnorpp et al added whole blood to a solution of HES in saline to give
a final concentration of 15> HES. The mixture was frozen in liquid
nitrogen with continuous agitation using the Linde Automatic Blood
Processing Unit. Upon thawing 97-4 percent of the red cells were
recovered intact. Thus HES was as effective as PVP and, offered the
advantage of being gradually metabolized by the body. The average
M.W. initially used was 450,000.
The efficiency of HES in protecting red cells against injury of
rapid freezing was confirmed by Robson in 1969- He reported an in
vitro recovery over 3&% by this method. The method of freeze preser¬
vation of the blood by HES was slightly modified to employ packed red
cells instead of whole blood (Knorpp et al 1971) - Packed erythrocytes
were added to HES - saline solution to give a final concentration of
14$ of HES. Although HES is considered non-immunogenic and nontoxic
(Maurer and Bererdinalli 1968) infusion of such a highly viscous
mixture may represent a potential hazard to the transfused recipient.
In the first instance because of its high viscosity, HES-erythrocyte
mixtures gave severe difficulty and delay in transfusion, besides
its presence in the circulation might encroach upon the renal
haemodynamics (Stella Baar 1973). Secondly the introduction of a
mixture with such a high viscosity might interfere with blood
coagulation mechanism and results in bleeding djathesis (Thompson &
Gadsden 19^5> Lee et al 1968). Thirdly because of the post-thaw
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unstability of erythrocytes processed by this method, the free haemo¬
globin content of such blood is very high (Blagdon 1972). Fourthly
red blood cells, preserved by this technique lose 87$ of its intra¬
cellular K+ to the surrounding medium (Meryman (1971c), a matter which
might affect its in vivo survival (Valeri and Runck 1969a) and increase
the extracellular K+ concentration to an unacceptable level.
In spite of the fact that in vivo studies in monkeys showed no
adverse effect of HES-frozen blood on the blood coagulation, reduction
of the viscosity of the HES-blood suspension was advised as an
additional safety measure. As a method of lowering the viscosity,
HES can be washed out of the erythrocyte-HE3 mixture without comprom¬
ising the biological value of the product (Knorpp et al. 1971 )• In
so doing the authors claimed a substantial improvement in the post-
thaw stability of the cells in saline besides the complete removal of
the excess haemoglobin and potassium.
Instead of washing, the HES could be diluted to the required
degree by the addition of a physiological salt solution to the thawed
blood. This reduces the concentration and hence the viscosity of the
HES in the blood to limits which permit its transfusion without
difficulty, (Stella Baar 1973). An alternative approach to avoid
transfusion of HES of high viscosity is to use low molecular weight
starch (Weatherbee et al. 1974). Preliminary experiments showed that
this form of starch provided even better protection to the red cells
than the high molecular, plasma expander type.
It has always been emphasized that the ultimate aim in blood
preservation by rapid freezing is the production of a preparation
that, after thawing, require no further processing. Verification of
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this ideal one-step method, would have eliminated the need for the
exhaustive post-thaw washing which is demanded by the glycerol
technique. However none of the above described methods has achieved
this aim. Post-thaw processing has been a necessary step either to
remove the product of haemolysis or the undesired additives or both.
The acceptable limits of these substances represent the major obstacles
opposing the development of rapid-freezing techniques. Excessive
haemolysis results from the use of low concentration of additives,
while higher concentration of the latter brings about osmotic problems.
THE LYTIC MECHA.NSIM OF RAPID FREEZING
Meryman (195&) defined rapid freezing as the rate at which
intracellular ice crystals are produced. When the rate of cooling is
rapid, the tendency for preferential extracellular nucleation ceases,
and nucleation takes place throughout the specimen leading to ice
crystal formation that are predominantly intracellular. Mazur in
1968 and 1970 explained the sequence of events which leads to this
result. Exposing the cells to subzero temperatures results in the
formation of ice, first outside the cell, at the same time water
inside the cell tends to supercool. Because the vapour pressure of
the supercooled water is higher than that of the external ice, a
vapour pressure gradient Is produced which then dictates a process of
equilibration. The method of equilibration depends mainly on the
rate of cooling. Thus, if this rate is slow, intracellular water
will have sufficient time to flow out of the cell and added to the
external ice. On the other hand if the specimen is cooled rapidly
equilibration is restored by solidification of the intracellular water
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in situ. In the latter case ice crystals are formed as a result of
homogeneous nucleation, where the nuclei are created from aggregation
of the solvent molecules themselves (Meryman 1956).
MODE OF INJURY
Several theories have been put forward to explain the nature of
damage and/or the mechanism of protection afforded by rapid freezing,
(i) Ice crystal formation;
Whereas, the presence of extracellular ice appeared to be
insignificant (Lovelock 1953a, Meryman 1956, 1963), intracellular one
has to be considered seriously. If these crystals are allowed to
grow, and they have the liability to do so, beyond the size of the
cell that contains them the outcome is obvious. It needs very high
rates of cooling to create intracellular ice (Meryman 1956) and when
this is reached red cell haemolysis is massive. However it is not
known whether the intracellular ice injure the cell during the process
of freezing or on rewarming when migratory recrystalization tends to
occur. Luyet et al. (1963) were of the latter opinion. They
consider that, in the absence of any protective agent, there occur
an optimal cooling rate, above and below that rate haemolysis increased
rapidly. As regards the cause of haemolysis at the supra-optimal rate,
the authors referred it to the formation of intracellular ice during
freezing which undergoes recrystallization during warming. Meryman
(1963) considered that very rapid freezing leads to the formation of
intracellular ice, and thus it is uniformly lethal to mammalian cells.
Mazur in (1968 and 1970) has clearly identified the rate beyond which
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intracellular ice formation appeared. He indicated that without the
addition of additive, maximum red-cell recovery occurs at a cooling
rate of 3000°C per minute. Intracellular crystallization of water
starts at rates of 5000°C per minute and this coincides with the
rates at which red cell recovery declines. He also suggested that
cooling rates below-optimum exposes the red cells to the effect of
high salt concentrations.
As regards protection, no additive has yet been discovered to
check the deletrious effect of intracellular ice formation (Hurn 1968).
(ii) Salt Concentration;
Whatever the rate of cooling might be, as freezing proceeds
gradual diminution of the liquid-water occurs both inside and outside
the cell. This exposes the cells to the deletrious affect of
increased concentration of intra and extracellular salts. Since the
latter produces its effect through a bio-chemical reaction, the rate
of this reaction shows both time and temperature dependence (Meryman
1956). It follows that, at a relatively higher range of temperature,
rapid freezing allows no sufficient time for the concentrated salts
to produce its effect. As the temperature drops the rate of the
chemical reaction ceases and comes to a halt below certain temperature
level.
Protection against salt concentration effects required an agent
capable of penetrating the cell membrane.
(iii) Dehydration:
That dehydration beyond a certain level is a primary cause of
injury has been suggested by Doebbler and Rinfret (1962) Rinfret 1963
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and Meryman (1967).
Rinfret in 1963 demonstrated that as high as 90$ of the freezable
water in the specimen can be converted into ice and still give little
haemolysis. However any water removed beyond that results in massive
haemolysis. Rinfret's experiment did not only show the importance
of cellular-hydration, but also demonstrated that intracellular ice
formation is insignificant until the ultimate stages of phase transition.
Luyet and Kroener (1967) showed that freezing' of the blood slowly to
-3°C removes 80$ of the liquid-water without lysis, at -8°C 92$ of the
water is removed but haemolysis is progressive. Rapid freezing
through the same temperature reduces the haemolysis. The authors
interpreted these results as the fraction of liquid-water between 80$
and 92$ is critical and if sufficient time is allowed for its trans¬
formation, lysis of the red-cells occurs. Rapid cooling protects the
cells by giving insufficient time for the freezing of the last fraction
of water. Red cells injured from this cause could be protected by
the addition of extracellular cryoprotective agents which can
hydrogen-bind the vital fraction of water and stabilize the surface
hydration of the cell (Doebbler and Rinfret 1962, Hurn 1968).
(iv) Adenosine triphosphatase (ATP-ase) activation:
Studying the biochemical changes in the previously frozen-thawed
blood, Rinfret (1963) observed an abnormal activity of the ATP-ase and
choline-esterases which suggested damage to the cation exchange
mechanisms of the erythrocytes. Takehara and Rowe (1968) have also
investigated the conditions of freezing that increases the activity
of ATF-ase in the red cell-membranes to explore the mechanism of
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freezing damage. They found that the faster the cooling rate, the
more the activation, and that many cryoprotectives could inhibit this
activation. They concluded that the rate of cooling is more
important factor in the activation of erythrocyte membrane ATPase
activity than the absolute temperature attained. They also
suggested that activation of membrane ATPase might be casually
associated with the change in cation and electrolyte permeability
together with the haemolysis that takes place when red cells are
frozen in the absence of cryoprotective additives.
MECHANISM OF EXTRACELLULAR CRYOPROTECTION
With a slow cooling rate at a few degrees per minute, high
concentrations of glycerol provide good protection to the red cells
against freezing damage (Smith 1950). Glycerol, and similar small
molecular weight additives, appear to act colligatively, by buffering
the concentration of salts in equilibrium with ice at any given
temperature above the eutectic point (Lovelock 1953b, 1954).
Luyet in 1949, found that, in the absence of any additive, very
rapid cooling rates at hundreds of degrees per second would protect
the red cells against haemolysis. Further improvement in recovery
was achieved by the addition of sugars (Meryman and Kafig 1955) and
polymers (Bricka and Bessis 1955). At a less rapid cooling rate,
several degrees per second, sugars and polymers were still effective
in preventing haemolysis (Strumia et al. 1958a, 1960a, 1960b,
Doebbler and Rinfret 1959)* The mechanism by which these additives
produce its action was ascribed to its effect in slowing the rate of
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ice crystal growth (Lusena and Rose 1956). The nature of this effect
has not been definitely identified but It might be connected to the
property of these compounds to be strong hydrogen-bonders (Glauser
and Talbot 1956, Strumia et al. 1960a, Meryman 1956, Lusena and Rose
1956). All compounds found effective in inhibiting freeze-thaw
haemolysis have a polar carbon to oxygen bonds. The oxygen atom is
also available to bond with the hydrogen of the water molecule (Olauser
and Talbot 1956). At moderate cooling rates, good correlation between
the concentration of potential H-bonding groups and the degree of
protection has been observed by Doebbler and Rinfret (1962). In
addition to binding water, H-bonding sites, also form and stabilize an
extended region of oriented water around each molecule. It seems
that such solutes would act by preventing completion of the phase
transition which normally takes place during freezing (Rinfret 1963,
Rinfret et al. 1964, Doebbler and Rinfret 1965). Under these
conditions the water will be available as solvents for the salts but
does not contribute in the formation of ice crystals. However,
Meryman (1971a) has not been able to find any support for this
assumption. On the other hand he observed that metastable state of
water occurs only at supra-optimal rates of freezing at which complete
haemolysis of the red cells takes place. Meryman suggested that at
optimal rate of freezing all the "freezable" water has crystallized
and the system was in equilibrium. Since the cells under these
conditions must have been exposed to the full salt concentration
predicted, their recovery means that avoidance of the effects of these
salts rather than failure of the solute to be concentrated is the
cause of recovering the cells intact. Moreover, after rapid freezing,
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the recovered cells showed a great change in electrolyte content
which suggested that their recovery was due to temporary reversible
alteration in cell permeability. The latter allowed "influx and
efflux" of solutes as a result of stresses which would otherwise
burst the erythrocytes. That such cells could survive after trans¬
fusion is an evidence for the reversibility of these changes (Meryman
and Hornblower (1972b). Since a high percentage of red cells could
be recovered by very rapid freezing, in the absence of any additives,
the cryoprotective agent is, thus, not necessary for the establishment
of reversible membrane leak, however, it serves to decrease the rate
of cooling necessary to obtain maximum recovery and stabilizes the
cell membrane component against the irreversible post-thaw changes.
Another concept of the mode of action of the extracellular
additives has been advanced by Rinfret (1963) and Rinfret et al. (1964).
It was postulated that extracellular additives are adsorbed to the
red cell surface where they surround sensitive sites in the cell
membrane and protect them from the deletrious effect of salt concen¬
tration. Greiff and Seifert (1968) developed a membrane adsorption
test for determining the effect of addition of cryoprotective compounds
on the cryosensitive, mucopolysaccharide, sites at the surface of the
membrane of chicken red-cells. They indicated that the mechanism of
protection seemed to be through the external binding of these compounds
to the sensitive sites of the cell membrane.
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FREEZING AND THAWING PARAMETERS
I. FREEZING
A. HEAT TRANSFER:
In order to freeze a biological specimen it has to be immersed in
a cooling bath which has a temperature considerably lower than -50°C
(Cowley et al. 1961). However, to maintain a constant temperature,
in the bath, one has to choose a cooling liquid with a boiling point
below this temperature. A great variety of natural liquids are
available e.g.
Helium -270°C Argon -185°C
Hydrogen -252°C Oxygen -183°C
Neon -245°C Methane -161.5°C
Nitrogen -196°C
Of all these fluids, liquid nitrogen has gained the greatest popularity
because it is easily available at relatively low cost and is safe to
use. However, because liquid nitrogen is only available at its
boiling point, its use in cryobiology has been limited by the formation
of a thermally insulating layer of vapour around the immersed object
(Cowley et al. 1961, Meryman 1956).
When a warm object is immersed in liquid nitrogen several stages
exist in the transfer of heat from the solid surface to the cold
liquid. First heat is transferred from the immersed object to the
liquid and causes it to boil. Because the initial temperature
difference is large, boiling is very vigorous and results in the
generation of a stable insulating layer of vapour around the solid
object. The low thermal conductivity of this layer causes severe
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reduction in the rate of heat transfer "film boiling" (Luyet 1961).
Heat is transferred during this stage by radiation (Cowley et al. 196l).
Secondly, as the temperature difference is decreased, the rate of heat
transfer is slowly increased as a result of breaking the continuous
layer of vapour into bubbles of gradually decreasing size (Luyet 1961).
The maximum theoretical heat flux occurs at the "nucleate boiling"
point at which the temperature difference between the solid surface and
the coolant is 3.5°C (Cowley et al. 1961). Further decrease in the
temperature difference results in reduction in the nucleation sites and
hence of heat transfer. Initially at this stage vapour bubbles were
forming turbulance in the liquid and therefore rapid heat flux,
however the rate of heat transfer rapidly diminishes as the temperature
difference decreases below 3.5°C.
As regards freezing of blood, the range of temperature during
which rapid cooling is optimal lies between -3°C and -40°C (Lovelock
1953a). However, the rate of cooling within the material depends
mainly, on the rate of heat transfer, which is in turn largely
determined by the type of boiling at the surface (Luyet 196l). "Film"
boiling leads to slow heat transfer and "nucleate" boiling to rapid
transfer and hence rapid cooling rate.
The application of thin layers of thermally insulating materials,
to the outer surface of the metal container, results in a remarkable
increase in the cooling rate when the sample is immersed in liquid
nitrogen (Cowley et al. 1961). The surface coating serves to decrease
the surface temperature rapidly to the range of nucleate boiling where
the heat transfer is maximum, cooling then proceeds at this higher
rate of heat transfer. A wide range of organic materials could be
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used as surface coating. Cowley et al. have used vaseline and
glycerine but they also mentioned that the addition of a powder on
the insulating coat further increased the cooling rates. After the
development of the blood freezing system at Linde Company PVP in
methanol was found to give the best results when the metal container
was dipped into that mixture immediately prior to freezing (Rinfret
et al. 1962). It should, however, be pointed out that the method of
improving the heat transfer by the application of surface coating is
effective only with boiling liquids (Cowley et al 1961).
B. AGITATION
Methods of preservation of blood in bulk volumes by rapid freeze-
thaw techniques was first introduced by Strumia et al. (1958a) and was
adopted later by the Linde Co. and have since been used by many
investigators. Blood was frozen in a thin walled metal container of
high thermal conductivity. The problems facing the heat transfer
were mathematically reported by Rinfret in I960. He indicated that
ip cooling any liquid in an aluminium tube the transfer of heat is
impeded by four separate barriers which are, from inside outwards,
1. The liquid core in the centre 2. The crystalline ice layer
3. The container wall 4. The vapour layer surrounding
the container
If we consider the resistance of the aluminium wall to transfer of
heat as one unit, then, during freezing the highest resistance is
offered by the vapour layer and the unfrozen core in the centre.
Since reduction in one of the greatest insulators would most effectively
reduce the total resistance, then reduction of the resistance of the
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vapour laver to one tenth of its value would lower the total resistance
by about AOt. As we have seen previously the resistance of the
container - coolant interface could be reduced by coating the outer
surface of the container with thin thermally insulating material
(Cowley et al. 1961). However, it is not sufficient to accelerate
the cooling rate only at the interface between the container and the
coolant liquid. Further increases in the cooling rate could be
achieved by agitation of the container, a process which promotes
convection (Strumia et al. Strumia 1998b, 1960a, Rinfret 1963, Sakaida
et al. 1969). Acceleration of the rate of heat transfer to high
degrees are not always benificial, as extremely rapid rates of cooling
are destructive.
II. THAWINGf
It is assumed that the use of cryoprotective agents would minimize
most of the hazards produced by freezing or thawing so that neither
rapid cooling nor rapid warming is essential. However, there is ample
evidence in the literature that even in the presence of additive, rapid
rates of thawing are beneficial.
Thawing of blood, which has been previously frozen in aluminium
tubes proceeds much more slowly than the freezing process (Rinfret
i960). It took the phase transition front approximately double the
time- during thawing, to reach the same distance travelled during
freezing. This is due to the fact that latent heat has to be conducted
through the liquid sector which has the greatest thermal resistance
under these conditions. The important point in this case is that
the solid central core, because of its relatively high conductivity,
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will reach an equilibrium at a temperature just below the melting
point. This means that the red cells, in this region, will be held
in the critical range of temperature all the time the phase transition
boundary is proceeding towards them. Rinfret (i960) calculated that
a reduction of the liquid resistance by 50$ would decrease the total
thermal resistance by 40$. He suggested that this could he achieved
by continuously shaking the container during thawing, a matter which
allows transmition of heat via convection, rather than conduction, and
thus cut down the time of thawing.
The advantage of agitation of blood was first reported by Strumia
et al. (1958b). Agitation of blood during freezing and thawing
resulted in much higher recoveries and allowed the use of containers
with a larger cross-section or the use of lower concentrations of
additives (Strumia et al. 1958b, Rinfret 1963). than when no agitation
was employed. Shaking during thawing is more important than during
cooling, although the latter has the advantage of spreading the blood
all over the entire surface of the container, especially when it is
partially full, and thus reduce the distance through which heat has
to travel (Hurn 1968). There is a positive correlation between the
red cell recovery and the frequency of shaking, however, the relation
is not absolute as excessive shaking can bring about mechanical
damage to the cells (Rinfret 1963).
COOLING RATE
Study of the relationship between cooling rate and red cell
recovery have shown that there is a certain range of cooling rates at
which maximum recoveries are obtained (Luyet et al. 1963, Rapatz et al.
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1968). This effective range, however, varies according to the presence
or absence and to the nature of the additive. Thus without any
additive maximum recovery was obtained at cooling rates of 1600°C to
3500°C per minute. Some additives like glycerol prevent haemolysis
at low cooling rates. At 10$ concentration its maximum effect is
seen at a range of temperature from 5°C to 150°C per minute whereas at
rapid rates of cooling it is not only ineffective but actually exerts
a damaging effect. Other additives e.g. dextrose are effective only
at high cooling rates of the order of 2,500 to 3,500°C per minute.
Cooling rates above and below these ranges produces excessive haemolysis.
Optimum rates of cooling are the result of interaction of the two
types of freezing events. High salt concentration produces damage of
the red cells at sub-optimal cooling rates and intracellular ice
formation at cooling rates above-optimal (Mazur 1970). The optimum
rate can therefore be defined as that rate which is "slow enough to
prevent production of intracellular ice and yet is rapid enough to
minimize the length of time during which cells are exposed to salt
concentration effects" (Mazur 1970).
In the range of slow and moderate rates of cooling an increase
in the cooling rates causes an increase in the red cell recovery and
improves the level of protection afforded at a given additive concen¬
tration (Doebbler et al. I960, Doebbler and Rinfret 1965). At slow
cooling rates, a considerably higher concentration of additive is
necessary, in order to obtain good red cell recovery (Doebbler et al.
i960, Rapatz et al. 1968). On the other hand the protection afforded
by many additives decreases rapidly to nil and may even become
negative at increasing cooling rate (Luyet et al. 1963).
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STORAGE
For successful preservation, rapidly frozen blood, should be stored
at temperatures considerably lower than that at which recrystallization
of ice could take place or salt concentration could produce its effects.
There are many reasons to believe that (-79°C), temperature of dry ice,
is unsatisfactory temperature for long-term storage (Rinfret 1963,
Meryman 1963). Ice crystals are still able to grow at temperatures
as low as -70°C (Strumia et al. 1960b). Although, all the evidence
indicates that temperatures in the order of -93°C (Strumia et al.
1960b) or -100°C (Meryman 1963 - Rinfret 1963) are cold enough to
maintain the viability for periods of up to two years, most cryobiolog-
ists preferred to employ liquid nitrogen refrigerators. In its liquid
form, nitrogen has a temperature of -196°C while the temperature in
the vapour phase is approximately -190°C. Liquid nitrogen is easily
obtainable, safe and inexpensive.
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INTERMEDIATE RATE OP FREEZING
Up to 1962, long-term preservation of human erythrocytes at sub¬
zero temperature has been accomplished by either one of two methods.
The first utilized a very rapid rate of cooling coupled with extra¬
cellular cryoprotective agents e.g. sugars or PVP. It was hoped that
blood preserved by this method could be directly transfused without the
need for further processing. However, sugars were soon excluded
because being of low molecular weight, its administration into the
circulation produces a substantial increase in the osmotic pressure
of the plasma and hence pulmonary haemorrhage and renal damage (Pert
et al. 1964). After the exclusion of sugars, PVP was found to be
most efficient in protecting the red cells against rapid freezing, but
this time, it was its high molecular weight that caused the problems
involving its use. Because of its large molecular size, a high
percentage of the amount transfused could not be excreted by the
kidneys and was retained by the reticulo-endothelial system for very
long times (Altemeier et al. 1954, Pert et al. 1963). Even after
the introduction of hydroxyetbyl starch (HES), (an extracellular
cryoprotective substance of high molecular weight which can be easily
digested in the circulation by the enzyme amylase), the final product
could not be transfused directly after thawing because of the high
residual free haemoglobin content.
The second method of blood preservation by freezing employed a
slow rate of cooling associated with a high concentration (40$ w/v)
intracellular additive, glycerol. However, the removal of such high
concentrations of glycerol has proved difficult (Meryman 1968b).
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Intensive care, considerable amounts of time and large columes of wash
solution are required for washing the glycerol out of the red cells
without injuring them.
It was such considerations that led to the development of a new
method which employed an intermediate rate of freezing (less than 10°C
per sec) together with a mixture of low concentration of glycerol and
small amounts of sugars as an extracellular additive.
Pert et al. (1963) were the first to show that a glycerol concen¬
tration of the order of (l4g^) and sucrose (2,76g$) combined with
freezing in liquid nitrogen provided excellent protection to the
preserved human red blood cells. They also demonstrated the presence
of a relationship between the glycerol concentration and the cooling
rates (Pert et al. 1965). The range of glycerol concentration that
produced the highest red cell recovery was from 14-20 vol.%. Below
14 vol.$ glycerol, a high degree of accuracy is required in order to
control both the cooling rate and the glycerol concentration. Glycerol
concentrations above 40 volume £ permitted the use of any freezing rate
with good red cell recovery. At glycerol concentration of 20 vol.£
a wide selection of freezing rates could be employed.
In the recommended dose (l4g^)» glycerol was promptly and
efficiently removed from the red cells by the so called "batch washing".
This type of washing consists of a sequential series of centrifugal
sedimentations decantations and re3uspensions in a new solution.
Because glycerol is used in low concentration, gradient washing are
not required. The glycerolized thawed red cells are first diluted
with an equal volume, of 30g£ sucrose followed by 1000 ml of 0.85 Per
cent sodium chloride. The erythrocytes are then separated by
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centrifugation and washed twice with sufficient volume of isotonic
saline. The first wash, a hypertonic sucrose solution, serves as
an osmotic gradient to remove the water and the glycerol from the
red cells. Utilizing Teflon bags and this method of freezing and
washing the authors reported an in vitro recovery of 96 to 99>5$ and
24-hour chromium survival in the range of 86 to 95A* The total volume
of wash solution used was 2.5 litres and it took about 2b hours to
process one unit. After completion of the wash process the glycerol
concentration was reduced from 14g^ to 0.1g$.
In 1969 Pert et al. used plastic containers (Teflon and Hemoflex
bags) for freezing in liquid nitrogen and were able to adapt the method
of continuous-flow centrifugation employing the ADL-bowl for washing
red blood cells frozen by their method and obtained almost the same
results.
In 1964 and 1965 Krijnen et al. introduced further improvements
on the original method proposed by Pert and associates. They showed
that 17»5 per cent w/v glycerols is optimal for protection of red cells
frozen in flat stainless steel container. The glycerolizing solution




Equal volumes of this solution and packed red cells were mixed in a
stainless steel container 255 x ^55 x 9 aim and frozen by direct
immersion in liquid nitrogen. After thawing the red cells were
separated by centrifugation and washed once with 300 ml of 16a
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sorbitol in 0.9? saline. This was followed by two successive saline
washes. Under the condition of experiment they reported an in vitro
recovery of 97 to 98? and autologous in vivo survival with -^Cr of 94
to 99? at 24-hours.
Rowe et al. (1968) have also utilized the low-glycerol-intermediate
freezing technique to preserve human red blood cells for transfusion,
Equal volumes of packed red cells and glycerolizing solution were
frozen in flat stainless steel container (10xl0x§ inch) by immersion




After thawing, the blood-additive mixture was transferred to a plastic
bag and washed with a serial centrifugation technique. The first wash
consisted of 16? mannitol in isotonic saline, this was followed by two
isotonic saline washes. The mannitol acted as an osmotic gradient
to extract the glycerol from the erythrocytes and the last two washes
for the removal of the residual glycerol, mannitol free haemoglobin,
cell debris, platelets and leucocytes. The mannitol was preferred
only because it was a commercially available licenced product in the
U.S.A. whilst sorbitol was not. The total volume of wash solution
used was less than one litre, the red cell recovery was more than 90?
and the in vivo survival was 96 - 1.5?* Rowe and his colleagues
have also reported their experience in transfusing 380 units of blood,
that were frozen and stored in liquid nitrogen for up to 12 months
to recipients with various diseases without adverse reactions.
In (1969b) Valeri and Runck used two different methods, serial
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and continuous centrifugation, for washing red blood cells that were
frozen with Rowe's method in flat stainless steel container. They
showed that washing by serial centrifugation required 0,75 litres of
wash fluid and was very efficient as evidenced by the level of the
supernatant glycerol (250 mg/lOO ml). However, the method required
almost two hours and a substantial effort from the technician.
Nevertheless, the in vitro recovery, supernatant haemoglobin and in
vivo survival were more or less similar with both methods. Using the
continuous-flow-centrifugation technique in A.D.L. reusable bowl the
processing time was 30 minutes, utilizing litres of wash solution
but resulting in almost double the amount of residual glycerol in the
supernatant (536 - 222) mg/lOO ml. With either method the intra¬
cellular potassium was not affected by the washing process.
Rowe (1971) and Rowe and Lenny (1972) introduced two modifications
into their original method. Firstly they substituted a polyethylene
bag, (Hemoflex bag) for the stainless steel container in which the
glycerolized blood was frozen. Rowe (1971) indicated that the plastic
bags are superior to the metal container for they are easier to handle.
Furthermore the invitro recovery wa3 significantly higher and the
supernatant haemoglobin was lower with plastic bags than with stainless
cans. Secondly, the authors used the Elutramatic, an automated
blood washing machine that utilizes the continuous-flow centrifugation
principle, for processing the blood frozen by their technique. As
a result of these changes the processing time was reduced to 5^ minutes
for two units instead of two hours.
In 1970 Krijnen et al. also replaced their stainless steel
container with a seamless, cylindrical, aerosol can, made of aluminium,
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in which they successfully froze red blood cells with a glycerol-
sorbitol solution. The can was formed of two separate portions, a
screw-cap neck and a body, which were assumbled before use by forcing
the former part with a rubber ring into the body. They also developed
a five-tailed plastic pack for processing.
Jenkins and Blagdon (1971) were concerned about the safety of
Krijnen canister because of the possibility of liquid nitrogen leakage
through the joint between the neck and the body. This carries the
potential danger of explosion or bacterial contamination. They
developed a new method of sealing the same can but it was sealed at
the top by a rubber stopper which had a turnover skirt and was wired
into place with three turns of copper wire. It was also found
desirable to increase the glycerol concentration to 20^ w/v.
Glycerolized blood was cooled in liquid nitrogen at an average rate of
0.7°C per second, then stored in the vapour phase of liquid nitrogen
at -150°C. After thawing the blood was transferred to a five-tailed
plastic pack, modified to give access to standard U.K. giving ports,
and washed with serial centrifugation according to the method of
Krijnen et al. (1964). The total red cell haemolysis of blood processed
by this method was approximately 10 per cent, and the 24-hour post¬
transfusion survival, measured by the automated differential
agglutination, was from 90-95^ (Blagdon 1972). After processing the
blood was transfused as packed red cells, with a haematocrit of 75^,
in saline. The maximum period of post-thaw storage was 12 hours.
In 1972 Akerblom and Hogman described a method of freezing red
blood cells that permitted deglycerolization by any of three methods:
serial centrifugation (batch washing), continuous-flow centrifugation
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and reversible agglomeration. In their method, 100 ml of freeze-
protective solution was added to hard packed red cells from one unit
and the mixture was transferred into a plastic bag made of Kapton/
Teflon -FEP laminate.





Distilled water ad 100 ml.
The bag was then placed in an aluminium envelope and frozen in liquid
nitrogen. After thawing, the blood could be processed by serial
centrifugation "batch washing" by transferring it into either a glass
bottle or into a five-tailed plastic pack where a hypertonic (3.7^)
NaCl solution was added to it in the ratio of 1:2. The red cells
were then separated and given three washes with isotonic saline
(Akerblom and Hogman 1974). Alternatively the thawed blood could be
washed in an automatic continuous-flow washing machine (Elutramatic
Ultra Flo.) in which two units could be processed simultaneously. If
the demand for blood was high, deglycerolization could be accomplished
rapidly by the agglomeration washing procedure, the low extracellular
sodium chloride helped to fulfill the requirements for this method.
The authors (1974) pointed out that it was the actual urgency for the
blood that determined the method of deglycerolization. Thus if only
a few units are required for a non-urgent case, then the centrifugation
methods, either serial or continuous, would be satisfactory because
either method yielded afaigh red cell recovery and low supernatant
haemoglobin. When the blood was required in large amounts, then the
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agglomeration method would be the most adequate in spite of the
higher residual free haemoglobin and the lower red cell recovery.
Following experience in Europe with the low glycerol-liquid
nitrogen method it became apparent that this method offered several
advantages over the high glycerol-slow freeze technique. The former
method provided a wide selection of post-thaw washing processes. Of
special importance was the "batch washing"; a method which offered the
advantage of high red cell recovery, small volumes of wash solution
and the use of equipment available in any blood transfusion service.
Possibly the reasons for Blood Banks in America retaining the high
glycerol-slow freezing method at -80°C was their inability to obtain
a licence for using aluminium containers and the high cost of liquid
nitrogen. Furthermore by the time the low-glycerol-liquid nitrogen
method has fully developed, a hugh amount of money was already invested
in mechanical refrigerators that work at -80°C. However, most of
our recent knowledge about the frozen blood came from experience with
the high glycerol-slow-freezing technique at -80°C. Little has been
published concerning detailed evaluation and experience with blood
frozen with low glycerol in liquid nitrogen.
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CLINICAL EVALUATION OF THE FROZEN BLOOD
The necessity for quantitative evaluation of the blood recovered
after freezing and thawing has been emphasized by many investigators
(Rinfret 1963, Tullis 1963). It is not sufficient that a certain
method of freeze-preservation yields a high percentage of morpho¬
logically intact red cells: of utmost importance is that these cells
show both in vitro stability and in vivo viability and function.
It has long been realized that red blood cells frozen in the
presence of intracellular cryoprotective agents will, after thawing,
become osmotically unstable and, unless the additive is removed, it
will undergo excessive haemolysis if resuspended in physiological
medium. However, the prolonged experience with the frozen blood
showed that even after washing out the intracellular additive,
instability in physiological media was a constant feature of all
previously frozen-thawed erythrocytes on storage, whatever the method
used for its preservation (Tullis et al. 1998, Doebbler and Rinfret
1959). This instability was evident by the continuous increase in
the level of the supernatant haemoglobin. This implied that
determination of the post-thaw stability in physiological media as
well as standardization of physiologically acceptable levels of free
haemoglobin in the supernatant fluid must be made before recommending
a particular method for clinical application.
Some of the recovered cells might be irreversibly damaged so
that they are rapidly removed from the circulation once they are
transfused. If the removal of these cells is not accompanied by
haemoglobinaemia, then the determining factor of acceptability, as far
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as the free haemoglobin is concerned, will be the level of the
haemoglobin in the supernatant fluid. Following administration the
free haemoglobin will be bound by the haemoglobin-binding protein
(hapotoglobin) in the recipient circulation until the latter is
saturated. The excess free haemoglobin will remain as such in the
blood and, if it exceeds the renal tubular threshold, it appears in
urine (Valeri 1965b). Although haemoglobinuria might be well
tolerated by healthy as well as patients with normal blood pressure
and blood volume, it might, in seriously ill or shocked patients,
precipitate acute renal failure (Valeri 1970). However, high levels
of supernatant haemoglobin are not uniformally toxic, for free
haemoglobin and stromal protein introduced in compatible transfusion
are easily tolerated without untowards side effect and has to be
separated from the serious effects of incompatible transfusion
(Zwilling 1958).
Different procedures undertaken in the preparation of freeze-
preserved red cells for transfusion may result in significant physical
ar)d biochemical changes of these cells. Thus in spite of the fact
that the total concentration of the intracellular cations appeared
unchanged, differential cation estimation showed a substantial
increase in the sodium and significant decrease in the potassium
content of the cells (Doebbler and Rinfret 1965).
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ORGANIC PHOSPHATE COMPOUNDS
In the last few years, much attention has been paid to the
functional status of preserved red cells, particularly, the ability
to deliver sufficient amounts of oxygen to the tissues. In vivo
viability is no longer considered the only criterion for successful
preservation, as red cells may have normal in vivo survival but are
still unable to bind and release oxygen physiologically (Akerblom et
al. 1968, Valeri and Hirsch 1969> Portier et al. 19&9) Bunn et al.
1969).
That erythrocyte function might be affected by routine storage
was first observed by Valtis and Kennedy in 1954- Those authors
noticed that blood stored in acid-citrate-dextrose (ACD) at 4°C for
longer than one week had an increased affinity for oxygen, demonstrated
by a significant shift to the left of the oxygen dissociation curves.
This means that the amount of oxygen unloaded to the tissues by this
blood would be substantially lower than that released from fresh
blood. Administration of such blood in large volume to anaemic
patients would result in shift to the left of the oxygen dissociation
curve of the recipients' blood, the extent and the duration of that
shift was proportional to the quantity and period of storage of the
transfused blood. However they demonstrated that in vivo restoration
of the oxygen dissociation curve occurred, but that several hours
were required after transfusion in order that the oxygen function
would return, even partially, to normal levels.
Other investigators (Bartlett and Barnet i960) had demonstrated
that during storage of ACD-blood at 4°C the organic phosphate compounds
of the red cells, especially 2,3 DPG and ATP, progressively decreased.
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They estimated that, approximately all the red cell content of 2,3
DPG disappeared in two weeks, however the rate of disappearance of
ATP, during this period, was much slower, but increases rapidly
thereafter.
Human red blood cells are known to contain large amounts of
organic phosphate compounds as a result of metabolic glycolysis.
A major proportion of these compounds in a normal red cell is con¬
verted to 2,3 DPG and ATP; the former being four times greater in
concentration than the second; (Chanutin and Curnish 1967) and in
molar concentration it is equivalent to the haemoglobin tetramer
(Bunn and Jandl 1970). With the exception of red cells, all the
tissues metabolize 1,3 DPG into 3-PG with production of one mole of
ATP. In the red cell, however, most of the 1,3 DPG is metabolized
through a different route by being transformed into 2,3 DPG first and
after completion of the cycle into 3-PG. No high energy phosphate
bond is liberated (Bunn and Jandl 1970).
The relationship between the oxygen affinity of the haemoglobin
and the level of the red-cell organic phosphates compounds has been
demonstrated by several investigators by a great variety of in vivo
and in vitro experiments.
Sleetrophoretic analysis of haemoglobin solutions prepared from
fresh blood revealed the presence of a separate zone which moved
slower than the haemoglobin itself and this was designated as the
B-component (Sugita and Chanutin 1963). This slow moving zone was
absent on electrophoresis of haemolysates made up from stored
erythrocytes, but it reappeared on addition of either 2,3 DPG or ATP.
Studies of the oxygenation curves of haemoglobin solutions which
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have been stripped of organic phosphates showed a very high affinity
for oxygen evidenced by a substantial shift to the left of the
oxygen dissociation curve (Benesch and Benesch 1967). Addition of
increasing amounts of 2,3 DPG or ATP resulted in a progressive
reduction of the oxygen affinity and restoration of the oxyhaemo-
globin dissociation curves to normal (Benesch and Benesch 1967*
Chanutin and Curnish 1967).
When inosine was added to stored blood, it resulted in restorat¬
ion of the deficient 2,3 DPG and ATP compounds of the red cells
(Bartlett and Shafer 1961). Moreover, Akerblom et al, (1968)
demonstrated that addition of inosine to stored blood reduced the
oxygen affinity of the haemoglobin to normal and shifted to the right
the oxygen dissociation curves.
From all these observations, there remains little doubt that the
increased oxygen affinity observed by Valtis and Kennedy i3 primarily
due to the deficiency of 2,3 DPG and ATP (Benesch and Benesch 19&7>
Chanutin and Curnish 1967). It has been shown that in molar concen¬
trations ATP is as effective as 2,3 DPG in lowering oxygen affinity
(Benesch and Benesch 1967). However, since 2,3 DPG exists in
unusually high concentrations, four times greater than ATP, (Chanutin
and Curnish 19^7) and since ATP concentration is but slightly altered,
during the first two weeks of storage in ACD at 4°C it can be argued
that the concentration of 2,3 DPG correlates very well with oxygen
affinity of stored blood alone (Bunn et al. 1969). Benesch et al.
1968 maintained that 2,3 DPG reacts mole formole with deoxy_haemo-
globin and they determined an equilibrium constant of this reaction.
Because of this binding 2,3 DPG lowers the haemoglobin affinity for
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oxygen. When this equilibrium constant was applied to the high
haemoglobin concentration that exists in the erythrocytes, it was
found that a significant increase in oxygen affinity would occur only
when the cellular 2,3 DPG concentration decreased to half the normal
values (Bunn et al. 1969).
The clinical significance of the increased affinity of haemo¬
globin to oxygen is not clear. Valtis and Kennedy 1954 observed
that the administration of erythrocytes that have increased affinity
for oxygen resulted in a shift to the left of the oxy - haemoglobin
dissociation curve of the recipient blood, and that the extent and
duration of this shift is related to the volume and period of storage
of the transfused blood as well as the general condition of the
recipient (O'Brien and Watkins i960). Thus anaemic patients, who
received large quantities of stored blood may suffer from a shortage
of oxygen supply to their tissues for several hours until the
transfused cells resynthesize the necessary amounts of 2,3 DPG and
ATP. However Valeri (1971) reported that transfusion of stable
nonsurgical anaemic patients with 3 to 5 units of washed blood that
has been stored at 4°C for two to three weeks had no effect on the
systemic oxygen consumption or cardiac output. He also found that
the systemic arterio-venous difference in oxygen content was greatly
reduced soon after transfusion, but within four hours it had returned
to normal together with partial restoration of the intracellular
2,3 DPG content and an elevation in the p50 (Partial oxygen pressure
at which half the haemoglobin is oxygenated) value of the oxygen
dissociation curve. Nevertheless he emphasized that in certain
clinical situations in which large amounts of blood are needed, it
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may be necessary to transfuse red blood cells which are able to
circulate and function immediately upon infusion.
Transfused red blood cells that have been completely depleted
of its 2,3 DPG, start to build up this compound immediately after
infusion. Using the differential agglutination technique of Ashby
to distinguish the donor cells which had been preserved in ACD,
Valeri and Hirsch (1969) found that at least 25$ of the final level
of 2,3 DPG was restored within three hours after transfusion and by
24-hours more than 50$ was resynthesized. Thereafter the rate of
synthesis is slow and reach a plateau in nine to 11 days. Contrary
to 2,3 DPG, the ATP content of the transfused cells increases rapidly
during the first 24-hours and this was combined with rapid reduction
in the sodium ions (Fortier et al. 1969). Potassium ion content of
the donor red cells increases very slowly after transfusion and this
was apparently related to the absolute level of 2,3 DPG (Valeri and
Hirsch 1969). Other investigators (Beutler and Wood 19^9) reported
rapid rate of restoration of 2,3 DPG of the transfused cells.
Approximately 50$ of the 2,3 DPG that disappeared on storage was
restored within four hours of transfusion.
The pH of the cell is an important factor in determining the
level of red cell 2,3 DPG (Bunn and Jandl 1970). Rorth (1970) also
confirmed that the red cell 2,3 DPG concentration was dependent on
the intracellular pH and indicated that this dependency reflected
the effect of pH on the red-cell enzymes 2,3 DPG mutase and 2,3 DPG
phosphatase. k decrease in the red-cell pH resulted in a reduction
of the 2,3 DPG content and thereby an alteration in oxygen dissociation
curve due to increased oxygen affinity of the haemoglobin. Blood
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preserved in solutions with reasonably high pH maintains its 2,3 DPG
concentration, and hence its haemoglobin function, at nearly normal
levels for approximately two weeks (Dawson et al. 1972). Unfortunately
such high pH solutions have a deteriorating effect on the ATP content
and hence on red cell viability (Dawson et al. 1972).
In a search for an optimal pH that maintains the levels of both
2,3 DPG and ATP for long periods Dawson et al. (1972) found that a
preservative with pH 6.0 was most suitable, as it conserved the 2,3
DPG similar to these with higher pH and in addition it had an inter¬
mediate effect between high and low pH solutions in maintaining the
ATP concentration. For this reason CPD and CPD adenine are considered
superior anticoagulants than ACD and ACD adenine for preserving the
blood at 4°C (Chanutin 1967). Blood preserved with CPD showed a
slower rate of disappearance of its 2,3 DPG and ATP content.
Akerblom et al. (1968) demonstrated that the increased oxygen
affinity of haemoglobin which occurs during storage of the blood in
ACD or ACD-adenine could be reversed by the addition of inosine.
They pointed out the potential advantage of late addition of inosine
(after 16 and 35 days of storage) when the glycolytic processes are
inhibited by the loss of ATP and the decreased pH. ATP is known to
affect the rate of glycolysis by acting as cofactor for the hexokinase
reaction (Strumia et al. 1970)* When inosine is added to stored
blood it functions as a substitute for glycolysis by being transformed
to ribose-phosphate compounds, the latter could be easily converted
to glyceraldehyde-3-phosphate thereby, bypassing the hexokinase
reaction. Bunn et al. (1969) added inosine to fresh blood at the
time of collection and in so doing were able to maintain the oxygen
89
affinity for haemoglobin at the initial level for about two weeks.
Strumia et al. 1970 confirmed the early observations that the addition
of adenine and inosine to stored blood increased the ATP content and
thus improved the viability of the erythrocytes and prolonged the
storage period to \2 days with post-transfusion survival greater than
70^ after 24-hours.
The transformation of glyceraldehyde-3-phosphate (G-3-P), resulting
from ribose and which in turn is derived from splitting of inosine,
into 1,3 DPG requires the presence of glyceraldehyde-3-phosphate
dehydrogenase (G-3-PD) and the availability of coenzyme I, nicotinamide
adenine dinucleotide, (NAD) as hydrogen carrier. However, the
accumulation of NADH was found to have an inhibitory effect on the
enzyme (G-3-PD). Addition of pyruvate would ensure the continued
availability of NAD, while the pyruvate itself is converted to lactic
acid. Pyruvate and inosine and inorganic phosphate all in a final
concentration of 10 mM were successfully used, in vitro to resynthesize
the lost 2,3 DPG in blood stored for 21 and 28 days (Oski et al. 1971).
While inorganic phosphates and pyruvates represent no problem as
far as toxicity is concerned, the intravenous administration if
inosine, especially in the amounts required for the resynthesis of
ATP and 2,3 DPG in multiple units, may have an adverse effect on the
recipients. Degradation of inosine results in the production of uric
acid and hypoxanthine which might persist in the circulation for 24-
hours (Valeri 1971). Again adenine is metabolized to 2,8-
dioxyadenine which is potentially nephrotoxic (Shields et al. 1970).
Strumia and Strumia (1972) suggested a single washing of the red cells
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prior to transfusion to remove these potentially toxic metabolites.
Maintenance of the 2,3 DPG and ATP levels in stored blood up to
the time of transfusion could now be achieved by any of the different
methods of freeze-preservation (Valeri 1970, 1971 )• Many investigators
reported that the process of freezing, thawing and washing of the red
cells had only slight or no effect on the concentration of the 2,3 DPG
and ATP content of the frozen erythrocytes (Akerblom and Kreuger 1974,
Valeri (1974a). Naturally the amount of these two compounds, recovered
with red cells after thawing and washing would depend on the concen¬
tration present prior to freezing which in turn is affected by the
period of storage in the liquid state as well as the anticoagulant
used for collection. In this respect, CPD had again shown superiority
over ACD anticoagulant (Valeri (1974a). Red blood cells collected on
either ACD or CPD and stored at 4°C for up to seven days before freezing
maintained a satisfactory concentration of 2,3 DPG and ATP after
storage at -80°C for about 30 months.
O'Brien and Watkins( 196 0) have reported that if the blood is frozen
within five hours of donation (in the presence of high concentration
of glycerol and utilizing the slow freeze-thaw technique) it maintained
a normal oxygen transport function after thawing, washing and
resuspension, irrespective of the anticoagulant used.
However, because it might be inconvenient to freeze all the blood
immediately upon collection, combination of both liquid and freeze
preservation could be used to obtain maximum benefit from each method
and at the same time to overcome the ever existing problems of supply
and demand. Blood was collected in the normal way in any of the
routine anticoagulants, stored at 4°C and if it is not used until it
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is outdated, or depleted of the vital metabolic compounds, it could be
frozen after rejuvenation with high concentrations of organic phosphate
regenerating compounds (Valeri and Zaroulis 1972). The latter consists
of pyruvate, inosine, glucose and phosphate with or without adenine.
Because post-thaw washing is a necessary step with all method of
freezing in current use today there should be no fear of the potential
hazards of these compounds on transfusion. Valeri and Zaroulis (1972,
1974b) applied this technique for both ACT) and CPD outdated blood
which has been frozen with either the high glycerol slow-freeze-thaw
technique or with the low glycerol rapid freeze-thaw technique and
obtained satisfactory post-transfusion in vivo survival and oxygen
transport function.
Normal red cell oxygen-transport function depends, mainly on the
concentration of 2,3 DPG inside the cell (Benesch and Benesch 1967 >
Chanutin and Curnish 1967* Valeri and Zaroulis 1972, Valeri 1974a and
1974b). The normal value of this compound is about 12 - 1.2yu mole
per gram haemoglobin (Valeri and Hirsch 1969? Valeri and Zaroulis 1972).
Normal values of ATP content of the red cells were also reported by
Valeri and associates in 1969 and 1972, to be 3.9 - l.Cyu moles per
gram haemoglobin. Dern et al 1967 observed a correlation between
the intraerythrocytic ATP concentration and the post-transfusion in vivo
viability of stored red blood cells. This work was further extended
by Strumia et al 1970 and Strumia and Strumia 1972 who suggested that
70 per cent of the original ATP content of the red cells at the day





The term survival indicates the percentage of transfused red cells
that remain in the recipient circulation in a physiologically active
form after transfusion (Turner 1969? 1970).
Although in vivo survival is the ultimate and most decisive
criterion of efficacy of a proposed technique for red cell preservation,
it is relevant only after satisfactory in vitro evaluation tests. It
must be emphasized that there is no positive correlation between the
in vitro recovery and in vivo survival percentage, for in many instances
in vitro red cell recovery may be very poor yet the i-ecovered cells
survive vary well following transfusion (Mollison et al. 1952); the
reverse is also true (Strumia et al. 1958b, Strumia et al. 1960b).
Freezing and thawing bring about certain degrees of damage to the
red cells, some of the cells are irreversibly destroyed by the process
of freezing, thawing and post thaw processing, and these are rapidly
removed from the recipient circulation after transfusion (Struma et al 1960b)
Other cells are reversibly affected by these processes, as evidenced
by the increase in intracellular sodium and decrease in potassium ion
concentrations, but upon transfusion they are rapidly restored to
normal (Crawford and Mollison 1955* Valeri and Hirsch 1969) and thus
resume the potential for long-term-survival (Valeri 1971)- Since the
discovery of red cell preservation by freezing, a great number of
methods have been proposed for the determination of the percentage of
the red cells that survive in the recipient circulation after
transfusion. However, at the present time there is no in vitro
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determination that can predict the number of cells capable of surviving
in the recipient circulation after transfusion. The only way of
determining the number of irreversibly damaged cells is by in vivo
measurements of post-transfusion survival of red cells.
Many investigators have shown that red cells which are irreversibly
damaged by freezing are removed from the circulation within the first
24 hours post-transfusion and those cells which survive this period
have the potential for surviving normally after that (Strumia et al 1960b,'
Schmidt and Steinfeld I960, Mollison 1972, Szymanski and Valeri 1968,
Valeri and Runck 1969a, Valeri 1971). However in vivo, long terra
survival of the preserved red cells is largely determined, not by the
technique of preservation or by the duration of storage in the frozen
state, but by the recipient's general condition and intravascular
environment, for the recipient in order to be able to restore the
irreversibly injured cells, his circulation must be free of any
immunologic, toxic or chemical factors (Szymanski and Valeri 1971).
In the past red cell survival was determined by the so-called
differential-agglutination technique (First proposed by Ashby in 1919)-
This involved the transfusion of test cells which are antigenically
different, but compatible, from that of the recipient. The percentage
of test cells surviving at a certain time could be determined in a
sample of blood by separation of the two populations of cells using
a highly potent serum to agglutinate the recipient cells only.
Nevertheless, the method was abandoned because of the technical
difficulties. However, in 1968 Szymanski and her associates automated
the original differential agglutination technique using the Technicon
Auto Analyzer. They claimed that this made possible the study of the
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effect of different methods of preservation on the in vivo survival
in the same recipient.
Because some of the transfused red cells are removed very rapidly,
within the first few minutes of transfusion, an accurate estimation
of the in vivo survival can only be made if the red cell volume of the
recipient is determined (Mollison 1972). Study of the survival of
preserved red cells involves comparison of the ratio of transfused
cells to those of the recipient. The survival is computed from the
alteration of this ratio from the time of administration. When a
great proportion of the transfused cells disappear rapidly from the
recipient's circulation before mixing is complete, the initial value
of comparison is diminished, this results in an overestimation of the
red cell volume and hence a falsely high in vivo survival. For this
reason precise estimation of the red cell volume is of the utmost
importance. In 1958? Mollison, Robinson and Hunter introduced the use
of two different isotopes, one for the test cells and the other for
the control cells, to estimate the recipient red cell volume. They
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suggested chromium Cr for labelling the preserved, test cells, and
phosphorus 32p to label the recipient freshly drawn red cells, the
control. However as 32p is |£ -emitter it presents some difficulty in
radioactive counting (Dacie and Lewis 1970 and Button et al 1965)*
In 1962 Doebbler et al introduced the double-chromium technique.
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In this method the same radioactive isotope, Cr, was used to label
both the test and the control cells. Fresh recipient red cells
were first injected after labelling with the minimal possible dose of
radioactive chromium. After allowing sufficient time for mixing,
peripheral blood samples are withdrawn to supply an estimate of red
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cell volume. The test cells, labelled with 10 times the radioactive
dose, are then injected. Survival at any required time is computed
by correction for the chromium count observed at this time assuming
normal survival of the control cells. Because very small dose of
radioactive label is used with the control cells any small variation
in its survival is further minimized and thus does not affect the
results. However, a major disadvantage of this method is the
requirement of two procedures for every survival determination (Button
et al. 1965)- Moreover, the process lacks complete accuracy because
of the use of two samples for injection and two standards for counting
(Mollison 1972).
Red cell volume can be determined in healthy subjects indirectly,
from an estimate of plasma volume and peripheral venous haematocrit
and a correction factor. The latter corrects the directly measured
peripheral venous haematocrit to the total body haematocrit. When
total body haematocrit (TBH), calculated from direct independent
measurement of red cell volume and plasma volume, is compared with the
peripheral venous haematocrit (pvh), the pcv after correction for the
trapped plasma, the former is usually found to be smaller than the
latter, the ratio TBH/pVH is close to 0.9 (Glass 1973).
Plasma volume may be determined by the use of Evans Blue dye
(Gibson & Evans 1937) and the dilution technique. However the use of
this method was abandoned for a more accurate method using radioactive
iodine-labelled albumin (Button et al. 1965). At first iodine
("^"'"i) was suggested for this purpose, but the difficulty in
separating the superimposed peaks of 131i and ^1Cr led to its abolish¬
ment (Button et al. 196b). The best radioactive iodine suitable for
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labelling the human serum albumin is -\E, it has a half-life of 59
days and this permits extended storage. Moreover because it
disintegrates by pure gamma emission it can easily be separated from
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that of Cr (Button et al. 1965). The most popular protein used
for determination of plasma volume is human serum albumin. A
bigger molecular weight protein might give a better estimate of the
plasma volume, but albumin offers the advantage of being heat-treated
to inactivate serum hepatitis virus (Glass 1973).
Although iodinated serum albumin offers a satisfactory estimate
of plasma volume in healthy subjects its use in the diseased recipient
is not reliable, due to the rapid loss of the albumin molecules (while
mixing is still incomplete), into the extravascular spaces as a result
of increased capillary permeability in these conditions (Valeri et al
1973). For this reason, it is always advisable not to compute the
blood volume in diseased patients from estimations of the plasma
volume alone. Independent estimations of the red cell volume (RCV)
and plasma volume (PV), by using respectively radioactive ^Cr and
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I labelled serum albumin, is the most reliable method under these
conditions (Glass 1973 - Valeri et al. 1973).
Red cell volume and plasma volume can be estimated from the body
surface area of the subject, these are extracted from charts based on
the height and weight of the person at the time of transfusion
For men the RCV = BSA (m2) x 1091
For women the RCV = BSA (m2) x 806
and the plasma volume could be calculated as follows
For men PV = BSA m2 x I56I
Valeri et al 1973, Szymanski & Valeri 1971*
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As a red-cell label Cr, in the form of sodium chromate, is the
most suitable (Glass 1973)- It was first introduced by Gray and
Sterling in 1950 for the estimation of the red cell volume, but
Gibson and Scheitlin 1955 were able to adapt it for the determination
of post-transfusion survival of stored human red cells. Since then
most of the work conducted for study of the in vivo survival of red
cells has employed radioactive chromium. Its use in experimental
and clinical studies has made possible a better understanding of the
in vivo behaviour of red cells preserved under different conditions
of storage.
Radioactive chromium (^Cr), has a half-life of 2J.8 days (Dacie
and Lewis 1970). The label is usually in the form of anionic
hexavalent compound and the most commonly used salt is the sodium
chromate. When added to red-cell suspensions radioactive chromate
(~^Cr) rapidly diffuses into the inside of the red cell where it is
reduced to the trivalent form. As the red cell membrane is impermeable
to the trivalent chromium the chromium released from the damaged red
cells would be incapable of labelling others (Gibson & Schietlin 1955).
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Inside the red cell Cr strongly binds with the haemoglobin,
specifically, to its ^-polypeptide chain (Dacie and Lewis 1970) and
it is not toxic in the small doses used. However, doses larger than
5^/ug/ml block the enzyme glulathione reductase and if more than 10
it interferes with glycolysis probably due to its oxidising effect.
Chromium uptake;
Estimation of the post-transfusion survival of the red blood cells
labelled with radioactive chromium is based on the principle that the
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red cells pick up the chromium at the time of labelling and will keep
it all the time they survive in the circulation until it is released,
and hence removed from the circulation after their destruction.
The percentage survival on a certain day is determined by comparing
the radioactivity of blood sample withdrawn on that day to that of
time zero.
After the addition of chromium the process of labelling is allowed
to proceed for about 20 minutes at room temperature, following which
the excess unattached chromium is removed by washing the cells twice
with a sufficient volume of sterile isotonic saline (Dacie and Lewis
1970)* When the chromium is used to label the recipient's own cells
for estimation of blood volume it i3 preferable to expose the cells
to as little trauma as possible in order to avoid falsely high results.
In this case the excess hexavalent chromium could be reduced to
trivalent inactive compound by the addition of ascorbic acid (Doebbler
et al 1962). However, Valeri (1968b) showed that even this process
is not necessary since the chromium uptake is almost complete whether
the cells were fresh, ACD-stored or previously frozen. At the same
time he did recommend not to wash the red cells after labelling in
order to avoid selective loss in vitro of the irreversibly damaged
cells. Differential chromium labelling of stored red cells has
also been studied by Valeri (1968b). In his experiments, he separated
the red cells of both ACD-stored and previously frozen-thawed blood
into three fractions on the basis of cellular density. Preferential
labelling with chromium was noted, the lightest fraction showed
significantly higher uptake than the heaviest one.
When the survival of the red-cells was estimated by the
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differnetial agglutination technique and the radioactive chromium
labelling technique a difference between both methods was consistently
observed (Emerson and Bove I960); the decline in chromium radio¬
activity was greater than could be accounted for by red cell loss.
This was attributed to spontaneous leakage of chromium from the intact
erythrocytes and was referred to as "Chromium elution". Elution of
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Cr from intact cells differs from one person to the other and it
usually occurs in two phases, a rapid and slow phase. The rapid
phase of chromium elution occurs within the first 24 hours post¬
transfusion and was estimated to be about 10$ of the chromium label
(Dacie and Lewis 1970) and is influenced by the technique of ^Cr
labelling (Valeri and Szymanski 1973). The slow phase of elution
proceeds at a rate ranging from 0 - 1.06$per day (Valeri and Szymanski
1973) and has a half-time about 77 days (Dacie and Lewis 1970).
Because of the substantial variation in the extent of elution, there
is no valid correction factor. Even when the observed radioactivity
is corrected for elution it does not give rise to survival curves
which resemble those obtained with Ashby method, and hence there appears
little benefit in applying such corrections (Dacie and Lewis 1970).
Measurement of radioactivity in frozen blood
Estimation of the post transfusion survival of previously frozen
blood is based on the observation that chromium uptake by, and elution
from the red cells is not influenced by the processes of glycerolization,
freezing, thawing and washing (Morrison et al. 1968, Valeri and Runck
1969a). The last named authors demonstrated that red cells stored
in the frozen state for up to six years had chromium uptake and
elution characteristics similar to those stored for short duration
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and that the rate of chromium elution was not accelerated for these
cells.
The twenty-four hour post-transfusion survival represents the
percentage of the transfused red blood cells that remain in the
circulation after that time. All those who have studied the post¬
transfusion survival of frozen or unfrozen blood have shown that red-
cell which survive the first 24 hours after transfusion have normal
long-term survival (Mollison 1972). However Dacie and Lewis (1970)
suggested that the most significant single measurement in red-cells
survival studies is the Tj- ^Cr, a normal value for this measurement
lies between 25 and 33 days (Dacie and Lewis 1970). The mean life
span of chromium labelled red cells (T-half Value) is usually expressed
as the time in days when half the chromium label is still present in
the circulation. As far as the frozen cells are concerned, red cell
life span is not influenced by the preservation injury, nor is it
affected by the duration of storage in the frozen state or the
technique of freezing (Szymanski and Valeri 1971). On the other hand
life span of the donor cells may be influenced by host factors, e.g.
immunological chemical, mechanical or unidentified toxic factors.
Experience and Variables;
The earliest report of measuring the post transfusion survival
of previously frozen red cells was that of Sloviter (l95db)» He
utilized radioactive ( p) and radioactive {/ Cr) to tag rabbit red-
blood cells which had been previously frozen and thawed in the presence
of glycerol. He found that both the control and frozen cells have
approximately the same survival values during the first few days.
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It was suggested that many factors may have an effect upon red
cell survival e.g. the method employed in freezing, period of storage
before and after freezing, temperature and duration of storage in the
frozen state and the resuspension media.
Thus Brown and Hardin (1953) showed that as the storage temperature
decreases the survival percentage increases. Using the differential
agglutination technique to distinguish the donor cells and radioactive
32p method to determine the red cell volume of the recipient they
studied the survival of red-cells stored at -70°C in glycerol for
6-£ months and that stored at -15°C for 50 days. The former cells
showed an in vitro recovery of over 90$ and post transfusion survival
of 64$, while for the latter the recovery was 79$ and the survival was
47$.
Chaplin et al. (1957) used radioactive chromium (^Cr) to label
red-cells, that were previously frozen at -20° for 13 months in
buffered citrate-glycerol with added ascorbic acid, and that stored at
-45°C for 18 months in buffered citrate glycerol. After labelling,
the red calls were washed three times in saline and 50 ml of the
washed red cell suspension were used for autotransfusion. Plasma
volumes were determined using Evans blue dye. The 100$ retention
value was determined by extrapolation of the radioactivity at 10, 20,
and 40 minutes back to zero time. They reported that the red cells
stored at -20°C showed a 24 hour post-transfusion survival of 5^$ of
the cells transfused. By contrast, those cells stored at -45°0
showed a 24-hour post-transfusion survival of 96$ of the transfused
cells.
Previously Chaplin et al. (1956) showed that red cells modified
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with glycerol in a final concentration 30# w/v and stored for 21
months at -79°C had a recovery of 90# and post transfusion survival of
80# and indicated that the post transfusion survival was not affected
by the period of storage. The absence of progressive deterioration
suggested that the metabolic processes were arrested at -79°C, this
was further supported by the absence of changes in the concentration
of dextrose during the period of storage for one year. In this
series of experiments they utilized the differential agglutination
technique for the estimation of survival and 32p and other methods
for determination of the red cell volume. In some of the cases post
transfusion survival was determined both by the differential agglutin¬
ation method and by labelling the red cells with radioactive chromium
• 51 .
( Crj. They indicated that the estimates of survival by the two
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methods agreed quite well, but the method of labelling with Cr was
far more convenient than the method of differential agglutination.
Strumia et al. (1958a) studied the post-transfusion survival of
five human blood donations frozen and thawed, in the presence of
sugars, without an appreciable period of storage. They reported that
the 24 hour post-transfusion survival of the previously frozen cells
was only 2# below the optimal established for fresh autotransfused
erythrocytes. After the first 24 hours the declining curve of
survival of the frozen cells was parallel to that of the fresh blood.
Under the condition of their experiments the red-cell post-transfusion
survival was found to be dependent on the storage temperature. With
storage at -58°C both rates of recovery and survival deteriorated
rapidly. At -70°C, although the recovery was fairly maintained for
about 40 days, survival progressively deteriorated. At -93°C both
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recovery and survival were satisfactorily maintained for 6 months.
In 1960b Strumia et al reported the results of further studies
on the post transfusion survival of blood frozen in the presence of
dextrose and lactose stored for longer periods in the frozen state.
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They showed that the 24 hour post-transfusion survival of Cr-
labelled red cells frozen at -93°C were maintained at a steady level
of 77$ of the original amount of the red cells frozen for at least two
years. This compared with an optimal survival of fresh autologous
Cr-labelled red cells which averaged 94$ - 2 and that of ACD liquid
stored blood after 21 days of storage which varied between 70 and
84$. They maintained that the post-transfusion survival of red cells
frozen with the addition of sugars did not necessarily follow the
recovery in vitro, for in their experiments whole ACD blood frozen
in the presence of 15$ and 25$ of dextrose showed a very high in vitro
recovery but upon transfusion most of the red cells were immediately
destroyed. They also indicated that the red cell life span was not
related to the length of storage in the frozen state and that cells
which have not been damaged in the process of freezing and thawing
would survive normally while those damaged by freezing and thawing
were immediately removed upon infusion.
That storage at a temperature of -80 or -120°C for very long
periods was practical and that the survival of red cells was independent
of the duration of storage has been amply demonstrated. Tullis et al
(1958) studied the post-transfusion survival of 94 units of blood which
were glycerolized, frozen and stored for up to 19 months at either -80
or -120°C. Post-transfusion survival was normal and appeared
therapeutically equivalent to cells stored in ACD at 4 C for up to
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21 days. By i960 (Tullis et al 1962) more than 1300 units of
glycerolized frozen blood stored for about 44 months had been transfused
with normal post-transfusion survival, erythrocyte behaviour and
clinical response. Valeri and Runck (1969a) reported that human red
blood cells preserved with 45$ w/v glycerol, frozen by slow freeze
thaw technique and stored at -80°C for up to six years and then
deglycerolized by continuous centrifugation with electrolyte solutions,
stored for 24 hours at 4°C showed acceptable clinical post-transfusion
survivals. They also claimed that 24-hour post-transfusion survival
was significantly related to the intracellular potassium content.
By contrast to this, Huggins processed red blood cells that were stored
for more than two years and showed that they had decreased post-thaw
stability while cells stored for more than three years washed by his
technique and kept at 4°C for more than 12 hours had a post-transfusion
survival of less than 60$. Valeri and Runck (1969b) evaluated the
method of freezing which employs the low glycerol liquid nitrogen
refrigeration and stainless steel container by measurement of the
post-transfusion survival of chromium labelled autologous red cells.
They reported that the in vitro recovery was more than 90$ and the
24-hour post-transfusion survival was approximately 85$. They also
found that the post-trnasfusion survival was inversely proportional
to the level of supernatant haemoglobin and directly proportional to
the intracellular potassium level at the time of transfusion.
Szymanski and Valeri (1971)» using the automated differential
agglutination technique, studied the 24-hour red blood cell curvival
and the life-span of the red cells in stable anaemic patients to
explore the relationship between the red cell life-span and the method
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of preservation. They came to the conclusion that the red cell life¬
span was not influenced by either the duration of storage at +4 or
-80°C or the method of preservation but it might be affected by the
in vivo environmental host factors e.g. immunological, chemical,
mechanical or other unidentified toxic factors.
Another problem that is related to survival of frozen red cells
is the type of resuspension medium used for reconstitution of the
thawed-washed erythrocytes and period of storage at 4°C post-thaw.
Schmidt and Steinfeld (i960) approached this problem in their studies
of the post-thaw stability of red cells that had been previously frozen
and stored at -45°C for 3 months. Evaluation of the recommended
resuspension media was performed by testing the post-transfusion
survival of the cells stored, after thawing, in that medium for the
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required period. After labelling with radioactive ' Or, the preserved
cells were washed three times with saline and resuspended in saline
to a haematocrit of 40^. Blood volume of the recipient was determined
either by Evans blue solution or by "^"'"I-iodinated serum albumin.
They found that although resuspension media, had little effect on
in vitro recovery, it substantially affected in vivo survival. Red
cells previously frozen and stored at -45°C for three months could be
further stored for an additional ten days at ordinary refrigerator
temperature. With reconstitution in the proper medium, the in vivo
survival was over 85^ after both auto - and hemotransfusion. Valeri
(1965a) also studied the effect of resuspension media on the post-
thaw stability and the post-transfusion survival. Red-blood-cells
were frozen and stored at -80°C for one month, then deglycerolized
labelled with radioactive chromium and resuspended in one of three
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media: autologous plasma, an artificial 5% human albumin and out¬
dated 5$ albumin medium. The 24-hour post-transfusion survival was
satisfactory (70% or more) after a post-thaw storage period of 21,
12, and 6 days respectively.
RESUSPENSION MEDIA
Since the early days of experimental work on frozen blood,
investigators resuspended the thawed-washed cells in a physiological
medium. Thus Sloviter (1951a.) reconstituted the previously frozen-
thawed-washed erythrocytes in ACD plasma. However once processed the
reconstituted blood had to be used immediately, without further storage
at 4°C, because of the potential hazards of possible bacterial
contamination. With the introduction of the Cohn fractionator, a
closed semiautomated system, for both glycerolization and processing
(Tullis 1956) it seemed probable that sterility could be maintained
and thus storage of the blood after processing at 4°C was attempted.
The problem that emerged was one of finding a medium that maintained
the stability of the processed cells up to the time of transfusion.
Tullis et al (1958) reported their experience with 94 units of blood
that have been glycerolized, stored frozen at -80°C or -120°C for up
to 19 months, deglycerolized, reconstituted and stored at 4°C for
up to 11 days and then used clinically. Following deglycerolization
the packed cells were resuspended in 60 ml of a medium that
contained:
400 mg % dextrose
20 m Eq/L of potassium
2 g % (final concentration) albumin
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The pH of the final product was 7.1. The authors indicated that
storage at 4°C permitted transportation and the use of the blood in
locations far away from the processing centres. However, because
of the progressive accumulation of free haemoglobin in the supernate,
the product was used only within one week of thawing. On the day of
processing the supernatant haemoglobin was 150 mg/lOO ml but after
one week of storage at +4°C it increased to 240 mg/lOO ml. The
reasons for such lysis was not known and it was found later that it
is a common feature of all frozen-thawed erythrocytes after any of
the processing methods (Doebbler and Rinfret 1959)* This implied
that tests for post-thaw stability are as important as any other in
vitro tests used for evaluation of a proposed freezing method.
Substitution of 30 ml of autologous ACD plasma for the dextrose-
potassium-albumin media had greatly reduced the haemoglobin level in
the supernate (Tullis et al. 1958). However, because of the scarcity
of the plasma, (it was fractionated into its valuable components) and
because of the potential danger of transmission of serum hepatitis,
other resuspension media had been sought by the group of investigators
at the U.S. Naval Hospital in Chelsea, Mass. (Haynes et al. i960).
A solution of 5$ serum albumin was found to be satisfactory for this
purpose. Previously frozen packed red cells were resuspended to a
volume of 500 ml with 5$ albumin solution and used successfully as a
volume expander and for volume replacement in surgical patients.
Up to i960 a total of 1014 units of blood were transfused in serum
albumin, in addition 154 units have been given in their own plasma.
As regards the therapeutic efficacy there was no clinical difference
between 5$ albumin solution and the plasma as a resuspension media.
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After the transfusion of 800 units of frozen red blood cells
resuspended in heated albumin solution, not a single case of serum
hepatitis was detected. On the other hand, of the 184 units, of
frozen blood transfused after resuspension in their autologous plasma,
one patient developed the disease after receiving two units of such
a product. In addition to saving plasma for fractionation and
minimizing the incidence of serum hepatitis, resuspension of frozen
red blood cells in 8albumin solution made it possible to "tailor"
the final product according to the patient's need (Haynes et al. 1962).
These last authors indicated that blood which was previously frozen
and reconstituted in 5% albumin solution could be stored in a
conventional refrigerator at +4°C for up to 14 days, during this period
the blood could be used for medical and surgical patients as well as
priming the pump-oxygenator in cardiac surgery. Up to the first of
September 1961, Haynes et al used 2280 units of frozen washed blood
for the transfusion of 683 patients, most of these units were
resuspended in 8^ albumin medium which contained also NaCl, potassium
phosphate and glucose. They observed far less incidence of febrile
reactions, caridovascular pressor effects and urticarial reactions
than with the standard ACD - liquid stored blood. Furthermore the
incidence of serum hepatitis was believed to be diminished with the
use of previously frozen red blood cells resuspended in albumin medium.
In spite of the fact that such blood was completely devoid of plate¬
lets and blood clotting factors, the bleeding problems which were
commonly reported with the use of massive transfusion of ACD- liquid
stored blood were not observed.
Schmidt and Steinfeld (i960) examined AO resuspension media to
109
choose the most suitable medium for preserving the cellular integrity.
Their criteria for suitability were in vitro haemolysis and cellular
fragility. The media recommended by them for resuspension of red-
blood cells that were previously frozen and thawed contained:
Na Citrate 5.82 g
Citric acid 1.21 g
Dextrose 3.0 g
Na CI 5-56 g
Mg Cl2 0.2 g
K CI 0.374 g
Na2 HP04 0.268 g
Na2 304 0.710 g
Water to 1000
using this media allowed red blood cells that were frozen and stored
at -45°C for three months to be kept for an additional ten days at
standard refrigeration temperatures. Storage for ten days in the
above described media at + 5°C causes no more than 3 per cent in vitro
haemolysis and after transportation the red blood cells had in vivo
survival of over 85$ following both auto and homo transfusion. The
authors indicated that the advantage of their medium was that it did
not contain any protein and therefore was easily autoclaved and stored.
Murray et al. (1962) used what they called "synthetic plasma"
which was formed of:
Serum albumin 5$
Na CI 0.15 M
Dextrose 0.4^
Potassium phosphate q 0025 M
monobasic * ";
Using the "synthetic plasma" the authors were able to keep the blood,
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after thawing and processing, for 21 days in a similar fashion to
ordinary ACD blood. Reconstituted blood stored for 12 days at 4°C
had a 24-hour post-transfusion survival of 77«8$.
Because of the progressive increase of free haemoglobin and
potassium in the supernatant fluid on storage at 4°C, washing the red
cells was recommended before transfusion to reduce the level of these
two substances in the transfused blood (Tullis et al 1938)- However,
major clinical difficulties, haemoglobinaemia, haemoglobinuria and acute
renal insufficiency were noted with the transfusion of deglycerolized
albumin resuspended blood that had been stored at 4°C for three days
and then washed before transfusion (Valeri (1965a). Because no such
difficulties were observed with red blood cells resuspended in plasma
it was suspected that these complications were related to the albumin
resuspension media itself. Albumin solutions were found to be unstable
when diluted to 5'X in the presence of dextrose or when it is outdated
(Tullis et al 1963). For these reasons, evaluation of resuspension
media was undertaken by Valeri (1965a and 1965c). He reported that,
with autologous plasma as a resuspension medium, the supernatant
haemoglobin in the unit ranged from 200 mg to 1750 mg on the day of
deglycerolization and from 350 to 3150 mg on the day of transfusion,
after storage at 4°C for one to 14 days. Using 5$ albumin medium and
storage at 4°C for one to 17 days, the supernatant haemoglobin in the
unit ranged from 120 mg to 2365 mg on the day of deglycerolizaticn and
350 mg to 6130 mg on the day of transfusion (Valeri 1965c). He also
found that the resuspension media affect the post-transfusion survival
of the frozen red cells that were stored at 4°C after washing. Deglycer¬
olized red cells resuspended in autologous plasma and stored for 21 days
at 4°C showed an acceptable, (more than 10%), 24-hour post-transfusion
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survival. On the other hand deglycerolized red cells resuspended in
5't albumin had a 24-hour survival less than 10% if stored more than
6 days at 4°C. He also demonstrated that units resuspended initially
in 5$ albumin medium and stored for five days at 4°C did not tolerate
subsequent washing, while those suspended in plasma tolerated this
step with acceptable post-transfusion survivals (Valeri 1965b).
Because of these difficulties Valeri and Runck (1969b) substituted
glucose-saline medium (250 ml of buffered saline solution pH 1.2
containing 50 mg glucose/lOO ml) for 5$ albumin solution or autologous
plasma. However a significant decrease of the intracellular potassium
and increase of the supernatant free haemoglobin was observed during
the post-thaw storage at 4°C in such medium. Red-blood cells
preserved by the low-glycerol-rapid-freeze-thaw technique in stainless
steel container showed on the day of deglycerolization a supernatant
haemoglobin level in the range from 102-699 mg/unit and intracellular
K+ range of 6.7 to 8.3meq/lO^ red blood cell depending on the method
of deglycerolization. On post-thaw storage for 4 to 48 hours at 4°C
in glucose-saline medium these figures were further deteriorated to
360-1728 and 5.5 to 8.4 respectively. Using glucose-sodium chloride-
phosphate medium red blood cells preserved by the high glycerol-slow
freeze-thaw technique could only be stored for 24-hours post-processing
a
and transfused with/satisfactory 24-hour post-transfusion survival.
However, at the time of transfusion (24-hours post-thaw) the red-
blood cells had to be concentrated by centrifugation and the
accumulated free haemoglobin and extracellular potassium removed
beforehand (Valeri 1974a).
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FROZEN BLOOD AND HEPATITIS ANTIGEN
Australia antigen (HB-Ag) has been implicated as a cause of serum
hepatitis following the transfusion of blood that contains such
antigen. Incidence of serum hepatitis following blood transfusion
could be reduced by the administration of blood that is devoid of
HB-Ag. Following the application of frozen blood in clinical practice
it was observed that the incidence of post-transfusion hepatitis was
reduced. Thus in a retrospective study, Haynes et al (19^0) observed
the absence of homologous serum jaundice after the transfusion of bOO
units of previously frozen, thawed red blood cells resuspended in 5$
albumin solution which was preheated at 60°C for ten hours. On the
other hand a prospective study of the transfusion of 194 units of
frozen, thawed erythrocytes resuspended in autologous plasma showed
the occurrence of the disease in one of the patients who received two
units of such blood. Tullis and Lionette (1966) reported that no
clinical cases of icteric hepatitis was observed in 2000 recipients
of frozen-washed red cells which were resuspended in albumin media,
but two cases occurred in the first 300 recipients of similarly
processed cells resuspended in autologous plasma. In 1969 Huggins
reported the absence of "clearly documented cases of homologous serum
hepatitis" after the transfusion of approximately 20,000 units of
blood frozen and thawed by his method. However, in these and in
many other studies the observed decrease in the incidence of post¬
transfusion hepatitis was not based on sequential follow-up
observations and the conclusions were reached before the development
of the modern procedures of screening of the donor blood for HB-Ag.
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In 1970 Tullis et al presented the most carefully documented data in
this subject to date. In their study IO65 units of frozen, thawed
washed red cells were transfused to 214 recipients who were clinically
followed for up to six months after transfusion. Serum hepatitis
was not detected in 11C recipients of 623 units of frozen-thawed red
cells suspended in albumin medium, whilst four out of 104 recipients
of 442 unit3 of frozen, thawed blood resuspended in autologous plasma,
showed histological evidence of serum hepatitis and one of them was
icteric. In 1973 Huggins and Oroverasmussen reported that in the
period between 1963 and 1971» 88 patients with chronic renal diseases
who were subjected to frequent haemodialysis and renal allograft had
received 299® units of frozen blood. Retrospective study of their
clinical and laboratory records revealed the absence of clinical or
sub-clinical hepatitis. Furthermore investigation of the postmortem
records of 40 patients who died, failed to reveal any histological
evidence of hepatitis. Examination of sera collected from most of
these patients before and after transfusion and at different periods
during the course of the disease showed that none of the sera had
changed its reactivity.
The mechanism by which the hepatitis virus is removed or
inactivated is not known. Tullis et al believed that freezing,
storage, and thawing were not essential for the protective effect
since red blood cells resuspended in plasma had transmitted the disease
in spite of the fact that it has been treated in the same way a3 red
cells resuspended in albumin. In fact they attributed the protective
effect of their method to the so-called "transmembrane wash",
accomplished as glycerol squeezes out of the cell under the effect of
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their continuous-flow washing procedure. On support of this view
Werch et al (1971) reported that six out of seven units of blood that
were initially positive for HB-Ag became negative after deglyceroliz-
ation and the antigen could be detected in wash solution in five of
the seven cases.
Meryman (1974) on the other hand, believes that glycerolization
and freezing are not essential for efficient elution of hepatitis virus
but washing, and simple washing with a sufficient volume of isotonic
saline without either glycerolizaticn or freezing may be satisfactory.
WHITS CELL CONTENT OF FROZEN BLOOD
The extensive application of blood transfusion in the therapy of
patients has led to ever increasing varieties of sensitization to
different blood components. Sensitization resulting from blood
transfusion is not only restricted to antibodies against red blood
cells as antibodies to leucocytes, platelets and plasma protein have
also been described (Kaplan 1972). In fact the most frequent
sensitization seen today develops from exposure to incompatible
leucocytes and/or platelets (Dausset and Colombani 1967).
In the last few years there has been significant progress in
organ transplantation, this has led to a rapid development of knowledge
in the field of leucocyte and platelet antigen group systems. The
latter has made possible a better understanding of the immunological
problems associated with leucocyte and platelet transfusion. Thus
we now realize that leucocytes and platelets carry a variety of alio—
antigens, some of which are common to erythrocytes, leucocytes and
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platelets e.g. A, B, H, M and N antigens and others shared by leucocytes,
platelets and other tissues, like the histocompatibility antigens, and
still others which may be restricted to leucocytes or even one type
of leucocytes e.g. the lymphocytes, granulocytes or neutrophils
(Dausset and Colombani 1967). The latter type of antigen (NA-l) might
be responsible for the newborn neutropenia as a result of foeto-
maternal alloimmunization (Mollison 1972). However the alloantigens
most powerfully expressed on leucocytes and platelets are those of
the HL-A system. In order to pick up a suitable donor for tissue
transplantation, lymphocytes or platelets are usually used in the tests
of tissue-typing. The HL-A system consists of two series, the LA
and the Pour series. The first contains nine alleles at the LA
sublocus and the second contains 13 alleles at the Four sublocus on
the HL-A chromosomal region. Because the two sub-loci are very close
to each other they are always transmitted together. The combination
of one LA and one Four determinant forms an HL-A haplotype. Two
haplotypes are present in each individual giving him a unique genotype.
There are at least 100 haplotypes and more than 8000 theoretical
genotypes. One parent can only pass one of two haplotypes to his
offspring so that the chance of finding two identical individuals
between siblings is at least 25$. The chance of finding two identical
persons E.mong randomly selected people is low. For this reason, in
renal transplantation, the best matched donor is accepted rather than
waiting for an identically compatible individual.
Since leucocytes and platelets carry a variety of antigens
specific to themselves, it would thus be expected that the introduction
of incompatible leucocytes and/or platelets may lead to the production
116
of antibodies against the foreign antigens transfused.
Antileucocyte and antiplatelet antibodies do not occur naturally,
they are always of immune origin produced after blood transfusion
(Dausset 1954), after pregnancy (Payne and Rolfs 1958) and sometimes
after tissue or organ transplantation (Thorsby and Kissmeyer-Nielsen
1968). Biochemically these antibodies are 7S gamma-globulins, active
at 37°C. They can be detected by leucoagglutination (Dausset et al
1954)? cytotoxicity, complement fixation or antiglobulin consumption
techniques (Dausset and Colombani 1967).
The frequency of detecting leucocyte and platelet antibodies in
the sera of transfused recipients increases with increasing numbers
of transfusions. In general this frequency varies from 5-l^ in
patients received 10 transfusions or less, to 5^ in those transfused
25 times or more (Brittingham 1957)* However, it appears that this
incidence was underestimated as isoimmunization due to blood trans¬
fusion may occur with the production of incomplete antibodies,
detectable by antiglobulin consumption, rather than the complete type
detectable by leucoagglutination (Van Loghem et al 1958).
Experimental studies have shown that seven or eight transfusions
might be necessary to produce alloimmunization to leucocytes (Dausset
and Colombani 1967). Marchal et al. (1958) have used whole blood
from a single cource for the immunization of each of six volunteers.
Each individual received 75 of whole blood from only one donor at
weekly intervals for 12 to 19 weeks. After seven transfusions, four
out of the six recipients developed leukoagglutinins against the
donor leucocytes in their sera. Brittingham and Chaplin (1961)
immunized a normal individual with fresh leucocytes from a leukaemic
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patient. A laucoagglutinin was produced after 10 intravenous
injections, but the survival of the transfused cells was shortened
after only five injections.
The frequency of detecting leucocyte antibodies in transfused
females is significantly higher than that in males. This is probably
the result of alloimmunization produced by previous pregnancies
(Payne and Rolfs i960). Again the incidence among multiparous women
is a function of the number of pregnancies (Mollison 1972).
Leucocyte antibodies have also been demonstrated in sera of
patient received skin grafts (Thorsby and Kissmeyer-Nielsen 1968).
The cytotoxicity test is the most suitable technique for detection of
the latter type of antibodies. The importance of leucocyte antibodies
lies mainly in the role they play in febrile transfusion reactions as
well as their presence in sera of potential organ transplant recipients
can jeopardize the survival of the transplanted organ.
Hazards of transfusion of incompatible leucocytess
A - Sensitization of the recipient against HL-A factors which may
result, in:
1. Development of febrile transfusion reaction cn subsequent
transfusion.
2. Jeopardize the survival of organ transplant.
B - In special circumstances viable lymphocyte may produce graft
versus host disease.
C - Carry the ri3k of transmission of leucocyte-bone viruses.
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TRANSFUSION REACTION
During the past two decades considerable attention has been given
to leucocyte antibodies as a cause of blood transfusion reactions.
Nonhaemolytic episodes represent more than $0 percent of all transfusion
reactions (Heinrich et al 1973). The great majority of these are
febrile and in the latter definite leucocyte antibodies could be
demonstrated in most of them (Payne and Rolfs I960).- The frequent
demonstration of leucocyte-alloantibodies in sera of patients with
febrile transfusion reactions had originally led to the concept that
these antibodies were primarily responsible for nonhaemolytic trans¬
fusion reactions (Brittingham and Chaplin 1957> Payne and Rolfs I960,
Perkins et al 1966). Indirect proof for this hypothesis came from
the demonstration that febrile nonhaemolytic transfusion reactions
were successfully prevented, in patients with leukoagglutinins in their
sera, by administration of leucocyte-poor blood (Brittingham & Chaplin
1957, Payne and Rolfs i960). The direct evidence was produced from
an experiment performed by Brittingham and Chaplin (1957) in which one
of the authors was injected by blood containing a fairly high concen¬
tration of leukoagglutinins. The recipient developed typical febrile
reaction within 45 minutes of infusion.
Patients who receive repeated transfusion of whole blood for the
treatment of their illness may become immunized against incompatible
leucocytes in that blood. The development of these antibodies
correlates with the number of transfusions (Cannon 1970). Many
techniques have been developed for the detection of these antibodies
e.g. leuko-agglutination, lymphocytotoxicity, complement fixation etc.
(Thulstru.p 197l). However it was only recently that Heinrich et al.
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(1973) showed that most, if not all, of these antibodies are directed
against antigens of the HL-A system. These antigens are present on
granulocytes, lymphocytes, and platelets, as well as all nucleated
tissue cells (Mollison 1972).
The role of leucocytes in producing a transfusion reaction in a
presensitized recipient has been directly established by transfusion
experiments with blood fractions. The transfusion of plasma, white
blood cells or red blood cell suspensions separately showed the
occurrence of transfusion reactions only when leucocytes were introduced
(Dausset and Colombani 1967). This was later confirmed by the work
of Thulstrup (1971) who showed that, if serum from patient with
repeated transfusion reaction was mixed with leucocytes from the
respective donor, incompatibility was always seen.
Perkins et al (1966) showed that the severity of febrile non-
haemotytic transfusion reactions has a direct correlation with the
number of incompatible white blood cells transfused. They also
demonstrated that not only granulocytes but also lymphocytes and
platelets be capable of inducing a febrile transfusion reaction.
The number of stimuli required for induction of leucocyte
alloantibodies in a nonsensitized individual was found to be seven
injections, from the same donor, given intravenously at weekly
intervals (Marchal et al 1998). Apart from parous women who may
react to the first or second transfusion, the number of transfusions
necessary to produce febrile nonhaemolytic reactions lie3 between 10
and 20 when random donors are used (Payne and Rolfs i960).
There is a wide variation in the literature concerning the
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threshold dose necessary to produce a reaction in a presentized
recipient. While Brittingham and Chaplin (1961) found that 0.4 x 10^
is a subminimal dose, Perkins et al (1966) showed that the threshold
9 9
value varies from O.25 x lCr to more than 2.5 x 10 . The last named
authors have defined a significant reaction as a 1°C rise in
temperature over the baseline level. Nevertheless, little is known
about the minimal dose of incompatible leucocytes required to
sensitize a normal individual. It is also not known whether antibody
formation is dependent upon the 'infusion' of intact and viable cells.
Despite the fact that febrile nonhaemolytic transfusion reactions
are usually not severe, they are not desirable because of the great
discomfort they cause to both the patient and physician. Moreover,
the reaction may be a cause of waste of blood and results in delay in
transfusion while red blood cell incompatibility is ruled out.
Whilst prevention of sensitization is difficult, elimination of further
reaction can be achieved by giving blood from which the buffy coat
has been removed (Brittingham and Chaplin 1957)-
Leucocyte transfusion and transplantation:
Patients with chronic renal failure who are potential recipients
of kidney transplants are usually kept on frequent haemodialysis.
During this period of maintainance the majority of these patients
require repeated blood transfusion. Since leucocytes and platelets
in the transfused blood carry antigens of the HL-A system which are
also shared by other tissues including the kidney, it is not surprising
that many of these patients become immunized against a subsequent
renal allograft. The presence of antibodies in the sera of patients
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directed against HL-A antigen on the kidney at the time of trans¬
plantation is usually associated with a high incidence of early graft
failure (Kissmeyer-Nielsen et al 1966, Patel and Terasaki 1969).
For this reason many centres have employed a compatibility test
between recipient's serum and donor lymphocytes, as a measure of
safety prior to transplantation. Transplantation of the kidney in
spite of a positive crossmatch has resulted in an 80$ failure in the
early stages after the operation in one series (Patel and Terasaki
1969)« If the lymphocytotoxic crossmatch is negative the existence
of cytotoxic antibodies, even if they are not directed against the
donor kidney, would have an adverse effect on the survival of the
transplanted kidney.
The effect of pre-existing antibodies in the serum of a recipient
becomes more evident when the transplanted kidney is obtained from
random "cadaveric" rather than from genetically related donor (Patel
et al 1971» Terasaki et al 1971). In these cases 80^ failure of
the graft occur in the early stages of transplantation. This was
believed to be due to the multiplication effect of the graft
incompatibility by the pre-existing leucocyte antibodies which was
produced by multiple blood transfusion.
Leucocyte antibodies are not only detrimental to renal transplants
but also to other tissue and organ grafts. Their presence at the
time of transplantation may jeopardize the survival of bone marrow
graft. Experimental studies with animals showed that transfusion
of whole blood, whether from a sibling marrow donor or from unrelated
donors, prior to marrow transplantation results in acute graft
rejection (Storb et al 1972).
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Hattler et al (1966) have also demonstrated that the transfusion
of 500 ml of whole blood to a healthy recipient sensitized him
against a skin graft from the blood donor and led to accelerated
rejection of the transplanted tissue.
Leucocyte and graft versus host disease:
Animals with a deficient homograft rejection mechanism, if
challenged with a sufficient dose of competent allogenic cells,
develop a fatal graft versus host reaction (Hong et al 1968). A
similar reaction was obtained when viable allogenic lymphocytes were
administered to immunologically deficient children. However the risk
of graft versus host reaction also exists in patients under severe
immunosuppression (for the prevention of transplant rejection) and
in patients with an acquired cellular immunological deficiency as a
result of diseases. The clinical implication of this, is that when
blood transfusion is considered for such patients every effort should
be made to avoid the administration of large doses of viable
lymphocytes with the transfused blood.
It would thus appear that the transfusion of incompatible
leucocytes is undesirable and the question now is what can be done to
avoid this? HL-A typing and antibody screening is not a routine
technique in any red cell cross matching service and even if it is to
be applied it is not infeasible in practice to transfuse identical or
HL-A compatible blood. However, since in most of the cases where
blood transfusion is needed the blood is given with the sole object
of supplying red cells, reduction or elimination of immunization
against HL-A antigens could be achieved if the erythrocyte preparation
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are made sufficiently devoid of them. In fact leucocyte - poor blood
has been a standard preparation in many centres for quite a long time
and several methods have been proposed for that purpose.
Methods of preparation of leucocyte-poor blood
The realization that febrile non-haemolytic transfusion reaction
could be minimized by the removal of the buffy coat (Brittingham and
Chaplin 1957) has led to the development of various methods for the
preparation of leucocyte-poor blood.
Differential Centrlfugation:
This is based on the fact that the density of cells increases
from platelets, to lymphocytes, to granulocytes to erythrocytes.
Two different techniques could be used, either light centrifugation,
in the upright position followed by expression of the supernatant
plasma, buffy coat and the upper layer of the red cells or by hard
spinning in an inverted position followed by removal of the red cells
from underneath the buffy coat and the plasma through one of the
outlet ports in the plastic bags. Both methods give more or less
the same results with the removal of 70 to 80^ of the white cells
and loss of about 25^ of the red cells (Polesky et al 1973, Miller
et al 1973, Tenczar 1973, Perkins et al 1973). It has the
advantage of simplicity, a minimum requirement for special equipments
and using a closed system. However, the high red blood cell loss
is a major drawback as this will expose the patient to the risk of
multiple transfusion from additional donors in order to reach the
desired level of haemoglobin. Platelets and lymphocytes are fairly
124
completely removed by this method but granulocytes heavily contaminate
the upper layer of the packed red cells, however, the final product
was found adequate for the prevention of febrile reactions in
recipients sensitized to leucocytes. The fact that red cell
suspensions prepared by differential centrifugation contain seven
times more leucocytes per gram of red cells than products prepared
by other techniques (Miller et al 1973) would imply that blood
prepared by this method is more antigenic and hence unsuitable for
candidates for renal transplantation.
Nylon filteration:
This method was introduced in 1962 by Green Walt et al. It
makes use of the fact that granulocytes, under normal circumstances,
adhere to the nylon material. The process is enhanced at 37°C
temperature and at pH above 7.0 (Prey-wettstein and Bachman 1974)
in the presence of heparin as anticoagulant, while it is inhibited
by acid-citrate-dextrose (Halterraan et al 1973). Nylon-wool filters
retain virtually all the granulocytes but allow the red-cells and
lymphocytes to pass through. However, the presence of the latter
must be taken seriously, because the lymphocytes have a very long
biological half-life and thus are immunologically competent (Miller
et al 1973).
When the process of nylon-wool filteration was followed by
centrifugation of the blood in an inverted position the final product
was relatively pure (97$ of the leucocytes and platelets are removed)
but the red cell loss is considerably higher. In addition the
process requires a long preparation time and the shelf-life of the
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is short (Miller et al 1973).
A further disadvantage of fiIteration of heparinized blood
through a nylon-wool colomn is the limited shelf-life, and the
inability to salvage any of the blood components. Halterman et al
(1973) described a method which combined nylon fiIteration and
differential centrifugation and overcame most of the disadvantages
of either technique alone. In their method blood was collected in
ACD anticoagulant as usual, centrifuged and the plasma and the upper
50 ml of the packed cells removed separately. The packed cells could
then be stored for up to 1C days and when required heparin and calcium
chloride, necessary for phagocytosis were added. This is followed
by nylon filteration which removed 97$ of the leucocytes. However
the method has the disadvantage of losing 30$ of the erythrocytes.
Recently Frey-wettstein and Bachmann (1974) suggested that blood
collected in CPD were suitable for filteration through nylon filters,
even after storage for up to seven days at 4°C. When filteration
was followed by differential sedimentation and removal of the upper
30 ml of the packed cells, the final product was relatively pure,
red cell loss was about 25$ and in addition plasma was salvaged for
fractionation.
Diepenhorst et al (1972 a,b,c) developed cotton wool filters
which retained about 95$ of the leucocytes and 90$ of the platelets
from whole blood or red cell suspensions that had been stored at
4°C for up to three weeks. After filteration the red cell recovery
was over 90$ and the blood could be stored for an additional week.
Blood processed by this method required no heparin^ ACD or CPD
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blood is sufficient. Furthermore, both granulocytes and lymphocytes
were removed by this process. However the filters are locally
produced and not readily available.
Dextran sedimentation:
This was introduced in 1959 by Chaplin, Brittingham and Cassel
and based on the agglomerated erythrocyte sedimentation principle.
The method is highly efficient in removing leucocytes and platelets
from whole blood or red cell concentrates that are collected on either
ACD or CPD using high molecular weight dextran (M.W. 185,000)
Polesky et al (1973) reported more than 90 percent removal of
leucocytes and platelets while the red-cell loss was less than 10^.
The remaining cells, mostly granulocytes, were intact and viable.
Although the final product appeared to be highly satisfactory as
a leucocyte-poor preparation its use in practice has been hindered
by the slight risk of anaplylactic reactions to the dextrans (Cannon
1970). A method based on sedimentation of the red cells by dextran
100,000 to 200,000 M.W. followed by washing the red cells in the
elutramatic cell washer, to remove the residual dextran was suggested
by Tenczar (1973). However, the poor red-cell recovery (65 per
cent) was a major drawback. Moreover, the requirement to enter the
unit during processing limited the shelf-life of the preparation due
to the increased risk of bacterial contamination.
Saline Washing:
This method has been advocated by many centres as a method of
preparation of leucocyte—poor blood. Washing of red cells could be
127
accomplished with either "batch washing" (manual or automatic) or
with a continuous-flow centrifugation In one of the commercially
available machines. However, washing with either method was found
to be inefficient in removing the white blood cells (Cannon 1970,
Tenczar 1973). Residual leucocyte content in the final preparation
has been reported to be over 20 percent and 30 percent with manual
batch washing and continuous-flow washing, respectively (Poleskry et
al 1973). Furthermore the red cell loss was relatively high so that
additional transfusions may be required to obtain the desired level
of haemoglobin.
Frozen blood;
It has long been assumed (though without much evidence) that
frozen blood i3 a satisfactory leucocyte-poor preparation suitable for
patients in whom the administration of leucocytes and platelets is
undesirable.
The first investigators to draw the attention to the usefulness
of frozen blood in the treatment of patients with repeated febrile
reactions were Tullis and his colleagues (1958). They observed that
in spite of the large number of units of frozen blood transfused not
a single febrile transfusion reaction was reported even in those
patients who used to develop a reaction with every transfusion of
liquid-stored blood. With the massive increase in the use of
frozen blood in the therapy of patients evidence accumulated which
supported these observations (Haynes et al I960, Haynes et al 1962,
Murray et al 196%Higgins 1965). However little information has been
published about the actual amount of leucocytes present in the
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frozen blood as well as the viability of these leucocytes and the
antigen status of the frozen blood as a whole.
Meryman and Hornblower (1973), utilizing high-glycerol slow-
freezing techniques, studied the leucocyte content in red cell
suspensions processed by different automatic devices. They found
that while there were modest differences in red-cell recovery in the
three systems (Haemonetics, Elutramatic and IBM) the residual
leucocytes in the final products were approximately the same. How¬
ever they indicated that there was a wide variability in leucocyte
content from one unit of blood to the other. They suggested that the
glycerolization and freezing procedures damaged the white cells so
that during washing, the damaged material aggregated to form a mucous-
like mass which adhered to the wall of the washing chamber. Neverthe¬
less, some intact cells remained in the final red-cell suspension and
almost all of them appeared to be lymphocyte in origin.
Polesky et al (1973) compared the quality of the final product
of red cell suspension from different freezing techniques in terms
of red-cell recovery and residual leucocytes and platelets. Included
in their study was blood frozen by the Huggins technique and
deglycerolized with Huggins cytoglomerator, blood frozen by the high-
glycerol slow freezing method and washed in the Haemonetics or the
Elutramatic system, and red cells frozen by the low-glycerol rapid
freezing technique and processed by manual batch washing according to
the method of Rowe et al (1968). They found that although all these
methods were equally effective in removing the platelets, there were
marked differences in leucocyte removal in each of the four systems.
Best results were obtained with continuous-flow washing (whether in
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the Haemonetic or Elutromatic systems) where the red-cell recovery
was around 90 percent and the residual leucocytes were 1.8 - 0.8
percent. Next in efficiency was the Rowe technique where the red
cell recovery was 92.2 - 8.0 percent and the residual leucocyte were
5«3 - 1.8 percent. The Huggins method gave the highest leucocyte
contamination (17-1 - 8.4 percent) and the lowest red cell recovery
(86 percent). However when blood frozen by Iluggins' technique was
deglycerolized by methods other than Huggins Cytoglomerator the
leucocyte removal was improved. The authors also found that most
of the residual leucocytes were unidentifiable smudges and basket
cells and when the viability of these cell3 was tested by the trypan
blue exclusion test, all of them were non-viable. It would there¬
fore, appear that freezing techniques are the most promising methods
for preparing leucocyte poor blood. However, Helgeson et al (1973)
have pointed out that although no viable leucocytes were recovered
from frozen blood, serious problems of residual cell fragments with
antigenic activity may limit the effectiveness of these preparations
in preventing immunization of the recipients.
Crowely and Valeri (1974) utilizing the high-glycerol slow-
freezing technique, suggested that glycerolization caused most cf
the damage which occurred to the white cells and that during washing
in the Haemonetics-disposable bowl, the damaged cells agglomerated
in large masses which were either washed out or remained adherent
to the washing bowl. They maintained that these events effected
mainly the polymorphnuclear granulocytes, as 70 percent of the
remaining cells were lymphocytes. When the viability of the latter
was tested by their ability to exclude the trypan blue dye, most
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of them appeared to be viable. Also HL-A antibody adsorption tests
showed that particulate antigens were still present in the
previously frozen red-cell suspension after washing, but these
antigens were removed completely after passing the blood through
a micropore filter.
It is thus evident that in spite of the fact that most of the
work conducted in this subject was performed on blood frozen by the
high-glycerol slow-freeze technique, the data obtained from
different laboratories is conflicting. At the same time no
information is available on the leucocyte content of blood frozen
by the low-glycerol rapid-freeze-thaw technique in aluminium cans.




DESCRIPTION OF THE SYSTEM
The system adopted for freeze preservation of blood in Edinburgh
Blood Transfusion Service is an adaptation of that system used by
Jenkins and Blagdon at Brentwood (1971) which is itself derived from
the work of Krijnen in Holland (1964) and Pert in the U.S.A. (1963,
1964, 1965) • The system is a low glycerol-liquid nitrogen-aluminium
can system.
The liquid nitrogen is stored in a BOC TWN/500/l horizontal tank
having a liquid capacity of ^>00 litres. As supplied, the tank is
unsatisfactory and a number of modifications have been introduced to
it. The contents are indicated directly by a load cell (Darenth-
Helios Hydraulic). The pressure gauge was replaced with a 0-60 psi 7"
gauge; remote mounted. The safety relief valves were replaced by
"Circle-Seal" valves. The bursting discs were replaced with 47 psi
aluminium discs.
Experience has shown that no automatic filling system can operate
reliably below 29 psi and thus the tank pressure is always maintained
at 30 psi. Experience has also shown that no design of safety relief
valve will reliably re-seal when cold and they should thus be mounted
on extension pipes.
The boil off from this tank is allegedly 5 litres per day, but
this does not include the liquid consumed in pressure raising.
The liquid is fed into the building through a half-inch brazed
copper pipe insulated to 6" diameter with polyurethane foam. The
(Fig. Ml.)
(Fig. M 1.) top view.
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filling time, similarly constructed is fed into the tank outlet via
a tee-piece and extra valve.
The refrigerators used are Union Carbide 250 litre models (Pig. M.l).
These are cylindrical, open top steel Dewar vessels with split foam tops
providing either half or full opening. These refrigerators are very
convenient to use, as the operator can reach to the bottom without
difficulty. The filling from the manifold system is performed via
electrical solemoids of eight-inch orifice, these have proved to be very
reliable.
The level of liquid nitrogen is maintained just below the false
floor of the refrigerator by automatic level sensors. In addition, a
third emergency low level alarm sensor is fitted. The storage area
of the refrigerator is thus operated entirely in the vapour phase
which has important bearing on the safety of operation. The temper¬
ature in the top and bottom of an empty refrigerator has been measured
and found to be -188°C at the floor and -175°C at the top. Paradoci-
cally, when full, a refrigerator is colder than when it is empty.
This is due to the increased "heat leak" provided by the blood cans,
causing more nitrogen to boil up from the base reservoir and cool the
upper section. In practice, we find that the refrigerator switch on
the supply approximately once every 24 hours and that each refrigerator
consumes 12 litres per day. Added to this are 10 litres per day
lost in the transfer lines giving a total weekly consumption for five
refrigerators of 49^ litres.
The refrigerators are divided up by vertical rods in a hexagonal
pattern which allows for the close packing of cans (Fig. M.2) two
layers can be filled, with 102 cans per layer. The can used in this
( Fig. M 2.)
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system (Fig. M.3) is slightly smaller than that previously developed
(Jenkins and Blagdon 1971) and thus takes up less space for the same
amount of blood. The can also has a narrower internal neck diameter
with convolutions which serve to give a better seal against the
ingress of nitrogen. These cans have been pressure tested to
destruction and the following sequence of events was observed:-
At 80 psi the concave base everted into a convex base, and at 100 psi
the base was blown cleanly off and downwards, the rest of the can and
seal were left intact. It is therefore believed that this is an
inherently safe can since the seal at the top does not fail, the
operator is given warning 20 psi before failure and the can base which
is smooth and light is blown downwards away from the operator.
Furthermore, since the sides of the can are not ripped open, no jagged
metal is exposed. Finally this can is of British manufacture and
costs approximately half of the imported Printal can from Finland.
Preparation of cans for freezing:
Cans are soaked in 1$ v/v alkaline laboratory detergent (RBS 25)
in hot water for not more than 15 minutes. Prolonged soaking might
lead to subsequent leaching out of aluminium into the blood.
Cans are next rinsed in 0.2$ v/v acetic acid to neutralize the
alkaline detergent. Contact time should again be limited.
Rinse three times in distilled water and three times in hot
pyrogen free water. Cans are then dried in an air oven at 110°C.
Two ml of pyrogen free water are dispensed into each can. This is
preferred over saline to minimize the leaching out of aluminium.
The neck is sealed with a boiled Suba-Seal No.57* The latter is
moistened with glycerol and pushed in until four rings remain visible.
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The seal joint is then liberally smeared with phenol-glycerol reagent
and the skirt immediately turned down and wired into place with two
turns of 1.6 mm enamelled copper wire. The wire seal has now been
replaced by a shrink fit TPS (Dupont Tj" roll cover) approx. f-" length.
During autoclaving this shrinks tightly around the cap. The upper
surface of the seal is marked in a horizontal line with a felt-tipped
marker. Can seals are covered with temporary dust seals of two
paper cake cases held in place with elastic bands (Fig. M.4).
The cans are then weighed on a top pan balance to within C.lg
before and after autoclaving. The observed weights are noted on the
base of each can. The cans are autoclaved at 121°C for 20 minutes.
The presence of the water inside the can generates a differential
pressure of about 35 P3* which is a good test of assembly. The whole
process should be completed in six hours. After autoclaving the cans
are reweighed and any cans which have decreased in weight by more than
0.5g from that prior to autoclaving are discarded.
COLLECTION OF BLOOD:
400 ml of blood is collected from healthy volunteers in routine
sessions into plastic packs containing one of the following anti¬
coagulants according to the need of the department.
a - ?0 ml ACD from Tuta, Lane Cove, N.S.W. Australia,
b - 70 ml CPD (Tuta, Laboratories Australia),
c - EDTA (Tuta Laboratories Australia).
Plasma is separated after centrifugation at l,300g for 60 minutes and
the packed cells are stored at +4°C for not more than one week.
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G LYCSROLIZ ATION:
During the early period of this study we were interested in
finding out the glycerol concentration that gives the highest red
cell recovery. Therefore it was essential to determine the volumes
of the glycerolizing solution and that of the blood used each time.
The volumes were worked out from the weights and the density of each
substance and the observed readings were recorded in special form.
In this study blood of any group and genotype was used, however,
for routine storage we use only group 0 blood of genotype ^2^2 0r
rr. Only packed red cells, less than one week old, were frozen.
The red cells were prepared from blood donated in routine sessions and
collected on ACD, CPD or EDTA.
METHOD:
The red cell pack (including a plasma transfer line), the Freezing
Protective agent (FPA) bottle and the aluminium can are weighed to the
nearest O.lg on a top-pan balance (Mettler P 1000 N). The plastic
pack containing the red cells is connected via the giving port to the
plastic spear of the transfer line.
With the clip of the line closed, the needle at the other end of
the line is entered into the half-MRC bottle containing the FPA.
An airway needle is also introduced into the bottle. The blood pack
is placed on horizontal Luckhams Shaker and the FPA bottle is hung
from its base above it as high as possible (Fig. M.5)« The shaker is
switched on at a rate of 200 rpm and the line clip is opened to allow
the FPA into the blood pack. When the FPA is completely transferred
( Fig. M Z*. )
( Fig. H 5.)
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into the plastic pack the line clip is closed and the pack is
disconnected from the FPA bottle. The full pack and the empty
bottle are reweighed. The glycerolized blood is then transferred
into a prepared aluminium can (Fig. M.6). Since the puncture seal
is well maintained when the smallest possible gauge is used, we
preferred to fill via 19 SWG needle and use a 21 S1VG needle as an
airway. The puncture site on top of the Suba-seal is marked with a
felt-tipped pen line so that entry needles puncture along the line
and emptying needles across it. This avoids the accidental entry of
two needles at the same site.
Whilst the blood is running into the can, and before the line is
disconnected, the can and pilot tubes must be labelled with the details
of the unit. A record of freezing file card is also made out and
indexed by the "liquid nitrogen - number" LN - this number also appears
on the can side and base and pilot tubes. The record card is also
made out with a full genotype of the blood as far as the availability
of antisera permit (The latter information was obtained from the
serology laboratory).
When the can is filled, the remaining blood in the transfer line
is expressed with a tubing stripper to provide two aliquots of one ml
for each of the two pilot tubes. The plastic bag is then disconnected
from the can and both are reweighed.
The upper seal surface is smeared with phenol-glycerol mixture,
the latter serves as both bacteriostatic and cryogenic seal. Two
finger cotts (latex rubber) are placed over the top seal and the two
pilot tubes are held in place by a thin copper wire which passes
through the body of the pilot tube and is tied around the neck of the
can.
( Fig. M 6.)
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FREEZING:
Cans are frozen by direct immersion in liquid nitrogen. Single
cans are frozen in 4^5 L Dewar flask whilst up to 12 cans may be
frozen simultaneously in a Union Carbide LNR 40 refrigerator (Fig. M.7).
Care should be taken to keep the liquid level up to the can shoulder
during the rapid stage of boil-off.
When the liquid nitrogen stops boiling vigorously, usually in
10-12 minutes, the cans are removed and transferred to the storage
refrigerator. Under no circumstances should unfrozen cans be placed
directly in the storage refrigerators.
The LN number, the blood group and genotype details are entered
onto a wall map (Fig. 14.8), which is a full size replica of the
refrigerator interior. Arranged on the map in hexagonal close packed
array are the circular sites representing 102 positions. Since two
layers can be placed, the total refrigerator capacity is 204 units
and so each map position is divided horizontally to represent the
upper and lower sites (Fig. M.9). The under surface of the map is a
reproduction of the plan showing can sites and position codes only.
The over surface is of transparent map-covering acetate film and it
is on this surface that the details of each can are entered. If a
felt-tipped marker is used, it may be cleaned off with chloroform.
THAWING:
When required the desired unit of blood is retrieved, the pilot
tube is detached and thawed in a water bath at 37°C. The contents are
transferred to a conical 10 ml centrifuge tube and one ml of prewarmed
19$ w/V sorbitol saline is added. After one minute of equilibration
( Fig. M 8.)
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a further 8 ml of prewarmed saline is added with continuous mixing.
The resulting mixture contains 10 ml of 3^ v/v cells in 2t glycerol
and 2$ sorbitol. This mixture can be used directly for cross¬
matching without any further interference, however, if desired the
cells can be centrifuged and resuspended to give a more concentrated
sample.
In order to avoid any confusion resulting from mixing up of pilot
tubes, we preferred to use samples collected directly from the
processing bag for cross-matching. This sample is collected immed¬
iately after washing is completed.
Assuming a negative cross-match, the required can is then taken
out of the refrigerator using 18" crucible tongs and industrial asbestos
gloves (the latter are not impermeable to liquid). Single or double
units can be thawed in a sink of hot water at 37-41°C by continuous
shaking at about one cycle per second. However, for convenience in
handling, up to four cans may be thawed in the gyratory action thermos-
tated washing machine (the latter is home made and was developed after
Mitchell et al 1973). This has the additional advantage that any
hazard from exploding cans is much reduced by the machine lid.
The completion of thawing is detected by the absence of "sloshing"
inside the can and/or the absence of a cold sensation when holding
the can. This takes from six to ten minutes. In no case should the
of
cans be allowed to warm up to more than 40 C as the rate/haemolysis
is very high at this temperature.
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PEOLYCBROLIZ ATI ON;
This may be performed either manually or automatically (in the
IBM 2991 Automatic Cell Processor). In either case the washing is
a serial centrifugation or batch washing.
MAMUAL DBOLYCEROLIZATION:
n
Prepare four dry clean MRC bottles and mark them as follows
0 - post thaw supernatant
1 - wash I "
2 - wash II
3 - wash III "
Get ready a Tuta five-tail washing pack (Pig. M.10) and with a felt-
tipped marker enter the details of the thawed unit on its surface.
The pack is placed on a Luckham3 shaker. After thawing, the can is
clamped in sin inverted position at about 15" high above the shaker,
the outer elastic covers are removed, the outer surface of the Suba-
seal is swabbed with iso-propanol and the first line of the five-tail
pack is entered into the Suba-seal. Any gas pressure is now
manifested by the expulsion of a volume of blood prior to airway
entry. If the volume exceeds 10 ml then the can seal was not perfect.
We have had several leaks when using conventional British long airways
and have found the thinner needles of plasma aspirating sets to be
more satisfactory. Both Baxter (6j") and Avon (9") sets have been
used.
Having filled the pack via the first line, this is either clipped
off or heat sealed and cut off. The bag is then centrifuged at
( Fig. M 10.)
( Fig. M 11.)
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2^00 rpm in a swing out rotor centrifuge for ten minutes. The
viscosity of the glycerol dictates the longer spin time.
Using a Renwal plasma expressor, the post-thaw supernatant is
expressed via line 2 into the MRC - 0 bottle and then wash I solution
(Sorbitol) is allowed to run in via line 2. At this stage the
shaker should be operating to ensure thorough mixing of the pack
content and the incoming wash solution to avoid hypertonic stress to
the cells. The effect of the sorbitol is to shrink the cells and
"wring out" any residual glycerol and these cells are thus much
smaller and denser.
Line 2 is then cut off and the pack is again centrifuged at 2500
rpm but for five minutes only this time. The cells pack down very
hard and wash I supernatant is expressed via line 3. Wash II (0.9
per cent NaCl Solution) is run in through line 3 whilst the pack is
on the rotary shaker. It is at this stage that most haemolysis
takes place for the shrunken cells are exposed to an expanding medium
and care should be taken that all the "sludged" cells at the corners
and edges of the pack are resuspended.
Line 3 is cut off and the pack centrifuged at 2,500 rpm for five
minutes. Wash II supernatant is expelled via line 4 and wash III
(also isotonic saline) is run in via line 4 whilst the pack is on the
rotary shaker.
Line 4 is cut off and the final spin is again performed at 2,500
rpm for five minutes. The wash III supernatant is expressed via
line 5 an^ desired resuspension medium is introduced via line 5
to give the required haematocrit.
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The choice of swing out versus angle rotor depends on the time
factor, processing in a swing out rotor (as described) is slower but
gives a cleaner interface. Angle rotors are faster but the cell-
supernatant interface, especially after wash II, is very hard for
inexperienced operators to see.
The whole process takes about 90 minutes, and up to four units
of blood can be processed simultaneously.
AUTOMATIC WASHING IN THE IBM SYSTEM
Similar to manual washing the wash process utilized in the IBM
2991 Bed Cell Processor is discontinuous and serial. Unlike the
manual washing the IBM wash system is a closed and automated system.
Description of the system: (Fig. M.ll)
A plug board at the front of the machine allows the presetting of
the number of wash steps as required and the order of wash solutions.
Up to seven wash cycles can be programmed during which up to three
different wash solutions can be applied. Dials permit the selection
of the speed of spinning of the centrifuge bowl as well as the length
of time of each spin operation.
Blood enters the system by gravity through one of the tubing lines
and is collected into the processing bag in the centrifuge bowl.
The processing chamber is a circular plastic bag which is integrally
connected to a single-channel rotating 3eal and a tubing harness.
The latter connects the processing bag to the blood, wash solutions,
and supernatant collecting containers. The bag and its related seal
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and harness are disposable and supplied as an integrated, sterilized
unit.
The centrifuge bowl can be spun at any required sneed, up to a
maximum of 3000 rpm (l250g), by presetting the corresponding rotary
switch. Separation of cells and cell-supernatant interface are
visible during spinning through a transparent centrifuge cover and
bag. This allows intervention of the operator at any stage should
anything go wrong,
A manual prime step is necessary to drive the air out of the system
after which the various steps of wash cycle (centrifugation, removal
*
of the supernatant, addition of a new wash solution and mixing) take
place automatically and are preprogrammed.
When the spinning-time ends a valve to the supernatant-collect
container is opened and a pump starts forcing hydraulic fluid under
the flexible membrane in the centrifuge cavity. This squeezes the
supernatant out to the container. When the erythrocytes appear at
the red cell detector, the pump and centrifuge bowl stop and a
preselected wash valve opens, allowing wash solution to flow into the
blood processing bag. As the wash solution flows in, it is mixed
with the red cells by a gentle reciprocating agitation cycle of the
centrifuge bowl. At the end of this cycle, the bowl again spins at
the preselected rate and time interval and the cells are again
separated from the supernatant. This cycling continues until the
present cycles are completed.
This system can also be operated manually. Manual operation is
similar to that described above except that the operator at each step
has to select and initiate the wash solution to be mixed with the
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red cells. Push buttons and rotary selector switches at the front
board of the machine permit manual operation.
Operation of the system:
Previously frozen-thawed red cells are deglycerolized in the IBM
2991 Automatic Cell Processor according to a wash protocol developed
in our laboratory to suit our freezing programme.
By the time the frozen unit is thawed, the machine is set up
for operation. The tubing harness is mounted in the solenoid pinch
valves, the integrally connected blood processing bag is placed in the
centrifuge bowl and the plastic spikes are attached to the wash
solution containers. The machine is programmed so that the red cells
receive three wa3h cycles each oonsists of spinning for two minutes
at 3,000 rpm,removal of the supernatant at a rate of 450 ml per minute,
addition of a new wash solution together with mixing at an appropriate
speed to allow thorough mixing.
Once the unit is thawed, it is connected to the system through the
corresponding line and blood allowed to run into the processing bag.
When the transfer of blood is completed, air is removed from the
system and wash I is allowed to flow into the processing bag until
it is completely filled. We found that this step is necessary not
only because it allows for the difference between blood volume (400
ml) and bag capacity (65O ml) but also it gives better washing and
higher red cell recovery. The machine is then switched to automatic
operation to run according to the presetted programme.
After the separation of the post-thaw supernatant the red cells
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are given one-cycle wash with wash I (19 per cent sorbitol in saline)
followed by two cycles with 0.9 per cent sodium chloride.
At the end of the last spin, the supernatant is expelled and
the cells are resuspended in the desired resuspension medium. A
sample of the final product is then expelled, through the extra
line left unused, for bacteriological, haematological and biochemical
tests. The time required to process one unit in the machine is
about 20 minutes.
For the sake of study the tubing line leading to the supernatant
collect chamber was severed past the corresponding valve and the
supernatant from each wash step was collected separately into a dry
clean measuring cylinder for biochemical analysis.
The blood is sent to the wards for transfusion in the circular
processing bag after sealing off the rotating seal with its harness
lines (Fig. M.12).




Union Carbide 250 litres vivostats with control units. Supplied
by Union Carbide Cryogenic Division, Redworth Way, Ayecliffe, Co.
Durham.
Liquid Nitrogen Storage:
a. Portable, self pressurising 160 litre Dewar flasks (LS-l60)
supplied by Union Carbide.
b. For larger volumes, TWN-5OO-I horizontal 500 litre storage tank,
with mannual pressure raising circuit. Supplied by British
Oxygen Co., (BOC) cryoproducts Division, Manor Way, Crawley, Surrey.
Freezing Containers:
a. For single cans, 4.5 litre glass Dewar flasks (With polypropylene
covers) from Day-Impex, Earls Colne, Essex.
b. For up to 12 cans a Union Carbide LNR-40 refrigerator (40 litres,
wheel base) is used.
Aluminium Blood Cans;
Metal Box Co., 69 mm by 160 mm, 485 ml capacity, screw cap
aluminium bottles with white exterior lacquer supplied in boxes of 70.
From the Metal Box Co., Cowlairs Industrial Estate, Glasgow Nl.
Rubber Seals;
Stoppers are Suba-Seal No.57 with turn-over skirt. From W.
Freeman, Stain Cross, Barnsley, Forks, in lots of 100.
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Pilot Tubes:
2 ml polypropylene tubes with screw caps. Manufactured by Nunc
of Denmark and sold by Sterilin and Jobling-Vestric in the U.K.
Rotary Shaker;
Luckhams "Rotatest" from Luckharas, Burgess Hill, Surrey. A
custom fabricated plate with retaining straps is required to take 4
packs.
Airways and Transfer Lines:
Baxter AE-2 or AE-8 plasma transfer lines. Baxter BR-325 plasma
aspirator sets are used as long airways, needle length 6^". Avon
plasma aspirating set D-80 also used as long airway, needle length 9"«
Plastic Washing Bags:
Tuta five-tail washing packs (I6-O5O), from Tuta plastics (UK)
Ltd., 242 Tolworth Rise South, Surbiton, Surrey, England.
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RESUSPENSION
At the end of the washing process the red cells may he resuspended
in the required medium. When the cells are processed by the manual
technique the resuspension medium is added via the line number "5" of
the five-tailed processing bag, which is then cut off. With the IBM
washer, resuspension medium may be added through the unused line of
the processing set, while the latter is still in place, the contents
are then thoroughly mixed by reciprocal agitation.
In our investigation for a resuspension medium that gives the best
post-thaw stability, the following method of resuspension and sampling
was used.
After deglycerolization the packed red cells were divided into
two equal parts, 100 ml each, and distributed into two sterile, dry
transfer packs (200 ml capacity (Tuta 16-050)). This distribution
was aseptically achieved by using a three-way tap (Pharma-Seal Inc,
K75) and a 5® ml disposable syringe. Both portions were then
resuspended to a haematocrit of 45^ - 5'X> °ne in isotonic saline,
which served as a control, and the other in the medium under investi¬
gation. The following media were investigated:
a. Human Serum albumin solution 5 Per cent (w/v in 0.9 per cent
sodium chloride^ This was supplied sterile from the protein
fractionation centre.
b. Sodium chloride solution 0.9 per cent (w/v) to which is added








c. Human serum albumin solution 5 per cent W/v in isotonic
saline to which is added 70 ml of the ACD solution as in "b".
d. Sodium chloride solution 0.9 per cent + 70 ml of a solution
which contained:
Citric Acid 0.327 g
Sodium Citrate 2.630 g
Mono sodium phosphate 0.222 g
Dextrose 2.550 g
Water to 100 ml.
e. Human serum albumin 5 per cent in isotonic saline + 70 ml of
the same solution as "d".
f. Ringer Lactate-solution (Baxter) Each 1000 ml contains:
Sodium chloride 6.0 g
Sodium lactate 3.22 g
Potassium chloride 400 mg
Calcium chloride 270 mg
g. Tis-U-Sol solution (Orlina et al 1972) which was composed of
Potassium chloride 5.8 m Molar
Sodium chloride 137.0 m Molar
Magnesium Sulphate 1.6 m Molar
Disodium phosphate 0.4 m Molar
Glucose 1C0.0 mgfi
After resuspension the following samples were withdrawn and every effort
was made to maintain sterility.
1. 10 ml sample into a 10 rnl calibrated conical TPX centrifuge tube
which wa3 spun in MSE Super-Minor centrifuge for 30 minutes at 3000 rpm
for determination of the packed cell volume. The latter was used for
calculation of the intracellular potassium as it will be described
1ater.
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2. 10 ml sample into 15 ml conical TPX centrifuge tube which was spun
for 10 minutes at 3000 rpm for separation of the supernatant fluid.
The latter was used for estimation of free haemoglobin and potassium.
3. Five ml samples for estimation of blood pH, total blood haemoglobin
total potassium, 2,3 DPG and ATP content.
4. A sample of resuspended blood, into EDTA sequestrene tube for
estimation of:
R.B.C., W.B.C., PCV, MCV, MCHC and for making smears for haematological
examination.
5- A sample of 10 ml was taken every day for nine successive days
into a 15 ml conical TPX centrifuge tube for separation of the super¬
natant as described in "2" for estimation of free haemoglobin and
potassium. During this period the blood was stored in a conventional
refrigerator at + 4°C without mixing apart from sampling.
PREPARATION OF SOLUTIONS
Freezing Protective Agent (FPA)
Because of the physical nature of the reagents it is convenient to
weigh all the constituents separately in plastic beakers and transfer
with rinsing into a final large mixing vessel which is calibrated to
the desired volume.










dust is seen to be a problem it must be removed in the way as set out
below for Wash I. As a check on the correctness of making up, the
batches should be checked to see that the refractive index is 1.395
at 20°C. The solution is then dispensed in 200 ml volumes in half
MRC bottles and autoclaved, at 121°C for 20 minutes.
Wash I solution:
Sorbitol 190 g
Sodium chloride 9 S
Water to 1 L.
This solution often contains visible dust and we always filter this
on-line when filling the bottles. This is done by pumping the solution
through a Whatman Gamma - 12 glass fibre filter of perosity 8 microns.
The filtered solution is pumped through the filter and directly into
the bottles by a Glen Creston variable speed peristaltic pump.
The solution is dispensed either as 300 ml in half - MRC bottle
for manual batch washing or as 750 ml in one litre MRC bottles for
automatic washing in the IBM 2991 processor. The bottles are then
autoclaved at 121°C for either 20 minutes (for the small bottles) or
30 minutes for the 1L MRC'S.
Wash II and III
Normal physiological saline (NaCl 0.9g per cent) dispensed either
in half - MRC bottles are 300 ml volumes or in 1L MRC as 1000 ml
volumes. During the course of the study we shifted to commercial
sodium chloride solution supplied in Viaflex bags by Baxter. The
latter provided an extra precaution against bacterial contamination
as an airway needle is not required.
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Phenol-Glycerol-Bromophenol Blue
To 100 ml of glycerol in a glass beaker add lg of phenol and 5 rag
of bromophenol blue. The mixture is best dissolved by placing it on
top of a heated magnetic stirrer with a few drops of glycerol under¬
neath the beaker. This solution is most conveniently dispensed in
150 ml conical tipped polythene dropper bottles ( Azlon).
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HAEMOGLOBIN MEASUREMENT
A. The Cyanmethaemoglobin Method:
This method was used for blood samples and supernatant fluid
containing haemoglobin level more than 60 mg/dl. The procedure
followed was the same as described by Dacie and Lewis (1970).
Principle:
If a solution containing potassium cyanide and potassium
ferricyanide is added to a haemoglobin containing solution, the
haemoglobin, methaemoglobin and carboxyhaemoglobin are all transformed
to cyanmethaemoglobin. The optical density of the latter can be
conveniently measured at 540 run in photoelectric colorimeter.
Reagent:
This was locally prepared and contained
Potassium ferricyanide (M & B)
Potassium cyanide BDH (Analar)




This reagent was kept at room temperature for up to six months in
dark-coloured glass container.
Method:
One ml of the supernatant fluid or 0.02 ml of blood was added to
4 ml of the reagent solution into dry clean test tube.
The content of the tube was mixed by gentle inversion for a few







the reaction to be completed.
The optical density was then compared to that of the contents of
a cyanmethaemoglobin standard (BDH) ampoule, at 540 nm in an EEL -
SPECTRA 60 colorimeter using reagent solution as blank.
Calculation:
Haemoglobin concentration mg/dl =
OD. of the test sample v „ ,, , , . / /Jn\v .. „' X cone.of the standard(mg/dl;X dilution factor
OD. of the standard
When the colour of the cyanmethaemoglobin of the test sample is too dense
to be read, it was further diluted with reagent solution and the result¬
ing O.D. was multiplied by the dilution factor.
B. The Ortho-tolidine method:
This method was used for estimation of haemoglobin levels in
supernatant fluids and plasma below 60 mg per dl. The procedure
followed was the same as described by Lewis (1965).
Reagents:
1. Ortho-tolidine reagent:
Glacial acetic acid (BDH Analar) 90 ml is added to 10 ml of
distilled Water, covered and left overnight at room temperature.
0.25g orthotolidine is dissolved in the acetic acid prepared in
the previous step. The reagent is kept in a refrigerator at +4°C and
should be prepared freshly every eight weeks.
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2. Hydrogen peroxide;
1.2 ml of 100 volume f> solution of hydrogen peroxide was pipetted
into a IOC ml flask and the volume was completed up to the mark with
distilled water. This reagent is kept in a refrigerator at +4°C and
should be prepared freshly every week.
3. Haemoglobin standard solution:
Supplied by BDH.
4. Acetic acid diluent:
In a one litre measuring cylinder 100 ml of glacial acetic acid
was made up to one litre with distilled water.
Method;
Three 15 ml glass test tubes are prepared for each unknown and
marked TEST, STANDARD and BLANK. Into these tubes the following










Leave for 2 minutes at room temperature
Hydrogen peroxide solution 1ml 1ml lml
Leave for exactly 10 minutes
Acetic acid diluent 10ml 10ml 10ml
2. The contents are then mixed by inversion of the tubes, transferred
to 10 mm light path cuvettes and the optical density is immediately




... /,, O.D. of the testHb concentration mg/dl « rr r—3—x x CO.D. of the standard s
= concentration of the standard (mg/ dl ).
TOTAL AND FREE POTASSIUM ESTIMATION
Immediately after washing, before the addition of the resuspension
medium, the following samples were collected:
a. A sample of 10 ml collected into 10 ml conical TPX centrifuge
tube. This was spun for 20 minutes at 3000 rpm in M3E
Super Minor centrifuge and the haematocrit was read and
recorded. A sample of the supernatant was used for
estimation of the free potassium.
b. A two ml sample of blood in a plain tube for estimation of
total potassium in whole blood, and for red cell count, by
a Coulter Counter model "S".
Potassium in the supernatant and whole blood was estimated by
flame photometery (Corning Eel 227 Flame Photometer).
Intracellular potassium content was calculated and expressed as
12
m mol per 10 red blood cells from the formula:
conc. of K per 10 RBC = x 10
where
R = red blood cell count per ml.
Kc = conc. of K. per ml of R.B.Cs and derived from the formula:
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where K = conc. of K in whole blood
w
= conc. of K+ when freely distributed in both the apparent
and trapped supernatant and is obtained from the following equation.
(P.V.)T x Kg
Kf " 100
= conc. of K. as measured in the supernatant
(P.V.)^ = The true plasmatocrit and equals
' <P-V->app+ 13 155
(P.V.) = 100 - haematocrit (Hct)
app v '
Hct in this experiment represents the percentage packed cell volume as
determined after centrifugation of 10 ml blood in 10 ml capacity
conical TPX centrifuge tube for 20 minutes at 3000 rprn in MSE Super-
Minor Centrifuge.
The number (13) refers to the standard percentage of trapped plasma
(when 10 ml blood are centrifuged in 10 ml conical TPX centrifuge tube
for 20 minutes at 3000 rpm in MSE Super-Minor centrifuge).
Determination of the percentage of trapped plasma:
Into a 10-ml conical TPX centrifuge tube 5 ml of previously frozen
washed erythrocytes were placed. To the latter 5 ml of isotonic
saline were added, followed by two drops of dilute Blue Dextran-2000
dye solution in 0.9 percent saline.
After thorough mixing the tube was centrifuged in USE Super-
Minor centrifuge at 3000 rpm for 20 minutes. The supernatant volume
was measured, aspirated by a Pasteur pipette and collected in a dry
clean tube and marked supernatant (l).
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The cells were resuspended to the original volume by isotonic
saline, mixed and recentrifuged for 20 minutes at 3000 rpm.
The supernatant solution was removed and marked supernatant (2).
The optical density (O.D.) of both supernatant were measured in an
EEL-SPECTRA colorimeter at 650 nm using 10 mm light path cuvette.
A solution of saline is used as a blank. Previous experience had
shown that haemoglobin did not interfere with Blue Dextran dye at that
wave length. The percentage of trapped plasma was calculated from
the following formula:







Vg = volume of the second supernatant
Sj = O.D. of the first supernatant
= O.D. of the second supernatant
P.C.V. = volume of the packed cells
The experiment was repeated several times and the answer was always
the same. The percentage of trapped plasma was 13$.
ALUMINIUM ESTIMATION
At least 100 ml of previously frozen thawed and washed erythrocytes
contained in the processing bag were sent to the Department of Health
and Social Security (D.H.S.S.) for estimation of the aluminium level
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in the blood. Aluminium was estimated by the atomic absorption
spectroscopic technique.
Blood pH:
This was measured at 20°C with a Corning - EEC Model 110 digital
pH meter.
HAEMAT0L0G1C AL MEASUREMENTS
The red cell count, white cell count, mean cell volume, haematocrit,
mean cell haemoglobin, mean cell haemoglobin concentration were deter¬
mined in a Coulter Counter Model "S".
CALCULATION OF RED CELL RECOVERY
Calculation of the percentage of red cell recovery was based on
the sum of supernatant haemoglobin in all the wash solutions plus the
intact cellular haemoglobin in the resuspended cells. This was
assumed as 100^ value and rarely agreed with the total haemoglobin
input into the can. The reason is obscure but may be related to the
technical problems of estimating accurately the haemoglobin dissolved
in different solutions before and after processing.
intact cellular Hb recovered
, .. x 100
percentage red cell recovery =
intact cellular Hb recovered + sum of
Hb in wash solution.
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BACTERIOLOGICAL EXAMINATION
One hundred units of packed red cells were used in this study.
All the units were obtained by random from the routine red cell
concentrate stocks which have been stored for five days or less.
The packed red cells were individually glycerolized, frozen and stored
in the vapour phase of liquid nitrogen, as described previously, for
variable periods of time. On the day of processing the desired unit
was taken out of the refrigerator, thawed at 40°C and processed in the
IBM 2991 Automatic Cell Processor. At the end of the washing
procedure the red cells were resuspended in approximately equal volume
of isotonic saline that contained 70 ml of acid-citrate-dextrose
solution. While the red-cell suspension was mixed, by reciprocal
agitation of the centrifuge bowls, the line used for introduction of
the suspension medium was modified so that sampling from the bag under
sterile conditions was possible. This was achieved by attaching, to
the plastic spear, a short sterile plastic junction, which terminated
in a male luer fitting, into the latter a sterile disposable needle
1$G was fixed.
A sample of 5 ml of the washed resuspended cells was then pumped
into each of the following containers:
a. Bacto-Blood culture bottle containing 50 ml of Fluid
Thioglycolate medium (Difco laboratories) for anaerabic
culture at 37°C.
b. Bacto-Blood culture bottle containing 50 ml Fluid Tryptic Soy
Broth (Difco laboratories) for aerobic culture at 37°C.
c. Bacto-Blood culture bottle containing 50 ml Fluid Tryptic Soy
o
Broth for aerobic culture at 20 C.
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The above bottles served as primary cultures and were maintained at
the specified temperature for seven days.
When all the samples required for examination were obtained the
tubing harness and the rotating seal were cut off and the bag contain¬
ing the resuspended cells was kept in a conventional refrigerator at
+4°C.
On the seventh day of incubation of the primary cultures, sub¬
cultures were performed onto blood agar plates (Oxoid). Three plates,
corresponding to the three primary culture bottles, were used for each
unit. The blood plates were incubated as follows:
One plate kept aerobically at 20°C (room temperature)
A second plate was maintained aerobically in an incubator at 37°C- The
third plate was incubated at 37°C inside self containing gas pack
Anaerobic System (a transparent polycarbonate jar in which an anaerobic
atmosphere was generated with the aid of specially designed foil
envelope that generates hydrogen + carbon dioxide). An anaerobic
indicator should always be used to make sure that the system is working
perfectly. All plates were examined after 72 hours. If bacterial
growth was present, a 1.0 ml aliquot was obtained from the original
bag and a colony count was performed on nutrient agar. At the same
time samples were taken for repeated cultures.
Since one of the main objects of this study was to extend the
shelf-life of the processed blood from a few hours to several days,
examination for bacterial contamination after storage was essential.
For this reason samples from the original units were aseptically with¬
drawn after 10 days of post-thaw storage, these were innoculated onto
bottles of fluid Thioglycolate and Tryptic Soy Broth and examined in
the same way as those obtained on zero day of processing.
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2,3 DIPHOSPHOGLYCERATB (2,3 PPG) PETBRMINATION
Principle:
In 1970 Rose and Liebowitz found that the enzyme phosphoglycarate
mutase (PGM), prepared from rabbit's mucles, possesses a phosphatase
activity which is capable of hydrolizing 2,3 PPG into 3 - phospho-
glycerate (3-PGA) and phosphate.
2,3 DIG 2'3 DPG phosphatase > 3 . pfjj + p
Glycolate - 2 - phosphoric acid
The enzymatic activity which catalyzes this reaction was called 2,3 PPG
phosphatase and it was necessary to add Glycolate 2 - phosphoric acid
(Phosphoglycolic acid) as a stimulant for the reaction. One phosphate
group is produced from the hydrolysis of one mole of 2,3 PPG. This
released phosphorus could be measured colorimetrically at 660 nm by
means of the Fiske and SubbaRow reaction. This formed the basis of
a procedure for the determination of 2,3 PPG in the blood in this study.
Procedure:
All the reagents for this procedure were supplied by Sigma Co.
(Kit No. 665). Before starting to measure the 2,3 PPG in the test
samples a calibration curve was first prepared as follows:-
1. Into six test tubes marked 1,2,3 6, the following reagents
were added:
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2. To each tube add 1.0 ml of acid molybdate solution (Reagent B) and
contents are gently mixed by shaking.
3. Add to each tube 0.25 ml of the Fiske and SubbaRow reducer solution
(Reagent F). The contents are then mixed by inversion and allowed
to stand at room temperature for 10 minutes for the colour to develop.
4. Transfer to 10 mm lightpath cuvette and read the optical density
(O.D.) of all tubes at 660 nm using tube No.l as a reference. Reading
was carried out in SFL-Spectra-colorimeter and has to be completed
within an additional 10 minutes (total 20 minutes from the time the
Fiske and SubbaRow reagent was added).
Microgram
The Optical Density phosphorus ax Moles of 2,3DPG
Tube No. obtained per tube ' 1 ml of blood
1 0 0 0
2 0.11 6 .1.55
3 0.22 12 3.10
4 0.33 18 4.65
5 0.44 24 6.2
6 O.56 30 7-75
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The curve obtained by drawing the 2,3 DPO content per ml whole blood
against the optical density at 660 nm was a straight line. All
measurements in this study were performed on the same colorimeter and
the results were read from the same calibration curve.
Procedure for 2,3 PPG Determination
(Sigma Tentative Technical Bulletin No.665 1970)
1. One ml of the blood sample (packed cells or whole blood) is pipetted
into a test tube containing 3 ml of cold 8$ Trichloroacetic acid. The
mixture is vigorously shaked for several seconds after which it is
centrifuged for 10 minutes at 3000 rpm (in MSE Super-Minor Centrifuge)
to obtain a clear protein free supernatant.
2. Two test tubes are prepared and labelled Blank and Test, into which














(Reagent C) Stock No.665-2
- 0.1 i
3. Both tubes are then incubated in a 37°C water bath for 18 minutes
for the reaction to take place.
4. Remove from the water bath and add to BOTH tubes 2,0 ml Sfr
trichloroacetic acid (Stock No. 665-8) to stop the reaction. The
contents are mixed by inversion.
5. To the BLARK tube only, add 0.1 ml phosphoglycolic acid solution.
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6. To each tube add:
1.0 ml Acid molybdate solution Stock No. 661-11
0.25 ml Fiske and SubbaRow reducer solution (Stock No. 661-8)
The contents are then mixed by inversion and left for 10 minutes at
room temperature for the colour to develop.
7. Transfer to 10 mm lightpath cuvettes and read the O.D. of the test
tube at 660 nm using the blank as a reference. This reading is then
used to determine the 2,3 DPG concentration in oneml sample from the
calibration curve.
8. The haemoglobin concentration in the test blood was determined by
the cyanemethaemoglobin method and the 2,3 PPG concentration is
related to one gram haemoglobin according to the following formula:
concentration of 2,3 PPG per gram haemoglobin =
conc. of 2,3 PPG/ml sample
cone. of Hb/ml of the sample
Reagents for 2,3 PPG estimation
1. Triethanolamine Buffer Solution
Contains Magnesium ions and EDTA obtained from Sigma London
Chemical Co. Ltd. Stock No. 665-5•
2. Phosphoglycerate Mutase (PGM)
Enzyme suspension in Ammonium sulfate obtained from Sigma London
Chemical Co. Ltd. Stock No. 665-3.
3. Phosphoglycolic acid
50 mg preweighed vial reconstituted with 5*0 ml distilled water.
Obtained from Sigma London Chemical Co. Ltd. Stock No. 665-2.
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4. Acid molybdate solution
contains:
1.25 (NH4)6 M0? 0, . 4 H?0 in 2.5 H2 S04
Obtained from Sigma London Chemical Co. Ltd. Stock No. 661-11.
5. Fiske and SubbaRow reducer
Supplied by Sigma London Chemical Co. Ltd. as l.Og solid in vials.
The contents of the vial are dissolved in 6.3 ml distilled water.
Stock No. 661-8.
6. Trichloroacetic acid 8$
Prepared locally by dissolving 8g of Trichloroacetic acid (M&B)
in 100 ml of distilled water.
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ADENOSINE TRIPHOSPHATE (ATP) DETERMINATION
Principle:
One phosphate radicle is removed from ATP and transferred to
3- phosphoglycerate (PGA), to form 1,3 diphosphoglycerate. This
reaction is catalyzed by the enzyme phosphoglyceric phosphokinase
(PGK).
PGK
ATP + 3-phosphoglycerate —-—>• ADP + 1,3 diphosphoglycerate.
Another enzyme glyceraldehyde phosphate dehydrogenase (GAPD) is used
to transfer the 1,3 diphosphyglycerate into glyceraldehyde-3-phosphate.
Reduced coenzyme I (diphosphopyridine nucleotide (DPKH) acts as
hydrogen donor in this reaction, and as a result it is oxidized to DPN.
Gr A.PD
1,3 diphosphoglycerate + DPNH — glyceraldehyde-3-phosphate + DPN + P
As a result of oxidation of DPNH to DPN the optical density at 340 nm
is decreased, and this forms the basis for ultraviolet determination of
ATP.
Procedure:
The first step in this determination is the formation of a protein-
free filtrate from the blood by precipitation of the protein by 0.6 M
perchloric acid. On application of the method of preparation of
protein free fiIterate from frozen blood as recommended by Sigma
Chemical Company (the supplier of the Kit) we found great difficulty
in obtaining a clear supernatant. A slight modification was introduced
at this stage for the precipitation of the proteins and separation of
a clear supernatant.
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1. One ml of blood is added to 1.0 ml of 0.6 M perchloric acid in a
conical TPX centrifuge tube.(The contents of the tube are immediately
mixed on a whirli-mixer for several seconds. The mixture is then
kept in a refrigerator for an additional 15 minutes to insure complete
protein precipitation).
2. Centrifuge for 10 minutes at 3000 rpm to obtain as clear a super¬
natant as possible.
3. Using a pasteur pipette the supernatant is aspirated and collected
in 2 ml - capacity polycarbonate microcentrifuge tubes which are then
spun in a microcentrifuge (Quickfit-Instrumentation) for one minute at
12,000 rpm. The resulting supernatant was always clear.
4. Into a 0.3 mg - DPNH vial, No. 340-13 the following reagents are
added:
1.0 ml PGA buffered solution stock No. 366-1
1.8 ml distilled water
0.2 ml of the clear supernatant prepared in step (3).
The vial is then capped and the contents dissolved by inversion.
5. The content of the vial is transferred into a cuvette of 10 mm
lightpath making sure to pour as much of the contents as possible into
the cuvette.
6. The optical density is read at 340 nm (in the ultraviolet range) in
Uvichem Spectrophotometer. This reading i3 recorded as the INITIAL
O.D.
7. With the aid of Hamilton Dispensing Syringe 0.04 ml GAPD/PGK (Stock
No. 366-2) is added to the cuvette which is then inverted gently for
several times and replaced again in the spectrophotometer and left for
at least 5 minutes before the FINAL O.D. is recorded.
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Calculation:
A OD = INITIAL OD - PINAL OD
jo. Moles of ATP per ml = x 3.0 x 10
where
The factor (3.0) represents the volume of liquid in the cuvette.
The factor (6.22) is the millimolar extinction coefficient for P-DPNH
at 340 nm. Since the reaction mixture contains the equivalent of 0.1 ml
of original sample, the factor 10 is used to correct it to 1 ml.
The haemoglobin concentration of the blood under investigation is
determined by the cyanemethaemoglobin technique. The ATP concentration
is expressed as yu Moles per gram haemoglobin using the following
formula.
„ , .m,-,/ ,iv A1 Moles ATP per ml/u Moles ATP/gram Hb - /■=: — r-r-/ ' Hb concentration gram/ml
Reagents for the Ultraviolet Determination of
ADENOSINE - 5' - TRIPHOSPHATE
Kit No. 366
Used for 30 assays and contains
a. B - DPNH Stock No. 340-13
30 Preweighed vials, each vial contains 0.3 mg ^ -DPNH.
b. PGA Buffered Solution, Stock No. 366-1 ^>0 ml bottle.
3-Phosphoglyceric acid containing magnesium ions and triethanolamine
at pH 7.8 at 25°C. Stable for six months when stored at 0~5°C.
c. OAPP/PGK Enzymes, Stock No. 366-2
1.5 ml vial containing giyceraldehyde phosphate dehydrogenase and
phosphoglyceric phosphokinase suspension in ammonium sulfate.
Stable for six months when stored at 0-5°C.
169
d. 0.6 M Perchloric acid solution
This item does not come with the previous kit and is prepared
locally in the laboratory as follows'.
Pipette 5*0 perchloric acid 70$ and
dilute to 100 ml with distilled water,
this gives a0.6M solution.
The kit 366 was supplied by Sigma London Chemical Co. Ltd.
12 Lettice Street, London S.W.6. England.
ESTIMATION OF RESIDUAL GLYCEROL AND SORBITOL CONTENT IN THE FROZEN BLOOD
Glycerol and sorbitol content in the supernatants of the previously
frozen processed red blood cells was estimated by gas-chromatograohy of
their respective alditol acetate (Niederraeier 1971)» using mannitol as
a reference.
Principle:
When acetic anhydride is added to either glycerol or sorbitol a
volatile Tri-O-acetyl glycerol or Hexa-O-acetyl sorbitol is produced.
These substances could then be estimated by gas-chromatography with
reference to a substance of known concentration e.g. mannitol which
is similarly treated. Pyridine is added with the acetic anhydride
to prevent any increase in the hydrogen ion concentration that results
from the formation of acetic acid as a by-product of the reaction.
Method:
1. The following standards were prepared:
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STANDARD I : a solution of mannitol in water containing 5/ug/^ul
STANDARD II : a mixture of glycerol, mannitol and sorbitol
(2.9/ug/yul of each in water).
The test samples are prepared from the supernatant fluid of
previously frozen-processed red blood cells before the addition of
any resuspending medium.
1.0 ml volume of the test sample was pipetted into Amicon (F.50)
ultrafilteration cone which was fitted into an MSE 50 ml centrifuge
tube.
The sample was ultrafiltered by spinning in an MSE Super-Minor
centrifuge for 5 minutes at 3000 rpm.
A volume of 2^ ax\ of the filtrate was added to an equal volume of
STANDARD I (mannitol) in a Kontes 0.3 ml Microflex vial which was
then marked TEST.
50yul of a STANDARD II Solution was pipetted into another Kontes
0.3 ml vial which was marked STANDARD.
The contents of both vials were lyophilized.
Into both vials the following reagents were added to the lyophilized
materials:
50yul acetic anhydride (BDH - Analar)
2<jju.1 pyridine (BDH - Analar)
The vials were then placed in Statim Thermoblock preheated to 100°C
for 60 minutes. 1.5yul of the content of the STANDARD vial was
then rapidly injected through the rubber septum into a gas-
chromatography colomn (Hewlett Packard Model 402 FID). The apparatus
was preheated to 115°C and programmed so as to increase by 5°C every
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minute to a final temperature of 200 C. The colomn which is
4mm x 2.0 meters was packed with 3$ ECNSS-M on AW-HMDS gas chrora
Q 100/l20 mesh.
11. The compounds contained in STANDARD II solution appeared in the
following sequence:
Glycerol after 2.6 minutes
Mannitol after 18.8 minutes
Sorbitol after 20 minutes
The appearance of these compounds was recorded on a chart in the
form of triangular areas. The surface area of these triangles was
recorded with a Vilar 6230 Electronic Integrator.
12. When the elution of all the constituents of the STANDARD II was
completed, the apparatus was allowed to cool and the same process
was then repeated with the TEST samples.
Calculation:










G = The surface area of the glycerol triangle in the test sample
M = The surface area of the mannitol triangle in the test sample
S = The surface area of the sorbitol triangle in the test sample
(R.F)^ = The response factor for glycerol and =
The surface area of the glycerol triangle in the STANDARD sample
The surface area of the mannitol triangle in the STANDARD sample
(R.F)„ = The response factor for sorbitol and
►D
The surface area of the sorbitol triangle in the STANDARD sample
The surface area of the mannitol in the STANDARD sample
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ESTIMATION OF 24-HOUR POST-TRANSFUSION SURVIVAL OF AUTOLOGOUS FROZEN BLOOD
From each volunteer, usually a member of the staff, 400 ml of blood
were collected into plastic packs containing 70 ml ACD or CPD whichever
is available. The pack was centrifuged at l,300g for 60 minutes and
the plasma separated. The packed red cells retained in the plastic
pack were glycerolized, frozen and stored in the vapour phase of liquid
nitrogen at -180°C. When required the can was taken out of the
refrigerator and thawed as described previously.
Chromium labelling;
C I
Approximately 30^iCi of Cr as sodium chromate (Radiochemical
Centre Amersham) was injected into the can immediately post-thaw and
prior to washing, through the rubber Subaseal, under strict aseptic
precautions. The can was immediately agitated and kept on an automatic
Coulter Mixer for 30 minutes at room temperature.
Washing:
When manual washing was desired, the contents of the can were
transferred into a Tuta five tail washing pack and processing was
proceeded according to the method described earlier. In the IBM 2991
Automatic Cell Processor the cells were washed according to the
programme described in the previous chapter.
Post-thaw Storage:
Units processed by the manual technique were transfused to the
original donor after resuspension in isotonic saline on the same day
and immediately after processing. Some of the units processed by the
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IBM 2991 were transfused on the day of processing resuspended in saline,
others were resuspended in 70 ml of acid-citrate dextrose solution and
stored for up to five days at +4°C before being autotran3fused. In
each case the bag containing the blood to be transfused was weighed
immediately before transfusion.
Infusion and sampling:
The subjects were rested for at least 19 minutes prior to transfusion
to avoid any fluctuations in the packed cell volume which may be caused
by muscular exercise or excessive movements.
2. A sample of 10 ml venous blood was withdrawn from the cubital vein.
This blood was collected into a lithuim-heparin tube (Searle) and used
for the following estimations:
a. Haematocrit
b. Haemoglobin content of the blood
c. Plasma haemoglobin
d. Other haematologi cal parameters
3. The gross weight of a giving set as well as the blood pack was
determined to one tenth of a gram on a top-pan balance.
4. The whole unit was infused, saving about 12 ml in the recipient
line, into the subject within approximately five minutes through 150
needle or through 16G Mediout cannula (Aloe-Medical).
The time of start and finish was recorded.
5. Three 12 ml samples were withdrawn from the opposite arm at 15,30
and 45 minutes, of these, 2.5 ml was collected into an 5PTA tube for
estimation of haematocrit and other haematological parameters and the
rest was collected cn lithuim heparin.
174
The latter samples were used for:
a. Triplicate one ml samples of whole blood placed in Tek lab
51tubes for radioactive Cr counting.
b. The rest is centrifuged and plasma separated and distributed
into three 1.0 ml aliquots in Tek-lab tubes for radioactive
iodine counting and another sample for estimation of plasma
haemoglobin.
6. The emptied pack and giving set were reweighed and this weight was
subtracted from the pretransfusion gross weight to obtain the net
weight of the infused blood. This when divided by the density will
give the volume of the blood transfused:
About 12 ml sample was removed from the giving set for:
a. Kaematocrit and other haematological parameters estimation,
2.5 ml in an EDTA tube.
b. Estimation of density on Anton Parr - DMA 10 - Digital
Densitimeter, (about 2 ml).
c. Radioactive counting - Three 1.0 ml aliquots in Tek-lab tubes.
d. Separation of supernatant from the remaining blood after
eentrifugation for 10 minutes at 3000 rpm. Free haemoglobin
level was determined in this supernatant by the method
described previously.
7. Another sample of 12 ml venous blood was withdrawn from the
51
recipient after 24 hours for - Cr count. When determination of the
life-span of the transfused cells was required additional samples were
withdrawn every week for four successive weeks.
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Determination of plasma volume:
125
Human albumin, labelled with I, was used for these estimations.
This was either injected separately into the recipient or given
12S
simultaneously with the chromium labelled cells by injecting the -
labelled albumin into the blood pack immediately before transfusion.
Both methods will be described in detail.
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1. Method using separate injection of I - labelled human serum albumin:
In the first five experiments of this study, those units processed
by the manual technique, the material used for injection was prepared
sterile and supplied by the University Department of Medical Physics as
5yuCi ^ ^1 in 12 ml aliauots.
a. About 10 ml of this solution was taken into a sterile syringe,
and all the bubbles removed. The syringe with the needle and
its guard were accurately weighed.
b. The contents of the syringe were then injected intravenously
into one of the cubital veins. The empty syringe was
reweighed to obtain the weight of the injected solution.
One gram of the solution was considered equal to one ml
without substitution of the density.
c. Blood samples, of about 12 ml volume, were collected at 15,
30 and 45 minutes from the opposite arm to avoid contamination
from the injection site. These samples were dealt with as
described above.
d. Radioactive iodine standards were prepared by measuring 1.0 ml
of the labelled solution and transferring it to 100 - ml
graduated flask already containing about 5 ml of 10 per cent
solution of carrier unlabelled human albumin. The contents
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of the flask were then diluted to exactly 100 ml with
distilled water containing lg/litre potassium iodide.
Triplicate 1.0 ml aliquots from this standard were placed
in Tek-lab tubes to be counted with the samples.
1252. Method using simultaneous injection of I labelled albumin and
<51
Cr-labelled red blood cells:
125In the remaining experiments of this study the I-labelled human
1 2R
albumin was supplied as 1.0 ml iodinated ( I) human albumin (from the
12S
Radio chemical Centre Amersham) containing 5/u Ci of radioactive I.
The volume injected, varied according to the time of storage of the
solution. In all the experiments we used the volume that contained
125
i of radioactive I. The required volume was injected into the
blood pack immediately before transfusion and the contents were
125
thoroughly mixed. In this case the I standard was the whole blood
as collected from the recipient 3et.
Radioactive counting:
The activity of all samples was counted in well-type-scintillator
gamma counter (Tracerlab-Gamma/Ouard 150). The radioactivity was
measured in triplicate aliquots of one ml of both the standard and
samples. Counting was performed for a minimum of 5 minutes.
51
With the method using single injection, since some of the Cr gamma
125
radiation would be detected under the optimum conditions for I, a
51
pure Cr preparation was also measured under optimum conditions of
both an(j ^Cr. iphe percentage of ^Cr contribution in the ^^1
125
counts was determined and the actual I activity was calculated.
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CALCULATION
A. Calculation Of Plasma Volume:
125
1. When I-labelled serum albumin was administered separately:
V D Ns V D Ns V D Ns
PV = — or ——t— or
N N1Kf N + N,n+ N.c° 15 15 30 45
PV <= Plasma volume in ml.
V = Volume of labelled albumin solution injected
I) = Dilution factor of the standard
12R
= Average I activity of the standard in CPM/ml (Count perN
minute per ml).
125
N = I activity of the plasma sample corrected to zero time.
o
125
2. When I - labelled albumin solution was simultaneously introduced
51
with the Cr-labelled red cells
125 51
In this case the I counts must first be corrected for the Cr
activity interference. This was calculated according to the following
formula:
^1
I' = I - C x
c
I* = The corrected sample value (CPIil)/ral
I = Uncorrected sample value (CPM)/ml
C = The -^Cr sample value (CPM)/ml
= Activity of pure ^Cr preparation as measured in the ^1
channel (CPM/ml).
51 51
SQ = Activity of pure Cr preparation as measured in the Cr
channel (CPM/ml).
l?8
Plasma volume was then calculated according to the formula:
r)*r Ns V V Ns V NsPV = —r:— or t?—■= orNo N f N + N + N
15 15 30 45
PV = plasma volume (inl)
IOC
N = Average I activity of the transfused blood (after correction
® n
for Cr interference) CPM/ml.
V = Volume of transfused blood (ml)
f = (1.02) and represent the rate of disappearance of I from the
circulation in 15 minutes
1 QC
Nq I activity of the plasma sample corrected to zero time (CPM/ml)
B. Calculation of the Blood Volume:
PV
l* ,,BV " 1 - 0.9 (H15+ h30+ H45
WBV = Whole blood volume (ml)
PV = estimated plasma volume
. _ _ , . „ , whole body haematocritG.9 => Correction factor = :—; s r t rr7 peripheral venous haematocrit
H,c = Venous haematocrit at 15 minutes post-transfusion
15
= Venous haematocrit at 30 minutes post-transfusion
H,,. = Venous haematocrit at 45 minutes post-transfusion
45
125
2. Calculation of the blood volume using the I counts:
N V N V
WBV = s or s
C X 1.05 (C + c30+ c45^'°5
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Average I activity of the transfused blood (CPM/ml)
V = Volume of blood transfused
12b
Cq = I activity of whole blood sample corrected to zero time
1.05 = Correction factor = ^°.4y. plasmacrit ^Venous plasmacrit
C. Calculation of the Red Cell Volume
RCV =* WBV - PV
RCV = Red cell volume in ml.
WBV = Whole blood volume in ml.
PV = Estimated plasma volume (ml)
D. Calculation of the 100 per cent activity
A.
100 RCV
C = Average ^Cr activity in the transfused blood (CPM/ml)
s
V * Volume of the blood transfused (ml)
RCV = Red cell volume (ml)
E< Calculation of the 24-hour Post-transfusion Survival
A24
24-hour post-transfusion survival = —r x 100
A100
a _ ""^Cr CPM/ml of whole blood sample ,nr)
24 ~ Haematocrit ' " J
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PREPARATION OF LYMPHOCYTE SUSPENSIONS
A. Preparation of Lymphocyte Suspensions From Small Volumes of
Fresh Blood:
In this study pure lymphocytes suspensions were prepared from
defibrinated blood. Peripheral venous blood was always used for this
purpose.
Method:
1. Approximately 20 ml peripheral venous blood was collected into
MacCartney bottles containing 15 x 4 mm glass beads.
2. Blood was defibrinated by gentle inversion of the tube for 10
minutes.
3. Six ml of defibrinated blood was carefully layered on top of 4.0
ml Ficoll Triosil (density gradient mixture) see page (196 ) in a 16 mm
diameter plastic tube. Great care was taken to avoid mixing at the
interface.
4. The tube was centrifuged for 25 minutes at 2000 rpm (400 x g). A
thin white band of lymphocytes appeared at the interface between the
serum above and the Ficoll-Triosi1 below, while the heavier erythrocytes
and granulocytes sedimented to the bottom of the tube.
5- The lymphocyte band was harvested, using a Pasteur pipette, and
collected into a sterile plastic tube (NUNC).
6. The lymphocytes were washed twice in large volume of 199 tissue
culture medium. Each time the tube was spun for five minutes at 2000
rpm (400 x g).
7. After the last wash the lymphocyte-pellet was resuspended in 1.0
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ml of 199 tissue culture medium. A drop of this suspension was
transferred by Pasteur pipette, onto a Neubauer Haemocytometer Grid
and a cell count performed under phase contrast microscopy.
The number of viable lymphocytes present in 5 3mall squares were
counted. When this number was divided by 20 the number of lymphocytes
(in millions) present in 1.0 ml suspension was obtained. Cells
prepared by this technique were used for lymphocyte culture.
B. Preparation of Lymphocyte Suspensions from Large Volumes of
Fresh Blood:
From a healthy volunteer 350 ul venous blood was collected into a
half - MHC bottle that contained 250 glass beads. Blood was defibrin-
ated by continuous gentle inversion for 10 minutes.
One volume (10 ml) of de-fibrinated whole blood was carefully
layered on top of one volume Ficoll-Triosil in a plastic sterile
universal tube. The tubes were spun for 15 minutes at 4000 rpm (2000g).
The lymphocyte bands at the interface were havested and collected into
15 ml sterile plastic centrifuge tubes (NUNC).
The tubes were filled with 199 tissue culture medium and spun for
5 minutes at 2000 rpm (400g). The supernatant was decanted and
replaced with fresh medium and the process was repeated once more.
At the end of the second wa3h the lymphocyte pellet was resuspended
in a 1 ml volume of 199 tissue culture medium and cell count performed
as described above.
Lymphocytes prepared by this method were used after labelling
125
with radioactive iodine I for determination of the residual
lymphocyte and lymphocyte debris in the frozen blood.
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SEPARATION OF LEUCOCYTES FROM FROZEN BLOOD
My experience with the leucocyte content of the frozen blood has
shown that only 5 per cent of the original leucocytes in the fresh
blood remained intact after freezing, thawing and deglycerolization.
The great ma.iority (99%) of these leucocytes are lymphocyte in origin.
So it was evident that any method to be applied for separation of
leucocytes from the frozen blood is in fact a method for lymphocyte
separation.
Some time was required to develop an efficient method for
separation of lymphocytes from the frozen blood. At the beginning,
attention was directed to a density gradient separation by a dextran
solution that was successfully used by Chaplin et al (1959) for
separation of leucocytes from fresh blood. A solution of 6 per cent
dextran (M.W. 70,000) in 0.9 percent sodium chloride was tried in
different volumes. However, I found that previously frozen-thawed-
washed erythrocytes sedimented poorly in that solution. Pextran of
higher molecular (250,000) and in various concentrations were also
tried without success. Plasmagel and hydroxyethyl starch gave no
better results than the dextran.
After exhaustive experiments I noticed that the addition of a
small quantity of human plasma to the frozen-thawed-washed erythrocytes
improved the sedimentation rate of the latter, in either dextran or
hydroxyethyl starch, to a great extent. No satisfactory reason could
be provided at this time to explain the beneficial effect of plasma
in this respect, however it seems that the fibrinogen plays a ma.jor
role in this phenomenon.
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Because of the very low content of leucocytes in the frozen blood
it was necessary to sacrifice the whole unit for separation of a
reasonable amount of lymphocytes sufficient to perform one experiment.
The method routinely used for separation of lymphocytes in our
laboratory employed the addition of small quantity of AB plasma to the
erythrocytes after processing and was carried out as follows:
1. After thawing and processing in the IBM 2991 Automatic Cell
Processor 40 ml of AB plasma was added to the erythrocytes in
the processing bag. This was followed by the addition of 100 ml
of 6 per cent hydroxyethyl starch (Presenius-Pharma).
2. After thorough mixing the contents of the bag were dispensed as
30 ml volumes into 30 ml capacity sterile universal container
"Sterlin Products".
3. The blood-HEIS-plasma mixture was then incubated for 45 minutes
in 37°C incubator.
4- The supernatant fluid, containing the leucocytes, was then
aspirated and collected into sterile centrifuge tubes (NUNC).
5. The tubes were spun for 15 minutes at 2000 rpm, (400g) the
supernatant was decanted, replaced by 10 ml of 159 tissue culture
medium and the process of washing was repeated once more.
6. At the end of the last wash the pellet was resuspended in sufficient
volume of 199 tissue culture medium.
7. Because of red cell contamination, leucocytic count was performed
by the visual method after lysing the red cells with a diluting
fluid that contained 2 per cent acetic acid which was coloured
violet with gentian violet dye.
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PREPARATION OF PURE GRANULOCYTE SUSPENSION FROM LARGE VOLUMES OF
FRESH BLOOD
1. Collection
400 ml of blood was collected by venepuncture from a healthy
volunteer, into plastic pack containing 2250 U.S.P. heparin solution
"Fenwal Laboratories".
2. Filtration
Granulocytes were separated from the blood by passing it through
a Nylon-Leucocyte-fiIter, (Leuco-Pak) "Fenwal Laboratories", immediately
after collection. Filtration was performed by placing the unit in a
37°C incubator. Granulocytes were retained on the filter as they
adhere to the nylon material by phagocytosis. Tnis property is
enhanced at 37°C and at a slightly alkaline pH (7-4).
3. Eluticn
The adherent granulocytes were eluted from the filter by washing
them with 400 ml ACD plasma pH 6.5. Plasma was passed through the
filter under pressure of 25O m.m.Hg. The eluent was received into
500 ml sterile plastic transfer pack.
4. Separation
The granulocytes were sedimented from the suspension by centri-
fugation for 20 minutes at 5°0 rpm in a DAM0N/-6 centrifuge, the
temperature of which was adjusted to 10°C. This was followed by
squeezing out of the supernatant fluid.
5• Purification
As the sedimented granulocytes were heavily contaminated with red
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cells purification was achieved by sedimenting the red cells through
a hydroxyethyl starch solution. 30 ml volume of 6 per cent
hydroxyethyl starch solution was added to the cellular sediment in the
transfer bag and after thorough mixing the contents were transferred
to a 100 ml capacity measuring glass cylinder. The latter was
incubated for 45 minutes at 37°C., after which period the supernatant
fluid containing the granulocytes was aspirated and transferred to
sterile plastic centrifuge tubes (NUNC). The tubes were spun for 15
minutes at 3000 rpm. the supernatant decanted and the cellular pellets
resuspended in 2 ml "Shock Solution" (See below), thoroughly mixed on
Whirlimixer and an additional 8 ml of "Shock Solution" was added.
The content was mixed by gentle inversion of the tubes and then
incubated for 10 minutes in 37°C waterbath.
After incubation the tubes were spun at 1000 rpm for 7 minutes,
supernatant decanted and the cellular pellet resuspended in sufficient
volume of 199 tissue culture medium.
Leucocyte count performed on a sample of the suspension as
described previously.
Contents of the "Shock Solution"
Ammonium chloride 0.8$
Tri-Sodium EDTA 0.1$
Potassium dihydrogen phosphate 0.01$
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PREPARATION OF PURE PLATELET SUSPENSION
1. Freshly prepared platelet concentrates were supplied by the Component
Laboratory of our department in 20 ml. volumes.
2. The suspension was transferred into 50 ml "Oak Ridge" tube.
3. The platelet rich plasma was centrifuged for 20 seconds at 5000 rpm
in M3E Super-Minor centrifuge.
4- Supernatant containing the platelets was aspirated and the volume
replaced by isotonic saline and recentrifuged for another 20
seconds at 5000 rpm.
5- All the supernatant fluids were added together and spun for 10
minutes at 4000 x g.
6. The supernatant was then decanted and the cellular sediment was
resuspended in 50 ml volume of isotonic saline.
7. The process of spinning and decantation was repeated once more
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after which the platelets were labelled with radioactive T as
it will be described later.
LABELLING OF THE CELL-MEMBRANE OF LEUCOCYTES OR PLATELETS WITH
RADIOACTIVE (12^I - Nal).
This process was performed for the purpose of studying the
leucocyte and/or platelet derived material of the frozen blood.
Lymphocytes, granulocytes and platelets were studied separately in this
respect and will be explained later in detail.
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Princi pie:
"Chloraraine T" is an oxidising agent, it releases iodine from
sodium iodide salt. The released iodine will react with the tyrosine
or unsaturated lipid content of the cell membrane and is prevented
from penetrating into the inside of the cell by the fact that it
remains attached to the unsaturated double bond in the fat. However
as an extra precaution the reaction is stopped at the level of the
cell membrane by the addition of sodium sulphite, a reducing agent.
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When sodium iodide salt that was labelled with radioactive I is
used then the cell membrane of any cellular suspension would be
radioactively labelled.
Method:
This method was designed to label cellular material of 50/ul
packed volume, however when larger volumes of cells are to be used,
the reagent volumes could be consequently doubled according to the
volume of the cell suspension.
1. The cell suspension is hard packed by centrifugation for 10
minutes at 3000 rpm.
2. Decant the supernatant.
3. Suspend the cellular-pellet in equal volume (50/ul) of phosphate
buffered saline pH 7«5«
4. Add 200yuCi of ^^1 labelled Nal (Radiochemical Centre Amersham-
England).
5- Add lOyul (50yug) of chloramine T. solution.
6. Mix thoroughly on a whirlimixer, wait for 10 seconds then stop the
reaction by the addition of 200yul (120^/Ug) of sodium sulphite
(Na2 S2 0 ).
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7. Add 1 ml (200/ug) of potassium iodide (Kl).
8. The excess radioactive material is removed by thorough washing
of the cells as follows:
a. The suspension containing the labelled cells is carefully
layered onto 5 ml of 10 per cent solution of bovine albumin
(Miles Laboratories inc.) in 0.9$ NaCl. (in case the labelled
cells were platelets this solution was made up of 3$ bovine
albumin in 0.9$ Sodium Chloride Solution).
b. Centrifuge for 10 minutes at 2000 rpm (400g) (5000 rpm with
the platelet). The cells will thus sediment at the bottom of
the tube leaving the supernatant fluid, containing the excess
radioactive material, clear.
c. Aspirate the supernatant fluid with a Pasteur pipette from
above downwards taking care not to disturb the cellular-pellet.
d. Resuspended in 1.0 ml phosphate buffered saline and layer the
suspension again on top of 5 ml 10 per cent albumin solution.
e. The process of washing is repeated for at least 6 times after
which radioactivity is checked in samples from all the wash
solutions and the final cell suspension to make sure that all
the excess radioactivity is washed out.
9. After the last wash the cell-pellet was resuspended in sufficient
volume of phosphate buffered saline. A drop was transferred by
Pasteur-pipette onto a Neubauer Haemocytometer Grid and examined
under phase contrast microscopy for counting and to ensure that
there was no contamination by other cells.
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MEASUREMENTS OF LYMPHOCYTE, GRANULOCYTE AND PLATELET DERIVED MATERIALS
IN FROZEN BLOOD
Total lymphocyte, granulocyte, and platelet derived materials were
separately measured in previously frozen-thawed-washed erythrocyte
suspension by radioactive labelling of a pure suspension of each of
these cells separately which were added to the blood to be frozen.
Methods:
1. Pure suspensions of lymphocytes, granulocytes and platelets were
prepared separately by methods described above.
1252. Radioactive I - Na I was used as a cell membrane marker.
3. A total of 31 units of packed red cells of less than five days old
were used in this study. 13 units were injected with labelled
lymphocyte suspensions so that each unit received the volume
equivalent to 50 million labelled lymphocytes. 8 units were used
for granulocyte studies - each unit injected with the 50 million
labelled granulocytes. 10 units used for the platelet study.
4. After thorough mixing the units were glycerolized, frozen in liquid
nitrogen and stored in the vapour phase of liquid nitrogen for at
least 48 hours.
5- When required the units were thawed at 40°C and processed in the
IBM 2991 Automatic Cell Processor. Some units were processed with
the usual programme i.e. with the buffing coat intact. Some were
processed with the buffy coat removed after the last wash step.
This was achieved by manual overriding of the optical device for a
few seconds so that the upper layer of the packed cells, believed
to contain most of the white cells, wa3 washed out with the
190
supernatant. Other units were processed with the buffy coat
removed after each wash step.
6. In order to find out the system that gives the best removal of
the white cells, the efficiency of filtration of the following
system was examined.
a. BR-10-Blood Administration Set (Baxter).
b. Ultipor-blood transfusion filter (Pall Corporation, Biochemical
Product).
c. Swank Transfusion Filter (Extracorporeal liedical Specialities
Inc-).
Following the washing procedure, each of these filters was
separately fitted into the blood processing bag, some of the washed
cells were allowed to pass through and a sample was collected for
radioactive counting.
7. The volume of the wash fluid was measured and sample taken for
haemoglobin measurement and radioactive counting.
8. The volume of the blood after glycerolization, thawing and washing
was determined from the net weight and density. Samples were also
collected after each of those steps for haemoglobin measurements
and radioactive counting.
9. Triplicate 1.0 ml aliquots were prepared from each sample and
radioactive counting was performed for all the samples on the same
time in a well-type scintillator gamma counter (Tracer Lab, Gamma/
Guard 150) for at least five minutes.
Calculations;
„ , ,, Intact cellular haemoglobin recoveredRed cell recovery = Intant cellular haemoglobin recovered +
haemoglobin loss in the wash solution.
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*
IOC per cent radioactivity =
*
CPM/ml of post-thaw sample X volume of the blood post-thaw
radioactivity recovered
CPL'j/ml of post-wash sample X volume of the blood post-wash
*
radioactivity removed
CPll/ml of wash solution sample X volume of the wash solutions.
*
percentage of the radioactivity recovered =
Radioactivity recovered .„„
TTtFsr —r: * 100100% radioactivity
STUDY OF THE VIABILITY INT) ANTIGEN-STATUS OF THE LEUCOCYTES IN THE
FROZEN BLOOD
In this study viability of the leucocytes was determined by two
different methods:
I. Dye exclusion method
II. Phytohaemagglutinin (PHA) stimulation method.
I. DYE EXCLUSION TEST
Equal volumes of the isolated leucocyte suspension and 0.1$ Trypan
blue dye in saline were incubated at 37°C for 30 minute3.
A sample of the mixture was then examined on a Neubauer
haemocytometer under phase microscopy.
The percentage of viable cells was determined by counting those
cells which exclude the dye from a count of 100 leucocytes.
192
II. PHA STIMULATION
This measures the ability of the separated lymphocytes to respond
to PHA in tissue culture. The latter is expressed as DNA radioactive-
thymidine- uptake of a known number of cells.
Method:
1. Lymphocyte suspensions of either fresh or frozen blood were prepared
as previously described.
2. The volume of a cell suspension equivalent to one million lymphocytes
was pipetted into each of two 100 mm x 14 mm sterile screw cap,
tissue culture tubes (NUNC) which were marked TEST and CONTROL.
3. To the TEST tube 6 ,ug of Welcome purified PHA solution was added
and the volume was then made up to 4.0 ml with tissue culture media
prepared as page 195 item (5). To the CONTROL tube only tissue
culture media was added to make the volume 4-0 ml.
4. After thorough mixing Triplicate 1.0 ml aliquots were prepared
from each tube, so that each of the TEST cultures contained 250,000
lymphocytes and 1.5/ug PHA per ml and the CONTROL cultures contained
only 250,000 lymphocytes per ml.
5. The cultures were then incubated in a 37°C incubator for five days
after which 1.0/uCi of tritiated Thyimidine TRA-61 (Radio Chemical
/
Centre Amersham) was added to each culture and the tubes were
reincubated for an additional four hours.
6. The content of each tube was then poured into a. separate well of
a Millipore Filter box containing' a Whatman GF/c glass fibre filter
and washed with 40 ml of phosphate buffered saline pH 7-2 (Oxoid).
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7. Acid insoluble materials were precipitated onto the filter by the
addition of 20 ml of 5 per cent trichloroacetic acid.
8. Lipid materials were then dissolved and the remaining red cell
pigments were decolourized by washing with 40 ml of methylated
s pi ri t (M & B ) .
9« Filters containing the acid precipitate were transferred into
plastic scintillation counting bottles (NEN) and dried by incubation
in 50°C oven for 1 hour.
10. The tubes were then taken from the oven left for a while to cool
and then 10 ml of liquid scintillation solution NE231 (Nuclear
Enterprizes) were added.
11. The activity was measured in a well-type B - scintillation Counter
ICN Tracerlab Corumatic 200 and expressed as count per million cell
per minute.
12. After subtraction of the CONTROL counts from that of TEST, the
response to PHA of both frozen and fresh blood from the same person
collected at the same time could be compared.
LEUCOCYTE ANTIGEN CONTENT OF THE FROZEN BLOOD
The leucocyte antigen content of the frozen blood was determined
by the ability of lymphocytes and leucocyte derived material, separated
from that blood, to stimulate lymphocytes of a third party in one way
mixed lymphocyte cultures. This was measured in terms of DNA-
radioactive thymidine uptake of the responding cells and compared to




1. Collection of blood
400 ml of venous blood was collected from a healthy volunteer into
a plastic blood giving pack containing 70 ml ACD. This was followed
by the withdrawal of 15 ml venous blood into each of two McCartney
bottles containing glass beads. The blood in the McCartney bottles
\va3 defibrinated by gentle inversion for 10 minutes.
2. Glycerol!zation and freezing
The pack containing the ACD-blood was 3pun for 60 minutes at
1,300 x g at 20°C. The plasma was separated and the pack cells were
glycerolized, frozen by immersion in liquid nitrogen and stored in
the vapour phase until required.
3. Preparation of lymphocyte suspensions
a. Fresh stimulating lymphocytes - see above
b. Frozen stimulating lymphocytes - see above
c. Third party responding lymphocytes: these were either prepared
fresh or supplied from the frozen lymphocyte stock by the
tissue-typing and transplantation laboratory in our department.
When the latter type of responding cells were used, the same
batch of cells were used in both the frozen and fresh blood
experiments.
4• Preparation of mitomycin treated lymphocytes
In order to produce a one way mixed lymphocyte culture the
stimulant cells must be treated with mitomycin to stop them from being
stimulated by the other cells- This was achieved by the following
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procedure:
(i) The volume of lymphocyte suspension equivalent to 6 x 10
lymphocytes was pipetted into a 10 ml conical centrifuge tube. This
was made up to 10 ml with tissue culture medium prepared in Step (S).
(ii) 250yug (25yug/ml) mitomycin (Dale Pharmaceutical) suspension
was added to the mixture and the contents were thoroughly mixed and
placed in a 37°C water bath for 30 minutes.
(iii) The tube was then spun for 5 minutes at 2000 rpm (4C0g),
supernatant decanted and replaced with a new solution of tissue culture
medium.
(iv) The process of spinning, decantation, and resuspension was
repeated twice after which the cell pellet was resuspended in 1.0 ml
of tissue culture medium and. a cell count performed.
5. Preparation of tissue culture medium for growing the lymphocytes
(i) The following reagents were added to 180 ml of sterile distilled
water into a half HRC bottle:
- 4»0 ml of T.C. bicarbonate solution 10$ (Pifco).
- 20 ml T.C. medium 199 x 10 X (Difco Laboratories)
- 14 ml of H3PES buffer solution 30 mH (H&W).
(ii) 40 ml of this mixture was removed and replaced by equal
volume of pooled he at-deactivated human serum.
Prepared as follows:
10 young non-transfused volunteers (5 group 0, 4 group A and 1 group B)
are bled (400 ml) into plain half - MRC bottle. Serum was separated -
deactivated by heating at ^>6C C for 30 minutes, sterilized by filtration,
and dispensed in 20 ml volumes in Universal plastic oontainers which are
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stored at -40°C.
(iii) 2.0 ml of penicillin-streptimycin solution, containing 10,000
units of penicillin and lOOCyug streptomycin per ml, was then added to
the mixture to keep it sterile.
6. Preparation of Ficol1-Triosil for lymphocyte separation
Solution A:
9% Ficoll: (M.W. 4650,000 Pharmacia, Uppsala, Sweden) 90gms Ficoll are
dissolved in 1000 ml distilled water (better at 37°C water bath).
Solution B:
33-9$ Triosil: (Triosil 440, Myegaard & Co. Oslo, Norway).
200 ml Triosil 440 are made up to 445 ml with distilled water.
Mix 960 ml solution A with 400 ml solution B. Adjust specific gravity
to I.O76 - I.O78 Distributed into Medical Flats (approximately 75 ml
into each).
Autoclave for 10 minutes at 151 lb/inch Store in the dark at 4°C.
One way mixed lymphocyte culture and PHA stimulation
1. Lymphocyte suspensions, to be used as stimulating cells, either
from fresh or frozen blood and those to be used as responding cells
were prepared as described previously.
2. Tissue culture medium was prepared as described above.
3. Stimulating and responding cells were used in the ratio of 3:1 and
triplicate cultures were made from each experiment.
4. The following system was followed for the same blood both before
and after freezing.
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a. PHA Stimulation of the Test cells.
One million test cells + 6yug PHA (Test tube)
One million test cells alone (CONTROL tubes)
b. PHA Stimulation of the responding cells (to check their viability).
One million responding cells + 6yug PHA (TEST tube)
One million responding cells alone (CONTROL tube)
c. One way mixed lymphocyte culture
3.0 million test cells (mitomycin treated)+ 1.0 million respond¬
ing cells.
Each of these mixtures was prepared in 100 mm x 14 mm screw cap
sterile tissue culture tubes. The volume of each tube was then
made up to 4«0 ml with tissue culture medium.
After thorough mixing triplicate 1.0 ml volume cultures were prepared
from each suspension and dispensed into new 100 mm x 14 mm tissue
culture tubes so that each tube contained one fourth of the
corresponding quantity.
The cultures were then incubated in a 37°C incubator for 5 days
at the end of which 1yuCi of tritiated thymidine (TRA 6l) was added
to each tube and the tubes were then reincubated for an additional
4 hours.
Each culture was then washed onto Whatmann GP/c glass fibre filter
in a Millipore filter box using phosphate buffered saline pH 1.2.
Following 40 ml saline wash, acid insoluble materials were precipi¬
tated on the filter by the addition of 20 ml of 5$ trichloroaecetic
acid.
Lipid materials were dissolved and the remaining red-cell pigments
were decolourized by washing with 40 ml methylated spirit.
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10. Filters containing the acid precipitate were then transferred
into plastic scintillation counting bottles and dried at 50°C
for at least one hour.
11. After cooling 10 ml of liquid scintillation solution NF231 were
added and the activity measured in a well-type scintillation
counter. (ICN Tracer lab Corumatic 200).
IN VIVO TESTING OF THF FROZEN BLOOD ANIGFNICITY IN RABBITo
1. Rabbit injection:
15 Butch White Rabbits were screened for the absence of antihurnan
lyphocytotoxic antibodies before the experiment begun.
The rabbits were divided into three groups
Group I (Nos. 1,2,3,4,15) received fresh blood
Group II (N03. 9,6,7,8,9) (received frozen-swank filtered blood)
Group III (Nos. 10,11,12,13,14) (received frozen blood).
Fach rabbit received 1.0 ml of blood, (50 per cent haematocrit) by ear
vein on a fixed day of the week.
before the blood was injected a 2.0 ml sample of venous blood
was collected in a plain tube which was left in a refrigerator at +4°C
overnight. Serum was separated by centrifugation and stored in a
deep freeze until required.
The experiment was repeated at four weekly intervlas, a total of
four injections and five bleedings.
The blood used on any one day was collected from a single donor.
All donors used have the same ABO group and Eh type.
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II. Preparation of Blood:
On the day before injection, jOO ml of venous blood was collected
from a healthy volunteer into a plastic pack containing CPP anticoagulant.
This was followed by the collection of 20 ml venous blood into a
McCartney bottle containing glass beads for defibrination.
The blood was processed as follows:
Pure lymphocyte suspension was prepared from the defibrinated blood
by separation on Ficoll-Triosi1. The lymphocytes were washed twice
and suspended in human 10% AB - serum, 80$ McCoy's 5a medium, DM30 10$.
The lymphocyte suspension was then dispensed in straws each containing
0.5 ml (5 million lymphocytes).
10 ml CPD-blood was taken for injection into rabbits No. 1,2,3,4
and 15. The remaining cells were then packed and the plasma removed.
The packed cells were glycerolized and 20 ml of the mixture was
taken and frozen separately in small aluminium tins according to the
method described by Pepper et al (1973). On the day of injection
(after 24 hours) the frozen unit was thawed, washed by the IBM 2991
Automatic Cell Processor and half of it was filtered through a Swank
filter.
Both the filtered and unfiltered blood was diluted to 50$
haematocrit with isotonic saline before injection into the corresponding
rabbits.
Screening:
When four successive weeks had elapsed the post-immunization sera
were adsorbed with a red cell pool from the small aliquots of that
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frozen in the small tins to remove red cell antibodies. The pre-
immunization samples together v/ith the four adsorbed sera were screened
simultaneously against a mixed pool of lymphocytes prepared from the
straws that were previously frozen.
LYMPHOCYTOTOXICITY TSST
Hach of the pre-immunization and adsorbed sera was serialy diluted,
up to 1:512, with heat inactivated human AB- serum.
Sera were then plated out in one microlitre amounts, using a
microdisjjenser (Hamilton), in a microtest plate (home made) under liquid
paraffin. Duplicate examination of each sample was performed.
Lymphocyte pools from the four donors, which were previously frozen,
were prepared by rapid thawing of the straws in an excess of warm 199
tissue culture medium (prepared as previously described). The
lymphocytes were washed twice in the same medium and resuspended in
AB heat inactivated human serum. The suspension was standardized to
contain 8 million lymphocytes per ml.
One volume of lymphocyte suspension was diluted with three volumes
of rabbit complement and 1.0 microlitre of the mixture was added to
each well of the microtest plate (containing lyul of the rabbit sera).
A positive control was set up with each plate consisting of l.Oyul
of anti-human lymphocyte globulin (supplied by the Tissue-Typing
Laboratory). A negative control of heat inactivated AB-3erum was also
included. The plates were incubated for one hour at 37°C. One yUl of
1.2$ Trypan blue was added to each well and the test was read under a
phase contrast microscope.
A positive test is that well in which 70$ of the lymphocytes were
found dead (i.e. had taken up the dye).
THE RESULTS
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1 - Characterization of fresh and liquid stored blood
In order to standardize the methods used in the evaluation of
frozen blood as well as to establish normal control values the
biochemical characteristics of fresh and liquid stored blood have been
studied.
In the author's hands the normal values for the intracellular
potassium content of freshly drawn red blood cells varied between
8.7 to 11.5 ra moles/lC ~ red blood cells with a mean value of
9.91 _ 0.77 n = 20 (Table l.l). The normal value for the 2,3
diphosphoglycerate (2,3 DPO) content of fresh red-blood cells,
collected from healthy individuals, was between 9-8 and 15.2yu mole/
gram haemoglobin with an average value of 13.01 - 1.79 n = 17 (Table
1.2). However this compound rapidly disappears on liquid storage of
the blood in ACD at 4°C, so that after only two days of storage the
intracellular 2,3 DPG decreased by about 29/ to 9*24 - 1.28 /a mole/
g Hb (n = 12) (Table 3.9)- After three days of storage in ACD at
+4°C the 2,3 DPO decreased to 57/ of its normal value, 7*52/u mole//
g Hb - I.46 n = 5 (Table 1.5)« By the ninth day of storage it was
observed that the intracellular 2,3 DPO had completely disappeared
from the red cells (Figure 1.1 and Table l.b).
As regards the ATP content of red cells the normal values ranged
from 2.34 to 4•17yu mole/g Hb with a mean value of 3.14 - 0.54 n = 20
(Table 1.3).
Although the concentration of this compound also decreased during
storage of ACD blood at 4°C, the rate of its disappearance was slower
than that of the 2,3 DfO. The level of ATP gradually declined from
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the normal level to 2.84 - 0.3Cyu rnole/g Hb (i.e. 30% of normal)
after three days of storage, reaching 2.18 - 0.24 (69t of normal)
after nine days and becoming 1.16 - 0.09 (37'X of normal) after
fifteen days.
Storage of blood in ACT) at 4°C results in a gradual increase
in the plasma free haemoglobin and potassium and a decrease in blood
pH (Table 1.4). By the end of three weeks storage at 4°C the plasma
potassium may be as high as 16-28 m moles/l with a mean value of
21.4 - 4.01 (n = 10). Observed plasma haemoglobin, however, has not
increased to the same extent as the potassium, and the highest level
observed was 0.31 g/l (Table 1.4). We also observed a slightly
lower blood pH after three weeks storage than that reported in the
literature (Bunker 1966) for fresh ACT) blood (Table 1.4). The
observed level for the blood pH after three weeks was 6.72 - 0.08,
whilst the reported level for the fresh ACD blood was 6.9 to 7.0.
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TABLE 1.1
Intracellular K+ concentration of fresh red-blood cells


























2,3 DPG content of fresh red-blood cells collected
from healthy individuals





















































Plasma haemoglobin, plasma potassium and pH of ACD-blood
stored at +4°C for three weeks
Age of free plasma Cone.of K in PH
Pack No. the blood Hb the plasma Whole
(days) mg/dl (m mol/l) blood
1. 31519 21 22 16 6.7
2. 31734 21 27 21 6.6
3. 31738 21 29 20 6.8
4. 31691 21 31 25 6.8
5- 31749 21 14 18 6.7
6. 32965 21 25 26 6.7
7. 31668 21 16 23 6,8
8. 61718 21 29 28 6.6
9- 32249 21 28 17 6.7
10. 61691 21 28 20 6.8
• Mean 21 24.9 21.4 6.72
S.D. 0 5.78 4.01 0.08
n 10 10 10 10
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TABLE 1.5
Rate of disappearance of 2,3 DPG and ATP from blood
collected in ACD and stored at +4°C




















48036 7.0 2.93 0 2.19 0 1.20
47936 8.1 3.02 0 2.32 0 1.27
47944 8.7 2.96 0 2.34 0 1.05
47951 5.2 2.3 0 1.76 0 1.1
47961 8.6 2.97 0 2.30 0 1.2
Mean 7.52 2.84 0 2.18 0 1.16
5.D. 1.46 0.30 O.24 0.09
n 5 5 5 5
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Effect of anticoagulant in Freezing
There was no statistically significant difference between the
final red cell recoveries of frozen-thawed washed blood collected in
ACD anticoagulant and that collected in EDTA, irrespective of the
method of deglycerolization used.
There was no statistically significant difference between the
supernatant free haemoglobins of frozen-thawed-washed blood that was
collected in ACD and that collected in EDTA whether the method of
washing was manual or automatic (table 2.5).
There was no statistically significant difference between the
supernatant free potassium of frozen-thawed-washed blood that was
collected in ACD and that collected in EDTA regardless of the method
of washing (Table 2.5).
Also, there was no statistically significant difference between
the concentration of intracellular potassium in frozen-thawed-washed
erythrocytes that were collected in ACD and those collected in EDTA
irrespective of the method of washing (Table 2.5).
Similarly there was no statistically significant difference
between the 2,3 DPG content of frozen-thawed-washed erythrocytes that
were collected in ACD and those collected in EDTA, whether the blood
was washed manually or automatically in the IBM 2991 Cell Processor
(Table 2.5).
TABLE 2.1
Comparison of manual and automatic methods



























1. 19950 2 23 90.5 290 1.0 N.D. 2.8 6.5
2. 19521 2 23 84 240 0.5 N.D. 1.0 6.5
3. 01968 2 3 96.4 290 1.0 8.8 N.I). 6.8
4. 12277 2 48 96.6 105 1.0 8.4 4-5 N.D.
5- 12353 2 47 96.1 158 1.0 7.4 5.0 N.D.
6. 5156O 2 36 84 2,150 8 4.9 9.9 N.D.
7- 19528 2 11 86.4 200 1.0 7.1 N.D. N.D.
8. 19519 2 11 75.6 860 1.0 7-5 N.D. N.D.
9. 52521 N.I). 26 96.5 163 6.0 7-9 12.7 N.D.
10. 01965 2 3 96 230 1.0 8.5 N.D. 6.8
11. OI969 2 3 96.3 160 0.5 8.5 N.D. 6.9
12. 01962 2 3 96.3 160 1.0 7-9 N.D. 6.8
13. OI96O 2 9 91.2 110 0 8.1 N.D. 6.4
14. 34933 3 16 93.8 210 0.5 8.6 N.D. 6.7
15. O6442 2 14 92.3 250 0.5 7-5 N.D. N.D.
16. 62101 2 12 92.3 180 1.8 6.7 5.4 6.0
17- 34947 3 16 91.1 230 0.5 7.8 N.D. 6.1
18. 05695 2 32 91.9 370 2.0 6.2 N.D. 6,0
19. 34950 4 13 94.9 86 1.0 6.0 7.0 6.0
20. 06432 3 15 94.5 200 0.5 11.9 N.D. 6.0
21. 06444 2 13 90 300 1.0 5.8 N.D. 6.2
22. 06446 2 70 93.2 80 0.5 6.1 N.D. 6.0
23. 34956 4 71 92.3 120 1.0 6.2 N.D. 6.4
24. 62075 2 13 92.7 100 0.5 7.2 5-8 6.1
25. 05698 2 32 94.1 160 0.5 5.6 N.D. 5-9
26. 62100 2 13 88 1,720 5.0 7-8 7-6 6.0
27. 06428 3 15 89.I 630 2.0 7.0 N.D. 6.0



















* N.D. not determined.
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TABLE 2.2

























04776 2 7 96.5 87 0.5 7.4 6.1 6.0
05489 5 1 96.1 52 0.5 7.5
*
N.D. 6.0
05507 5 1 94.7 200 0.5 6.9 N.D. 6.1
04781 2 7 96.6 67 1.0 6.5 9.2 6.0
06573 2 8 96.5 90 1.0 8.3 N.D. 6.0
06589 2 8 95-8 100 1.0 8.1 N.D. N.D.
06449 2 7 96.4 400 6.5 8.1 N.D. 6.8
34945 3 69 95 430 5.75 7.4 N.D. 6.6
06588 2 6 95.2 420 0.5 8.6 N.D. 6.8
06594 2 6 95.6 390 0 7.6 N.D. 6.8
06599 2 6 93.6 410 1.0 8.4 N.D. 6.8
06593 2 6 95.6 340 0.5 8.3 N.D. 6.7
06572 2 7 96.6 240 0.5 8.3 N.D. 6.7
06583 2 7 94.3 920 2.0 8.2 N.D. 6.8
O6451 2 9 92 2160 3.75 7-1 N.D. 6,8
O6584 2 7 95.6 390 0.5 8.8 N.D. 6.8
06591 2 7 95.4 400 1.0 8.9 N.D. 6.8
Mean 2.41 9.94 95-38 417.41 1.56 7.91 7.65 6.53
S.D. 1.0 15.37 1.22 496.85 1.92 O.69 2.19 0.36





























51344 2 6 92.5 360 4.0 10
*
N.D, N.D.
51387 2 8 94.7 220 2.0 8.1 N.D. N.D.
52594 3 6 94.6 180 2.0 8.1 N.D. N.D.
52612 3 6 93.1 350 2.0 6.5 N.D. N.D.
52258 1 16 95-6 110 2.0 9-3 N.D. N.D.
52243 1 30 93.4 180 1.0 8.3 3.3 N.D.
52558 3 53 95 430 1.0 5.6 6.4 N.D.
52527 3 47 91.1 600 4.3 5-7 7.3 N.D.
52251 1 47 92.3 430 1.8 4.7 6.0 N.D.
52528 3 53 89.7 960 2.5 5.6 7-8 N.D.
24136 1 12 94.5 470 2.0 8.6 6.2 7
24139 1 12 94.9 290 1-5 6.0 6.2 7
24137 1 12 96.3 200 0.5 11 6.0 7
24142 1 12 92.8 310 2 8.7 5-9 7
20819 2 12 92.1 260 1.0 N.D. 3.3 6.6
20798 2 12 86.4 360 1.0 N.D. 5-5 6.6
24938 1 52 92.7 155 7-5 7.1 5.0 7
26032 N.D. 16 96.8 230 1.0 6.6 4.6 7.1
26021 N.D. 15 95.4 310 0.5 8.9 4.4 7-1
20817 2 62 90.8 300 1.0 9.4 4.7 7.1
20799 2 4 94.7 200 0.5 7.6 15.4 N.D.
20795 2 6 94.8 340 1 7.3 14.6 N.D.
Mean 1.85 22.68 93.37 329.32 1.91 7.66 6.62 6.95
S.D. 0.81 19.51 2.4 182.55 1.6 1.68 3.38 0.19
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0.056 3.273 <0.01 0.497 ->0.1— 2.031
<0.1>0.05




1.2162.7 >0.1< 05 0.3683 099 ><0.02 0.2061.467 >0.1
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Comparative Study Between Manual and Automatic
Techniques of Washing
The Manual method of washing red cells that have been previously
frozen with low-glycerol in liquid nitrogen is a standard technique in
Britain. However little data have been published concerning the
characterization of the process or of the red cells so produced. For
this reason and because we have introduced some changes in the original
method adopted in Britain, we have studied the manual technique as
used in our department as well a3 the physical, and chemical character¬
istics of the final red cell suspension. Also we have made a
comparative study between the standard method of processing and the
automatic technique that utilizes the IBM 2991 Automatic Cell Processor.
1. In vitro red cell recovery
The average in vitro red cell recovery obtained by our method is
92.5$ with the manual method and 95$ with automatic method. In order
to obtain this recovery we use approximately equal volumes of packed
red cells, about "JOt haeinatocrit, and glycerol solution to give a final
concentration of 21$ w/v glycerol (Table 3.1 and 3.2).
2. Wash Solutions
As regards the wash solutions used with the manual technique, the
total volume ranged from 880-1300 ml, divided into three roughly equal
washes, the first is 19$ sorbitol while the second and third are 0.9$
sodium chloride, (Table 3.1, 3.2, 3.3 and 3.15) • We found that in
vitro red cell recovery was not significantly correlated with the
volume of wash solutions (r = 0.0099 p>0.1 n = 49)-
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With the automatic method of washing, the volume of wash solution
was about one and half times that used with the manual method (Table
3.3 and table 3.15). This is because of the larger capacity of the
processing bag and the necessity of centrifuging it full. for the same
reason it was necessary to top up the bag containing the thawed
glycerolized blood with approximately 240 ml of wash I (post-thaw
predilution). Retrospective studies have shown that this give3 a
slightly better in vitro red cell recovery than the manual method
(t = 3.2844 P< 0.0025 "2 = ^ = 49 respectively, (Table 3.3 and
Table 3.15)• Table 3.3 also shows that this improved recovery is due
to a reduction in the amount of haemolysis in the subsequent three
washes, as there is no significant difference between both methods as
regards the freeze-thaw haemolysis (t = O.I78 p>0.4 n^ = 34 and
n^ = 49 respectively).
Automatic washing not only gave higher red cell recovery but also
resulted in better washing. This was evidenced by the residual
glycerol and sorbitol in the supernatant of the washed cells. The
figures for the glycerol and sorbitol indicated in Tables 3.4 and 3.5
were obtained from estimation made in the supernatant of red-cell
suspensions immediately after the end of the washing procedure and
before resuspension in any medium. Although the Hot of the product
obtained with the automatic method (82.3$) was higher than that with
the manual method (69.13$), the glycerol and sorbitol concentrations
in the former were significantly lower than those of the latter,
0.19 - 0,22 and 0.29 - 0.21 as compared to 0.84 - 0.26 and O.76 - 0,51
(t « 6.242 and 2.696 and P-( 0.0005 and < 0.0125 respectively (Table
3.14, 3.15).
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3. Intracellular Potassium Concentration
Intracellular cation content, particularly potassium, is regarded
as an indirect indicator of the state of the membrane permeability
which is in turn a reflection of the stability of the red-cell membrane-
Because of this, and because of the recent speculation about the
correlation of the i_n vivo survival of the frozen-thawed and deglycerol-
ized red cells with the intracellular potassium level (Valeri and Runck
1969b) an estimate of the intra-cellular potassium content in our
product was made.
There was a significant reduction (20$) (t test = 6.259 P< 0.0005
n^ = 26, n^ = 20 respectively) in the intracellular potassium levels of
the previously frozen-thawed red cells when deglycerolized by the
manual technique, when compared to those of the fresh red blood cells
(Table 1.1 and Table 3.6).
There was a significant reduction (21$) (t - test = 9.161 p < 0.0005
n^ = 29, n£ = 20 respectively) in the intracellular potassium levels of
the previously frozen-thawed red cells when deglycerolized by the
automatic method, as compared to those of the fresh red-blood cells
(Table 1.1 and Table 3.7). However there was no statistically
significant difference between the intracellular potassium content of
+ 12
red cells processed by the manual method (7-94 - 1.23 m mol/lO R.B.C.)
+ 12
and those washed by the automatic method (7.8l - 0,8 m mol/lO R.B.C.)
(t-test * O.46I p >0.3 n. = 26, n? = 29 respectively) Table 3.14 and
3.15).
4. 2,3 Diphosphoglycerate Content of the Red Cells
In recent years much attention has been given to the 2,3 DPG content
of the red cells as it has a direct relation to the oxygen transport
function.
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A normal level for the 2,3 DPG content of fresh red cells was
established for the method used in this study and was 13.01 - 1.79^u mole/
g Hb (Table 1.2). We have estimated the 2,3 DPG content of erythrocytes
that were previously frozen-thawed and washed with the manual method,
and observed that the level of 2,3 DPG was 6.8 - 3.4 /u mole/g Hb for
/
red cells stored for 2.65 days at 4°C prior to freezing and 27.4 days
in the frozen state, and that after processing the pH was 6.6.
Therefore there was a significant reduction (l8/) (t - test = 1.941
p<0.05 n^ = 26, n^ = 23) in the levels of 2,3 DPG of red cell that
were frozen by the low-glycerol rapid freeze-thaw technique and
deglycerolized by the manual method (n^ = 26), when compared to those
of the same erythrocytes prior to freezing (n^ = 23) Table 3.8,
Red-blood cells that were stored at 4°C for 1.8 days, glycerolized
and frozen according to our protocol, stored for about 25 days, and
then thawed and deglycerolized by the automatic technique had a mean
2,3 DPG level of 7.07 - 2.23/u mole/g Hb at a pH of 6.6 (Table 3.9).
There was a significant reduction (23'/) (t - test = 3.126 p < 0.005
n^ = 27, n^ = 12 respectively) in the levels of 2,3 DPG of the latter
cells compared to the same cells prior to freezing.
The method of deglycerolization appeared to have no effect on the
2,3 DPG level as the difference between the levels of the 2,3 DPG of
red cells processed by the manual method and those of red cells
processed by the automatic method was not statistically significant
(t - test = 0.346 p >0.4 n = 26) Table 3.14 and Table 3.17* Moreover,
there was no statistically significant difference between the percent
reduction of 2,3 DPG following glycerolization, freezing, storage,
thawing when processed by either the manual or the automatic method
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(t - test ■ 0.3663 p >0.35 = 22 and = 11 respectively), Table
3.17* Finally, there was no significant correlation between the period
of storage in the frozen state and the level of 2,3 PPG recovered by
either the manual or the automatic method (r = 0.380 and O.O696
respectively and p )> 0.05 and > 0.1).
5• Adenosine triphosphate content of the frozen red cells
The importance of estimation of the ATP content in stored blood
arises from its role in maintaining the erythrocyte discoid shape,
elasticity and viability (Mollison 197?). Moreover a depletion of
the red cell ATP results in loss of lipid content of the cell membrane.
A normal level of the red cell ATP, as measured in fresh blood by the
method used in this study, was 3.144 - 0.54^/u mole/ g Hb (Table 1.3).
However, on storage of the blood at 4°C there was a slow and gradual
decrease in its ATP content over the two weeks of study (Table 1.5)
The ATP content of i"ed cells that were collected in CPD and stored
at 4°C for 4.4 days, frozen and stored at -l80°C for 48.6 days then
thawed and deglycerolized with the manual method was 1.5 - O.38^umol/g Hb.
There was a significant decrease (t - test = 6.236 p < 0.0005 n = 10)
in the levels of ATP of erythrocytes that were frozen-thawed and
deglycerolized by the manual method, when compared with those of the
same cells before freezing (table 3.10).
The ATP content of red cells that were stored for 3 days at 4°C
in ACD, frozen and stored at -l80°C for 23.6 days, then thawed and
deglycerolized with the automatic method was 1.9 - 0.35^u mole/g Hb.
This level is lower than that estimated for the same cells prior to
freezing; the difference was statistically significant (t - test = 3.396
p < 0.005 n = 10) Table 3.11.
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^• Mean Red Cell Corpuscular Volume
In this work the red cell mean corpuscular volume was considered
as an approximate indicator of the state of fragility of the cells.
Throughout the whole work the MCV was determined by a Coulter Counter
Model S. The normal range of MCV as determined by the Coulter was
from 80 to 94 (fl) for males and from 81-99 (fl) Tor females.
The mean MCV for the red cells prior to freezing was 90.1 fl - 4-26
n = 88 (Table 4.25 and 4.26). The mean MCV for red cells previously
frozen, thawed and then deglycerolized with the manual method was
93.22 fl - 4.52 n = 37 (Table 3.12). The mean MCV of red cells frozen,
thawed and then washed by the automatic method in the IBM 2991 Wf*s
91.41 - 6.11 fl n = 34 (Table 3.13). The difference between the
values of the MCV of cells processed manually and those of cells
processed by the IBM 2991 was not statistically significant (t - test =
1.415 P 0.05 n^ = 37» = 34) Table 3.14- Preliminary results
showed that when blood is badly processed the final resuspended cells
may have an MCV in excess of 100 fl.
7• Aluminium Content of Blood Frozen in Aluminium Cans
Recent interest in the toxic effects of hyperaluminaemia (Berlyne
et al 1970 and Waldron-Ddward et al 1971)» has concerned those who
freeze, store and thaw blood in aluminium cans. However, no published
data is available on this subject. For this reason we have investi¬
gated the aluminium content in our final product.
The mean aluminium level in the processed blood was found to be
11.1 /u mol/l (n = 33) Table 3.19)» as determined by Atomic Absorption
Spectroscopy. The normal level in blood (published for the same method)




Summary of solution volumes used and per cent haemolysis
obtained at each processing step of manual washing
No.of ex¬
periments Mean H ange
Input red cell volume (ml) 63
1.





Glycerol volume added (ml) 63
2.





Volume of thawed blood (ml) 63
3.





Post-thaw supernatant volume (ml) 49
4-





Sorbitol wash supernatant volume (ml) 49
5*





Saline wash (l) supernatant volume(ml) 49
6.





Saline wash (2) supernatant volume(ml) 49
?.






8. Cellular Hb recovered (g) 49 53.4 - 6.9 36.1-67.8
N.B. items No. 1,2 and 3 are the same as those in table 3.2.
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TABLE 3.2
Summary of solution volume used and per cent haemolysis
obtained at each processing step of automatic washing
No.of ex¬
periments Mean Range
Input volume of packed cell3 (ml) 63
1.












Volume of thawed blood (ml) 63
3.





Supernatant volume from predilution spin 34
4. (ml)





Sorbitol wash supernatant volume (ml)
5.





Saline wash (l) supernatant volume (ml)
6.





Saline wash (2) supernatant volume (ml)
7-





8. Cellular Hb recovered (g) 34 50.8-6.8 31-63
N.B. Items No. 1,2 and 3 are the same as those in Table (3.1).
TABLE3.3
Summaryofcomparisonvolumesfw hsoluti s,haemolysisandrec veryf cellsprocessedbythautomaticanmanualprocedures
Total Hb recov¬ ered




Total volumef washsol- ution(ml)
Freeze-thaw haemolysis (*)
haemolysis after WashI (*)
haemolysis after Wash11 (*)

























































































Glycerol and sorbitol concentration in the supernatant of









1. 62100 0.73 0.68 . 0.717
2. 06428 0.67 O.64 O.69O
3. 06444 1.26 1.18 0.686
4. 62075 O.48 O.52 0.646
5- 06442 0.92 0.22 0.841
6. 06432 0.62 0.32 0.603
7- 34947 0.68 0.22 0.724
8. 34933 O.84 0.16 0.759
9- 34950 O.58 0.83 0.690
10. 05695 0.94 1.31 0.643
11. 05698 I.07 1.44 O.669













N.B. The glycerol and sorbitol were measured in the supernatant or
red-cell suspensions after the second saline wash, and before




Glycerol and sorbitol concentration in the supernatant of









1. 06572 0.095 0.16 0.833
2. O6584 0.128 0.182 0.877
3. 06583 O.146 0.350 O.892
4. 06 591 0.13 0.19 0.824
5- 06588 0.127 0.20 0.861
6. 06593 0.120 0.17 0.823
7. O6594 0.160 0.20 0.849
8. O6599 0.03 0.12 0.798
9. 06451 0.816 0.60 0.906













N.B. Glycerol and sorbitol were estimated in the supernatant of red-
cell suspensions immediately after the second saline wash, and
before reauspension in any other medium, with a haematocrit as
indicated in the Table.
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TABLE 3.6
Intracellular potassium concentration of red-blood cells processed







































Intracellular potassium concentration of red-blood cells processed






































2,3 DPG content of previously frozen red-blood cells processed
by the annual method





Unit No. at 4°C before in the froz¬
en state PH
1. 26032 N.D. 16 N.D. 4.6 7.0
2. 52243 1 30 11 .1 3.3 N.D.
3. 12353 2 50 9-4 5-0 It
4- 12277 2 47 9.3 4.5 It
5- 24938 1 28 11.5 4.0 7-0
6. 19521 3 24 7.3 1.0 6.5
7- 19550 3 24 7.7 3.6 6.5
8. 20798 4 13 6.0 5.5 6.6
9- 20819 4 13 5-1 3.3 6.6
10. 5156O 3 36 7.5 9.9 N.D.
11. 52558 3 22 8.0 6.3 II
12. 52527 4 16 9.0 8.1 It
13. 52251 2 16 7.5 6.1 It
14. 20817 3 63 7.9 4.8 7.1
15- 26021 N.D. 15 N.D. 4.5 7.1
16. 20799 3 63 8.1 15.3 N.D.
17. 52528 3 53 7.8 7.9 II
18. 20795 3 66 7.0 14.6 II
19- 52521 N.D. 28 N.D. 12.7 6.0
20. 62101 3 12 9.1 8.4 6.0
21. 62075 3 13 7.1 5.7 6.0
22. 62100 3 13 8.1 7-9 6.0
23. 24136 2 13 8.2 7-2 6.9
24. 24137 2 13 9.5 7.5 6.9
25- 24142 2 13 9-3 7-5 6.9
26. 24139 2 13 8.9 7.5 N.D.
Mean 2.65 27.4 8.28 6.8 6.6
S.I). 0.83 18.05 1.44 3.4 0.45
n 23 26 23 26 15
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TABLE 3.9
2,3 DPG content of previously frozen red-blood cells processed by
the automatic method












1. 24942 1 53 N.D. 6.0 6.8
2. 24947 1 53 ft 5.0 6.8
3. 24946 1 57 tt 9-5 6.8
4. 24939 1 57 ft 11.0 6.9
5- 27673 2 17 II 4.5 6.7
6. 26033 N.D. 17 ft 4.3 6.9
7. 26753 2 21 tf 5.8 6.8
8. 26661 2 21 ft 5.7 6.7
9- 26025 2 14 ft 9.4 6.6
10. 26024 2 14 tt 8.7 6.6
ii. O478I 2 7 It 9.2 6.0
12. 04776 2 7 ft 6.0 6.0
13. 31151 2 7 tt 11.7 6.1
14. 31163 2 7 ft 11.1 6.1
15- 47242 2 27 7-9 4 6.3
16. 47269 2 27 10.4 7.3 6.5
17. 47115 3 27 10.3 6.8 6.4
18. 47249 2 27 10.5 7.1 6.4
19. 47246 2 27 7.9 5-5 6.4
20. 53507 2 20 7.9 7.0 6.8
21. 53479 2 20 11.3 8.2 6.8
22. 53475 2 20 9.9 7-5 6.6
23. 53492 2 20 N.D. 4.6 6.7
24. 53468 2 26 8.8 N.D. 6.8
25. 53467 2 26 7.3 4.1 6.8
26. 53959 2 26 9-3 7.2 6.7
27. 53953 2 26 9-4 6.6 6.6
Mean 1.77 24.8 9-24 7.069 6.6
S.D. O.65 14-5 1.28 2.232 0,28
n 26 27 12 26 27
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TABLE 3.10
ATP content of the red cells prior to freezing and after processing
by the manual technique
Duration of storage (days) ATP conc. /u mole/g Hb








1. 51868 5 9 2.6 1.5
2. 51992 4 9 2.85 2.0
3. 51993 4 9 1.87 1.1
4- 51998 4 9 2.62 2.0
5- 66696 4 75 2.42 1.9
6. 66714 4 75 2.44 1.7
7- 66720 4 75 2.58 1.4
8. 14327 5 75 2.37 1.4
9. 14329 5 75 1.24 1.1
10. 14330 5 75 1.15 1.0
Mean 4.4 48,6 2.21 1.5
S.D. O.52 34.1 O.59 0.38
n 10 10 10 10
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TABLE 3.11
ATP content of red cells prior to freezing and after processing
by the automatic technique
Duration of storage (days) ATP (/u mo le/g Hb)










1. 53507 3 20 2.6 2.0 6.8
2. 53479 3 20 2.5 2.1 6.8
3. 53475 3 20 2.6 1.8 6.6
4. 53492 3 20 2.0 1.7 6.7
5- 52468 3 26 2.6 1.7 6.8
6. 53467 3 26 3.4 1.1 6.8
7. 53959 3 26 2.6 2.1 6.7
8. 53953 3 26 2.8 2.3 6.6
9- 53951 3 26 2.7 2.2 6.8
10. IO512 3 26 5.0 2.0 6-5
Mean 3 23.6 2.88 1-9 6.71
S ,D. 0 3.1 0.82 0.35 0.11
n 10 10 10 10 10
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TABLE 3.12
Mean corpuscular volume and white cell content of previously frozen









1. 19550 IOC 2.04 30. 20819 92 1.92
2. 19521 107 0.83 31. 20798 95 1.18
3. 12277 94 1.2 32. 24938 94 1.10
4- 12353 89 1.32 33. 26032 89 2.57
5. 51560 103 3.3 34. 26021 90 1.11
6. 19528 94 5.55 35- 20817 83 0.44
7. 19519 97 4.73 36. 20799 93 3.32
8. 52521 88 3.17 37. 20795 91 2.6
9. 62101 92 2.87 Mean 93.22 2.85
10. 34947 96 1.27 S.D. 4.52 2.15
11. 05695 87 2.38 n. 37 37
12. 06432 93 1.57
13. O6444 90 O.87
14. 62075 90 1.43 N.B. (l) mean MCV for red ce
15- 05698 95 4.87 prefreeze is 90.1 (fl)
16. 62100 97 1.33 (2) mean Hb content of
17- 06428 93 3.10 unit 53.4 g-
18. 34933 94 1.25
19- 06442 96 0.7 6
20. 51344 95 6.85
21. 51387 90 3.64
22. 52954 88 5.11
23. 52612 94 5.74
24. 52288 95 1.97
25- 52243 92 2.20
26. 52558 87 2.74
27. 52527 97 2.72
28. 52251 96 11.11




































macular volume and white cell content of previously frozen









86 4.42 26033 80 3.43
91 1.65 26025 85 1-57
92 3.5 26024 83 2.87
83 4.86 24947 91 2.4
96 4.O6 24942 96 4.43
92 4.3 Mean 91.41 2.52
94 1.12 S.D. 6.11 1.26
95 3.84 n. 34 34
100 2.25
93 2.23
96 1.59 N.B. (l) mean MCV for red cells
92 1.53 prefreezing is 90.1 (fl)
92 0.38 (2) mean Hb content of one

















Summaryofbioche icalandhaematologicalparameteri nu ldIBMpro essedbl o Residual glycerol (g/lOOml)Residual Sorbitol (g/lOOml)Intracellular K* (mmol/lORBC)M.C.V. (fl)














































































Overall characteristics of both methods, manual versus automatic
Manually processed IBM processed
Mean S.D. n. Mean S.D. n.
Supernatant volume from predilution 217
+
45 49 418- 39 34
spin (ml)
Predilution volume (ml) N.D. N.D. N»D. 227
Post-thaw haemolysis ($) 2.5
+
2.7 49 2.4- 0.6 34
Sorbitol wash supernatant volume(ml) 350
+
42 463- 49
Sorbitol wash haemolysis (%) 1.13
+
0.6 0.44-0.27
Saline wash(1)supernatant volume(ml) 351
+
45 442- 54
Saline wash(l)haemolysis (%) 1.97
+
1.3 1.0- 0.6
Saline wash(2)supernatant volurae(ml) 337
+
41 449- 35
Saline wash (2) haemolysis ($) 1.96
+
1.6 1.27- 0.7
Total volume of wash solutions(ml) 1038
+
103 49 1575- no
Total haemolysis (%) 7.5 5-2
Overall recovery (%) 92.5
+
4 95- 1-5
Residual glycerol (g$) 0.84
+
0.26 12 0.19-0.22 10
Residual sorbitol (g$) 0.76
+
O.51 12 0.29-0.21 10
Intracellular K+ (m mole/lO^R.B.C.) 7.9 + 1.2 27 7.8 - 0.8 29
Mean corpuscular volume (MCV) fl 93
+
4.5 37 91- 6.0 34
Residual leucocyte content(lO^/g Hb) 2.85 + 2.15 37 2.5 - 1-2 34
Cellular 2,3 DPG content^u mole/gHb) 6.8
+
3.4 26 7.1 - 2.2 26
Cellular ATP content (ja mole/g Hb) 2.01
+
0.43 10 1.90^ 0.35 10
24-hour post-transfusion survival($) 93.38
+
6.15 5 95.22± 4.26 5
Time required to process one unit
(minutes)
Time required to process four units
(minutes
Capital cost N.D.







Effect of glycerolization, freezing, thawing and washing on the organic









































10512 3 54 6.5 6.5 1.3 5.0 2 93.7 2.1 79 95
45026 7 48 6.6 2.8 0 2.4 1.5 29.5 1.7 88 92
44936 8 50 6.5 0 0 1.5 1.33 112.5 0.83 100 94
63628 14 50 6.7 0 0 3.5 1.9 22.4 1.78 88 97
44395 15 48 6.6 0 0 1.87 1.3 23.6 4.9 90 81
09719 17 54 6.9 0 0 3.3 2.7 38.2 2.1 88 92
63585 18 48 6.6 0 0 1.6 1.4 22.5 3.8 92 102
43914 19 48 6.3 0 0 4.4 1.4 30 0.9 94 90
53507 3 20 6.8 7.9 7.0 2.6 2.0 41.2 1.9 106 107
53479 3 20 6.8 11.3 8.2 2.5 2.1 36.3 3.1 91 93
53475 3 20 6.6 9-9 7.5 2.6 1.8 64.5 8.0 101 101
53492 3 20 6.7 N.D. 4.6 2.0 1.7 30.4 7.3 91 94
53468 3 26 6.8 8.8 N.D. 2.6 1.7 34.8 N.D. 105 N.D.
53467 3 26 6.8 7.3 4.13 3.4 1.1 40.7 3.7 96 96
53959 3 26 6.7 9-3 7.2 2.6 2.1 56.8 2.9 91 91
53953 3 26 6.6 9-4 6.6 2.8 2.3 75.7 2.5 91 92







































All units were processed by the IBM 2991 and resuspended in isotonic
saline.
TABLE3.17






































































































































2. MH12 33.3 25. 55828 < 7.4
3. MH13 103.7 26. 53950 < 7-4
4. MH18 44.4 27. 53951 < 7-4
5- 51344 26.6 28. 13101 < 7.4
6. 51387 26.6 29. 12754 < 18.5
7. 52594 11.8 30. 34918 < 7-4
8. 52612 11.8 31. 13142 < 7.4
9. 52243 < 7.4 32. 53926 < 7.4
10. 52521 < 7-4 33. 53930 < 7.4
11. 51560 < 7.4
12. 12353 8.8 *
The method of analysis was







of the Government Chemist to
exclude artifacts which are
apparent in the 13 early
16. 53475 < 7.4 samples.
17. 53479 < 14.8
18. 53467 < 11.1
19. 53959 11.1
20. 53953 < 7.4
21. 14285 < 7.4
22. 53492 < 7.4
23. 51920 < 37
24. 12750 < 7.4
POST-THAW STABILITY OF PREVIOUSLY FROZEN-THAWED-WASHED ERYTHROCYTES
It was observed that haemolysis of previously frozen-thawed-washed
erythrocytes increases continuously during post-thaw storage at +4°C
(Fig. 4-1 and Tables 4.1 and 4.8). The maximum rate of haemolysis
occurs during the first 24 hours after which it continues to rise at
about half the initial rate. The level of free Hb in the supernatant
of cells resuspended in isotonic saline was found to be 370,650, and
1010 rag/dl at 4 hours, 24 hours, and 9 days after processing, respect¬
ively (Table 4«l). Due to technical limitations, zero time values were
actually performed 4 hours after thawing and washing.
Because of this poor in vitro stability of the processed cells and
because of the high risk of bacterial contamination, the shelf-life of
these frozen-thawed-washed red cells was restricted to 12-24 hours post¬
processing. Although this product, when used in this way, proved to
be clinically acceptable it presented difficulties for efficient blood
bank management, because frozen cells cannot readily be made available
on an emergency basis without significant wastage. Moreover, long¬
distance transport was severely restricted. For these reasons a
series of studies were designed to find a suitable medium in which the
shelf life of frozen-thawed-washed red cells destined for transfusion
can be significantly prolonged.
Different resuspension media were found tc have different effects
on the rate of haemolysis (Table 4.12 and Table 4.13). We observed
that 5% w/v albumin solution in isotonic saline was superior to 0.9$
W/V saline, Ringer's lactate solution and "Tis-U-Sol" in lowering the
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level of free Hb in the supernatant (Fig. 4.3 and Table 4.12). The
addition of 70 ml ACD to 200 ml of previously frozen-processed
erythrocytes lowered the pR of the blood from 6.9 - 0,1 to 6.1 - 0.1
and at the same time reduced significantly the amount of haemolysis,
even after only four hours of storage. Thus the free Hb was reduced
to 98 mg/dl at 4 hours post-processing and was only 390 mg/dl at nine
days (Fig. 4.1 and Table 4.5)* There was no significant difference
(t-test = 0.0563 p } O.48 n^ = 8, n^ = 10 respectively) between the
concentrations of free potassium in the supernatant of cells suspended
in saline and those of cells resuspended in saline + ACD at zero day of
processing (Fig. 4-2 and Table 4*13). However, from the first day of
post-processing storage through to the ninth day there was a significant
difference in the levels of free potassium in the supernatants of cells
resuspended in saline + ACD when compared to those supernatants of
cells resuspended in saline alone (Table 4.13).
When ACD and albumin (5$ w -'v in isotonic saline) were combined,
the results showed a further improvement with a free Hb of 60 mg/dl
and free potassium of 0.5 m mol/l at 4 hours post-processing and 280 mg/
dl and 10.2 m mol/l after nine days of storage (Fig. 4.1, Fig. 4.2,
Tables 4.6, 4.8, 4.12 and 4.13). Obviously the presence of glucose
has little or no effect on this improved stability (Fig. 4.4a and
Fig. 4.4b).
The effect of pH was then investigated by observing the post-thaw
stability of different groups of previously frozen-processed erythrocytes,
each group had a different blood pH, (pH 6.1, 6.5, and 6.8), but all
groups were finally resuspended in isotonic 3aline alone. The
required pH was achieved by adding different amounts of ACD or CPD to
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wash I, which was subsequently washed out during processing. The
results of these experiments are shown in (Fig. 4.5 and Tables 4.5, 4.9,
4.10, 4.11 and 4.14)* It was observed that lowering the pH of the
blood was accompanied by a reduction in the rate of haemolysis as
evidenced by the decrease in the supernatant free Hb.
Although reduction of the pH to 6.1 had a beneficial effect, it
is still not as good as that observed in the presence of citrate ions.
Thus at pH 6.1, blood which contained 4CD in the resuspension medium
had a lower rate of haemolysis on storage than that of blood at the
same pH without ACT (Fig. 4.5)•
The effect of citrate at different pH values was studied separately
by adding 70 ml of CPD to previously frozen/thawed/washed erythrocytes
and compared the results to those obtained previously with ACD. It
was observed that despite the fact that CPD has the same concentration
of citrate per unit (36 m mol/l final concentration) as ACD, the latter
still gave better results as judged by the rate of haemolysis (Fig.
4.6 and Tables 4.15 and 4.16). It is to be noted that all the above
results were obtained with blood processed by the IBM 2991 Automatic
Cell Processor, however, almost the same effect was observed with
units processed by the manual technique (Tables 4-17 - 4.?4).
Evaluation of Previously Frozen-Thawed-Washed Erythrocytes Pesuspended
In Saline - ACD Medium:
It was evident that the best post-thaw stability results were
obtained on resuspension of the washed cells in either albumin-ACD or
saline-ACD media, although the latter was preferred for reasons of
availablility, sterilization and lower cost. We have investigated the
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haematological and biochemical characteristics of red-blood cells that
were resuspended in saline-ACD medium after being frozen-thawed and
washed. We have also investigated the incidence of bacterial contam¬
ination in this product over a period of ten days of post-thaw storage
at +4°C. A total of one hundred units were used in this study and the
results of the individual units are shown in Table 4.25, while Table
4.26 shows a summary comparison between the characteristics before and
after processing.
Although the mean red cell volume of the processed resuspended
cells was within the normal range there was a significant difference
(t-test = 4.4307 p < O.OOO5, n^ = 94, n^ = 88, respectively) between
these levels when compared with those of the same cells before freezing.
There was a significant reduction (t-test = 20.3?4 P <(.0.0005
= 95, n2 = 86 respectively) in the white cell count in the processed
resuspended blood when compared to those of the same blood before
freezing. It might be observed that the leucocyte content of this
blood was higher than that obtained previously (Table 3.13 and 3.16).
This difference may be explained on basis of the method of sampling -
while the previous units were sacrificed and samples were obtained from
the bag itself, samples in the present series were taken from the
harness line of the processing set, which contains most of the buffy
coat.
There was a 25$ reduction in the levels of the 2,3 DPGf content of
the red cells due to the processes of freezing, thawing and washing.
Thus the intraerythrocytic levels of 2,3 DPG of three day old blood
was 7.33 - 3.3^/u mole/g Hb before freezing and was reduced to
5.53 - 3.16 after freezing, storage for 42 days, thawing, washing and
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resuspension in saline-ACD medium. This difference was statistically
significant (t-test = 3-7542 p <C 0.0005 n^ = 87, and ^ = 96
respectively). However, after storage of this blood at +4°C, there
was a further decrease in the 2,3 DPG content and the levels reached
2.4/u mole/g Hb after ten days (mean of 15 experiments).
There was also a reduction in the ATP content of the red cells,
after processing and resuspension in saline-ACP medium, by about 11^>
from that of the same cells before freezing. .Again this reduction
was statistically significant (t-test = 3.0712 p ^0.0025 n^ = 93
n^ = 85 respectively). On storage of this blood at +4°C there was
a further decrease in the intraerythrocytic ATP and after ten days
the mean ATP content was 0.99/u mole/g Hb n = 15-
 
Fig. 4. 2
-□5 7-albumin • • 57. albumin + ACD
-■ 0,9V, saline O o 0.9-/. saline + ACD
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TABLE 4•1
Hb concentration (mg/dl) in the supernatant of frozen red cells






















1. 400 700 760 770 780 840 870 890 970 1020 6.83
2. 390 730 770 780 790 850 870 880 940 980 6.88
3. 240 450 460 470 490 530 580 580 630 670 6.7
4. 340 530 690 720 720 720 750 760 870 870 6.71
5- 410 660 870 910 940 970 1000 1030 1100 1130 6,77
6. 390 640 810 850 860 870 870 900 970 1000 6.77
7. 420 670 850 870 880 890 900 900 1000 1040 6.64
8. 300 690 800 840 870 910 1030 1080 1140 1200 6.62
9- 430 740 850 900 910 970 990 1010 1040 1090 6.75
10. 400 770 890 980 970 1030 1050 1070 1110 1140 6.77
Mean 370 650 770 800 820 850 890 910 970 1010 6.75
S.D. 61 99 126 141 139 143 143 153 148 153 0.12
TABLE 4.2
Hb concentration (rng/dl) in the supernatant of frozen red cells
processed by the IBM 2991 and resuspended in 5$ albumin solution
DAY DAY DAY DAY DAY DAY DAY DAY DAY DAY pH
0 1 2 3 4 5 6 7 8 9
1. 280 470 480 480 490 500 510 530 560 600 6.83
2. 290 630 640 64O 650 660 670 720 740 780 6.88
3. 200 380 380 380 430 430 460 470 500 520 6.70
4. 290 440 56O 560 580 590 610 620 640 700 6.71
5. 390 56O 670 680 700 770 820 840 900 950 6.77
6. 340 590 750 770 770 800 800 820 840 940 6.77
7- 360 58O 730 740 750 760 790 800 840 900 6.64
8. 180 450 550 640 660 680 710 730 770 800 6.62
9. 220 370 390 400 440 450 460 470 470 500 6.75
10. 160 270 320 340 370 380 400 430 430 470 6.77
Mean 270 470 540 56O 58O 600 620 640 670 710 6.75
S.D. 79 115 150 155 143 154 157 159 - 171 185 120
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TABLE 4.3
(it ) level (m mol/l) in the supernatant of frozen red cell processed





















1. 1.0 4 6.28 8.0 10 11.9 12 14 19-9 16
2. 0.5 3.9 9.0 7.0 8.9 IC 10.9 12.9 13 13.9
3. 0.9 3.0 4.9 6.0 7.9 8.9 9.9 11.9 12 13
4. 0.5 2.9 9.0 6.9 8.9 9.0 10 10.9 12 12.9
9- 1.0 3.0 9.0 7.0 8.9 9.0 10 11 12 13
6. 0 2.9 9.0 7-0 8 10 11 11 13 14
7. 0.9 9.9 7-0 8.9 10 10.9 11.9 12.9 14 19
8. 0.9 3.9 6.9 8.79 10.9 11.79 12.29 14 14.9 19
Mean 0.56 3.4 9-9 7.3 8.9 10 10.8 12.1 13.29 14
S.D. 0.34 O.98 O.92 O.98 1.09 1.19 1.01 1.36 1.31 1.23
n 8 8 8 8 8 8 8 8 8 8
TABLE 4-4
If+ level (m mol/l) in the supernatant of frozen red cells processed





















1. 0 3.0 9.9 6.79 8.9 10 11.9 12.9 14 19
2. 0 3-9 6.0 7.9 9.0 11 12 13.9 19 16
3. 0.29 3.9 9.9 7.0 9-79 11 12 19 19-9 19
4- 1.0 3.0 9.79 7.29 8.79 10 11.9 12.29 13.79 19
9- 1.9 3.0 9-79 7.9 9.0 10.29 11.9 12.29 13 14.79
6. 0.29 3.29 7.0 9.29 11 12.79 14.29 19 17.29 19
7. 1.0 3.0 6.29 8.29 10 12 13.9 14 16 17.7
8. 0.9 4.0 7.9 9.9 11.9 12.29 14-9 16 16.9 17
9- 1.0 2.0 3.9 9.0 4.79 9.79 6.29 7.0 7-79 8.29
10. 0.29 2.0 3.29 9.0 6.0 7-0 8.0 9-9 10.29 11.2S
Mean 0.97 3 9.6 7-3 8.8 10.2 11.9 12.7 13.9 19.3
S.D. 0.92 0.63 1.34 1.91 2.08 2.24 2.6 2.72 2.94 3.38
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TABLE 4.5
Hb concentrations (mg/dl) in the supernatant of frozen red cells






















1. 4781 60 210 190 250 250 290 320 320 370 370 6.0
2. 4776 80 140 200 180 190 220 240 250 280 300 6.0
3. 31151 80 170 190 230 260 270 280 300 320 330 6.1
4. 31163 80 250 280 330 340 350 370 410 430 430 6.1
5- 31153 80 210 240 250 270 300 300 330 340 340 6.35
6. 31154 150 340 380 400 430 470 480 500 520 540 6.2
7. 5507 200 430 480 490 530 550 560 580 610 610 N.D.
8. 5489 60 180 210 230 25O 270 270 290 310 310 N.D.
9- 6589 100 230 260 290 300 310 310 360 380 400 6.0
10. 6573 90 180 210 230 240 260 280 290 310 320 5.93
Mean 98 230 260 280 300 330 340 360 380 390 6.08
S.D. 45 88 95 94 102 103 102 105 109 105 0.19
TABLE 4.6
Hb concentration (mg/dl) in the supernatant of frozen red cells






















1. 4781 50 130 150 170 180 220 230 230 270 280 6.0
2. 4776 50 120 120 130 160 160 170 170 190 200 6.0
3. 31151 60 120 120 160 180 190 200 210 210 220 6.1
4. 31163 50 160 180 210 230 230 240 280 290 300 6.1
5. 31153 40 120 150 180 200 200 220 230 250 250 6.35
6. 31154 60 210 240 260 290 330 330 350 370 370 6.2
7. 5507 120 300 330 340 360 380 380 410 430 430 N.D.
8. 5489 40 120 140 160 170 180 200 210 230 230 N.D.
9- 6589 82 150 180 200 210 250 250 260 260 270 6.0
10. 6573 61 130 160 170 180 200 200 210 210 220 5-93
Mean 60 150 170 200 210 230 240 250 270 280 6.08
S.D. 26 58 64 61 63 70 65 73 76 73 19
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TABLE 4.7
(K+) level (m mol/l) in the supernatant of frozen red blood cells





















4781 1 1.5 2.5 3-5 4.0 5.0 5.5 6.0 7.0 7-5
4776 0.5 2.8 4.0 5-0 6.5 7.5 8.1 9.0 9.5 10.5
31191 0.5 2.0 4-0 5-0 6.0 6.5 7-0 8.0 9-0 9.5
31163 0.2 2.0 4.0 4.5 5-5 7-0 8.0 8.0 8.5 8.5
31153 0.5 2.0 3.0 4.0 5.0 6.0 6.5 7.0 7-5 8.0
31154 0.5 2.0 3.5 4.2 5.0 6.5 6.5 7.0 7.5 8.0
5507 0.5 2.0 3.0 4.5 5.5 6.0 7-0 7.5 8.0 8.5
5489 0.5 2.0 3.0 4.0 4-5 5.0 6.5 6.5 7.0 7.5
6589 1.0 2.5 3.5 4.7 5.5 6.0 7.0 7.7 8.0 8.5
6573 0.5 3.5 6.0 6.5 7.5 9.5 10.5 11.5 12 13
Mean 0.57 2.2 3.6 4.6 5.5 6.5 7.2 7-8 8.4 8.9
S.D. 0.26 0.57 0.97 0.82 1.0 1.3 1.36 1.5 1.5 1.69
TABLE 4.8
(k} level ( m mol/l) in the supernatant of frozen red blood cells






















4781 1.2 1.5 3.0 4.0 5.0 6.0 7-0 8.0 8.5 9.5
4776 0.5 3.0 4.5 5-5 7.0 8.0 8.5 9.7 10.5 11.5
31151 0 2.0 4.0 4.5 5-2 6.0 7.0 7.5 7.7 9.0
31163 0 2.5 4.0 5.0 6.0 6.5 6.5 8.7 9-5 10
31153 0.5 2.0 3.5 4.5 5-5 6.5 7.0 8.0 9.0 9.5
31154 0.5 2.5 4.0 4.7 5.2 6.7 7.0 8.5 8.7 9.7
5507 0.5 2.0 3.5 4-5 5-5 6.5 7.5 8.0 8.5 9.5
5489 0.5 2.0 3.0 4.0 5.0 6.0 6.0 7.5 8.0 9.0
6589 1.0 2.5 3.7 5.0 6.0 6.5 7.5 8.2 9.0 9-5
6573 0.75 4.0 6.0 7-5 11.5 12 13 14.5 14.5 15
Mean 0.5 2.4 3.9 4.9 6.2 7-0 7-7 8.8 9-4 10.2


















Hb concentration (mg/dl) in the supernatant of previously frozen-

























36104 140 280 350 390 410 420 430 460 480 50c 6.1
63036 50 160 200 220 230 250 250 260 280 300 6.1
07413 100 390 480 540 550 580 56O 580 600 640 6.1
63042 80 380 460 520 530 550 560 620 630 650 6.0
63037 140 400 510 550 590 600 620 620 65C 660 6.2^
Mean 102 322 400 444 462 474 484 508 528 550 6.11
S.D. 39 103 127 141 146 142 148 153 154 154 O.09
TABLE 4.10
Hb concentration (mg/dl) in the supernatant of previously frozen-thawed
























36099 140 480 630 660 76O 760 770 790 830 850 6.4
63038 190 540 680 750 790 810 830 830 850 900 6.47
07365 240 740 930 1000 1060 1080 1110 1150 1190 1250 6.46
36748 220 600 730 830 880 890 900 910 910 960 6.63
63040 120 460 58O 620 660 680 680 680 710 710 6.44
Mean 182 564 710 772 830 844 858 872 998 934 6.48
S.D. 51 113 135 151 151 152 162 176 179 199 0.09
TAJ3LE4.11




















































































































































1.0.9$NaClsolution 2.Jlalbuminin0.9$ NaCl+ACT 3.0.9$NaCl+ACD 4.5$albuminin0.9 NaCl 5.Tis-U-Sol 6.Ringer'slactate Solution





65O 150 230 470 423 770
770 170 260 540 500 970
800 200 280 560 580 1010
820 210 300 580 625 1100
850 230 330 600 700 1200
890 240 340 620 N.D. N.D.
910 250 360 640 N.D. N.D.
970 270 380 670 N.D. N.D.




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































i 6.175 ' 0.136 190
TABLE4.26





































N.E.*afurther15unitswereexamin dft r0d ystoragepost-thawiACD-salinandfouth v ameanlevelof2.4/uo /gHb,3DPGand0 99/um l/ATP.
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BACTERIOLOGY RESULTS
At zero day of processing:- All units were sterile with the
exception of four units No.60581, 24236, 33647 and 24040 (Table B .l).
Although unit N0.6O58I showed a positive contamination with coliform
organism in the subculture blood agar plate which was kept at room
temperature, a colony count performed on nutrient agar using 1 ml
aliquots was negative. Also, when the primary and subcultures were
repeated there was no sign of bacterial growth. Unit No.24236 showed
the presence of contamination with staphylococcus albus (coagulase
negative) in the three subculture plates incubated, aerobically at
room temperature, aerobically at 37°C and anaerobically at 37°C.
However the colony count was negative as well as the repeated culture.
Unit No.23647 showed a bacterial growth of staphylococcus albus
(coagulase negative) in the plate incubated at room temperature and
coliform organisms in the plates incubated aerobically and anaerobically
at 37°C. Colony count and repeated cultures were negative. The last
unit also showed a staphylococcus albus (coagulase negative) growth in
the 37°C aerobic plate, but again the colony count and the repeated
cultures were sterile.
After 10 days of storage:- All units were sterile ('fable B.l
with the exception of unit No.01854 which was contaminated with coliform
bacilli; however the colony count was negative, when the cultures were
repeated the following organisms were demonstrated.
i) Coliform bacilli and staphylococcus albus (Coagulase negative)
in the plate incubated aerobically at 37°C.
ii) Coliform bacilli and micrococcus tetragenous in the anaerobic
plate incubated at 37°C.
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TABLE B. 1
Results of Bacteriology Testing










1. 61032 - - - - - -
2. 60596 - - - - - -
3. 24816 - - - - - -
4- 61038 - - - - - -
5- 02473 - - - - - -
6. 24822 - - - - - -
7. 02507 - - - - - -
8. 24808 - - - - - -
9- 02531 - - - - - -
10. 61062 - - - - - -
11. 24814 - - - - - -
12. 02508 - - - - - -
13. 24766 - - - - - -
14. 61040 - - - - - -
19. 24216 - - - - - -
16. 60598 - - - - - -
17- 02504 - - - - - -
18. 02474 - - - - - -
19. 61045 - - - - - -
20. 61065 - - - - - -
21. 61047 - - - - - -
22. 02331 - - - - - -
23. 6078O - - - - - -















25. 60781 - - - - - -
26. 23645 - - - - - -
27- 60793 - - - - - -
28. 02546 - - - - - -
29. 60748 - - - - - -







- - - - -
34. 24195 - - - - - -
















39- OI855 - - - - - -
40. 61071 - - - - - -
41. 24158 - - - - - -
42. 24845 - - - - - -
43. 60871 - - - - - -
44. OI887 - - - - - -
45. 60624 - - - - - -
46. 24028 - - - - - -
47. 02265 - - - - - -
48. 60779 - - - - - -
TABLE B.l (cont'd.)











49. 02502 - - - - - -
50. 02267 - - - - - -
51. 60770 - - - - - -
52. 24027 - - - - - -
53. 02271 - - - - - -
54. 61048 - - - - - -
55. 24025 - - - - - -
56. 24758 - - - - - -
57. 24197 - - - - - -
58. 02247 - - - - - -
59- 02248 - - - - - -
60. 02263 - - - - - -
61. 24042 - - - - - -
62. 60661 - - - - - -
63. 02215 - - - - - -
64. 02224 - - - - - -
65 • 24251 - i
1
- - -
66. 24041 - !
- -- -
67. 24209 - i _ - - -
68. 60785 - - - - -- -
69. 24238 - - - - -- -
70. 24040 - +
3.A1B-
- - - —
71. 60583 - - - - - -















73. 01876 - - - - - -
74. 02543 - - - - - -
75. 24242 - - - - -
76. 01893 - - - - - -
77. 61060 - - - - - -
78. 60587 - - - - - -
79- 6O56O - - - - - -
80. 23657 - - - - - -
81. 24825 - - - - - -
82. 23623 - - - - - -
83. 23650 - - - - - -
84. 60844 - - - - - -
85. 60767 - - - - - -
86. 02877 - - - - - -
87. 02492 - - - - - -
88. 6O6C9 - - - - - -
89- OI896 - - - - - -




91. 02505 - - - - - -
92. 01897 - - - - - -
93. 01892 - - - - - -
94. 01908 - - - -
- -















96. 60647 - - - - - -
97. 02495 - - - - - -
98. 0]853 - - - - - -
99- 24239 - - - - - -
100. OI885 - - - - -
R.T. = room temperature
Anaer. = Anaerobic
- = negative growth
Col. B = Coliform bacilli
S.Alb. = Staphylococcus albus
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IN VIVO SURVIVAL OF HHP CELLS PRESERVED BY LOW-flLYCEROL
RAPID FREEZS-THAW TECHNIQUE IN ALUMINIUM CANS
The ultimate criterion of success of any method of red cell
preservation is that the recovered cells should survive following
transfusion for a normal period. However, many investigators have
shown that cells which survive the first 24-hours after transfusion
will continue for a normal life span.
Because of the difficulties of accurate estimation of the blood
volume in diseased patients and in order to exclude factors of in vivo
red cell destruction other than the damage produced by the method of
processing, autologous post-transfusion survival was preferred over
the homologous tests.
We have investigated the autologous 24-hour posttransfusion
survival of frozen red cells that were processed by either the manual
i 51
or the automatic methods. In addition we have estimated the T Cr
for red cells processed by the automatic technique and transfused
immediately after processing and those resuspended in saline-ACD medium
and stored for a further five days, post-processing, at +4°C then
transfused to the original donors.
The results of the study on the in vivo survival of five autologous
units of frozen blood that were processed by the manual technique and
transfused on the day of processing are shown in Table 5«1* The niean
value for the 24-hour post-transfusion survival was 93.0$ - 6.2 (n=5).
The mean 24-hour post-tx-ansfusion survival of autologous frozen
blood processed by the automatic method and transfused immediately
after washing was 95*0$ - 4«3, n = 5 Table The in vivo survival
of these cells was also followed over a period of four weeks, the
279
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results shown in Table 5*2 represent the percentage Cr survival
(not corrected for elution) in each of the four weeks for the five
autologous transfusions. The mean survival was 76.0 - 9*6, 64 - 9-0,
56 - IO.5 and 48 - 7«5 after one, two, three and four weeks respect¬
ively. The T^- "^Cr for each of the five experiments was 19, 26, 39, 21,
and 26 days with a mean of 25 days (Fig. 5*1 )•
In vivo survival of frozen red cells resuspended in saline-
ACD and transfused after five days of storage at + 4°C
It was obvious that frozen red cells which are resuspended in
saline-ACD medium, after washing, remain stable and sterile over a
period of nine days of post-thaw storage at +4°C. However, the
behaviour of these cells after transfusion was not known. We have
studied the invivo survival of these cells in 10 autologous transfusions
after five days of post-thaw storage at +4°C. The results of these
experiments are shown in Table 5*3. The mean 24-hour post-transfusion
survival was 87$ - 5-7 n = 10. 'When the survival was followed over a
period of four weeks (5 experiments), we found that the mean survival
was 73$ - 3.0, 63$ - 2.4, 54$ - 3 and 44$ - 1.9 after one, two, three
*51
and four weeks respectively. The T|- Cr for each experiment was
23, 22, 23, 23 and 25 days with a mean value of 23 days (Fig. 5*2).
TABLE5.1
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OBSERVATION ON THE RECIPIENT LEUCOCYTE AND PLATELET COUNTS AFTER
THE TRANSFUSION OF AUTOLOGOUS FROZEN BLOOD
During the early experiments of the autologous in vivo survival
of frozen red cells we noticed a significant change in the leucocyte
count of the recipient as compared to the pretransfusion level. This
observation was interesting since we know that the frozen blood is
deficient in leucocytes. We extended our observation to the
differential count of the recipient as well as the level of the plate¬
lets. The result of these observations are shown in Tables 6.4 and
6.5- The mean total leucocyte count prior to transfusion was 6.45 -
1.21 x 10^/l (n=15). The mean total leucocyte count of the recipient
30 minutes after transfusion of one unit of autologous frozen blood
+ 9 /
was 13.0 - 4«7 x 10/1. Twenty-four hours post-transfusion the level
of the leucocyte count decreased again and the mean count became
5.5405 p<( 0.0005 n^= 12, = 15, respectively) in the level of the
total leucocyte count in the recipient 30 minutes after transfusion of
one unit of autologous frozen blood when compared to those prior to
transfusion (Table 5*4). Table 5•4 3hows also that this increase was
the result of increase in the neutrophil leucocytes. As regards the
platelet count the mean count in 10 individuals prior to transfusion
+ 9 /
was 173.0 - 23.9 x 10/1. After 30 minutes of transfusion of one
unit of autologous blood the count was not statistically significant
from the pre-transfusion level. However, twenty-four hours post¬
transfusion the platelet count has increased to levels higher than
-f 9 /
those of the pre-transfusion with a mean of 202 - 32.4 x 10 /l. This
increase was statistically significant (t-test = 11.5769 P < 0.0005
n1 (pre-transfusion) = 10, n^ (24 hour post-transfusion) = 9-
Thus, there was a significant increase (t-test =
TABLE5.4

























































































































































































































































































































Effect of autologous transfusion of frozen blood on the
platelet count of the recipient
Platelet count x 109/l
Pre-tx 30rnin-post Tx 24-hr post Tx
C.D. 155 124 155
J.C. 200 I85 228
M.C. 170 165 255
A.R. 154 150 190
D.B. 165 160 180
J.B. 180 210 175
C.D. 200 195 200
A.R. 210 215 N.D.
K.A. 154 124 195 '
D'.P. 139 160 240
Mean 173.0 169 202
S.D. 23.9 32.2 32.4
n. 10 10 9
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Effect of transfusion of frozen blood on the recipient plasma free
haemoglobin;
The mean plasma haemoglobin level prior to transfusion was 0.05 -
0.05 g/l n = 14.
The total free haemoglobin in the supernatant per unit of blood
transfused ranged from 0.263g to 2.387g. The total volume of blood
transfused to each individual together with the expected plasma
haemoglobin after transfusion are shown in Table 5-6. The change in
plasma haemoglobin after the infusion of the frozen blood is also
shown in the Table. In three out of 14 cases there was a slight
haemoglobinaemia in excess of the expected levels. Haemoglobinuria
was not observed in any of the recipients tested in this Table.
TABLE5.6




supernatant Hbinthe transfused blood(g/unit)
Expected plasmaHb ofthe recipientg'/l
observed plasmaHb ofthe recipientg/l





































































































































LEUCOCYTE CONTENT OF THE FROZEN BLOOD
Since, in the last few years, preparation of leucocyte poor blood
has received much attention, we have investigated our frozen blood for
its leucocyte content. First we studied the leucocyte content of the
blood before and after freezing, thawing and processing. Leucocyte
counting was performed electronically by the Coulter counter and
expressed as millions per gram haemoglobin.
The leucocyte content of the blood prior to freezing was ^0.16
(million/g Hb) - 28.91 in one series n = 17 (Table 3.16) and 49•09
(million/g Hb) - 20.19 in another series n = 88 (Table 4.26). The
leucocyte content of the blood after glycerolization, freezing and
washing decreased to 2.89 - 2.15 million/g Hb n = 37 for blood processed
by the manual method (Table 3.12) and to 2,5 - 1.2 million/g Hb n = 34
for blood processed by the IBM 2991 Automatic cell processor in one of
the series (Table 3.13) and to 3.17 - 2.12 million/g Hb n = 15 in
another series (Table 3.16). This represents 5-7$, 5/ and 6.3'/ of the
leucocyte input before freezing respectively. The amount of leucocytes
left in blood processed by the IBM 2991 was not significantly
different from that left after manual washing (t = 0.799 P^O.l = 34
and n^ = 37, respectively). In a third series processed by the IBM
2991 the residual leucocyte content of the resuspended blood after
freezing, thawing and washing was 5•97 -4.32 million/g Hb n = 95
(Table 4.26). This represents 12/ of the original leucocyte content
prior to glycerolization and freezing. In comparing this with the
previous series the only variable seemed to be the method of sampling.
In the first two series, the whole units were sacrificed so that
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sampling was direct from the processing bag after resuspension and
thorough mixing, while in the latter case the samples were obtained
from the line which contained most of the buffy coat. Stained smears
prepared directly from processed blood and from leucocytes after
concentration with dextran revealed the presence of mononuclear cells
only, however the majority of these cells were distorted.
Recovery assay with labelled cells:-
Becuase of the fact that the mechanism by which leucocytes are
removed from the blood during the various processes was not clear and
because we believed that some of the leucocyte debris might still be
present in the final product, we carried out what we call a recovery
assay with labelled cells. A total of 31 units of blood were frozen
after the addition of either lymphocytes, granulocytes or platelets,
125
the cell membranes of which were labelled with radioactive 1 - NaT.
Thirteen units were used for the study of lymphocyte derived material,
eight units for granulocytes and ten units for platelet studies. It
was hoped that such a study might correlate with the previous method
of assaying the leucocyte recovery and help us to get a better idea
of the amount of cellular debris left in the blood after processing.
Also we made use of this experiment to study the effect of passing
the processed blood through the following filter systems:-
1) BR-10 Blood Administration Set (Baxter).
2) Ultipor - blood transfusion filter (Pall corporation)
3) Swank Transfusion Filter
Table 5*1 shows the results obtained with labelled lymphocytes.
In the first group (Table 6.1a) of this series the blood was processed
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in the IBM 2991 Automatic Cell Processor without removal of the huffy
coat. It was found that about one third of the input labelled
material was washed out in the waste, while about 40$ of this material
still remained in the final product. The rest of the labelled
material was assumed to be in the processing bag. This latter
material was usually found in the form of a gelatinous mass sticking
to the wall of the processing bag. Sections of these gelatinous
masses revealed the presence of few intact mononuclear cells, while
most of the material was formed of white cell fragments.
There was a significant reduction (t-test = 3.0448 p<0.05 n = 6)
in the level of radioactive material in the processed blood after its
passage through a BR-10 Blood Administration set when compared with
that of the same blood before filtration. This suggests that some of
the leucocyte debris are removed by this 170yu filter.
Also there was a significant reduction (t-test = 2.27195 P< 0.05
n = 6) in the level of radioactivity of the processed blood after its
passage through the blood transfusion filter when compared to that
before filtration. However, there was no significant difference
(t-test = O.O8463 P>0.475 n = 6) between the radioactivity of the
processed - Ultipor filtered blood and that of the same blood which
passed through BR-10 Baxter Set.
The level of radioactivity in the processed blood was also
significantly reduced (t-test = 2.8847 P< 0.025 n = 6) by passing the
blood through a Swank-Transfusion Filter. The mean radioactivity
remaining in the Swank filtered blood of the six units in this group was lower
than that remaining after filtration through either BR-10 transfusion set
or liltipor-fiIter. This difference is statistically significant (t-test =
1.982 p = 0.05, n = 6).
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In group II of this series (Table 6.1b) the huffy coat was removed
at the end of the last wash step by manual overriding of the detector
device of the machine, during which the upper layer of the packed red
cells, containing most of the buffy coat, was removed. Under these
conditions the amount of radioactivity remaining in the processed
blood was decreased from about 4C$ in group I to 21$ in group II.
This difference was statistically significant (t - test = 3.964 P"^ 0.025
nl = 6, n£ = 4 respectively). However this improvement was achieved
by sacrificing more red cells (Table 6.1b). Table 6.1b shows that
this decrease was the result of removal of more radioactive labelled
material in the wash waste than that removed from blood in group I,
the difference is statistically significant (t-test = 10.7159 P< 0.0025
n = 4) • At the same time the amount of radioactive labelled material
left in the processing bag in the form of gelatinous like masses was
not significantly different from that in group I (t-test = 0,2756
P>0.4 n = 4)« Again when blood processed in this group was passed
through a BR-10 Blood Administration set almost the same amount of
radioactivity as in group I was removed. Neither the IJltipor nor the
Swank filters were superior to the conventional BR-10 set in this group.
In the third group the buffy coat was removed, after each wash
step. This resulted in washing out more radioactive material in the
wash solution than that observed in the first or the second group.
Thus there was a significant increase (t -test = 4.0258 P<0.01 =» 3,
n0 = 4 respectively) in the level of radioactivity detected in the
wash waste in group III, when compared to that in group II. Also
there was a significant reduction (t-test = 2.576 P-4 0.05 n^ = 3
n^ = 4 respectively) in the level of remaining radioactivity in blood
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processed under the condition of the third group when compared to that
in blood of group II. Table 6.1c also shows that, when the buffy
coat was removed after each wash step, there was no benefit in using
any of the filters tested, as the amount of radioactivity remaining
in the final product was not affected by any of them. Although
removal of the radioactive labelled material in group III was maximal,
under the condition of the experiment, the red cell loss was
significantly higher (about 25a).
In order to prepare a pure granulocyte suspension for the study
of the granulocyte derived material in the frozen blood, two units
of fresh blood were filtered through a Leuko-Palc nylon filter. The
effect of filtration through the Leuko-Pak filter, on the blood cell
parameters is shown in Table 6.2. The absolute number and the per
cent change in the white cell and platelet count due to filtration
are shown in Tables 6.3a and 6,3b.
Table 6.4 shows that when previously frozen-thawed erythrocytes
were washed in the IBM 2991 Automatic Cell Processor without removal
, 125
of the buffy coat, approximately 25% of the input I - labelled
granulocyte material was recovered in the processed blood. The
efficiency of the filters tested in removing the granulocyte derived
material increased from the BR-10 Baxter set to the Ultipor-Pall
filter to the Swank Filter. However, if the buffy coat was removed
after each wash step, most of this material was removed with the wash
solution and none of these filters were effective. Again in the
latter case the red cell loss was as high as 25%.
As regards the platelet derived material present in the frozen
blood, Table 6.5 shows that only about 2% of the platelet labelled
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material remained in the final resuspended red cell product. This
figure was not altered either by the technique of removal of the huffy
coat or by the use of any of the filters tested.
Assessment of the viability of the remaining lymphocytes
Since it was evident from the previous experiments that, even
after freezing, thawing and washing, some of the HL-A antigen containing
cells and debris remain in the final product we attempted to assay the
viability of those remaining cells and the antigen status of the blood
as a whole. Whether or not the cells are viable may be critical,
for in cases where the recipient is severely immunosuppressed, there
is a risk of graft versus host disease. Again it is also important
because viable cells may be more immunogenic than dead cells or cell
fragments.
In this work viability of the remaining white cells was assayed
by both the dye exclusion test and by the phytohaemaggutinin (PHA)
stimulation test. However, both tests gave controversial results,
for, while we observed that none of the cells examined were able to
exclude the Trypan blue dye, the PHA test showed that, in nine out of
15 experiments, there was a weak response to PHA. When the latter
was compared to the response of lymphocytes separated from the same
blood before freezing and the results are expressed as a ratio, we
found that this ratio varied from 4$ to 30$ with a mean of 13.44$ - 9
(Table 6.6).
In vitro assessment of the antigen status of the frozen blood:
The antigen status of the frozen blood wa3 assayed in vitro
utilizing; the mixed lymphocyte reaction technique. In this method
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lymphocytes separated from the frozen blood were incubated with viable,
antigenically different, lymphocytes in a one way mixed lymphocyte
culture. Antigenicity was measured in terms of the activity of
tritiated - thymidine incorporated by one million responding cells,
A positive control for this test was set up by producing a similar
reaction between lymphocytes separated from the same blood prior to
freezing and the same responding cells. In some experiments (1,2,3,4
and 5) (Table 6.7) the responding cells used were obtained from the
frozen-stock of the tissue-typing laboratory. Also in these
experiments, the fresh lymphocytes were tested for antigenicity on the
day of donation while the lymphocytes from the frozen blood were tested
approximately one year after. In either case the same batch of
responding lymphocytes were used and their viability was assessed on
each occasion (Table 6.7). A negative control was also included with
each experiment consisting of the responding cells alone. A test was
considered positive if the radioactive count, observed was at least
twice the negative control. In all the 15 experiments shown in
Table 6.7 the mixed reaction with the fresh stimulating cells was
strongly positive, while only one experiment, out of 15 utilizing
frozen stimulating cells showed a positive reaction. However the
latter might be an artifact as the baseline with this series of
experiments was higher than the others, possibly due to contamination.
In vivo assessment of the antigen status of the frozen blood:
The in vivo tests of antigenicity were performed in rabbits. A
preliminary experiment was performed in three groups of Dutch rabbits,
one pair each. The first group received one ml of fresh blood, the
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second one ml of frozen blood while the third was injected with one
ml of frozen-Swank filtered blood. The Swank filter was selected
because experiment with labelled cells shewed that it is the best
filter tested in removing the white cell debris. Injection of the
rabbits was performed at weekly intervals and continued for 6
successive weeks. Fresh and frozen blood were from different sources.
Serum samples were collected every week before the next injection.
At the end of the experiment all the sera including the preimmunization
sera were tested for the presence of anti-'-human lymphocytotoxic
antibodies using random human lymphocytes as target cells. The
result of this experiment is shown in Figure 6.1, where it can be seen
that while rabbits which received fresh and frozen blood developed
lymphocytotoxic antibodies after the first injection, it did not
appear until the third dose in those receiving frozen Swank-filtered
blood. Fig. 6.1 also shows that at any time of immunization rabbits
receiving fresh blood produced a higher antibody titre than those
receiving frozen or frozen-filtered blood and this holds true until the
fourth week, after which all the rabbits showed a similar response.
Following these results the in vivo test for antigenicity was
repeated with various modifications
1. Five rabbits were used in each group instead of two and
immunization continued only for four weeks.
2. Blood used in each single week of immunization was obtained
from the same donor for the three groups and all the donors
used were of the same ABO group and Rh type.
3. Sera collected after immunization were adsorbed with pooled
red cells from all the donors to remove the red cell antibodies.
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4. The target cells used in the lymphocytoxicity test were
pooled lymphocytes from the four donors.
5. Sera were diluted in double dilution and examined for
lymphocytotoxic antibodies up to the end titre.
The response of each rabbit is shown in Tables 6.8a, 6.8b and
6.8c, while Figure (6.2) shows the mean response of each group. These
results confirmed the findings of the preliminary experiments, except
that rabbits receiving frozen blood did not respond by antibody
formation after the first injection. Also in this experiment there
was a marked difference between the antibody response of each group,




Lymphocyte derived material assay with I labelled lymphocytes
Group I. Lymphocyte derived material. - buffy coat intact (Mean red cell
recovery 94•8$)







Processed blood after passing through processingbag
giving set Pall filter Swank filter
64597 N.D. 39-8 31.3 25.4 14.7 N.D.
46123 N.D. 37.6 23.5 23.5 23.5 N.D.
46132 39-9 49.0 38 40.8 17.5 11.1
46323 30.3 41.7 38.9 38.9 37.3 28.0
46336 33.6 41.7 34.6 34.6 33.8 24.7
11716 33.8 27.7 29.2 33 26.2 38.5
Mean 34.4 39.5 32.5 32.7 25.5 25.5
S.D. 4.0 6.97 5.81 7.01 8.87 11.3
TABLE 6. lb
Group 13. Lymphocyte derived material - buffy coat removed at
wash step (Mean red cell recovery 90$)
the last







Processed blood after passing through processing
bag
gi vi ng set Pall filtei Swank filter
64295 55 18.5 16.5 14.8 6 26.5
10467 52.3 30.5 18.2 14.6 14.2 17.2
10456 49.2 23.2 13.6 14.5 20.5 27.6
64289 50 12.9 11.8 12.8 14.8 ■ 37.1
Mean 51.6 21.3 15 14.1 13.8 27.1
S.D. 2.61 7.45 2.87 0.93 5.97 8.14
TABLE 6.1c
Group III. Lymphocyte derived material - buffy coat removed after every
wash step (Mean red-cell recovery 75$)
Unit
No.





Processed blood after passing through processing
bag
giving set Pall filter Swank filter
46254 79.5 11.6 14 10.7 9.2 9-9
28254 64.4 9-1 3.0 3.0 2.6 26.5
28262 91.0 8.5 6.2 6.0 5.7 0.5
Mean 78.3 9.73 7.73 6.57 5.83 12.3
S.D. 13.34 1.64 5.66 3.88 3.3 13.1
TABLE6.2





























































Total V/.B.C.(xl09/l) 5.0 1.9 62
Neutro (xlO^/l) 1.950 0.342 82.5 85.2
Lympho (xlO^/l) 2.150 1.501 30.2
Mono (xlO^/l) O.55O 0.057 89.7
E 0 so(zl09/l) 0.350 0 100










Total W.B.C.(xl09/l) 4.6 1.9 59
Neutro (xlO^/l) 1.840 0.418 77.3
Lympho (xlO^/l) 1.932 1.425 26.3 78.9
Mono (xlO^/l) O.69O C.057 91.8
Eoso (xlO^/l) 0.133 100




Granulocyte derived material assay with I - labelled granulocytes
i 1_;I count remaining in
Unit Wash Process¬ Processed ilood after passing through Processing
No. waste ed blood
Giving set Pall filter Swank filter bag
Group Is Buffy coat intact (Mean red cell recovery 94.8^)
66489 60.6 22.4 17.5 13-4 9.7 17
66524 73,3 22.7 20.7 17-3 12.5 4-0
66522 53,3 22.9 22.5 20.5 13-5 23.8
51807 34.0 35.7 25.9 15.0 9.8 30.3
Mean 55.3 25.83 21.65 16.55 11.38 18,78
S.I). 16,43 6.59 3.51 3.0 1.92 11.25
Group II: Buffy coat removed after each wash step (Mean red
recovery 74/0
cell
51550 71 8.9 9-5 7.5 11 20.1
14021 72,6 10.5 9.0 9.7 7.0 16.9
14086 52 10.5 10.0 9.5 8
'
37-5
51740 75 8.8 9-4 10.0 8.9 16.2
Mean 67.65 9.68 9.48 9.18 8.73 22.68













Processed blood after passing through Processing
baggiving set Pall filter Swank filter
Group I: Buffy coat intact (Mean red cell recovery 94.8%)
6.1106 N.I). 2.7 2.1 1.9 1.6 N.D.
61108 95 2.9 2.6 2.4 2.5 2.1
61209 N.D. 2.6 2.0 1.7 1.7 N.D.
61113 N.D. 2.7 2.2 2.2 1.6 N.D.
25954 96.6 1.9 1.5 1.4 1.4 1-5
Mean N.D. 2.56 2.08 1.92 1.76 N.D.
S.I). 0.38 0.4 0.4 0.43
Group II: Buffy coat removed after each wash step:
Mean red cell recovery (76*22 - 13.16X)
61107 92 2.5 2.6 2.8 2.6 . 5.5
61109 100 1.6 1.7 1.5 1.7 0
61123 96 2.0 1.9 1.9 1.7 2
61180 101 2.0 2.1 2.0 2.3 0
25956 98.5 1.6 1.6 1.7 1.7 0
Mean 97.5 1.94 1.98 1.98 2.0
S.D. 3.61 0.37 0.4 0.5 0.42
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TABLE 6.6
Comparison of the viability of lymphocytes separated from blood before
and after freezing as measured by its response to PHA and expressed as














































7. OI458 1 175,949 32,676 19
8. 02333 1 146,024 15,204 10
9. 02335 1 241,688 10,388 4
10. 01728 1 180,159 53,659 30
11. 01729 106,616 8,562 8
12. 01349 1 170,228 21,648 13
13. 01350 1 220,216 11,848 5
14. 01224 353 215,064 50,836 24
15. 13677 413 155,486 12,788 8
Mean 179,047 24,178 13.44
S.D. 41,678 17,516 9
N.B. The response in this table is expressed as the activity of




Comparison of the antigenic status of fresh and frozen blood
Expressed as the activity of - thymidine incorporated per
million lymphocytes when stimulated by antigenically different lympho¬

















1. 131686 320 88,324-100,340 65,318 < control
2. 13677 413 131,523-217,078 71,432 < control
3. 14590 398 117,978-170,095 108,367 447
4. 0460 323 81,241-272,993 59,435 2,384
5« 01224 353 130,848-254,216 68,048 control
6. 01349 1 229,444 150,100 17,284 N.3.
7- 01350 1 229,444 151,236 5,416 N.S.
8. 01728 1 116,927 133,958 95,824 +VE
9. 01729 1 116,927 103,343 17,756 N.S.
10. 02333 1 360,224 130,860 K control
n. 02335 1 360,224 56,560 2,620 N.S.
12. 86 1 35,348 57,640 control
13. 97 1 35,348 56,416 control
14. 01452 1 175,762 111,246 •n control
15- 01458 1 175,762 81,854 5,932 N.S.
Viability of the responding cells assayed by its response to PHA
3
and expressed as the activity of H - thymidine incorporated by
1 x 10^ lymphocytes.
Antigenic status of lymphocytes separated from fresh blood before
freezing and assayed by its ability to stimulate antigenically
different cells in one way mixed lymphocyte culture and expressed
as the activity of - thymidine incorporated by 1 x 101 responding'
cells.
***
Antigenic status of lymphocytes separated from the blood after
freezing, thawing and processing and assayed by its ability to
stimulate the same cells as in (**) and expressed in a similar way.
N.B. The stimulating cells in (*) and (**) belong to the same donor and
were separated from the same donation.
Fig 6.1






















Preimmunization 0 0 0 0 0 0
1st week 32 16 0 4 16 16
2nd week 512 128 32 512 "64 256
3rd week 256 256 256 512 128 256
4th week 512 512 512 512 256 612
TABLE 6.8b
Frozen Blood
Group II No. 10, No.11 No.12 No.13 No.14 Mean
Preimmunization 0 0 0 0 0 0
1st week 0 0 0 0 0 0
2nd week 16 64 64 16 32 32
3rd week 32 32 64 32 128 64
4th week 0 64 128 128 256 128
TABLE 6.8c
Frozen/Swank/Filtered Elood
Group Til No. 5 No. 6 No. 7 No. 8 No. 9 Mean
Freimmunization 0 0 0 0 0 0
1st week 0 0 32 0 0 0
2nd week 4 4 32 32 8 16
3rd week 8 16 16 16 32 16
4th week 32 64 2 8 128 64
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N.B.
During preparation of this thesis, the anticoagulant in which
the blood is collected during donation has been changed from
ACD to CPD. We have, thus, examined the effect of this change on
the characteristics of our final preparation. The results of
this experiment is shown in table 7.1.
TABLE7•1






















































































































































































































































The attention of the Edinburgh and South East of Scotland Blood
Transfusion Service was directed towards the freeze-preservation of
human red blood cells to fulfil the need for a safe and efficient
biologic product to supplement the present liquid stored blood
programme. The main stimulus for establishing such a programme was
the outbreak of Type B hepatitis in the renal dialysis and transplant
units in which both patients and staff had died. This cause will
remain valid as long as an absolutely certain method of detecting
all potentially hazardous donations is not available.
It has frequently been reported that the incidence of Type B
hepatitis is substantially reduced by transfusing previously frozen-
thawed-washed erythrocytes (Haynes et al I960, Haynes et al 1962,
Murray et al 1962, Tullis et al 1970, Meryman 1972). In addition,
clinical experience, has shown that frozen blood offers various
advantages over the liquid stored blood. Thus, freeze preservation
would enable stock piling of rare types of blood for transfusion
to patients who are sensitized to blood-group antigens that are common
in most donor populations. Frozen storage also makes possible an
autotransfusion programme. Since the storage period in the frozen
state is unlimited, freeze preservation would ensure the availability
of blood of all groups and types at all times and reduce the wastage
of outdating. Such a system, would thu3, provide a means of
provide
equalizing supply and demand, and/large stockpiles of frozen blood to
cope with civilian or military catastrophes. Moreover, due to the
fact that frozen blood is free of any plasma proteins, group "0" blood
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can be regarded as a safer universal donation. Thus no minor cross
matching will be required before its administration. Large stores of
only group "0" Rh positive and Rh negative would make possible better
blood bank management.
Other virtues claimed to be provided by frozen blood include
reduction or elimination of the incidence of non-haemolytic transfusion
reactions. This is claimed to be due to the removal of plasma
protein (especially IgA), platelets and leukocytes. For the same
reasons it has also been claimed that frozen blood is the most suitable
preparation for patients in renal transplant and dialysis units as
it may eliminate sensitization to HL.A antigens and hence avoid graft
rejection.
Apart from those advantages, frozen-thawed-washed blood possesses
additional advantages sufficient to justify its use. Thus, due to the
washing procedures used to remove the additives, the final product
has a very low content of free potassium, citrate, clotting factors
and particulate matter. For these reasons the blood can be "tailored"
with other needed components added, to suit individual requirements.
Blood with low potassium levels is suitable for exchange transfusion
in infante and for transfusion in patients with renal failure. Also
blood which is devoid of coagulation factors may be suitable for
administration to patients undergoing vascular surgery.
Since the demonstration by Smith, in 1950, that human red blood
cells could be preserved in the frozen state and then recovered in
high yields, a great deal of research and extensive effort has been
invested in finding the optimal conditions for frozen storage.
Various techniques of freezing have been described, which vary in
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the nature of the cryoprotectiv6, type of container, rate of freezing,
storage temperature and post-thaw processing.
In recent years a considerable degree of uniformity has become
obvious in the application of frozen blood banking. Thus, all
methods of freezing human red blood cells in current use today employ
glycerol, as an intracellular cryoprotective additive. Glycerol is
used either in high concentration (40$ w/v) combined with slow rate of
freezing (l°C/minute) and storage at -80°C in a mechanical refrigerator,
or in low concentrations (about 20$ w/v) together with a fast freezing
rate in liquid nitrogen and storage in the vapour phase of liquid
nitrogen at -150°C. In either case glycerol must be removed from
the red cells, by post-thaw washing, otherwise the preserved cells
will haemolyse on transfusion. The high glycerol-slow freezing method
was the first method described (Tullis et al 1958), and since that
time it has been continuously improved until it has become a fully
developed, practical technique used by most centres in the United
States.
Nevertheless, this method has been repeatedly criticised on the
grounds of difficulty in removing the high content of glycerol
(Meryman 1968b, Pert and Schork 1969). In order to remove 40$ w/v
glycerol from the glycerolized-thawed red blood cells, it i3 necessary
to use sophisticated equipment and large volumes of wash solutions
(Valeri 1970) which makes the process expensive. The reasons that
led the Americans to continue with this method of freeze-praservation
appears to be related to their inability to use aluminium containers,
which at the early stages of development was the only material
suitable for liquid nitrogen temperatures, (-196°c). Aluminium was
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not licenced for use in blood storage. By the time plastic bags
had been developed, a large amount of money had already been invested
in the development of mechanical refrigerators that operate at -80°C.
Furthermore, the high cost of liquid nitrogen in the U.S.A. discouraged
investigators from adopting the low-glycerol-rapid freezing technique.
In order to facilitate the post thaw washing procedure, the low
glycerol-rapid freezing technique was recommended by Pert et al, 1963,
Krijnen et al, 1964 and Rowe at al, 1968. Since its introduction,
the method has gained wide acceptance in Europe for the difficulties
encountered in its application in the U.S.A. were not valid in Europe.
Thus, both the liquid nitrogen and labour costs are lower in Europe
than in the U.S.A. Krijnen et al (1970) showed that aluminium cans
could be used as blood containers for frozen storage without problems
and the cost of the can has one tenth that of the plastic bag. This
has made possible the establishment of frozen-blood banks in which
low-glycerol-liquid nitrogen freezing in aluminium cans is coupled
with manual batch washing. The latter enables the use of standard
blood bank equipment and thus the heavy capital cost of automatic
machines can be avoided.
Having investigated various choices or processes and equipment
available worldwide, we chose the low glycerol-liquid nitrogen-
aluminium can system, adaptated from the 3ystern used by Jenkins and
Blagdon at Brentwood (1971)• The can used in our system (69 mm x
160 mm) is slightly smaller than that used at Brentwood, (Jertkin and
Blagdon 1971) and that used at Glasgow (Mitchell and Muir 1972).
In this way we have been able to pack 204 cans, into a 25O litre
Union Carbide refrigerator. This represents an advantage as regards
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both space and running costs. A similar size of refrigerator i3
packed with 175 Printal cans at Brentwood (Blagdon personal communi¬
cation) and 96 at Glasgow (Mitchell & Muir 1972). Finally the new
can is of British manufacture and costs approximately half of the
imported Printal can from Finland. Since the suggested can has
different dimensions from those of the can in common use in Britain
we have studied the optimization of variables. The critical
parameter in frozen storage is the rate of freezing in the range -4°C
to -40°C (Lovelock 1953a). This in turn is related to the can shape,
size and finish and thus dictates the required glycerol concentration.
For technical reasons it is convenient to keep the glycerol concen¬
tration as low as possible and this means a freezing rate as high as
possible. It was originally believed that freezing of whole units
of blood would require a can of large surface area and very small
blood thickness (Strumia et al, 1958a). However, it is now realized
that the limiting factor with such cans was not the thickness of
blood, but the thickness of the insulating layer of vapour surrounding
the can. In order to improve the rate of freezing, one has to
increase the rate of heat transfer by reducing the thickness of the
layer of vapour around the can (Luyet 1961). This was successfully
achieved by application of a thin layer of thermally insulating
materials to the outer surface of the metal container (Cowley et al
196l). Fortunately, it was found that the painted cans, as supplied,
were already optimal. The observed mean freezing rate over the
range -10°C to -40°C was 0.5 to 0.9°C per second. Glycerol concen¬
tration was varied over the range 10$ (W/V) to 35$ (w/v) an(l found to
be optimal at 21$ (v//v (Pepper and Amer, 1972; unpublished work).
In practice, this cannot be controlled to better than - 1.5$ w/v,
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however, this is not important since the optimum curve is rather flat
in this region (Pert et al 1965).
Starting a frozen blood programme according to the principles
mentioned above was trouble free and has an important advantage over
other blood freezing metliods: a minimum requirement of special
equipment (a liquid nitrogen refrigerator, aluminium cans for freezing
and five-tailed plastic bags for washing). Post-thaw processing
was performed manually using a conventional blood bank centrifuge and
plasma expressor.
Having chosen the system of fresze-preservation we then investi¬
gated in detail other variables within the system which might affect
the quality of the final product.
We have shown that the anticoagulant used in the collection of
blood has no specific effect on either the in vitro red cell recovery
or the biochemical characteristics of the final preparation immediately
post-thaw. In this respect our results contradict those reported
by Huntsman et al (i960) who found that BDTA had a better effect on
the red cell recovery than that of ACD. However the results reported
by these authors were obtained for blood frozen in droplet form
without the use of a cryoprotective agent.
The finding that blood collected in EPTA or CPD behaves similarly
to that collected in AC"D after glycerol!zation, freezing, thawing
and washing may be of some importance in cases where there is a
shortage of blood, for if whole blood has been collected in EDTA
and separated for the production of clotting factors II, VII, IX and
X, then the red cells can be glycerolized, frozen and stored. On
316
deglycerolization, tha EDTA Is washed out of the erythrocyte suspension
and thus the blood is suitable for transfusion.
Having found that the initial anticoagulant choice does not affect
the immediate recovery of cells in vitro, we then went on to
investigate the possible methods of washing. The choice lay between
manual batch washing in five tailed bags as described by Blagdon
(1972) or in one of the automatic machines. As it was financially
impossible to purchase and operate all three commercially available
machines, we studied their application in other blood banks and
together with published figures decided that the IBM 2991 would be
the most suitable machine for evaluation in the Edinburgh centre. We
thus compared the manual batch wash with the IBM 2991*
Both manual and automatic batch washing have been evaluated and
both methods have yielded excellent results.
Deglycerolization by manual batch washing required approximately
one litre of wash solution and was quite efficient as demonstrated by
the levels of the supernatant glycerol and sorbitol. The total amount
of red cell loss during the preparation procedures was about 7-5$> 0?
which one third was caused by the freeze-thaw process, whereas the
rest was due to the washing steps. The least haemolysis was observed
after the sorbitol wash where the red cells were maximally shrunken,
whilst the highest haemolysis was noticed after the first saline wash
step probably due to the rapid expansion of the shrunken cells in
the isotonic medium.
The time required to process one unit manually was about 9^
minutes, excluding thawing. However, four units of frozen blood could
be processed simultaneously in the same centrifuge, by one operator,
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in two hours.
Haematological examination of the final product revealed the
presence of a few crenated red cells and a slight increase, (though
still within normal limits)in the MCV, otherwise the cells appeared
normal in both shape and haematological parameters. Microscopic
examination of smears prepared from this blood also showed the presence
of a few mononuclear cells, however, many of them were unidentifiable.
No blood platelets have been identified in the examined blood films.
The results of the biochemical analysis agreed with those reported
by other workers and will be discussed later.
In vivo survival of the reconstituted manually processed cells
was measured in five cases of auto-transfusion by the method described.
The 24-hour post-transfusion survival ranged from 86$ to 99$ with a
mean value of 93.4 - 6.15.
Washing the frozen-thawed erythrocytes in the IBM 2991 Automatic
Cell Processor utilized about one and a half litres of wash solutions.
This is because of the larger capacity of the processing bag and the
necessity of centrifuging it while completely full. The latter
condition has also dictated a pre-wash dilution of the glycerolized
blood with about 200 ml of wash I. However, this was found to have
a beneficial effect on the final red cell recovery. The total red
cell haemolysis is approximately 5$ _ half of which was due to freeze-
thaw haemolysis while the rest was caused by the three wash steps.
We also observed that deglycerolization in the IBM 2991
more efficient than that by manual batch washing, this was evidenced
by the lower levels of residual glycerol and sorbitol in the
supernatant.
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The total processing time from thawing of the blood to the end
of the wash cycle is approximately 20 minutes. Most of this time
is spent in the automatic mode during which the technician is free to
prepare for the next unit or to do other work.
The haematological and biochemical characteristics of the final
product are not significantly different from those of blood processed
by the manual technique. Again the in vivo survival was determined
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in five autologous transfusions by the Cr and I technique as
described in this study. The results of the 24-hour post-transfusion
survivals were not significantly different from those observed for
red cells processed manually.
The manual method of processing offers the advantage of being
cheaper to run as it does not require special equipment other than
the processing bag. Any conventional blood bank centrifuge and
plasma expressor would be sufficient for processing. On the other
hand this method suffers from the following disadvantages:
1. It is time consuming - particularly if less than four
units are processed at the same time.
2. It requires the full attention of the operator nearly all
the time.
3. It requires many puncturing operations and thus we believe
that blood washed by this method should be used within 12-
24 hours of processing.
Automatic washing by the IBM 2991 Cell Processor has the following
advantages over the manual method.
1. It produces a higher in vitro red cell recovery.
2. It washes more efficiently as judged by the sorbitol and
glycerol concentration in the supernatant of the processed
blood.
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3. It saves both time and effort, as it does not require the
♦
operators attention except at the start and finish of
process.
4. Blood processed by this method is potentially less
susceptable to bacterial contamination, as the number of
"open" manipulations are significantly reduced.
However, automatic processing by the IBM 2991 suffers also from
the following disadvantages:
1. A higher capital cost of approximately £9000.
2. It is expensive to run - it adds on extra£4-0 per unit over
the manual method for the disposable harness.
3. Only one unit of blood can be washed at a time and thus if
four units of blood are to be processed, the machine would
not provide much of a time saving when compared to the
manual method.
Biochemical Characteristics of Liquid and Frozen Stored Blood
1. Intra and extracellular potassium:-
The results of measurements of intracellular potassium of fresh
red blood cells by the method described in this study are slightly
higher than those reported by Runck et al (1968). However this might
be due to the different age of the blood at the time of measurement.
12
While our value (9• 91 m mol/lO R.B.C.) represents the average
intracellular potassium content in red cells after only one day
12
storage at 4°C, those of Runck et al (8.49 m mol/lO R.B.C.) were
obtained for red cells stored for up to six days. It is known that
the intracellular potassium level is affected by the period of
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storage at 4°C, the longer the period the lower the intracellular
potassium (Runck et al 1968). For this reason, it can be argued
that the reduction in intracellular potassium observed in this study,
after glycerolization, freezing, thawing and washing, is due to
prefreeze storage at 4°C rather than being due to the effect of these
processes. This conclusion finds support from the observation that
deglycerolization of frozen blood with ionic solutions in a continuous
centrifugation system caused no significant change in their intra¬
cellular potassium (Runck et al 1968). In fact, in our experiments
it is difficult to separate the effect of prefreeze storage from that
of various processes involved in preparation of frozen blood in
causing intracellular potassium depletion. However, it can be seen
that all our measurements were performed on red cells that were stored
at 4°C for approximately two days before freezing. Thus a difference
of one day at 4°C between these cells and the control could not be
responsible alone for the 20% reduction in the level of intracellular
potassium observed. Also one has to consider the freezing rate
3.3 0
used in each case and its effect on the ATP—— and hence on the ATP
and electrolyte content of the cell (Takehara and Rowe 1968). While
Runck et al utilized slow freezing rate, our cells were frozen
rapidly when the ATP^^ activity is high. In this respect the
reduction in the intracellular potassium is consistent with the
reduction of the 2,3 DPG and ATP observed in our experiments as a
result of glycerolization, freezing, thawing and washing. Furthermore,
when the fast freezing rate was used Valeri and Runck observed (1969b)
a similar reduction in the intracellular potassium, although the
authors were not able to specify its cause. From the practical point
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of view, blood collected in any anticoagulant and stored at 4°C for
two days, then glycerolized, frozen by our method, then thawed and
deglycerolized will have approximately 80f of the intracellular
potassium of fresh blood irrespective of the duration of storage in
the frozen state. This is an important advantage of freeze
preservation.
As regards the extracellular potassium we observed that storage
of blood in ACD at 4°C resulted in potassium leakage from the red
cells into the plasma so that after three weeks the extracellular
potassium was as high as 16-28 m mol/l. These results were similar
to those reported by Bunker (1966) and Whitcher (1964). Since high
extracellular potassium concentrations are myocardiotoxic, physicians
have always been concerned about the production of serious hyper¬
kalemia as a result of multiple transfusions of 'elderly* ACD stored
blood. Freeze-preservation has the advantage of providing blood
with a low extracellular potassium. We observed that the supernatant
potassium of the frozen blood was usually between 0-2 m mol/l on the
day of washing and rarely exceeded 5 m mol/l. Such a preparation
would be beneficial for exchange transfusion in infants and for
transfusing patients with renal failure and those who need massive
blood replacement.
It is evident that the low extracellular potassium content of
the frozen blood is the result of its thorough washing in order to
remove the glycerol. However, during post-thaw storage, we observed
a continuous increase in the supernatant potassium, and at the end of
nine days storage in isotonic saline it may be as high as 14 m mol/l.
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Supplementation of the isotonic saline with 70 ml of ACD substantially
reduced the extracellular potassium so that after five days storage
at 4°C it was only 6.5 m mol/l and reached 8.9 m mol/l after nine
days. The reason for this reduction will be discussed later.
2. 2,3 Piphosphoglycerate
Much information has been published concerning the role of
2,3 PPG in the oxygen transport function in health and disease,
however, the normal level of this compound in fresh blood is reported
in only a few papers. Also the concentrations of the 2,3 DPG is
expressed differently in different reports. Some investigators
relate it to the red blood cells and the value is given as/U moles/ml
R.B.C. or^u moles/lO^ R.B.C. Others relate the compound to the
haemoglobin and expressed their values as /U moles/mole Hb or
yu moles/g Hb. This has resulted in some confusion and made the
comparison between values from different sources difficult. However,
in the recent literature, a uniformity in expressing the 2,3 DPG
concentrations as /U raoles/g Hb was noticed. Therefore, we have
adopted the latter terminology throughout this study.
The level of the 2,3 DPG in previously frozen-washed erythrocytes
is dependant on the initial amount, which in turn is determined by
the age of the blood prior to freezing. Normal levels of the
compound in fresh blood, as measured by the method described in this
study, were 13.01 - 1.8yu mole/g Hb. These results agree with those
reported by Fortier et al 1969> Valeri and Hirsch 1969» and Valeri
and Zaroulis 1972). However, during storage at 4°C the 2,3 DPG is
rapidly depleted from the red cells with a rate determined by the pH
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of the anticoagulant used at collection, the lower the pH, the higher
the rate. Thus we observed that during storage in ACD at 4°C, the
level of 2,3 DPG fell to 70$ after two days and 57$ after three days
and could not be detected after nine days. This would explain the
wide variation in the concentrations of the 2,3 DPG observed when
blood of different ages was used for freezing.
An additional fall in the levels of 2,3 DPG by about 20$ was
observed due to the processes of glycerolization, freezing, storage
in the frozen state, thawing and washing. This reduction was observed
with both the manual and automatic technique of processing and was
not affected by the period of storage in the frozen state. This
implies that if satisfactory levels of 2,3 DPG are to be conserved by
freeze preservation, the blood should be frozen within the first three
days of donation. Under these conditions the final red cell
suspension would be better than ordinary 7-10 day old banked blood as
far as 2,3 DPG is concerned.
3. Adenosine Triphosphate
The importance of ATP in the red cells has been discussed in the
introductory section. Unlike 2,3 diphosphoglycerate, red cell ATP is
present in lower concentration (approximately one fourth that of
2,3 DPG). For reasons of simplicity the value of this compound was
also expressed as ^u mole/g Hb. Initial values in fresh blood as
measured in this study varied from 2.34 to 4-17^/u mole/g Hb which
agrees with those reported by Fortier et al 1969* Valeri and Hirsch
1969, and Valeri and Zaroulis (1972). Again these levels are
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decreased during storage at 4°C. However, contrary to 2,3 DPG,
the lower the pH the slower the rate of ATP reduction. Thus we
found that during storage in ACD at 4°C, the level of ATP was 90$
of that in fresh blood after three days, 70$ after nine days and 37$
at the end of two weeks.
Similarly to 2,3 DPG, the level of ATP in the frozen blood is
dependant on the age of the blood prior to freezing. Also an
additional loss might be expected during processing. This was
observed with both manual and automatic washings and sometimes was
high as 34$. The latter values might be produced by the higher
activity of the enzyme ATP-ase, which i3 stimulated by rapid rates of
freezing and thawing (Takehara and Rowe 1968). However, by lowering
the pH of th9 wash solutions or by immediate addition of ACD to the
red cells after processing, this high loss was substantially reduced,
this point will be fully discussed later in the post-thaw stability
section.
4. Glycerol and Sorbitol Content in the frozen blood
Glycerol appears to be nontoxic when transfused to recipients,
as it is an intermediate product of metabolism, and it has been shown
that human subjects can tolerate the injection of 50 grams of glycerol
contained in one litre of solution (Sloviter et al 1957). However,
the transfusion of erythrocytes that contain a high concentration of
glycerol renders them osmotically unbalanced and results in their
haemolysis. It is for this reason that various methods of washing
have been proposed. Since some glycerol is compatible with red cell
survival it is not necessary to remove all the glycerol added. An
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arbitrary limit of 1 g% was empirically introduced as the highest
permissible level to be transfused with the red cells (Valeri et al
1969). The amount of the residual glycerol has often been thought
to reflect the efficiency of the washing procedure. With the manual
method of processing the residual glycerol in the supernatant varied
from O.48 to 1.26g/lOO ml with a mean of O.84 - 0.26g/l00 ml.
Whereas the amount of glycerol remaining after washing the blood in
the IBM 2991 ranged from 0.03 to 0.8l6g/l00 ml supernatant, with a
mean of 0.19 - 0.22g/l00 ml. This difference was statistically
significant (Table 3.14) and thus establishes an advantage of the
IBM 2991 over manual batch washing.
As regards the sorbitol, although it does not penetrate the cell
membrane and hence it represents no problem as far as the red cell is
concerned, because of its low molecular weight, it is osmotically
active. Thus if present in sufficient concentration it may cause an
increase in the recipient's plasma osmotic pressure with its side
effects (?ert et al 1964). Therefore, the sorbitol added to the
blood, with the glycerolizing solution or as the first wash, has to
be removed or reduced to a minimum before transfusion. Here again,
we found that the IBM 2991 was superior to the manual technique in
removing the sorbitol from the blood. Thus, whilst red cell3
processed manually have a residual supernatant sorbitol ranging from
0.22 to 1.59g/lOO ml, with a mean of 0.76g/l00 ml those processed in
the IBM 2991 have residual sorbitol concentrations ranging from 0.12
to 0.756g/l00 ml and a mean of 0.29g/l00 ml.
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5. Aluminium content in the frozen blood
In 1970 Berlyne et al reported the incidence of hyperaluminaemia
in three out of six patients with renal failure who were exposed to
dialysate with relatively high aluminium content. Although the
consequences of high serum aluminium was not known, the authors
recommended avoiding administration of drugs containing the metal in
cases of renal failure. In 1971> Waldron - Edward et al studies
the effect of hyperaluminaemia on human metabolism. They reported
that hyperaluminaemia has an adverse effect on activity of some of
the physiological enzymes. This was evidenced by the decreased level
of serum intestinal alkaline phosphatase, acid phosphatase and
adenosine triphosphate among people with high serum aluminium. They
also found a significant increase in the prothrombin time in these
individuals.
For these reasons and because of the possibility of leaching out
of aluminium into the blood, we decided to study the aluminium content
in the final red cell preparation. Aluminium measurement was
performed by Atomic Absorption Spectroscopy at the Laboratory Govern¬
ment Chemist. Levels of aluminium in normal blood as determined by
this method varies from 7 to ll^u mol/l (Berlyne et al 1970 and
Waldron-Edward et al 1971 )• Earlier results showed some very high
levels, however we have been asked to ignore them as the technique
used was not very accurate. Later, some improvements were introduced
to the method and since then the results have rarely exceeded
llyU mol/l. It is evident that the levels of aluminium present in
frozen blood are in the same range as those observed in vivo and thus
there is no possible risk from using aluminium cans.
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Post-Thaw Stability
After several years of comparative experience we have adopted
the IBM 2991 Cell Washing Machine because it suits our ultimate method
of issuing frozen blood in addition to its advantages in efficiency
of washing and automatic operation. It is our experience that if
patients are to receive frozen blood whenever necessary, the
processing delay, especially at night, must be eliminated. Therefore
we decided to operate a small bank of previously frozen-thawed-washed
cells which had been "speculatively" thawed (six "0" positive and three
"0" negative). As existing limitations of storage suggested that
haemolysis was the major limiting factor in the shelf-life, we began
an intensive study to optimise resuspension fluid and thus prolong the
shelf-life considerably. However, such a biochemical improvement
would be negated if the bacteriological status of the product was
unsatisfactory. Therefore we had to show that both conditions could
be satisfied simultaneously.
Despite all the advantages provided by the frozen blood it remains
expensive and limited in application, unless considerable losses are
accepted, because the shelf-life of the red cells once thawed and
washed is restricted to less than 24 hours (Blagdon 1972). This
restriction was based upon the instability of processed cells stored
at 4°C, manifested by spontaneous haemolysis, and the potential risk
of baoterial contamination occurring during open processing. The
short shelf-life of frozen thawed blood is a serious disadvantage to
its wide spread application.
Spontaneous haemolysis in physiological media is a common feature
of all frozen-processed erythrocytes irrespective of the method used
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for its preparation (Doebbler and Rinfret 1959) and is demonstrated
by the high and rapidly increasing levels of haemoglobin and extra¬
cellular potassium in the supernatant. However, the rate of this
haemolysis varies from one resuspension medium to another. Thus, the
level of supernatant haemoglobin was found to be lower with ACD-plasma,
as resuspension medium than that with 51° albumin (Tullis et al 195®
and Valeri 1965c).
However, neither the plasma nor the albumin would fulfil the
requirements of an ideal resuspension medium to be used with the
frozen blood. In the first place, the observed supernatant haemo¬
globin was high on the day of deglycerolization (up to 1750 mg per
unit with the plasma and to 2365 mg/unit with albumin) and increased
further on storage to 3150 mg and 6130 mg per unit respectively.
Secondly, resuspension in plasma would deprive the frozen blood of
many of its advantages namely the absence of transfusion hepatitis
(Haynes et al i960) and decreased incidence of urticarial and trans¬
fusion reactions which were due to the removal of immunoglobin3 and
other plasma proteins. Finally the use of plasma for resuspension
would certainly effect the protein fractionation programme and
compromise the component therapy programme.
Using 5$ albumin for resuspension of frozen-washed red cells,
despite the fact that it avoids some of the disadvantages observed
with plasma, can hardly be justified in terms of good blood bank
management, due to its high cost.
Extracellular free haemoglobin has always been a matter of great
concern as it was believed to represent one of the major difficulties
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encountered with frozen blood transfusion. It is known that some
of the frozen preserved cells might be irreversibly damaged so that
on transfusion they are immediately removed from the circulation.
If the removal of these cells is not accompanied by haemoglobinaemia,
then the determining factor of acceptability, as far as the free
haemoglobin is concerned, will be the level of the free haemoglobin
in the supernatant fluid. The physiologically acceptable levels of
free haemoglobin has not been accurately determined, it is believed
to be a matter of individual variability related to a number of
different factors. Of utmost importance, in this respect, is the
level of the haemoglobin-binding protein (haptoglobin) in the recipient
plasma. The normal level of this compound was found to be 1.068 -
O.259 g/l for males and 0.827 - 0.202 g/l for females (Mollison 1972).
Following infusion, the free haemoglobin will be bound by the
haptoglobin in the recipients circulation, until the latter is
saturated (l.Og haemoglobin per one litre plasma). This haemoglobin-
haptoglobin complex, due to its large molecular size, does not appear
in urine but it is slowly removed by the reticuloendothelial system,
predominantly by the liver. Free haemoglobin in excess of the
haemoglobin-binding capacity will circulate as such with the blood
until its level exceeds 25 mg/dl it starts to appear in urine (Mollison
1972). However, high levels of free haemoglobin in the supernatant
are not uniformally toxic, for levels as high as 1.5 gram of
haemoglobin and stromal protein per Kg body weight have been well
tolerated on administration into rabbits (Zwilling 1958). It is
probable that there is a great difference between the free haemoglobin
and stroma produced as a result of incompatible transfusion and those
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infused with the frozen transfused blood provided that the cells
from which they are derived are immunologically compatible. However,
although haemoglobinuria might be well tolerated by healthy individuals
as well as patients with normal blood pressure and normal blood volume,
it might, in seriously ill or shocked patients, precipitate acute renal
failure (Valeri 1970).
Another hazard produced as a result of the instability of the
frozen-thawed-washed erythrocytes on storage in physiological media
at 4°C is the rapid increase in the free extracellular potassium in
the supernatant fluid. This accumulated potassium is the result of
leakage from intact cells and liberation from haernolyzed erythrocytes.
A high level of extracellular potassium would deprive frozen-washed
red cells of another advantage, which is its suitability for massive
transfusion, and exchange transfusion in new-born infants. Further¬
more, a substantial decrease in the intracellular potassium is
corrolated with a decrease in the in vivo survival of the red cells
(Valeri and Runck 1969a).
Prolongation of the shelf-life of the previously frozen-thawed-
washed erythrocytes at 4°0 would thus be an important achievement
which would help in solving some of the difficulties encountered in
this aspect of blood transfusion.
During preliminary studies with the IBM 2991 Automatic Cell
Processor we realized that it offered the advantage that the end-
product might be less susceptible to bacterial contamination as the
number of "open" manipulations was significantly reduced. A planned
study was, thus, undertaken to examine the incidence of bacterial
331
contamination in 100 units after post-thaw processing and storage for
10 days at 4°C in saline-ACD medium. The results of this study
confirmed the earlier observations.
Units which showed contamination at zero day of processing came out
as negative on colony count test and on late repeated culture as well
as when cultured after 10 days of post-thaw storage. This might be
interpreted as follows:
a) The early contamination was slight and happened to be
picked up in the sample taken, and thus could not be
detected by the colony count test. A negative repeated
culture, in this case, would mean that the organism
detected has died due to the hostile environment.
b) A second explanation is that the blood was sterile but
contamination was introduced during the sampling process.
Out of the hundred units examined in this study only one unit showed
bacterial growth after ten days of post-thaw storage at +4°C. Although
the incidence of bacterial contamination was confirmed by repeated
cultures, the colony count test was negative which mean that the number
of the organism present was low, and inconsistent with contamination
having occurred ten days previously. An incidence of 1^ after 10
days of post-thaw storage at +4°C could be considered as a low rate
especially when compared with that of the fresh blood which is
variously reported to be from 1 to 3$ (Braude et al 1952, Walter et al
1957 and Parikh and Kulkarni I967X
It is very gratifying that the bacterial examination of unused,
thawed—washed blood which has been prepared for routine clinical use
and stored for 6-10 days has shown no contamination in over 5^0 units.
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We suspect that many if not all of the observed contaminant organisms
in the first trial of 100 units were introduced by the sampling
technique and therefore are artifacts.
Approximately one thousand units of frozen-thawed-washed blood
have been transfused after storage for one to five days without any
incidence of bacterial reaction.
In vitro instability of the frozen-thawed-washed erythrocytes,
when stored in physiological media at 4°C, probably results from the
effect of glycerolization, freezing, thawing and deglycerolization
which bring about a certain degree of damage to the red cells. When
the damage produced is severe, the cellular integrity is lost and the
cells are lysed during processing. A less intensive assault will
result in irreversible damage, but the cells will remain intact, and
on transfusion they are immediately removed from the circulation.
Still other cells might be reversibly affected by the processes of
glycerolization, freezing and washing as evidenced by the substantial
increase in their intracellular sodium and decrease in potassium ion
concentrations, however upon transfusion they are rapidly restored
to normal (Crawford and Mollison 195% Valeri and Hirsch 19^9) and
show a normal survival (Valeri 1971). The fact that the resuspension
media are unable to reverse the damage produced in the frozen-washed
cells would imply that these media either lack a substance which is
otherwise found in the circulating plasma or that a substance
essential for maintaining the viability of the cells, is rapidly
depleted on processing and post-thaw storage. The intravascular
environment probably provide suitable circumstances for the regener¬
ation of this vital substance or substances.
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In normal red cells, cation movement across the cell membrane is
mainly an active process that takes place against a concentration
gradient (pump) and in which sodium ions are driven outside the cell
in exchange for potassium. This process is energy-dependant, which
is provided by ATP (Hoffman 1966). The role of this sodium-potassium
pump may be to compensate for the changes that result from the
continuous passive leakage of these two ions into and out of the cell.
Since the cells that suffered from reversible damage as a result of
freezing, thawing and washing, show an increase in their intracellular
sodium and a reduction in the potassium concentrations then this would
suggest a dysfunction of the ATP - dependent cation transport. The
latter probably occurs due to a reduction in the intracellular ATP
content. Such a reduction has been previously reported to occur due
to the freeze-thaw processing (Hurn 1968) and is confirmed from our
results (Tables 3.10 and 3.1l). This would explain why these cells
are restored to normal upon transfusion, where a rapid regeneration
of the ATP will take place (Valeri and Hirsch 19^9) and hence a rapid
reduction in the intracellular sodium ion will follow (Portier et al
1969). On the other hand, if these cells are stored in vitro, under
unsuitable circumstances, the sodium will continue to penetrate the
cells, causing progressive swelling and ultimately lysis (Hurn 1968).
It is known that storage of blood, in the liquid state, at 4°C results
in progressive depletion of its ATP content (Bartlett and Barnet i960).
This is probably due to its breakdown to provide the energy necessary
for maintaining the active metabolism of the cell. Hydrolysis of
ATP is normally accomplished by an enzyme called adenosine
triphosphatase (ATP-ase) (Hurn 1968).
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Unlike liquid storage, a reduction in ATP in the frozen-washed
erythrocytes cannot be invoked as the basis of continued metabolism
during storage because metabolic activity is completely inhibited at
liquid nitrogen temperature. Therefore, this decrease must have
occurred during the processes of thawing and washing when ATP-ase
and metabolic activities are expected to be resumed. In fact an
abnormal activity of the former in frozen-thawed erythrocytes has been
observed by Rinfret in 1963, while Takehara and Rowe (1968) have
related the magnitude of the ATP-ase activity in these cells to the
rate of cooling used during freezing, the faster the cooling rate the
higher the activation.
We have observed that the addition of fO ml of ACD solution to
the previously frozen-thawed-washed erythrocytes resulted in a
substantial reduction in the rate of haemolysis of these cells on
storage at 4°C. This was evidenced by the decrease in the free
haemoglobin and potassium levels in the supernatant fluid, so that
the blood will remain transfusable even after nine days of post-thaw
storage. Earlier experiments have also shown that a solution of 5$
albumin in isotonic saline has advantages over isotonic saline alone,
as a resuspension medium, in reducing the rate of haemolysis during
post-wash storage (Tables 4«1, 4.2, 4.12, 4.17 and 4.18 and Pig. 4.1
and 4«3). When ACD and 5^ albumin were combined together in one
solution the beneficial effect was summated and the results were even
better than either medium alone. (Tables 4,5, 4.6, 4.7, 4-8, 4.12,
4.13, 4.21, 4.22, 4.23, 4.24 and Figure 4.l).
ACD might produce its effect through either, low pH (Maizles
1940) or citrate or because of its dextrose content. However, our
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results show that neither the CPD solution, which contains the same
molar concentration of citrate (Pig. 4.6), nor the low pH (Pig. 4.5)
gave the same effect as observed with the addition of ACD to the
resuspension medium. Also it is evident that glucose ha3 no effect
(Pig. 4«4a and 4-4b).
It was, thus, concluded that the beneficial effect of ACD in
maintaining the post-thaw stability is due to two factors combined
together, the low pH and citrate ions. When one of these factors
is used alone the effect is less marked. The relatively low pH
serves to maintain the ATP levels of the cells which is important in
the ATP - dependent cation transport mechanism through the cell
membrane which is, in turn, essential for prevention of red cell
swelling. The enzymatic activity of the ATP-ase is pH-dependent
with maximum activity occurring between pH 7.0 and 10.0 (Hurn 1968),
and it is possible that decreasing the pH diminished the breakdown of
ATP. Since, activation of ATP-ase i3 maximal after rapid freezing
and thawing (Takehara and Rowe 1968), this would explain the higher
recovery of intracellular ATP obtained with cells resuspended in
ACD-saline, than those resuspended in saline alone (Table 4.26).
This last table also shows that the recovered ATP levels after
freezing, thawing, washing and resuspensicn in ACD-saline at pH 6.2
were 89.5^ of the amount measured before freezing, while those of
erythrocytes similarly treated but resuspended in saline alone were
65.9$ (Fig- 3.1l). This would also explain the early beneficial
effect of ACD, even after four hours post-processing observed in all
experiments.
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Citrate is an anion which is incapable of penetrating the red
cell and thus, will stop the sodium ions from penetrating the cell
and hence help in preventing swelling and haemolysis.
Blood processed and reconstituted in this way has the following
characteristics:
A» Haematological characteristics
1. A total intact cellular haemoglobin of about 50 g which is
approximately 95$ of the total haemoglobin donated.
2. Red cell haematological parameters all within normal limits.
3. Intact white blood cell content about 5-6$ of the original
leucocyte content prior to freezing. Most of the leucocytes
recovered appeared to be of mononuclear origin and the majority
of them are distorted.
®* Biochemical characteristics
On the day of processing and reconstitution to 0.5 Hct the final
product has a supernatant free haemoglobin less than 0.2 g/unit and
extracellular potassium of about 0.5 m mol/l (Tables 4*5 and 4.7).
Whereas the intracellular potassium content of the recovered cells
12
averages 7.8 m mol/lO R.B.C. (Table 3.7)« As regards the organic
phosphate content, the recovered, reconstituted erythrocytes have
about 75$ of the pre-freeze value of 2,3 DPG and 90$ of the ATP.
Also, the pH of the blood is approximately 6.2.
When this blood is stored at 4°C for five days these levels are
expected to change so, that the supernatant haemoglobin would increase
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to about 1.0 g/unlt, supernatant K+ to 6.5 m mol/l whilst the levels
and
of the 2,3 DPG and ATP would decrease to 1.9,/l.lmol/g Hb
respectively (Table 7.1). However, of utmost importance is that the
blood is sterile during the whole period of storage.
C. In vivo survival
When the frozen-thawed-reconstituted red cells were transfused to
the original donor on the day of processing, the 24 hours post
transfusion *^Cr survival was 95$- Also, the life span of the
latter was normal (Table 5»2).
Furthermore, when the recovered-eella were stored at 4°C in
ACD-saline medium for five days and then transfused to the same donor,
CI
the 24-hour- post-transfusion Cr survival was 87$ and again the life
span was normal.
With these data in hand, we have started a frozen blood bank for
clinical use according to the following protocol:
1. Blood used for freezing should be less than four days old.
2. Only group "0" Rh positive and group "0" Rh negative blood
is frozen.
3. Frozen Blood should not be thawed before a minimum of period
of storage of six months (maximum incubation period of serum
hepatitis).
4. The thawed blood is processed automatically in the IBM 2991
Cell Processor. At the end of the last wash cycle 70 ml of
ACD solution together with the same volume of isotonic saline
are added to the washed cells and the mixture is thoroughly
mixed.
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5. We always keep a stock of nine units of frozen-washed
reconstituted red cells in saline-ACD medium ready to be
issued at any time and they are replaced after five days.
Thus, the emergency requirement for frozen blood is covered
day and night every day of the week.
In this way we have overcome the problem of the short shelf-life
of the processed blood and achieved a better management of the frozen
blood bank. At the same time the quality of the final product is
as good or even better than standard liquid stored blood of seven
days-old.
It might be argued that the low pH of that blood is a disadvantage,
first because, at this pH the 2,3 DPG content is not well maintained,
and second, the transfusion of such blood might be harmful. However,
it has to be remembered that ordinary blood collected in ACD and
stored at 4°C for three weeks has a pH as low as 6.4 or 6.5 (Bunker
1966). Such blood has been used successfully for many years and is
still in common use by many centres without untoward effects. This
might be due to the fact that the added acids in the blood are usually
buffered by the plasma bicarbonate and red cell haemoglobin before
transfusion, and thU3 does not represent the same danger caused by
transfusion of unbuffered acids. Transfusion of blood in which the
normal buffers have been diminished might result in lowering of the
recipient's blood pH as a result of dilution of his plasma bicarbonate.
However, it seems that the resultant acidosis is mild and very transient
and it is rapidly corrected by the addition of new bicarbonate
produced by the metabolism of citrate and lactate in the transfused
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blood (Bunker 1966). Since ACD contains large concentrations of
sodium, and because the bicarbonate is produced in large amounts,
such a transfusion may give a metabolic alkalosis. Bunker also
maintained that even when large volumes of blood are transfused
rapidly so that the recipient's plasma bicarbonates is diluted to half
its normal concentration, the blood pH of the patient would only fall
to 7*25 or 7.3, and this mild decrease would only last for a short
period. When we come to frozen blood, we found that despite the fact
that this blood is free of plasma, and thus it contains no bicarbonate,
it still has the high buffering capacity of 50 grams of haemoglobin.
In addition a dilution of the recipient's plasma bicarbonate, (providing
it is normal), to half its value would result only after the rapid
transfusion of six or eight units of frozen blood, such a condition
is hardly ever likely to be required in medical cases. Furthermore
if large volumes of frozen blood are to be transfused arrangements
could be made to resuspend this blood in isotonic saline alone and
transfuse the blood within 24 hours of processing.
As regards the 2,3 DFG, we know that this compound is important
in the role it plays in the transportation of oxygen. Thus, it is
known that the oxygen affinity of haemoglobin is rapidly increased
in the blood during its storage in ACD at 4°C (Valtis and Kennedy
1954)- This was found to be positively correlated with the observed
decrease in the red cell 2,3 DPG content (Benesch and Benesch 1967,
Chanutin and Curnish 1967) • Thus patients who receive large volumes
of blood stored in ACD for more than seven days are expected to have
an increase in the haemoglobin affinity for oxygen in their blood.
For this reason, it has been suggested that the latter blood is
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undesirable and that only blood with high levels of 2,3 DPG should be
transfused. Such a view, if adopted by many physicians would seriously
compromise blood bank management everywhere.
It seems likely that the importance of 2,3 DPG in transfusion has
been overstressed, for, although there is no doubt that the above
mentioned changes in the oxygen affinity of the recipient take place,
their pathological effects on diseased patients have not been defined.
On the other hand we know from the vast experience everywhere that
massive transfusion up to complete volume replacement with stored
blood does not compromise the delivery of oxygen to the tissues as
evidenced by the high rate of survival of those patients (Beutler et
al 1974). This is probably due to the fact that rapid restoration of
the depleted 2,3 DPG takes place immediately after transfusion (Valeri
and Hirsch 1969, Portier et al 1969).
Finally it has to be emphasized that the low pH of the frozen
blood resuspended in ACD-saline medium is important for maintaining
the ATP content of the red cells, which is in turn an important factor
in determining the in vivo erythrocyte survival. We believe that
this is more important than the 2,3 DPG level, because cells that are
capable of surviving after transfusion would have the opportunity to
resynthesize a normal content of 2,3 DPG.
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IN VIVO SURVIVAL OP FROZEN BLOOD
As mentioned in the introductory section estimation of the
post-transfusion survival of frozen-thawed red blood cells by the
radioactive chromium method was based on the assumption that
SI
labelling of the cells by Cr is not affected by the various processes
involved in the preparation of such cells. The reason for choosing
autologous transfusion studies have also been mentioned before; in
short, there are difficulties in estimating accurately the plasma
volume in diseased patients and eliminating immunological factors
which might affect the in vivo survival. We preferred to transfuse
the whole unit of blood in order to simulate what really occurs in
practice. The 100% chromium activity, in our study, represents the
real zero time recovery. We preferred this method of calculation
rather than that of extrapolating backwards from the chromium count
at 30 minutes or one hour to obtain a hypothetical zero time count as
the latter method assumes that there is no rapid ncn-linear loss of
labelled but damaged cells of the type which we were trying to measure.
The addition of the radioactive chromium post-thaw offers the
advantage that excess radioactivity, if present, is washed out during
routine processing and thus no extra washing is required which might
produce unnecessary damage.
The mean 24-hour post-transfusion survival of erythrocytes that
were frozen-thawed and processed by manual batch washing on the day of
processing was 93.4^ of the transfused cells. Since the in vitro
recovery of those cells was about 92.5$» it is thus concluded that
approximately 86^ of the original cells used for freezing were still
viable in the recipient's circulation 24 hours after transfusion.
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Valeri and Runck (1969a) have used the term therapeutic effectiveness
to describe the latter percentage which was computed by multiplying
the in vitro recovery (%) by the 24-hour chromium survival ($).
Red blood cells frozen, stored, thawed and processed by the IBM
Automatic Cell Processor then transfused to the original donor on the
same day of processing had a mean 24-hour post-transfusion survival
of 95.2$. However, the latter was not statistically different from
that of the manually processed erythrocytes.
Similarly the therapeutic effectiveness of the automatic method
of processing was computed and found to be approximately 90$- When
the survival of these cells was followed for four successive weeks,
1 51
it was found that they have a normal T5 Cr which indicates a normal
long-term survival. This confirms the observation of Jones et al
(1957) and Valeri and Runck (1969a) that red cells surviving the
first 24-hours after transfusion would continue for a normal life
span when transfused to the original donor who was a healthy
individual.
The observation that frozen-processed-chromium labelled red cells
have a normal T^ "^Cr suggested that the chromium elution from these
cells was not affected by the various processes involved in their
preparation.
Since saline-ACD was the medium of choice recommended for
reconstitution and post.-t.haw storage of the frozen-thawed deglycerol-
ized red cells, it was necessary to study the in vivo survival of
erythrocytes resuspended and stored for five days in such medium.
The survival of these cells was measured in ten cases of auto-
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transfusion utilizing the ^Cr - 12^I technique. The mean 24-hour
post-transfusion survival was 87$ - 5-7 which indicates a therapeutic
effectiveness of this method of preservation of about 82%. Also the
51Th Cr was determined in five of those cases and was found to be
about 23 days which indicates a normal survival.
Following transfusion, the recipients' plasma haemoglobin rises
to levels that depend on the amount of supernatant, haemoglobin and
the percentage of non viable (irreversibly damaged) red cells in the
transfused blood as well as on the state of the reticuloendothelial
system, the level of the haptoglobin of the recipient and the rate
of transfusion. The highest level of haemoglobinaemia was observed
30 minutes following transfusion after which the recipients' plasma
haemoglobin delcined but was still higher than the pretransfusion
level even after 24-hours.
The pre-transfusion levels of the plasma haemoglobin in the cases
studied ranged from 0.002 g/l to 0.22 g/l with a mean of 0.05 - 0.05 g/l.
This value was higher than the values reported by Dacie & Lewis 1970.
This is most probably due to the artificially produced haemolysis
during blood sampling and separation of the plasma.
Units of frozen-saline resuspended blood that were transfused on
the same day of processing (Table 5*2) had a free supernatant
haemoglobin ranging from 0.263 g/unit to 2.387 g/unit with a mean
value of 1.33 g/unit. However, in two of these units (C.D. and J.D.C.)
the supernatant was separated from blood that was left in the giving
set after transfusion overnight at room temperature and thus the free
haemoglobin levels was higher than that transfused. This is also
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evident from the wide difference between the expected and observed
values of the recipient's plasma haemoglobin in these two cases when
compared with the others.
Units of frozen erythrocytes resuspended in saline-ACD for five
days and then transfused showed a supernatant free haemoglobin levels
ranging from 0.268 to 1.243 g/unit, with a mean of 0.750 g/unit on
the day of transfusion.
It was expected that the highest haemoglobin levels in the
recipient's plasma would occur at the 15 minute post-transfusion sample,
assuming that complete mixing would have occurred and that non viable
cells would have been removed within this time. However, the
observation that the plasma haemoglobin in the 15 minute sample was
lower than that expected suggests that clearance of the haemoglobin
was rapid and started immediately. The increase of the plasma
haemoglobin observed in the 30 minute sample, thus perhaps reflects
the destruction and removal of irreversibly damaged cells.
With exception of three cases (G.S., J.D.C. and K.A.A.) out of
14, there was no unexpected haemoglobinaemia after the transfusion of
either zero or five day stored blood. Even in these three except¬
ions, the differences between the expected and the observed levels
of plasma haemoglobin were not so great that they could possibly be
due to technical errors. Also in none of the cases was there an
increase in the recipient's plasma radioactivity over that observed
prior to transfusion.
The absence of overt haemoglobinuria together with the gradual
fall in the recipient's plasma haemoglobin level suggests that all
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the haemoglobin in the circulation was combined with the haptoglobin
and was efficiently cleared by the reticulo-endothelial system.
Because of the low content of the frozen blood leucocytes and
platelets, there might be some concern about the effect of trans¬
fusion of large volumes of such blood on the levels of these cells
in the recipient circulation. In this study although only one unit
of blood was transfused at a time, the results show that even after
auto-transfu3ion, a single unit of frozen blood can provoke a
reactionary leucocytosis and thrombocytosis. This observation has
also been reported by Haynes et al (1962) and Murray et al (196?).
The leucocytosis started immediately after the transfusion and reached
a maximum after 30 minutes, whereas the thrombocytosis was observed up
to 24 hours later. Differential counts in the recipient's white
blood cells showed that the increase in leucocytes was mainly due to
neutrophil leucocytosis.
LSUCOCYTS CONTENT OF THB FROZEN BLOOD
Having satisfied ourselves that blood could be produced with,
a shelf-life of up to five days and with a satisfactory biochemical
and bacteriological status, post-thaw, we investigated a further
area where little data has been published. One of the major
advantages of frozen blood is its documented reduction in cases of
febrile transfusion reactions involving leucocyte antibodies.
However, practically nothing is known about the residual leucocyte
material which might be transfused. We have, therefore, investigated
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this problem in several different ways.
In the preliminary studies leucocyte counts were performed both
electronically using a Coulter Counter Model S and microscopically in
a haemocytometer using the method of Dacie and Lewis (1970). Counts
from both methods were found to be comparable. Sometimes the
electronic counts were higher than the visual ones, this is possibly
because some other cell fragments were counted as intact white ceils.
However, because the electronic method of leucocyte counting is a
standard method for calculation of the white cell content in HL-A-poor
blood elsewhere (Halterman et al 1972, Helgeson et al 1973, Miller
et al 1973, Tenczar 1973, Halterman et al 1973, Perkins et al 1973,
Polesky et al 1973, Meryman and Hornblower 1973), it has been adopted
as the sole method throughout the rest of this work. The leucocyte
content of the blood was expressed as million per gram of haemoglobin.
We preferred this method of computing the actual number of white
cells present in the blood rather than calculations based on the blood
volume as the latter might be misleading. The processes of
glycerolization, freezing, thawing and washing appears to be
destructive to the white cells. Throughout this study we systemat¬
ically obtained a reduction in the white cell count, due to the above
mentioned processes, ranging from 93.7 to 95$ of the original white
cell content prior to freezing. Smears prepared from leucocytes
after separation of recovered cells with dextran or hydroxyethyl
»»
starch, stained with May-Grunwald - (Jiemsa's stain, revealed the
presence of only mononuclear cells, particularly lymphocytes.
However the majority of these cells appeared distorted. This implies
that white cells other than the lymphocytes are too delicate to
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stand the processes of glycerolization, rapid freezing, thawing and
washing. These results agree with those obtained by Meryman and
Hornblower (1973) who separated leucocytes from a unit of whole blood
and resuspended them in human plasma. After glycerolization,
freezing, thawing and washing in a continuous-flow system, only 6%
of the original leucocytes were recovered intact, 99^ of which were
lymphocytes. Our results also agree with those published recently
by Crowley and Valeri (1974) who, though claiming a higher percentage
of polymorphnuclear cell recovery, have also observed a preferential
removal of polymorphnuclear leucocytes by the process of glycerol¬
ization, freezing, thawing and washing.
Although a frozen red cell suspension containing 5% of the normal
level of white cells might be considered as a satisfactory leucocyte-
poor preparation, the mechanism of removal of these cells was not
known and this threw some doubt on the acceptability of this blood
as an ideal preparation, because the blood might still contain some
HL-A Antigen in the form of leucocyte and platelet debris. Crowley
and Valeri (1974) suggested that the process of glycerolization
damages the white cells and that these damaged cells agglomerate into
clot like masses which are removed during the washing procedure. On
the other hand Meryman and Hornblower (1973) suggested that removal
of the white cells is not the result of washing them out of the red
cell suspension, but due to their aggregation into mucous-like masses
that stick to the wall of the processing chamber in all washing
systems. Despite this controversy, the implication is the same,
namely the blood will contain only a fraction of its original
leucocytes in the form of intact cells whilst the damaged cells are
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aggregated and either removed in the wash solution or adhere to the
wall of the processing bag.
Experiments with labelled leucocytes however, have clearly shown
that blood frozen by the low glycerol-rapid-freezing technique,
thawed and washed in the IBM 2991 Automatic Cell Processor, though
containing only 5-6$ of intact white cells, still has a high level
of input material in the form of leucocyte debris. However this
debris could be reduced on transfusion by passing the blood through
a Swank-Transfusion Filter. A more effective method of removing the
leucocyte debris from the processed blood, however, was to remove the
buffy coat automatically after each wash step. It is unfortunate,
however, that the latter technique, though most effective, results
in the loss of a further 20$ of the red cells.
Experiments with labelled lymphocytes showed that only about
one third of the labelled material was washed out of the red cell
suspension by the wash solutions. Approximately 25$ remained in the
processing bag in the form of gelatinous masses sticking to the wall
of the bag. The demonstration that as much as 40$ of the labelled
material was remaining in the final red cell suspension was most
surprising. Since the normal leucocyte recovery in our product, as
determined by the conventional methods was 5-6$ of intact cells, then
the major part of this material was in the form cellular debris.
A significant amount of this debris could be removed by either
filtration through a Swank-Transfusion Filter or by removing the buffy
coat at the last wash step. In the latter case the reduction was
obviously (Table 6.1b) due to an increase in the amount of debris
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removed by the wash solutions, for the amount of radioactivity
remaining in the bag was almost the same as that in Table 6.1a .
Maximum removal of the leucocyte derived material was achieved
by removing the buffy coat after each wash step, however this was
at the expense of losing a higher percentage of red cells. In this
case the majority of the leucocyte material was washed out in the
waste and a minimum amount remained in the processing bag. This
suggests that, if the leucocyte debris are given sufficient time in
contact with each other some of them will coalesce into gelatinous
masses and settle to the bottom where they stick to the wall of the
bag (Table 6.1a and 6.1b) otherwise they remain separate on the
surface and liable to be removed as a buffy coat.
What applies for the lymphocytes applies also to the granulocytes
in this respect. However, as regards the platelets only 2^ of the
labelled material remained in the final product, while the rest was
removed with the wash solutions. The amount of platelets remaining
seems to be highly dispersed in the blood as very fine particles
as they could not be removed with either filtration or by the
technique of buffy coat removal.
When the viability of the remaining cells was tested with the
dye exclusion test, none of the cells examined appeared viable.
However when these cells were stimulated by PHA in a tissue culture
media, some of them showed a weak response. When the viability in
the latter condition was expressed as the activity of tritiated
thymidine incorporated by one million lymphocytes and the results
were compared to that of lymphocytes from the same blood prior to
freezing we found that the ratio was 12>%. However, it has to be
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noted that in order to separate the number of lymphocytes which are
sufficient to set up one test we had to use a whole unit of frozen
blood, whilst in case of the fresh blood 20 ml would fulfil the
requirements. Taking these two figures together would indicate
that the ability to respond to PHA is reduced 200 fold in frozen
blood compared to fresh blood.
The conflict between both results of assaying the viability
of the separated frozen lymphocytes can probably only be explained
on the basis of the sensitivity of each test.
The finding that some lymphocytes separated from frozen blood
are viable is not surprising, both Meryman and Hornblower (1973)
and Crowley and Valeri (1974) have also reported the presence of
viable lymphocytes in their preparations.
However, although frozen blood contains some of the HL-A
antigen containing material in the form of intact lymphocytes and
fragments, and although a few of these cells are viable, yet they
are not antigenic to homologous lymphocytes when incubated with them
in the one way mixed lymphocyte culture.
This is probably due to some changes occurring in the cell
membrane, and which might have led to loss of the antigen sites,
as a result of the various processes involved in preparation of the
blood. Such changes are known to occur after freezing and thawing
Meryman and Hornblower (1973).
3*51
However, such speculation does not agree with the results
of testing the antigenicity of frozen blood in laboratory animals.
In vivo assessment of antigenicity in rabbits showed that
frozen blood does contain some human antigens in the form of
intact lymphocytes and cell fragments able to stimulate the pro¬
duction of lymphocyte antibodies. However, the amount of this
antigen seems to be lower than that present in the fresh blood.
Thus it might be possible that freezing and thawing produces
changes in the antigen sites of the lymphocytes to the extent that
these cells would not be recognised by third party human lympho¬
cytes in vitro, but could be identified by the intact immune
mechanism of the rabbit when injected in vivo. A significant
fraction of this antigen can be removed on transfusion by passing
the blood through Swank Transfusion Filters which probably removes
large and medium sized (4Cyu) leucocyte aggregates. Naturally,
what occurs in rabbits does not necessarily apply to human beings
and studies in man are required in order to confirm whether or not
frozen blood is antigenic and if so, what is the minimal dose of
antigen required to sensitize a recipient. A retrospective study
in one multiple transfused patient who experienced a non haemolytic
reaction with every transfusion of fresh blood, showed that frozen
non-filtered blood is antigenic and might cause a febrile non
haemolytic reaction if more than one unit of the blood transfused
shared a common leucocyte antigen to which the
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recipient was previously immunized (Pepper 1974 unpublished work).
In another recipient, who was apparently not immunized and
received only frozen blood, lymphocyte antibodies were detected in
his serum after multiple transfusion of frozen-non-filtered blood
(Pepper 1975 unpublished work).
It was, therefore, evident that frozen blood is immunogenic to
laboratory animals as well as to human beings. However, transfusion
of frozen blood processed in the way recommended in this study,
(with the buffy coat removed) was highly successful in prevention of
leucocyte - transfusion reaction and no incidence of such a reaction
was reported (apart from the above two cases) during the transfusion
of more than one thousand units. Whether or not this blood is
suitable for prospective transplantation candidates is not yet
settled. We know that frozen blood, is to date, the product v/ith
the lowest HL-A antigen content and therefore it is expected to be
the most suitable preparation for prospective transplant recipients.
On the other hand there is some recent speculation about the
necessity for some HL-A antigen in the transfused blood for a renal
transplant operation to fce successful (Opelz and Terasaki 1974).
The last named authors based their conclusions on retrospective
studies of the rate of one year renal graft survival in several
centres and concluded that a certain amount of antigen, capable of
producing immuno-tolerance but short of producing HL-A cytotoxic
antibodies is desirable in the blood to be transfused to those
patients before the transplant operations.
Whether or not this view i3 correct is a matter for speculation,
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and if correct will require a planned study to determine the amount
of antigen necessary for immunization of a non-sensitized recipient
as well sua the amount needed to produce tolerance.
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